phytoplasmas O
are O
insect B-physical_entity
vectored O
bacteria B-physical_entity
that O
cause B-abstraction
disease O
in O
a O
wide O
range B-abstraction
of O
plant B-abstraction
species B-abstraction
. O

the O
increasing O
availability B-abstraction
of O
molecular O
dna O
analyses O
, O
expertise O
and O
additional O
methods O
in O
recent O
years B-abstraction
has O
led O
to O
a O
proliferation B-physical_entity
of O
discoveries O
of O
phytoplasma O
plant B-abstraction
host B-physical_entity
associations O
and O
in O
the O
numbers B-abstraction
of O
taxonomic O
groupings O
for O
phytoplasmas O
. O

the O
widespread O
use B-physical_entity
of O
common B-physical_entity
names O
based O
on O
the O
diseases O
with O
which O
they O
are O
associated O
, O
as O
well B-physical_entity
as O
separate B-physical_entity
phenetic O
and O
taxonomic O
systems O
for O
classifying O
phytoplasmas O
based O
on O
variation B-physical_entity
at O
the O
16s O
rrna O
encoding B-abstraction
gene O
, O
complicates O
interpretation B-abstraction
of O
the O
literature B-abstraction
. O

we O
explore O
this O
issue B-physical_entity
and O
related O
trends O
through O
a O
focus B-abstraction
on O
australian O
pathosystems O
, O
providing O
the O
first B-physical_entity
comprehensive B-abstraction
compilation B-physical_entity
of O
information B-abstraction
for O
this O
continent B-physical_entity
, O
covering B-physical_entity
the O
phytoplasmas O
, O
host B-physical_entity
plants O
, O
vectors O
and O
diseases O
. O

of O
the O
33 O
16sr O
groups O
reported O
internationally O
, O
only O
groups O
i O
, O
ii O
, O
iii O
, O
x O
, O
xi O
and O
xii O
have B-physical_entity
been O
recorded O
in O
australia O
and O
this O
highlights O
the O
need B-abstraction
for O
ongoing O
biosecurity O
measures O
to O
prevent O
the O
introduction B-physical_entity
of O
additional O
pathogen B-physical_entity
groups O
. O

many O
of O
the O
phytoplasmas O
reported O
in O
australia O
have B-physical_entity
not O
been O
sufficiently O
well B-physical_entity
studied O
to O
assign O
them O
to O
16sr O
groups O
so O
it O
is O
likely O
that O
unrecognized O
groups O
and O
sub B-physical_entity
groups O
are O
present B-abstraction
. O

wide O
host B-physical_entity
plant B-physical_entity
ranges O
are O
apparent O
among O
well B-physical_entity
studied O
phytoplasmas O
, O
with O
multiple B-abstraction
crop B-abstraction
and O
non O
crop B-abstraction
species B-abstraction
infected O
by O
some O
. O

disease O
management B-abstraction
is O
further O
complicated O
by O
the O
fact B-abstraction
that O
putative O
vectors O
have B-physical_entity
been O
identified O
for O
few O
phytoplasmas O
, O
especially O
in O
australia O
. O

despite B-abstraction
rapid O
progress B-abstraction
in O
recent O
years B-abstraction
using B-abstraction
molecular O
approaches O
, O
phytoplasmas O
remain O
the O
least O
well B-physical_entity
studied O
group O
of O
plant B-abstraction
pathogens O
, O
making B-abstraction
them O
a O
" O
crouching O
tiger B-physical_entity
" O
disease O
threat B-abstraction
. O


background B-abstraction
alpha B-abstraction
bisabolol O
, O
also O
known O
as O
levomenol O
, O
is O
an O
unsaturated O
sesquiterpene O
alcohol O
that O
has O
mainly O
been O
used O
in O
pharmaceutical O
and O
cosmetic B-physical_entity
products O
due B-abstraction
to O
its O
anti B-physical_entity
inflammatory O
and O
skin B-physical_entity
soothing O
properties O
. O

alpha B-abstraction
bisabolol O
is O
currently O
manufactured O
mainly O
by O
steam O
distillation B-physical_entity
of O
the O
essential O
oils O
extracted O
from O
the O
brazilian O
candeia O
tree B-physical_entity
that O
is O
under O
threat B-physical_entity
because O
its O
natural B-physical_entity
habitat B-physical_entity
is O
constantly O
shrinking B-abstraction
. O

therefore O
, O
microbial O
production B-abstraction
of O
alpha B-abstraction
bisabolol O
plays O
a O
key B-physical_entity
role B-abstraction
in O
the O
development B-physical_entity
of O
its O
sustainable O
production B-abstraction
from O
renewable O
feedstock O
. O

results O
here B-physical_entity
, O
we O
created O
an O
escherichia B-physical_entity
coli O
strain B-abstraction
producing O
alpha B-abstraction
bisabolol O
at O
high B-abstraction
titer B-abstraction
and O
developed O
an O
in O
situ O
extraction B-abstraction
method B-abstraction
of O
alpha B-abstraction
bisabolol O
, O
using B-abstraction
natural B-abstraction
vegetable B-physical_entity
oils O
. O

we O
expressed O
a O
recently O
identified O
alpha B-abstraction
bisabolol O
synthase O
isolated O
from O
german O
chamomile B-physical_entity
matricaria O
recutita O
titer B-abstraction
3 O
mg O
l O
, O
converted O
the O
acetyl O
coa O
to O
mevalonate O
, O
using B-abstraction
the O
biosynthetic O
mevalonate O
pathway B-physical_entity
12 O
. O

8 O
mg O
l O
, O
and O
overexpressed O
farnesyl O
diphosphate O
synthase O
to O
efficiently O
supply B-physical_entity
the O
alpha B-abstraction
bisabolol O
precursor B-physical_entity
farnesyl O
diphosphate O
. O

combinatorial O
expression B-physical_entity
of O
the O
exogenous O
mevalonate O
pathway B-physical_entity
and O
farnesyl O
diphosphate O
synthase O
enabled O
a O
dramatic O
increase B-abstraction
in O
alpha B-abstraction
bisabolol O
production B-abstraction
in O
the O
shake B-abstraction
flask B-physical_entity
culture B-abstraction
80 O
mg O
l O
and O
5 O
l O
bioreactor O
culture B-abstraction
342 O
mg O
l O
of O
engineered O
e O
. O

coli O
harboring O
alpha B-abstraction
bisabolol O
synthase O
. O

fed O
batch O
fermentation B-physical_entity
using B-abstraction
a O
50 O
l O
fermenter O
was O
conducted O
after O
optimizing O
culture B-physical_entity
conditions O
, O
resulting O
in O
efficient O
alpha B-abstraction
bisabolol O
production B-physical_entity
with O
a O
titer B-abstraction
of O
9 O
. O

1 O
g O
l O
. O

moreover O
, O
a O
green B-physical_entity
, O
downstream O
extraction B-physical_entity
process B-physical_entity
using B-abstraction
vegetable B-physical_entity
oils O
was O
developed O
for O
in O
situ O
extraction B-abstraction
of O
alpha B-abstraction
bisabolol O
during O
fermentation B-physical_entity
and O
showed O
high B-physical_entity
yield B-abstraction
recovery B-physical_entity
98 O
. O

conclusions O
the O
engineered O
e O
. O

coli O
strains O
and O
economically O
viable O
extraction B-physical_entity
process B-physical_entity
developed O
in O
this O
study B-physical_entity
will B-abstraction
serve B-abstraction
as O
promising O
platforms O
for O
further O
development B-abstraction
of O
microbial O
production B-abstraction
of O
alpha B-abstraction
bisabolol O
at O
large B-abstraction
scale B-physical_entity
. O


a O
universal B-abstraction
feature B-abstraction
of O
the O
replication B-abstraction
of O
positive B-physical_entity
strand B-abstraction
rna O
viruses O
is O
the O
association B-physical_entity
with O
intracellular O
membranes O
. O

carnation B-abstraction
italian O
ringspot O
virus B-physical_entity
cirv O
replication B-physical_entity
in O
plants O
occurs O
in O
vesicles O
derived O
from O
the O
mitochondrial O
outer O
membrane B-physical_entity
. O

the O
product B-physical_entity
encoded O
by O
cirv O
orf1 O
, O
p36 O
, O
is O
required O
for O
targeting O
the O
virus B-physical_entity
replication B-physical_entity
complex B-physical_entity
to O
the O
outer O
mitochondrial O
membrane B-physical_entity
both O
in O
plant B-physical_entity
and O
yeast B-physical_entity
cells O
. O

here B-physical_entity
the O
yeast B-physical_entity
saccharomyces O
cerevisiae O
was O
used O
as O
a O
model B-abstraction
host B-physical_entity
to O
study B-abstraction
the O
effect B-abstraction
of O
cirv O
p36 O
on O
cell B-physical_entity
survival B-abstraction
and O
death B-abstraction
. O

it O
was O
shown O
that O
p36 O
does O
not O
promote O
cell B-physical_entity
death B-abstraction
, O
but O
decreases O
cell B-physical_entity
growth B-physical_entity
rate B-abstraction
. O

in O
addition B-physical_entity
, O
p36 O
changed O
the O
nature B-physical_entity
of O
acetic O
acid O
induced O
cell B-physical_entity
death B-abstraction
in O
yeast B-physical_entity
by O
increasing O
the O
number B-physical_entity
of O
cells O
dying O
by O
necrosis O
with O
concomitant B-abstraction
decrease B-abstraction
of O
the O
number B-physical_entity
of O
cells O
dying O
by O
programmed O
cell B-physical_entity
death B-abstraction
, O
as O
judged O
by O
measurements O
of O
phosphatidylserine O
externalization B-abstraction
. O

the O
tight O
association B-physical_entity
of O
p36 O
to O
membranes O
was O
not O
affected O
by O
acetic O
acid O
treatment B-abstraction
, O
thus O
confirming O
the O
peculiar O
and O
independent B-physical_entity
interaction B-abstraction
of O
cirv O
p36 O
with O
mitochondria O
in O
yeast B-physical_entity
. O

this O
work B-abstraction
proved O
yeast B-physical_entity
as O
an O
invaluable O
model B-physical_entity
organism B-physical_entity
to O
study B-physical_entity
both O
the O
mitochondrial O
determinants O
of O
the O
type B-abstraction
of O
cell B-physical_entity
death B-abstraction
in O
response B-physical_entity
to O
stress O
and O
the O
molecular O
pathogenesis B-physical_entity
of O
rna O
viruses O
. O

c O
2016 O
elsevier O
ireland O
ltd O
. O

all O
rights O
reserved O
. O


1 O
, O
2 O
dichloropropane O
1 O
, O
2 O
dcp O
and O
dichloromethane O
dcm O
are O
possible B-abstraction
causative O
agents O
associated O
with O
the O
development B-abstraction
of O
cholangiocarcinoma O
in O
employees O
working B-physical_entity
in O
printing B-abstraction
plant B-abstraction
in O
osaka O
, O
japan B-physical_entity
. O

however O
, O
few O
reports O
have B-physical_entity
demonstrated O
an O
association B-physical_entity
between O
these O
agents O
and O
cholangiocarcinoma O
in O
rodent B-physical_entity
carcinogenicity O
studies O
. O

moreover O
, O
the O
combined O
effects O
of O
these O
compounds O
have B-physical_entity
not O
been O
fully O
elucidated O
. O

in O
the O
present B-abstraction
study B-abstraction
, O
we O
evaluated O
the O
in O
vivo O
mutagenicity O
of O
1 O
, O
2 O
dcp O
and O
dcm O
, O
alone O
or O
combined O
, O
in O
the O
livers O
of O
gpt O
delta B-physical_entity
rats O
. O

six B-physical_entity
week B-abstraction
old B-abstraction
male B-physical_entity
f344 O
gpt O
delta B-physical_entity
rats O
were O
treated O
with O
1 O
, O
2 O
dcp O
, O
dcm O
or O
1 O
, O
2 O
dcp O
dcm O
by O
oral B-abstraction
administration B-abstraction
for O
4weeks O
at O
the O
dose O
200mgkg O
1 O
body B-physical_entity
weight I-physical_entity
1 O
, O
2 O
dcp O
and O
500mgkg O
1 O
body B-physical_entity
weight I-abstraction
dcm O
used O
in O
the O
carcinogenesis O
study B-physical_entity
performed O
by O
the O
national B-physical_entity
toxicology B-abstraction
program B-abstraction
. O

in O
vivo O
mutagenicity O
was O
analyzed O
by O
gpt O
mutation B-physical_entity
spi O
assays O
in O
the O
livers O
of O
rats O
. O

in O
addition B-abstraction
, O
gene O
and O
protein O
expression B-physical_entity
of O
cyp2e1 O
and O
gstt1 O
, O
the O
major B-abstraction
enzymes O
responsible O
for O
the O
genotoxic O
effects O
of O
1 O
, O
2 O
dcp O
and O
dcm O
, O
were O
analyzed O
by O
quantitative O
polymerase O
chain B-physical_entity
reaction I-physical_entity
and O
western O
blotting O
. O

gpt O
and O
spi O
mutation B-physical_entity
frequencies O
were O
not O
increased O
by O
1 O
, O
2 O
dcp O
and O
or O
dcm O
in O
any O
group O
. O

additionally O
, O
there B-physical_entity
were O
no B-abstraction
significant O
changes O
in O
the O
gene O
and O
protein O
expression B-abstraction
of O
cyp2e1 O
and O
gstt1 O
in O
any O
group O
. O

these O
results O
indicated O
that O
1 O
, O
2 O
dcp O
, O
dcm O
and O
1 O
, O
2 O
dcp O
dcm O
had O
no B-abstraction
significant O
impact B-abstraction
on O
mutagenicity O
in O
the O
livers O
of O
gpt O
delta B-physical_entity
rats O
under O
our O
experimental O
conditions O
. O

copyright B-abstraction
c O
2016 O
john B-physical_entity
wiley O
sons O
, O
ltd O
. O


this O
paper B-physical_entity
presents O
the O
simulation B-physical_entity
results O
of O
a O
linear O
, O
fully O
integrated O
, O
two O
stage B-abstraction
digitally O
programmable O
130 O
nm O
cmos O
power B-abstraction
amplifier B-physical_entity
pa B-physical_entity
operating O
at O
2 O
. O

4 O
ghz O
. O

its O
power B-physical_entity
stage B-physical_entity
is O
composed O
of O
a O
set B-abstraction
of O
amplifying O
cells O
which O
can B-physical_entity
be O
enabled O
or O
disabled O
independently O
by O
a O
digital O
control B-physical_entity
circuit I-physical_entity
. O

all O
seven O
operational O
modes O
are O
univocal O
in O
terms O
of O
1 O
db O
output B-abstraction
compression B-abstraction
point B-physical_entity
ocp1db O
, O
saturated O
output B-abstraction
power B-abstraction
p O
sat O
and O
power B-physical_entity
gain B-abstraction
at O
2 O
. O

4 O
ghz O
. O

the O
lowest O
power B-physical_entity
mode B-abstraction
achieves O
an O
8 O
. O

1 O
dbm O
p O
sat O
, O
a O
13 O
. O

5 O
db O
power B-physical_entity
gain B-abstraction
and O
consumes O
171 O
mw O
dc O
power B-abstraction
p O
dc O
at O
an O
ocp1db O
of O
6 O
dbm O
, O
whereas O
the O
highest O
power B-physical_entity
mode B-abstraction
reaches O
an O
18 O
. O

9 O
dbm O
p O
sat O
and O
a O
21 O
. O

1 O
db O
power B-physical_entity
gain B-abstraction
and O
consumes O
415 O
mw O
p O
dc O
at O
an O
ocp1db O
of O
18 O
. O

2 O
dbm O
. O


the O
glycogen O
branching B-abstraction
enzyme O
ec O
2 O
. O

4 O
. O

1 O
. O

18 O
, O
which O
catalyses O
the O
formation B-physical_entity
of O
alpha B-abstraction
1 O
, O
6 O
glycosidic O
branch B-physical_entity
points O
in O
glycogen O
structure B-abstraction
, O
is O
often O
used O
to O
enhance O
the O
nutritional O
value B-abstraction
and O
quality B-abstraction
of O
food B-abstraction
and O
beverages O
. O

in O
order B-abstraction
to O
be O
applicable O
in O
industries O
, O
enzymes O
that O
are O
stable B-physical_entity
and O
active B-physical_entity
at O
high B-physical_entity
temperature I-abstraction
are O
much O
desired O
. O

using B-abstraction
genome O
mining B-abstraction
, O
the O
nucleotide O
sequence B-abstraction
of O
the O
branching B-abstraction
enzyme O
gene O
glgb O
was O
extracted O
from O
the O
geobacillus O
mahadia O
geo O
05 O
genome O
sequence B-abstraction
provided O
by O
the O
malaysia O
genome O
institute O
. O

the O
size B-abstraction
of O
the O
gene O
is O
2013 O
bp O
, O
and O
the O
theoretical O
molecular B-O
weight I-O
of O
the O
protein O
is O
78 B-physical_entity
. O

43 O
kda O
. O

the O
gene O
sequence B-physical_entity
was O
then O
used O
to O
predict O
the O
thermostability O
, O
function B-abstraction
and O
the O
three O
dimensional O
structure B-physical_entity
of O
the O
enzyme O
. O

the O
gene O
was O
cloned O
and O
overexpressed O
in O
e O
. O

coli O
to O
verify O
the O
predicted O
result B-abstraction
experimentally O
. O

the O
purified O
enzyme O
was O
used O
to O
study B-physical_entity
the O
effect B-abstraction
of O
temperature B-abstraction
and O
ph O
on O
enzyme O
activity B-abstraction
and O
stability B-abstraction
, O
and O
the O
inhibitory O
effect B-abstraction
by O
metal O
ion B-physical_entity
on O
enzyme O
activity B-abstraction
. O

this O
thermostable O
glycogen O
branching B-abstraction
enzyme O
was O
found O
to O
be O
most O
active B-physical_entity
at O
55 O
degrees O
c O
, O
and O
the O
half B-abstraction
life I-abstraction
at O
60 O
degrees O
c O
and O
70 O
degrees O
c O
was O
24 O
h O
and O
5 O
h O
, O
respectively O
. O

from O
this O
research B-abstraction
, O
a O
thermostable O
glycogen O
branching B-abstraction
enzyme O
was O
successfully O
isolated O
from O
geobacillus O
mahadia O
geo O
05 O
by O
genome O
mining B-abstraction
together O
with O
molecular B-O
biology I-O
technique B-abstraction
. O


the O
microbial O
populations O
in O
the O
activated O
sludge O
of O
two O
polish B-abstraction
wastewater O
treatment B-abstraction
plants O
wwtps O
were O
identified O
and O
quantified O
using B-abstraction
illumina O
sequencing O
of O
16s O
ribosomal O
rna O
amplicons O
over B-abstraction
a O
2 O
year B-abstraction
period B-abstraction
. O

their O
dynamics B-abstraction
over B-abstraction
time B-abstraction
were O
compared O
to O
danish O
wwtps O
data O
collected O
in O
previous O
studies O
by O
center B-abstraction
for O
microbial O
communities O
, O
aalborg O
university B-physical_entity
. O

the O
bacterial O
communities O
in O
polish B-abstraction
and O
danish O
wwtps O
were O
similar O
to O
each O
other O
, O
but O
the O
microbial O
diversity B-abstraction
in O
polish B-abstraction
wwtps O
was O
lower B-physical_entity
. O

the O
dominant O
genera O
in O
polish B-abstraction
wwtps O
were O
more O
abundant O
than O
in O
danish O
wwtps O
; O
30 O
of O
them O
constituted O
more O
than O
half B-abstraction
the O
of O
activated O
sludge O
community B-physical_entity
. O

polish B-abstraction
wwtps O
showed O
a O
higher O
abundance B-abstraction
of O
bacteria B-physical_entity
involved O
in O
nitrogen O
and O
chemical O
oxygen O
demand B-abstraction
removal B-abstraction
proteobacteria O
and O
bacteroidetes O
, O
while B-abstraction
polyphosphate O
acculumating O
bacteria B-physical_entity
were O
the O
dominant O
bacterial O
group O
in O
danish O
plants O
. O

the O
microbial O
community B-physical_entity
structures O
in O
the O
examined O
polish B-abstraction
wwtps O
were O
relatively O
similar O
to O
each O
other O
and O
showed O
strong O
seasonal B-physical_entity
variations O
which O
are O
not O
normally O
observed O
in O
danish O
wwtps O
. O


background B-abstraction
broad B-physical_entity
range B-physical_entity
16s O
rrna O
pcr O
can B-physical_entity
be O
used O
for O
the O
detection B-physical_entity
and O
identification B-abstraction
of O
bacteria B-physical_entity
from O
clinical O
specimens O
in O
patients O
for O
whom O
there B-physical_entity
is O
a O
high B-physical_entity
suspicion B-abstraction
of O
infection B-abstraction
and O
cultures O
are O
negative B-physical_entity
. O

the O
aims O
of O
this O
study B-abstraction
were O
1 O
to O
compare B-abstraction
16s O
rrna O
pcr O
results O
with O
microbiolog O
ical O
culture B-abstraction
results O
, O
2 O
to O
assess O
the O
utility B-physical_entity
of O
16s O
rrna O
pcr O
with O
regard B-abstraction
to O
antimicrobial O
therapy B-abstraction
, O
and O
3 O
to O
compare B-abstraction
the O
yield B-abstraction
of O
16s O
rrna O
pcr O
for O
different O
types O
of O
clinical O
specimen B-physical_entity
and O
to O
perform O
a O
cost B-abstraction
analysis I-abstraction
of O
the O
test B-physical_entity
. O

methods O
a O
retrospective O
study B-abstraction
was O
performed O
on O
different O
clinical O
specimens O
which O
had O
16s O
performed O
over B-abstraction
3 O
years B-abstraction
2012 O
2015 O
. O

standard B-physical_entity
microbiological O
cultures O
were O
performed O
on O
appropriate O
media O
, O
as O
per O
the O
laboratory B-physical_entity
protocol B-abstraction
. O

patient B-physical_entity
clinical O
and O
microbiological O
data O
were O
obtained O
from O
the O
electronic O
medical B-abstraction
records O
and O
laboratory B-physical_entity
information B-abstraction
system I-abstraction
, O
respectively O
. O

16s O
rrna O
pcr O
was O
performed O
in O
a O
reference B-abstraction
laboratory B-physical_entity
using B-abstraction
a O
validated O
method B-abstraction
for O
amplification B-abstraction
and O
sequencing O
. O

the O
outcomes O
assessed O
were O
the O
performance B-abstraction
of O
16s O
rrna O
pcr O
, O
change B-abstraction
of O
antimicrobials O
rationalization B-abstraction
, O
cessation B-abstraction
, O
or O
addition B-abstraction
, O
and O
duration B-abstraction
of O
therapy B-abstraction
. O

concordance B-abstraction
of O
16s O
rrna O
pcr O
with O
bacterial O
cultures O
was O
also O
determined O
for O
tissue O
specimens O
. O

results O
thirty O
two O
patients O
were O
included O
in O
the O
study B-abstraction
, O
for O
whom O
an O
equal B-physical_entity
number B-abstraction
of O
specimens O
n O
32 O
were O
sent O
for O
16s O
rrna O
pcr O
. O

16s O
rrna O
pcr O
could O
identify O
an O
organism B-physical_entity
in O
10 O
of O
32 O
cases O
31 O
. O

2 O
, O
of O
which O
seven O
were O
culture B-physical_entity
positive B-physical_entity
and O
three O
were O
culture B-abstraction
negative B-abstraction
. O

the O
sensitivity B-abstraction
was O
58 O
confidence O
interval B-abstraction
ci O
28 O
. O

59 O
83 O
. O

5 O
and O
specificity B-abstraction
was O
85 O
ci O
61 O
. O

13 O
96 O
, O
with O
a O
positive B-physical_entity
predictive O
value B-abstraction
of O
70 O
ci O
35 O
. O

3 O
91 O
. O

9 O
and O
negative B-abstraction
predictive O
value B-abstraction
of O
77 O
. O

2 O
ci O
54 O
. O

17 O
91 O
. O

3 O
. O

antimicrobial O
therapy B-abstraction
was O
rationalized O
after O
16s O
rrna O
pcr O
results O
in O
five B-physical_entity
patients O
15 O
. O

6 O
and O
was O
ceased O
in O
four B-physical_entity
based O
on O
negative B-abstraction
results O
12 O
. O

5 O
. O

overall B-physical_entity
the O
16s O
rrna O
pcr O
result B-abstraction
had O
an O
impact B-abstraction
on O
antimicrobial O
therapy B-abstraction
in O
28 O
of O
patients O
9 O
32 O
. O

the O
highest O
concordance B-abstraction
of O
16s O
rrna O
pcr O
with O
bacterial O
culture B-physical_entity
was O
found O
for O
heart B-abstraction
valve I-physical_entity
tissue O
80 O
, O
followed O
by O
joint B-physical_entity
fluid O
tissue O
50 O
. O

conclusions O
despite B-abstraction
the O
low B-abstraction
diagnostic O
yield B-abstraction
, O
results O
of O
16s O
rrna O
pcr O
can B-physical_entity
still B-abstraction
have B-physical_entity
a O
significant O
impact B-abstraction
on O
patient B-physical_entity
management B-abstraction
due B-abstraction
to O
rationalization B-abstraction
or O
cessation B-abstraction
of O
the O
antimicrobial O
therapy B-abstraction
. O

the O
yield B-abstraction
of O
16s O
rrna O
pcr O
was O
highest O
for O
heart B-physical_entity
valves O
. O

c O
2017 O
the O
author B-physical_entity
s B-abstraction
. O

published O
by O
elsevier O
ltd O
on O
behalf B-abstraction
of O
international O
society O
for O
infectious O
diseases O
. O


brinjal B-physical_entity
little O
leaf B-physical_entity
bll O
is O
a O
widespread O
disease O
of O
phytoplasma O
etiology B-abstraction
in O
india O
that O
induces O
severe O
economic O
losses O
. O

surveys O
were O
conducted O
in O
eight O
brinjalgrowing O
states O
of O
india O
during O
july O
2014 O
to O
september O
2015 O
and O
eighteen O
bll O
samples O
showing B-abstraction
little O
leaf B-physical_entity
, O
phyllody O
and O
witches' O
broom B-physical_entity
symptoms O
were O
collected O
for O
phytoplasma O
identification B-abstraction
. O

presence B-physical_entity
of O
phytoplasmas O
was O
confirmed O
in O
all O
the O
eighteen O
bll O
samples O
using B-abstraction
polymerase O
chain B-physical_entity
reaction I-physical_entity
with O
phytoplasma O
specific B-abstraction
primer B-physical_entity
pairs O
p1 O
p6 O
, O
r16f2n O
r16r2 O
. O

pair O
wise B-abstraction
sequence B-physical_entity
comparison B-abstraction
and O
phylogenetic O
relationship O
of O
16s O
rrna O
gene O
sequences O
of O
bll O
phytoplasma O
strains O
confirmed O
that O
sixteen O
out B-abstraction
of O
eighteen O
bll O
strains O
belonged O
to O
clover B-physical_entity
proliferation B-physical_entity
phytoplasma O
16srvi O
group O
and O
two O
bll O
strains O
gkp O
a O
and O
gkp O
b O
from O
gorakhpur O
, O
uttar O
pradesh O
, O
were O
classified O
under O
16srii O
group O
. O

further O
virtual O
rflp O
analysis B-abstraction
of O
16s O
rdna O
sequences O
allowed O
finer O
classification B-abstraction
of O
bll O
strains O
into O
16srii O
d O
and O
16srvi O
d O
subgroups O
. O

bll O
phytoplasma O
strains O
belonging O
to O
16srvi O
d O
subgroup O
were O
found O
as O
the O
most O
widespread O
phytoplasma O
strains O
associated O
with O
bll O
disease O
in O
india O
. O

16srvi O
d O
subgroup O
phytoplasma O
association B-physical_entity
with O
two O
symptomatic O
weed B-physical_entity
species B-abstraction
viz O
. O

cannabis B-physical_entity
sativa O
subsp O
. O

sativa O
at O
noida O
, O
uttar O
pradesh O
and O
portulaca B-physical_entity
oleracea O
at O
iari O
fields O
, O
new O
delhi O
was O
also O
confirmed O
by O
nested O
pcr O
assays O
with O
similar O
set B-physical_entity
of O
phytoplasma O
specific B-abstraction
primers O
, O
pairwise O
16s O
rdna O
sequence B-physical_entity
comparison B-abstraction
, O
phylogeny B-physical_entity
and O
virtual O
rflp O
analysis B-abstraction
. O

out B-abstraction
of O
five B-physical_entity
identified O
leafhopper B-physical_entity
species B-abstraction
from O
bll O
infected O
fields O
at O
noida O
, O
uttar O
pradesh O
and O
delhi O
, O
only O
hishimonas O
phycitis O
was O
identified O
as O
carrier B-physical_entity
and O
natural B-physical_entity
vector B-abstraction
of O
16srvi O
d O
subgroup O
of O
phytoplasmas O
by O
nested O
pcr O
assays O
, O
sequence B-physical_entity
comparison B-abstraction
, O
phylogeny B-physical_entity
, O
virtual O
rflp O
analysis B-abstraction
and O
transmission B-physical_entity
assays O
. O


surveys O
for O
the O
cote B-physical_entity
d'ivoire O
lethal O
yellowing O
cily O
phytoplasma O
were O
conducted O
in O
eight O
severely O
cily O
affected O
villages O
of O
grand B-physical_entity
lahou O
in O
2015 O
. O

leaves O
, O
inflorescences O
and O
trunk B-physical_entity
borings O
were O
collected O
from O
coconut B-physical_entity
palms O
showing B-abstraction
cily O
symptoms O
and O
from O
symptomless O
trees O
. O

total B-abstraction
dna O
was O
extracted O
from O
these O
samples O
and O
tested O
by O
nested O
polymerase O
chain B-physical_entity
reaction I-physical_entity
rflp O
and O
sequence B-physical_entity
analysis B-abstraction
of O
the O
16s O
rrna O
, O
ribosomal O
protein O
rp O
and O
the O
translocation B-physical_entity
protein O
seca O
genes O
. O

the O
cily O
phytoplasma O
was O
detected O
in O
82 O
. O

9 O
of O
the O
symptom B-abstraction
bearing B-physical_entity
palms O
collected O
from O
all O
the O
surveyed O
villages O
and O
from O
all O
the O
plant B-physical_entity
parts B-physical_entity
. O

trunk B-physical_entity
borings O
were O
recommended O
as O
the O
most O
suitable O
plant B-abstraction
tissue I-abstraction
type B-abstraction
for O
sampling B-abstraction
. O

results O
indicate O
that O
the O
cily O
phytoplasma O
may B-physical_entity
have B-physical_entity
a O
westward O
spread B-physical_entity
to O
other O
coconut B-physical_entity
growing B-physical_entity
areas O
of O
grand B-physical_entity
lahou O
. O

cily O
phytoplasma O
strains O
infecting O
coconut B-physical_entity
palms O
in O
the O
western O
region B-abstraction
of O
grand B-physical_entity
lahou O
exhibited O
unique O
single B-abstraction
nucleotide O
polymorphisms O
on O
the O
rp O
sequence B-abstraction
compared O
to O
the O
strains O
from O
the O
eastern O
region B-abstraction
. O

moreover O
, O
single B-abstraction
nucleotide O
polymorphisms O
on O
the O
seca O
sequence B-abstraction
distinguished O
the O
cily O
phytoplasma O
from O
the O
cape B-physical_entity
st O
. O

paul O
wilt B-abstraction
disease O
phytoplasma O
in O
ghana O
, O
and O
the O
lethal O
yellowing O
phytoplasma O
in O
mozambique O
. O


advances O
in O
sequencing O
technologies O
continue O
to O
provide O
unprecedented O
opportunities O
to O
characterize O
microbial O
communities O
. O

for O
example B-abstraction
, O
the O
pacific O
biosciences O
single B-abstraction
molecule O
real B-O
time I-O
smrt O
platform B-physical_entity
has O
emerged O
as O
a O
unique O
approach B-physical_entity
harnessing O
dna O
polymerase O
activity B-physical_entity
to O
sequence B-abstraction
template B-abstraction
molecules O
, O
enabling O
long O
reads O
at O
low B-abstraction
costs O
. O

with O
the O
aim B-abstraction
to O
simultaneously O
classify O
and O
enumerate O
in O
situ O
microbial O
populations O
, O
we O
developed O
a O
quantitative O
smrt O
qsmrt O
approach B-abstraction
that O
involves O
the O
addition B-physical_entity
of O
exogenous O
standards O
to O
quantify O
ribosomal O
amplicons O
derived O
from O
environmental O
samples O
. O

the O
v7 O
9 O
regions O
of O
18s O
ssu O
rdna O
were O
targeted O
and O
quantified O
from O
protistan B-physical_entity
community B-physical_entity
samples O
collected O
in O
the O
ross O
sea B-physical_entity
during O
the O
austral O
summer B-abstraction
of O
2011 O
. O

we O
used O
three O
standards O
of O
different O
length B-abstraction
and O
optimized O
conditions O
to O
obtain O
accurate O
quantitative O
retrieval B-abstraction
across O
the O
range B-physical_entity
of O
expected O
amplicon O
sizes O
, O
a O
necessary O
criterion B-abstraction
for O
analyzing O
taxonomically O
diverse O
18s O
rdna O
molecules O
from O
natural B-abstraction
environments O
. O

the O
ability B-abstraction
to O
concurrently O
identify O
and O
quantify O
microorganisms O
in O
their O
natural B-abstraction
environment B-physical_entity
makes O
qsmrt O
a O
powerful O
, O
rapid O
and O
cost B-abstraction
effective O
approach B-abstraction
for O
defining O
ecosystem O
diversity B-abstraction
and O
function B-abstraction
. O

c O
2017 O
elsevier O
b O
. O

v O
. O

all O
rights O
reserved O
. O


1a6 O
drim O
is O
a O
nucleolar O
protein O
with O
a O
nucleolar O
targeting O
sequence B-physical_entity
in O
its O
3' O
terminus B-physical_entity
. O

bioinformatic O
analysis B-abstraction
indicated O
that O
human B-physical_entity
1a6 O
drim O
shares O
23 O
identity B-abstraction
and O
43 O
similarity B-abstraction
with O
yeast B-physical_entity
utp20 O
, O
which O
has O
been O
reported O
as O
a O
component B-abstraction
of O
u3 O
snorna O
protein O
complex B-physical_entity
and O
has O
been O
implicated O
in O
18s O
rrna O
processing O
. O

in O
the O
present B-abstraction
study B-abstraction
, O
we O
found O
, O
by O
utilizing O
rt O
pcr O
with O
rna O
extracted O
from O
anti B-physical_entity
1a6 O
drim O
inummoprecipitates O
and O
northern O
blotting O
, O
that O
1a6 O
drim O
is O
associated O
with O
u3 O
snorna O
. O

pulse B-abstraction
chase B-physical_entity
labeling O
assays O
showed O
that O
silencing O
of O
1a6 O
drim O
expression B-physical_entity
in O
hela O
cells O
resulted O
in O
a O
delayed O
18s O
rrna O
processing O
. O

furthermore O
, O
immunoprecipitations O
revealed O
that O
1a6 O
drim O
was O
also O
associated O
with O
fibrillarin O
, O
another O
u3 O
rnp O
component B-abstraction
in O
hela O
cells O
. O

these O
results O
indicate O
that O
1a6 O
drim O
is O
involved O
in O
18s O
rrna O
processing O
and O
is O
the O
bona O
fide O
mammalian B-physical_entity
utp20 O
. O

c O
2007 O
elsevier O
b O
. O

v O
. O

all O
rights O
reserved O
. O


aims O
22q11 O
. O

2 O
deletion B-physical_entity
syndrome B-abstraction
22q11 O
. O

2ds O
is O
a O
neurogenetic O
condition B-abstraction
associated O
with O
an O
increased O
risk B-abstraction
of O
developing O
schizophrenia O
. O

previous O
studies O
have B-physical_entity
shown O
that O
negative B-physical_entity
symptoms O
represent O
the O
most O
specific B-abstraction
clinical O
characteristic B-abstraction
of O
psychosis O
in O
22q11 O
. O

2ds O
and O
are O
strongly O
associated O
with O
outcome B-abstraction
. O

however O
, O
the O
psychological O
mechanisms O
associated O
with O
these O
symptoms O
in O
this O
population B-abstraction
are O
poorly O
understood O
. O

in O
accordance B-abstraction
with O
recent O
conceptualizations O
in O
the O
field B-physical_entity
of O
schizophrenia O
, O
the O
present B-abstraction
study B-physical_entity
aims O
at O
investigating B-abstraction
whether O
negative B-abstraction
symptoms O
are O
associated O
with O
the O
presence B-abstraction
of O
negative B-abstraction
performance B-abstraction
beliefs O
and O
cognitive O
deficits O
. O

methods O
thirty O
five B-physical_entity
participants O
with O
22q11 O
. O

2ds O
and O
24 O
typically O
developing O
individuals O
aged O
between O
11 O
and O
24 O
years B-abstraction
were O
included O
in O
the O
study B-physical_entity
. O

self B-physical_entity
reported O
schizotypal O
symptoms O
cognitive O
perceptual O
, O
paranoid B-physical_entity
, O
negative B-physical_entity
and O
disorganization B-abstraction
symptoms O
and O
dysfunctional O
beliefs O
negative B-abstraction
performance B-abstraction
beliefs O
and O
need B-abstraction
for O
approval B-abstraction
were O
assessed O
. O

measures O
of O
processing O
speed B-abstraction
, O
verbal O
memory B-abstraction
, O
working B-physical_entity
memory I-physical_entity
, O
executive B-physical_entity
functioning O
and O
face B-abstraction
recognition I-abstraction
were O
also O
extracted O
from O
a O
broad B-physical_entity
cognitive O
evaluation B-abstraction
protocol B-abstraction
. O

results O
adolescents O
with O
22q11 O
. O

2ds O
reported O
significantly O
higher O
score B-abstraction
on O
the O
negative B-physical_entity
dimension B-abstraction
of O
the O
schizotypal O
personality B-physical_entity
questionnaire O
than O
controls O
, O
even B-abstraction
when O
controlling O
for O
the O
influence B-abstraction
of O
anxiety O
depression B-abstraction
and O
intellectual B-physical_entity
functioning O
. O

negative B-abstraction
and O
paranoid B-physical_entity
symptoms O
were O
associated O
with O
the O
severity B-abstraction
of O
negative B-physical_entity
performance B-abstraction
beliefs O
and O
lower B-physical_entity
face B-physical_entity
recognition I-abstraction
abilities O
. O

mediation B-abstraction
analyses O
revealed O
that O
negative B-physical_entity
performance B-abstraction
beliefs O
significantly O
mediated O
the O
association B-abstraction
between O
face B-physical_entity
recognition I-abstraction
and O
negative B-abstraction
paranoid B-physical_entity
symptoms O
. O

conclusions O
these O
findings O
suggest O
that O
negative B-physical_entity
performance B-abstraction
beliefs O
and O
basic B-physical_entity
social O
cognitive O
mechanisms O
are O
associated O
with O
negative B-physical_entity
and O
paranoid B-physical_entity
symptoms O
in O
individuals O
with O
22q11 O
. O

2ds O
. O

implications O
for O
intervention B-abstraction
are O
discussed O
in O
this O
article B-physical_entity
. O


background B-abstraction
chromosome B-physical_entity
22q11 O
. O

2 O
deletion B-abstraction
syndrome B-abstraction
22q11 O
. O

2ds O
is O
a O
neurogenetic O
disorder O
that O
is O
associated O
with O
a O
25 O
fold B-abstraction
increase B-abstraction
in O
schizophrenia O
. O

both O
individuals O
with O
22q11 O
. O

2ds O
and O
those O
with O
schizophrenia O
present B-abstraction
with O
social O
cognitive O
deficits O
, O
which O
are O
putatively O
subserved O
by O
a O
network B-physical_entity
of O
brain B-abstraction
regions O
that O
are O
involved O
in O
the O
processing O
of O
social O
cognitive O
information B-abstraction
. O

this O
study B-physical_entity
used O
two O
tensor B-abstraction
tractography O
to O
examine O
the O
white B-abstraction
matter B-abstraction
tracts O
believed O
to O
underlie O
the O
social O
brain B-abstraction
network B-physical_entity
in O
a O
group O
of O
57 O
young B-physical_entity
adults O
with O
22q11 O
. O

2ds O
compared O
to O
30 O
unaffected O
controls O
. O

results O
results O
indicated O
that O
relative B-physical_entity
to O
controls O
, O
participants O
with O
22q11 O
. O

2ds O
showed O
significant O
differences O
in O
several O
dti O
metrics B-abstraction
within O
the O
inferior B-physical_entity
fronto O
occipital O
fasciculus O
, O
cingulum O
bundle B-physical_entity
, O
thalamo O
frontal B-physical_entity
tract B-physical_entity
, O
and O
inferior B-physical_entity
longitudinal O
fasciculus O
. O

in O
addition B-physical_entity
, O
participants O
with O
22q11 O
. O

2ds O
showed O
significant O
differences O
in O
scores O
on O
measures O
of O
social O
cognition B-abstraction
, O
including O
the O
social O
responsiveness B-abstraction
scale B-physical_entity
and O
trait O
emotional O
intelligence B-abstraction
questionnaire O
. O

further O
analyses O
among O
individuals O
with O
22q11 O
. O

2ds O
demonstrated O
an O
association B-abstraction
between O
dti O
metrics B-abstraction
and O
positive B-physical_entity
and O
negative B-physical_entity
symptoms O
of O
psychosis O
, O
as O
well B-physical_entity
as O
differentiation B-abstraction
between O
individuals O
with O
22q11 O
. O

2ds O
and O
overt O
psychosis O
, O
relative B-physical_entity
to O
those O
with O
positive B-physical_entity
prodromal O
symptoms O
or O
no B-abstraction
psychosis O
. O

conclusions O
findings O
suggest O
that O
white B-physical_entity
matter B-abstraction
disruption B-abstraction
, O
specifically O
disrupted O
axonal O
coherence B-abstraction
in O
the O
right B-physical_entity
inferior B-physical_entity
fronto O
occipital O
fasciculus O
, O
may B-physical_entity
be O
a O
biomarker O
for O
social O
cognitive O
difficulties O
and O
psychosis O
in O
individuals O
with O
22q11 O
. O

2ds O
. O


through O
the O
comprehensive B-abstraction
analysis B-abstraction
of O
the O
genomic O
dna O
sequence B-abstraction
of O
human B-physical_entity
chromosome B-physical_entity
22 O
, O
we O
identified O
a O
novel B-physical_entity
gene O
of O
702 O
kb O
encoding B-abstraction
a O
big O
protein O
of O
2481 O
amino O
acid O
residues O
, O
and O
named O
it O
as O
tprbk O
tpr O
containing O
big O
gene O
cloned O
at O
keio O
. O

a O
novel B-physical_entity
protein O
tprbk O
possesses O
25 O
units O
of O
the O
tpr O
motif B-abstraction
, O
which O
has O
been O
known O
to O
associate B-abstraction
with O
a O
diverse O
range B-physical_entity
of O
biological O
functions O
. O

orthologous O
genes O
of O
human B-physical_entity
tprbk O
were O
found O
widely O
in O
animal B-physical_entity
species B-abstraction
, O
from O
insecta O
to O
mammal B-physical_entity
, O
but O
not O
found O
in O
plants O
, O
fungi O
and O
nematoda O
. O

northern O
blotting O
and O
rt O
pcr O
analyses O
revealed O
that O
tprbk O
gene O
is O
expressed O
ubiquitously O
in O
the O
human B-physical_entity
and O
mouse B-physical_entity
fetal O
tissues O
and O
various O
cell B-physical_entity
lines O
of O
human B-physical_entity
, O
monkey B-physical_entity
and O
mouse B-physical_entity
. O

lmmunofluorescent O
staining B-abstraction
of O
the O
synchronized O
monkey B-physical_entity
cos O
7 O
cells O
with O
several O
relevant O
antibodies O
indicated O
that O
tprbk O
changes O
its O
subcellular O
localization B-abstraction
during O
the O
cell B-physical_entity
cycle B-physical_entity
at O
interphase O
tprbk O
locates O
on O
the O
centrosomes O
, O
during O
mitosis B-physical_entity
it O
translocates O
from O
spindle B-physical_entity
poles O
to O
mitotic O
spindles O
then O
to O
spindle B-physical_entity
midzone O
, O
and O
through O
a O
period B-abstraction
of O
cytokinesis B-physical_entity
it O
stays B-physical_entity
on O
the O
midbody O
. O

co O
immunoprecipitation O
assay B-abstraction
and O
immunofluorescent O
staining B-abstraction
with O
adequate O
antibodies O
revealed O
that O
tprbk O
binds O
to O
aurora B-abstraction
b O
. O

and O
those O
proteins O
together O
translocate O
throughout O
mitosis B-physical_entity
and O
cytokinesis B-physical_entity
. O

treatments O
of O
cells O
with O
two O
drugs O
blebbistatin O
and O
y O
27632 O
, O
that O
are O
known O
to O
inhibit O
the O
contractility B-abstraction
of O
actin O
myosin O
, O
disturbed O
the O
proper O
intracellular O
localization B-abstraction
of O
tprbk O
. O

moreover O
, O
the O
knockdown B-abstraction
of O
tprbk O
expression B-physical_entity
by O
small B-abstraction
interfering O
rna O
sirna O
suppressed O
the O
bundling B-abstraction
of O
spindle B-physical_entity
midzone O
microtubules O
and O
disrupted O
the O
midbody O
formation B-abstraction
, O
arresting O
the O
cells O
at O
g O
2 O
m O
phase B-abstraction
. O

these O
observations O
indicated O
that O
a O
novel B-physical_entity
big O
protein O
tprbk O
is O
essential O
for O
the O
formation B-physical_entity
and O
integrity B-abstraction
of O
the O
midbody O
, O
hence O
we O
postulated O
that O
tprbk O
plays O
a O
critical O
role B-abstraction
in O
the O
progress B-abstraction
of O
mitosis B-physical_entity
and O
cytokinesis B-physical_entity
during O
mammalian B-physical_entity
cell B-physical_entity
cycle B-abstraction
. O

c O
2012 O
elsevier O
b O
. O

v O
. O

all O
rights O
reserved O
. O


graphene O
and O
other O
two O
dimensional O
materials O
have B-physical_entity
received O
considerable O
attention B-abstraction
regarding O
their O
potential O
applications O
in O
nano O
electronics B-abstraction
. O

here B-physical_entity
, O
we O
report B-abstraction
top B-abstraction
gate B-physical_entity
nonvolatile O
memory B-abstraction
field B-abstraction
effect B-abstraction
transistors O
fets O
with O
different O
layers O
of O
mose2 O
nanosheets O
channel B-physical_entity
gated O
by O
ferroelectric O
film B-abstraction
. O

the O
conventional O
gate B-physical_entity
dielectric O
of O
fets O
was O
replaced O
by O
a O
ferroelectric O
thin O
film B-physical_entity
that O
provides O
a O
ferroelectric O
polarization O
electric B-physical_entity
field B-abstraction
, O
and O
therefore O
defined O
as O
an O
fe O
fet O
where O
the O
poly O
vinylidene O
fluoride O
trifluoroethylene O
p O
vdf O
trfe O
was O
used O
as O
the O
gate B-physical_entity
dielectric O
. O

among O
the O
devices B-abstraction
with O
mose2 O
channels B-abstraction
of O
different O
thicknesses O
, O
the O
device B-physical_entity
with O
a O
single B-abstraction
layer B-abstraction
of O
mose2 O
exhibited O
a O
large B-abstraction
hysteresis O
of O
electronic O
transport B-physical_entity
with O
an O
over B-abstraction
10 O
5 O
write O
erase O
ratio O
, O
and O
displayed O
excellent O
retention B-abstraction
and O
endurance B-abstraction
performance B-abstraction
. O

the O
possible B-physical_entity
mechanism B-physical_entity
of O
the O
device's O
good B-abstraction
properties O
was O
qualitatively O
analyzed O
using B-abstraction
band B-physical_entity
theory B-abstraction
. O

additionally O
, O
a O
comprehensive B-abstraction
study B-physical_entity
comparing B-abstraction
the O
memory B-abstraction
properties O
of O
mose2 O
channels B-abstraction
of O
different O
thicknesses O
is O
presented O
. O

increasing O
the O
numbers B-abstraction
of O
mose2 O
layers O
was O
found O
to O
cause B-abstraction
a O
reduced O
memory B-physical_entity
window B-physical_entity
. O

however O
, O
mose2 O
thickness B-abstraction
of O
5 O
nm O
yielded O
a O
write O
erase O
ratio O
of O
more O
than O
10 O
3 O
. O

the O
results O
indicate O
that O
, O
based O
on O
a O
fe O
fet O
structure B-abstraction
, O
the O
combination B-abstraction
of O
two O
dimensional O
semiconductors O
and O
organic O
ferroelectric O
gate B-physical_entity
dielectrics O
shows O
good B-physical_entity
promise B-abstraction
for O
future B-physical_entity
applications O
in O
nonvolatile O
ferroelectric O
memory B-abstraction
. O


relationships O
between O
the O
abundance B-abstraction
of O
potential O
geosmin O
and O
2 O
methylisoborneol O
producing O
2 O
mib O
cyanobacteria B-physical_entity
and O
bacteria B-physical_entity
, O
and O
concentrations O
of O
the O
two O
taste B-abstraction
and O
odour B-abstraction
compounds O
t O
os O
were O
examined O
in O
a O
7 O
day B-abstraction
incubation B-physical_entity
of O
natural B-abstraction
water B-physical_entity
from O
the O
surface B-physical_entity
and O
bottom B-physical_entity
of O
three O
reservoirs O
in O
southeast B-physical_entity
queensland O
, O
australia O
. O

only O
a O
single B-abstraction
known O
t O
o O
producing O
cyanobacterium O
geitlerinema O
spp O
. O

was O
detected O
by O
microscopy B-abstraction
at O
low B-physical_entity
density I-abstraction
, O
and O
only O
in O
one B-abstraction
reservoir B-physical_entity
. O

densities O
of O
potential O
t O
o O
producing O
streptomyces B-physical_entity
determined O
by O
quantitative O
polymerase O
chain B-physical_entity
reaction I-physical_entity
qpcr O
assay B-abstraction
were O
highest O
in O
the O
bottom B-abstraction
water B-physical_entity
and O
varied O
from O
0 O
. O

7 O
x O
10 O
3 O
to O
775 O
x O
10 O
3 O
cells O
l O
1 O
. O

geosmin O
ranged O
from O
6 O
to O
59 O
ng O
l O
1 O
with O
the O
highest O
concentrations O
in O
the O
bottom B-abstraction
water B-physical_entity
, O
while B-abstraction
2 O
mib O
varied O
from O
6 O
to O
47 O
ng O
l O
1 O
with O
the O
highest O
concentration B-abstraction
in O
surface B-abstraction
water B-physical_entity
. O

concentrations O
of O
both O
compounds O
declined O
during O
the O
incubation B-abstraction
under O
both O
light B-abstraction
and O
dark B-abstraction
conditions O
. O

presence B-physical_entity
of O
the O
geosmin O
synthase O
gene O
, O
geoa O
, O
in O
cyanobacteria B-physical_entity
and O
streptomyces B-physical_entity
was O
examined O
by O
different O
pcr O
approaches O
. O

cloning B-abstraction
of O
pcr O
products O
from O
amplification B-abstraction
of O
geoa O
showed O
a O
high B-physical_entity
similarity B-abstraction
to O
geoa O
in O
cyanobacteria B-physical_entity
, O
but O
not O
to O
streptomycetes O
. O

our O
results O
demonstrate O
that O
more O
research B-abstraction
on O
the O
ecology B-abstraction
and O
molecular B-O
biology I-O
of O
t O
o O
producers O
is O
required O
to O
better B-physical_entity
understand O
the O
dynamics B-abstraction
of O
t O
os O
and O
to O
monitor B-physical_entity
emerging O
t O
o O
episodes O
. O


we O
have B-physical_entity
carried O
out B-abstraction
animal B-physical_entity
toxicity B-abstraction
tests O
of O
chemicals O
for O
a O
chemical O
safety B-physical_entity
program B-abstraction
implemented O
by O
the O
ministry B-physical_entity
of O
economy B-abstraction
, O
trade B-abstraction
, O
and O
industry B-abstraction
of O
japan B-physical_entity
. O

here B-physical_entity
, O
we O
tested O
1 O
tert O
butoxy O
4 O
chlorobenzene O
in O
a O
combined O
repeat B-abstraction
dose O
and O
developmental O
and O
reproductive O
toxicity B-abstraction
test B-abstraction
. O

the O
test B-abstraction
chemical O
was O
administered O
daily B-physical_entity
by O
gavage B-abstraction
to O
9 O
week B-abstraction
old B-abstraction
crl O
cd O
sd O
rats O
at O
doses O
of O
0 O
, O
20 O
, O
100 O
, O
and O
500 O
mg O
kg O
d O
. O

males O
were O
treated O
for O
42 O
d O
beginning B-physical_entity
14 O
d O
before O
mating B-physical_entity
. O

females O
were O
treated O
from O
14 O
d O
before O
mating B-physical_entity
to O
day B-abstraction
4 O
of O
lactation B-physical_entity
. O

decreased O
spontaneous O
locomotion B-abstraction
, O
decreased O
respiratory B-O
rate I-O
, O
and O
incomplete O
eyelid O
opening B-physical_entity
were O
observed O
at O
500 O
mg O
kg O
d O
both O
sexes O
, O
but O
resolved O
within O
30 O
min B-abstraction
of O
administration B-abstraction
, O
suggesting O
central B-physical_entity
nervous O
system B-physical_entity
depression B-physical_entity
. O

no B-abstraction
notable B-physical_entity
changes O
were O
observed O
in O
body B-abstraction
weight I-abstraction
, O
food B-abstraction
consumption B-abstraction
, O
functional O
battery B-abstraction
tests O
, O
or O
blood B-physical_entity
test I-physical_entity
. O

increased O
liver B-physical_entity
weight B-abstraction
with O
centrilobular O
or O
diffuse O
hepatocyte O
hypertrophy O
was O
observed O
at O
100 O
and O
500 O
mg O
kg O
d O
both O
sexes O
. O

there B-physical_entity
were O
no B-abstraction
biochemical O
or O
histopathological O
changes O
related O
to O
hepatotoxicity O
. O

increased O
kidney O
weight B-physical_entity
with O
basophilic O
tubules O
, O
tubule O
dilatation B-abstraction
, O
and O
increased O
hyaline O
droplets O
were O
observed O
in O
males O
dosed O
at O
100 O
and O
500 O
mg O
kg O
d O
. O

immunohistochemical O
staining B-abstraction
indicated O
alpha B-abstraction
2u O
globulin O
nephropathy O
, O
a O
male B-physical_entity
rat B-physical_entity
specific B-abstraction
toxicity B-abstraction
. O

although O
kidney O
weight B-physical_entity
was O
also O
increased O
in O
females O
dosed O
at O
500 O
mg O
kg O
d O
, O
it O
was O
not O
considered O
to O
be O
an O
adverse O
effect B-abstraction
because O
there B-physical_entity
were O
no B-abstraction
histopathological O
changes O
. O

pup B-physical_entity
weights O
on O
postnatal O
day B-abstraction
0 O
were O
decreased O
at O
500 O
mg O
kg O
d O
and O
still B-abstraction
decreased O
on O
postnatal O
day B-abstraction
4 O
. O

our O
data O
indicated O
the O
no B-abstraction
observed O
adverse O
effect B-abstraction
level B-abstraction
for O
repeated O
dose O
and O
reproductive O
developmental O
toxicity B-abstraction
for O
1 O
tert O
butoxy O
4 O
chlorobenzene O
was O
100 O
mg O
kg O
d O
. O


the O
mu O
opioid O
receptor O
mor O
plays O
a O
mandatory B-physical_entity
role B-abstraction
in O
the O
action B-abstraction
of O
most O
opioid O
drugs O
, O
such O
as O
morphine O
, O
fentanyl O
, O
and O
heroin O
. O

it O
has O
been O
revealed O
that O
a O
deficiency B-abstraction
in O
the O
mor O
gene O
oprm O
1 O
or O
a O
difference B-abstraction
in O
the O
3' O
noncoding O
region B-abstraction
of O
the O
gene O
markedly O
affects O
the O
sensitivity B-abstraction
of O
mice O
to O
opioids O
. O

as O
the O
3' O
noncoding O
region B-abstraction
of O
the O
human B-physical_entity
oprm1 O
gene O
had O
not O
yet O
been O
characterized O
, O
in O
the O
present B-abstraction
study B-abstraction
we O
conducted O
3' O
rapid O
amplification B-abstraction
of O
cdna O
ends O
3'race O
pcr O
and O
identified O
the O
3' O
end B-physical_entity
of O
the O
human B-physical_entity
mor O
1 O
mrna O
, O
the O
most O
abundant O
transcript O
among O
oprm1 O
gene O
transcripts O
. O

the O
poly O
a O
signal B-abstraction
was O
located O
at O
13612 O
13617 O
nucleotides O
downstream O
from O
the O
stop B-abstraction
codon O
in O
the O
oprm1 O
gene O
. O

reverse B-abstraction
transcription B-physical_entity
pcr O
analyses O
showed O
that O
the O
region B-abstraction
from O
the O
stop B-abstraction
codon O
to O
the O
poly O
a O
signal B-abstraction
was O
transcribed O
. O

in O
the O
3' O
utr O
, O
we O
identified O
33 O
au O
rich O
regions O
and O
more O
than O
300 O
putative O
transcription B-abstraction
factor B-abstraction
binding B-abstraction
sites O
. O

furthermore O
, O
we O
compared O
the O
3' O
noncoding O
regions O
of O
the O
human B-physical_entity
and O
mouse B-physical_entity
oprm1 O
oprm1 O
genes O
and O
found O
apparent O
homology B-abstraction
. O

in O
northern O
blotting O
with O
mouse B-physical_entity
brain B-physical_entity
mrnas O
, O
a O
same O
size B-abstraction
band B-physical_entity
was O
detected O
by O
a O
probe B-abstraction
for O
the O
mor O
1 O
coding B-abstraction
region B-physical_entity
and O
by O
a O
probe B-abstraction
for O
a O
mouse B-physical_entity
genome O
region B-abstraction
corresponding O
to O
the O
human B-physical_entity
mor O
1 O
3'utr O
. O

since O
3'utrs O
affect O
gene O
expression B-abstraction
, O
the O
present B-abstraction
characterization B-abstraction
of O
the O
3' O
noncoding O
region B-physical_entity
in O
the O
human B-physical_entity
oprm1 O
gene O
should O
lead B-physical_entity
to O
a O
better B-abstraction
understanding B-abstraction
of O
the O
mechanisms O
underlying O
oprm1 O
gene O
regulation B-abstraction
and O
individual B-physical_entity
differences O
in O
sensitivity B-abstraction
to O
opioids O
. O

published O
by O
elsevier O
b O
. O

v O
. O


an O
integrated O
electronic O
photonic O
phase B-abstraction
locked O
loop B-physical_entity
pll O
modulates O
the O
frequency O
of O
a O
tunable O
laser B-physical_entity
for O
use B-abstraction
in O
frequency O
modulated O
continuous O
wave B-physical_entity
fmcw O
lidar B-physical_entity
3d O
imaging B-abstraction
. O

the O
proposed O
lidar B-physical_entity
can B-physical_entity
perform O
180k O
range B-physical_entity
measurements O
per O
second B-physical_entity
. O

the O
rms O
depth B-abstraction
precision B-abstraction
is O
8 O
mu O
m O
at O
distances O
of O
5 O
cm O
from O
the O
range B-abstraction
baseline O
. O

the O
range B-physical_entity
window B-physical_entity
is O
1 O
. O

4 O
m O
, O
with O
a O
precision B-abstraction
of O
4 O
. O

2 O
mm O
at O
the O
edges O
of O
the O
window B-abstraction
. O

optical O
circuitry B-physical_entity
, O
including O
input B-abstraction
light B-abstraction
couplers O
, O
waveguides O
, O
and O
photodiodes O
, O
is O
realized O
on O
a O
3 O
mm O
x O
3 O
mm O
silicon O
photonic O
chip B-physical_entity
. O

the O
0 O
. O

18 O
mu O
m O
cmos O
asic O
of O
the O
same O
area B-physical_entity
comprises O
the O
frontend O
transimpedance O
amplifier B-physical_entity
, O
analog B-abstraction
electro O
optical O
pll O
, O
and O
digital O
control B-abstraction
circuitry B-physical_entity
consuming O
1 O
. O

7 O
ma B-physical_entity
from O
a O
1 O
. O

8 O
v O
supply B-physical_entity
and O
14 O
. O

1 O
ma B-physical_entity
from O
a O
5 O
v O
supply B-physical_entity
. O

the O
latter O
includes O
12 O
. O

5 O
ma B-physical_entity
bias B-abstraction
current B-abstraction
for O
the O
distributed O
bragg O
reflector B-physical_entity
section B-abstraction
of O
the O
tunable O
laser B-physical_entity
. O

the O
two O
chips O
are O
integrated O
using B-abstraction
through O
silicon O
vias O
implemented O
in O
the O
silicon O
photonic O
chip B-physical_entity
. O


3d O
printing B-abstraction
has O
shown O
promise B-abstraction
for O
neural O
regeneration B-physical_entity
by O
providing O
customized O
nerve O
scaffolds O
to O
structurally O
support B-physical_entity
and O
bridge B-abstraction
the O
defect B-abstraction
gap B-physical_entity
as O
well B-physical_entity
as O
deliver O
cells O
or O
various O
bioactive O
substances O
. O

low B-physical_entity
level B-physical_entity
light B-abstraction
therapy B-abstraction
lllt O
exhibits O
positive B-physical_entity
effects O
on O
rehabiliation O
of O
degenerative O
nerves O
and O
neural O
disorders O
. O

with O
this O
in O
mind B-abstraction
, O
we O
postulate O
that O
3d O
printed O
neural O
scaffold B-physical_entity
coupling B-physical_entity
with O
lllt O
will B-abstraction
generate O
a O
new O
strategy B-abstraction
to O
repair B-abstraction
neural O
degeneration B-abstraction
. O

to O
achieve O
this O
goal B-physical_entity
, O
we O
applied O
red B-physical_entity
laser B-physical_entity
light B-physical_entity
to O
stimualte O
neural O
stem B-abstraction
cells O
on O
3d O
printed O
scaffolds O
and O
investigated O
the O
subsequent O
cell B-physical_entity
response B-abstraction
with O
respect B-abstraction
to O
cell B-physical_entity
proliferation B-physical_entity
and O
differentiation B-physical_entity
. O

here B-physical_entity
we O
show B-abstraction
that O
cell B-physical_entity
prolifeartion O
rate B-abstraction
and O
intracellular O
reactive O
oxgen O
species B-abstraction
synthesis B-physical_entity
were O
significantly O
increased O
after O
15 O
s B-abstraction
laser B-physical_entity
stimulation B-abstraction
follwed O
by O
1 O
d O
culture B-abstraction
. O

over B-abstraction
culturing O
time B-abstraction
of O
14 O
d O
in O
vitro O
, O
the O
laser B-physical_entity
stimulation B-abstraction
promoted O
neuronal O
differentiation B-abstraction
of O
neural O
stem B-physical_entity
cells O
, O
while B-abstraction
the O
glial O
differentiation B-abstraction
was O
suppressed O
based O
on O
results O
of O
both O
immunocytochemistry O
studies O
and O
real B-O
time I-O
quantitative O
reverse B-abstraction
transcription B-physical_entity
polymerase O
chain B-physical_entity
reaction I-physical_entity
testing B-abstraction
. O

these O
findings O
suggest O
that O
integration B-abstraction
of O
3d O
printing B-abstraction
and O
lllt O
might B-abstraction
provide O
a O
powerful O
methodology B-abstraction
for O
neural O
tissue O
engineering B-physical_entity
. O


with O
the O
advances O
of O
stem B-physical_entity
cell I-abstraction
research B-abstraction
, O
development B-physical_entity
of O
intelligent O
biomaterials O
and O
three O
dimensional O
biofabrication O
strategies O
, O
highly O
mimicked O
tissue O
or O
organs O
can B-physical_entity
be O
engineered O
. O

among O
all O
the O
biofabrication O
approaches O
, O
bioprinting O
based O
on O
inkjet O
printing B-abstraction
technology B-abstraction
has O
the O
promises O
to O
deliver O
and O
create O
biomimicked O
tissue O
with O
high B-physical_entity
throughput B-physical_entity
, O
digital O
control B-physical_entity
, O
and O
the O
capacity B-abstraction
of O
single B-abstraction
cell B-physical_entity
manipulation B-abstraction
. O

therefore O
, O
this O
enabling O
technology B-abstraction
has O
great B-physical_entity
potential O
in O
regenerative O
medicine B-abstraction
and O
translational O
applications O
. O

the O
most O
current B-abstraction
advances O
in O
organ B-physical_entity
and O
tissue O
bioprinting O
based O
on O
the O
thermal O
inkjet O
printing B-physical_entity
technology B-abstraction
are O
described O
in O
this O
review B-physical_entity
, O
including O
vasculature O
, O
muscle B-abstraction
, O
cartilage O
, O
and O
bone B-abstraction
. O

in O
addition B-physical_entity
, O
the O
benign O
side B-physical_entity
effect I-physical_entity
of O
bioprinting O
to O
the O
printed O
mammalian B-physical_entity
cells O
can B-physical_entity
be O
utilized O
for O
gene O
or O
drug O
delivery B-abstraction
, O
which O
can B-physical_entity
be O
achieved O
conveniently O
during O
precise O
cell B-physical_entity
placement B-abstraction
for O
tissue O
construction B-physical_entity
. O

with O
layer B-physical_entity
by O
layer B-abstraction
assembly B-physical_entity
, O
three O
dimensional O
tissues O
with O
complex B-abstraction
structures O
can B-physical_entity
be O
printed O
using B-abstraction
converted O
medical B-abstraction
images O
. O

therefore O
, O
bioprinting O
based O
on O
thermal O
inkjet O
is O
so O
far O
the O
most O
optimal O
solution B-abstraction
to O
engineer B-physical_entity
vascular O
system B-physical_entity
to O
the O
thick B-physical_entity
and O
complex B-physical_entity
tissues O
. O

collectively O
, O
bioprinting O
has O
great B-physical_entity
potential O
and O
broad B-physical_entity
applications O
in O
tissue O
engineering B-physical_entity
and O
regenerative O
medicine B-abstraction
. O

the O
future B-physical_entity
advances O
of O
bioprinting O
include O
the O
integration B-abstraction
of O
different O
printing B-abstraction
mechanisms O
to O
engineer B-physical_entity
biphasic O
or O
triphasic O
tissues O
with O
optimized O
scaffolds O
and O
further O
understanding B-abstraction
of O
stem B-abstraction
cell I-physical_entity
biology B-abstraction
. O


3 O
mercaptopyruvate O
sulfurtransferase O
3 O
mst O
was O
a O
novel B-physical_entity
hydrogen O
sulfide O
h2s O
synthesizing O
enzyme O
that O
may B-physical_entity
be O
involved O
in O
cyanide O
degradation B-abstraction
and O
in O
thiosulfate O
biosynthesis B-physical_entity
. O

over B-abstraction
recent O
years B-abstraction
, O
considerable O
attention B-abstraction
has O
been O
focused O
on O
the O
biochemistry B-abstraction
and O
molecular B-O
biology I-O
of O
h2s O
synthesizing O
enzyme O
. O

in O
contrast B-abstraction
, O
there B-physical_entity
have B-physical_entity
been O
few O
concerted O
attempts O
to O
investigate O
the O
changes O
in O
the O
expression B-abstraction
of O
the O
h2s O
synthesizing O
enzymes O
with O
disease O
states O
. O

to O
investigate O
the O
changes O
of O
3 O
mst O
after O
traumatic O
brain B-abstraction
injury B-abstraction
tbi O
and O
its O
possible B-physical_entity
role B-abstraction
, O
mice O
tbi O
model B-physical_entity
was O
established O
by O
controlled O
cortical O
impact B-abstraction
system B-physical_entity
, O
and O
the O
expression B-abstraction
and O
cellular O
localization B-abstraction
of O
3 O
mst O
after O
tbi O
was O
investigated O
in O
the O
present B-abstraction
study B-physical_entity
. O

western O
blot B-abstraction
analysis B-abstraction
revealed O
that O
3 O
mst O
was O
present B-abstraction
in O
normal B-abstraction
mice O
brain B-abstraction
cortex B-physical_entity
. O

it O
gradually O
increased O
, O
reached O
a O
peak B-abstraction
on O
the O
first B-physical_entity
day B-abstraction
after O
tbi O
, O
and O
then O
reached O
a O
valley B-physical_entity
on O
the O
third B-abstraction
day B-abstraction
. O

importantly O
, O
3 O
mst O
was O
colocalized O
with O
neuron B-physical_entity
. O

in O
addition B-physical_entity
, O
western O
blot B-abstraction
detection B-physical_entity
showed O
that O
the O
first B-physical_entity
day B-abstraction
post B-physical_entity
injury B-abstraction
was O
also O
the O
autophagic O
peak B-physical_entity
indicated O
by O
the O
elevated O
expression B-abstraction
of O
lc3 O
. O

importantly O
, O
immunohistochemistry B-abstraction
analysis B-abstraction
revealed O
that O
injury B-abstraction
induced O
expression B-abstraction
of O
3 O
mst O
was O
partly O
colabeled O
by O
lc3 O
. O

however O
, O
there B-physical_entity
was O
no B-abstraction
colocalization O
of O
3 O
mst O
with O
propidium O
iodide O
cell B-physical_entity
death B-abstraction
marker B-physical_entity
and O
lc3 O
positive B-physical_entity
cells O
were O
partly O
colocalized O
with O
propidium O
iodide O
. O

these O
data O
suggested O
that O
3 O
mst O
was O
mainly O
located O
in O
living B-abstraction
neurons O
and O
may B-physical_entity
be O
implicated O
in O
the O
autophagy O
of O
neuron B-physical_entity
and O
involved O
in O
the O
pathophysiology O
of O
brain B-abstraction
after O
tbi O
. O


oxidative O
stress O
is O
closely O
involved O
in O
neurodegenerative O
diseases O
. O

the O
present B-abstraction
study B-physical_entity
aimed O
to O
examine O
the O
effect B-abstraction
of O
anti B-physical_entity
oxidant O
dhm O
dihydromyricetin O
on O
3np O
3 O
nitropropionic O
acid O
induced O
behavioral O
deficits O
of O
experimental O
rats O
and O
striatal O
histopathological O
injury B-abstraction
by O
using B-abstraction
behavioral O
, O
imaging B-abstraction
, O
biochemistry B-abstraction
, O
histochemistry O
and O
molecular B-O
biology I-O
technologies O
. O

the O
experimental O
results O
showed O
that O
both O
motor B-physical_entity
dysfunctions O
and O
learning B-abstraction
and O
memory B-physical_entity
impairments O
induced O
by O
3np O
were O
significantly O
reduced O
after O
dhm O
treatment B-abstraction
. O

3np O
induced O
striatal O
metabolic O
abnormality B-abstraction
was O
also O
remarkably O
improved O
by O
dhm O
treatment B-abstraction
, O
showed O
as O
the O
increased O
glucose O
metabolism B-physical_entity
in O
pet B-physical_entity
ct O
scan B-physical_entity
, O
decreased O
mda O
malondialdehyde O
and O
increased O
sod B-physical_entity
superoxide B-physical_entity
dismutase O
activity B-physical_entity
in O
enzyme O
histochemical O
staining B-abstraction
. O

in O
addition B-abstraction
, O
the O
cell B-physical_entity
apoptosis O
was O
evidently O
detected O
in O
the O
striatum O
of O
the O
3np O
group O
, O
while B-abstraction
in O
the O
3np O
dhm O
group O
, O
the O
number B-abstraction
of O
apoptotic O
cells O
was O
remarkably O
reduced O
. O

3np O
treatment B-abstraction
obviously O
induced O
down B-abstraction
regulation B-abstraction
of O
bcl O
2 O
, O
and O
up O
regulations O
of O
bax O
and O
cleaved O
caspase O
3 O
, O
while B-abstraction
these O
changes O
were O
significantly O
reversed O
by O
dhm O
treatment B-abstraction
. O

the O
present B-abstraction
results O
suggested O
that O
dhm O
showed O
its O
protective O
effect B-abstraction
by O
anti B-physical_entity
oxidant O
and O
anti B-physical_entity
apoptosis O
mechanisms O
. O


the O
45 O
degrees O
beam B-physical_entity
splitting O
mirror B-abstraction
plays O
a O
vital O
role B-abstraction
on O
image B-physical_entity
quality B-abstraction
in O
the O
holographic O
system B-abstraction
, O
in O
order B-abstraction
to O
study B-physical_entity
the O
influence B-abstraction
of O
environment B-physical_entity
temperature B-abstraction
variation B-physical_entity
on O
the O
45 O
degrees O
beam B-physical_entity
splitting O
mirror B-physical_entity
in O
the O
holographic O
system B-physical_entity
, O
finite O
element B-physical_entity
analysis B-abstraction
method B-abstraction
is O
used O
to O
simulate O
the O
anti B-physical_entity
three O
through O
seven O
mirror B-physical_entity
deformation B-abstraction
at O
27 O
degrees O
c O
, O
28 O
degrees O
c O
and O
29 O
degrees O
c O
temperature B-abstraction
in O
theory B-abstraction
. O

a O
new O
real B-O
time I-O
monitoring B-abstraction
and O
displaying O
photoelectric O
system B-physical_entity
for O
ambient O
temperature B-abstraction
and O
beam B-abstraction
splitting O
mirror B-physical_entity
distortion B-abstraction
detection B-abstraction
is O
designed O
to O
provide O
real B-O
time I-O
temperature B-abstraction
change I-abstraction
and O
deformation B-abstraction
detection B-abstraction
, O
which O
is O
made O
up O
of O
laser B-physical_entity
speckle B-physical_entity
interferometer B-physical_entity
, O
chip B-physical_entity
temperature B-abstraction
sensor B-physical_entity
, O
two O
operational O
amplifier B-physical_entity
, O
mcu O
and O
led O
indicator B-physical_entity
. O

and O
the O
out B-abstraction
plane B-physical_entity
displacement B-abstraction
value B-abstraction
measured O
in O
the O
experiment B-abstraction
under O
the O
condition B-abstraction
of O
temperature B-abstraction
correspondingly O
are O
406nm O
, O
420nm O
and O
427 O
nm O
. O

finally O
, O
the O
relation B-abstraction
equation B-abstraction
of O
temperature B-abstraction
and O
mirror B-physical_entity
deformation B-abstraction
is O
established O
by O
the O
method B-abstraction
of O
exponential O
equation B-abstraction
fitting B-physical_entity
, O
which O
will B-abstraction
provide O
preliminary B-abstraction
theoretical O
and O
experimental O
reference B-physical_entity
for O
further O
research B-abstraction
. O


a O
thermotolerant O
bacterium B-physical_entity
paenibacillus O
thiaminolyticus O
with O
an O
ability B-abstraction
to O
produce O
extracellular O
mannanase O
was O
isolated O
from O
a O
soil B-physical_entity
sample B-abstraction
. O

bacterium B-physical_entity
produced O
45u O
ml O
mannanase O
at O
50 O
degrees O
c O
. O

the O
culture B-physical_entity
conditions O
for O
high B-abstraction
level B-abstraction
production B-physical_entity
of O
mannanase O
were O
optimized O
. O

optimized O
ms O
medium B-abstraction
wheat B-abstraction
bran O
2 O
w O
v O
, O
ammonium O
sulfate O
0 O
. O

3 O
w O
v O
, O
yeast B-physical_entity
extract O
, O
and O
peptone O
0 O
. O

025 O
each O
ph O
6 O
. O

5 O
was O
inoculated O
with O
2 O
of O
16h O
old B-abstraction
culture B-physical_entity
. O

the O
culture B-physical_entity
was O
incubated O
at O
50 O
degrees O
c O
for O
48h O
resulting O
in O
24 O
folds O
higher O
mannanase O
production B-physical_entity
1 O
, O
100 O
50u O
ml O
. O

optimum B-abstraction
ph O
and O
temperature B-abstraction
for O
enzyme O
activity B-physical_entity
of O
the O
crude O
enzyme O
was O
6 O
. O

0 O
and O
60 O
degrees O
c O
, O
respectively O
. O

the O
enzyme O
demonstrated O
65 O
relative B-physical_entity
enzyme O
activity B-abstraction
at O
37 O
degrees O
c O
. O

the O
hydrolytic O
activity B-physical_entity
of O
the O
crude O
enzymatic O
preparation B-abstraction
was O
assessed O
on O
various O
agro O
residues O
. O

thin O
layer B-physical_entity
chromatographic O
analysis B-abstraction
showed O
that O
the O
enzyme O
activity B-physical_entity
to O
saccharify O
heteromannans O
resulted O
in O
production B-physical_entity
of O
a O
mixture B-abstraction
of O
manno O
oligosaccharides O
mos O
and O
enzyme O
exhibited O
classic B-physical_entity
endo O
activity B-abstraction
. O

to O
evaluate O
the O
possible B-physical_entity
prebiotic O
potential O
of O
the O
mos O
thus O
obtained O
, O
initial O
screening B-abstraction
for O
their O
ability B-abstraction
to O
support B-abstraction
the O
growth B-physical_entity
of O
probiotics O
was O
carried O
out B-abstraction
by O
the O
pure O
culture B-abstraction
method B-abstraction
. O

bifidobacterium O
and O
lactobacillus B-physical_entity
sp O
. O

responded O
positively O
to O
the O
addition B-abstraction
of O
enzymatically O
derived O
oligosaccharides O
and O
their O
numbers B-abstraction
increased O
significantly O
. O

c O
2015 O
international O
union B-physical_entity
of O
biochemistry B-abstraction
and O
molecular B-O
biology I-O
, O
inc O
. O


serotonin O
n O
hydroxycinnamoyltransferase O
sht O
is O
a O
key B-abstraction
enzyme O
in O
the O
synthesis B-abstraction
of O
feruloylserotonin O
fs O
and O
4 O
coumaroylserotonin O
cs O
. O

these O
serotonin O
derivatives O
show B-abstraction
strong O
antioxidant O
activity B-physical_entity
, O
making B-abstraction
them O
valuable O
for O
both O
nutritional O
and O
pharmacological O
use B-physical_entity
in O
humans B-physical_entity
. O

ectopic O
expression B-abstraction
of O
sht O
under O
the O
control B-abstraction
of O
the O
endosperm B-physical_entity
specific B-abstraction
glutelin O
and O
prolamin O
promoters O
from O
rice B-physical_entity
was O
produced O
via O
agrobacterium O
mediated O
transformation B-abstraction
. O

sht O
expression B-abstraction
was O
confirmed O
by O
southern O
blot B-abstraction
analysis B-abstraction
, O
followed O
by O
northern O
blotting O
and O
sht O
enzyme O
activity B-abstraction
analyses O
using B-abstraction
total B-abstraction
rna O
and O
protein O
, O
respectively O
, O
extracted O
from O
transgenic O
seeds O
. O

the O
glutelin O
a3 O
glua3 O
promoter B-physical_entity
produced O
low B-physical_entity
sht O
mrna O
expression B-abstraction
in O
rice B-physical_entity
seeds O
, O
whereas O
the O
prolamin O
promoter B-physical_entity
expressed O
high B-abstraction
levels O
of O
sht O
mrna O
. O

in O
spite B-abstraction
of O
the O
ectopic O
expression B-abstraction
of O
sht O
in O
rice B-physical_entity
seeds O
, O
both O
transgenic O
genotypes O
accumulated O
levels O
of O
serotonin O
derivatives O
similar O
to O
those O
found O
in O
wild B-physical_entity
type B-abstraction
rice B-physical_entity
. O

furthermore O
, O
our O
data O
suggest O
that O
serotonin O
, O
rather O
than O
phenylpropanid O
coas O
, O
is O
the O
rate B-abstraction
limiting O
substrate B-physical_entity
in O
the O
biosynthesis B-physical_entity
of O
serotonin O
derivatives O
in O
sht O
overexpressing O
transgenic O
rice B-physical_entity
seeds O
. O


a O
compact B-physical_entity
, O
low B-abstraction
noise B-abstraction
and O
inexpensive O
preamplifier O
circuit B-abstraction
has O
been O
designed O
and O
fabricated O
to O
optimally O
readout B-physical_entity
a O
common B-physical_entity
cathode B-physical_entity
1 O
x O
16 O
channel B-physical_entity
4h O
sic O
schottky O
photodiode O
array B-physical_entity
for O
use B-physical_entity
in O
ultraviolet O
experiments O
. O

the O
readout B-physical_entity
uses O
an O
operational O
amplifier B-physical_entity
with O
10 O
pf O
capacitor B-physical_entity
in O
the O
feedback B-physical_entity
loop I-physical_entity
in O
parallel B-abstraction
with O
a O
low B-physical_entity
leakage B-abstraction
switch B-abstraction
for O
each O
of O
the O
channels B-abstraction
. O

this O
circuit B-physical_entity
configuration B-abstraction
allows O
for O
reiterative O
sample B-abstraction
, O
integrate O
and O
reset B-physical_entity
. O

a O
sampling B-abstraction
technique B-abstraction
is O
given B-abstraction
to O
remove O
johnson O
noise B-abstraction
, O
enabling O
a O
femtoampere O
level B-physical_entity
readout B-physical_entity
noise B-abstraction
performance B-abstraction
. O

commercial O
off O
the O
shelf B-physical_entity
acquisition B-abstraction
electronics B-abstraction
are O
used O
to O
digitize O
the O
preamplifier O
analog B-abstraction
signals O
. O

the O
data O
logging B-abstraction
acquisition B-abstraction
electronics B-abstraction
has O
a O
different O
integration B-abstraction
circuit B-abstraction
, O
which O
allows O
the O
bandwidth O
and O
gain B-abstraction
to O
be O
independently O
adjusted O
. O

using B-abstraction
this O
readout B-physical_entity
, O
photoresponse O
measurements O
across O
the O
array B-physical_entity
between O
spectral O
wavelengths O
200 O
nm O
and O
370 O
nm O
are O
made O
to O
establish O
the O
array B-physical_entity
pixels O
external B-abstraction
quantum B-abstraction
efficiency O
, O
current B-abstraction
responsivity O
and O
noise B-abstraction
equivalent B-abstraction
power B-abstraction
. O

published O
by O
elsevier O
b O
. O

v O
. O


silicon O
rf O
power B-physical_entity
amplifiers O
pas B-abstraction
are O
in O
various O
rf O
front B-abstraction
end I-physical_entity
modules O
fems O
today B-abstraction
for O
handset B-physical_entity
and O
wlan O
applications O
. O

even B-abstraction
though O
iii O
v O
semiconductor B-physical_entity
based O
rf O
pas B-abstraction
can B-physical_entity
still B-abstraction
offer B-abstraction
superior B-physical_entity
frequency O
and O
breakdown B-abstraction
performance B-abstraction
with O
higher O
pout B-physical_entity
and O
power B-abstraction
added O
efficiency O
pae O
and O
faster O
time B-abstraction
to O
market B-abstraction
, O
silicon O
based O
rf O
pas B-abstraction
do B-abstraction
have B-physical_entity
the O
advantages O
in O
offering B-abstraction
higher O
monolithic O
integration B-abstraction
with O
added O
functionalities O
e O
. O

g O
. O

, O
on O
chip B-physical_entity
digital O
control B-abstraction
and O
selection B-physical_entity
on O
power B-physical_entity
level B-abstraction
, O
modulation B-abstraction
, O
frequency O
band B-physical_entity
, O
matching O
, O
predistortion O
, O
etc O
. O

, O
which O
can B-physical_entity
translate O
to O
lower B-physical_entity
cost B-abstraction
and O
smaller O
sizes O
attractive O
for O
broadband O
multi O
mode B-abstraction
multi O
band B-physical_entity
handset B-physical_entity
transmitters O
. O

therefore O
, O
some O
key B-abstraction
techniques O
for O
designing B-abstraction
high B-physical_entity
efficiency O
4g O
5g O
wlan O
broadband O
wireless B-physical_entity
silicon O
pas B-abstraction
will B-abstraction
be O
discussed O
. O


although O
gain B-abstraction
of O
chromosome B-physical_entity
5p O
is O
one B-abstraction
of O
the O
most O
frequent O
dna O
copy B-physical_entity
number B-physical_entity
imbalances O
in O
cervical O
squamous B-O
cell I-O
carcinoma O
scc O
, O
the O
genes O
that O
drive B-physical_entity
its O
selection B-physical_entity
remain O
poorly O
understood O
. O

in O
a O
previous O
cross B-physical_entity
sectional B-physical_entity
clinical O
study B-physical_entity
, O
we O
showed O
that O
the O
microrna O
processor B-physical_entity
drosha O
located O
on O
chromosome B-physical_entity
5p O
demonstrates O
frequent O
copy B-physical_entity
number B-physical_entity
gain B-abstraction
and O
overexpression O
in O
cervical O
scc O
, O
associated O
with O
altered O
microrna O
profiles O
. O

here B-physical_entity
, O
we O
have B-physical_entity
conducted O
gene O
depletion B-abstraction
overexpression O
experiments O
to O
demonstrate O
the O
functional O
significance B-abstraction
of O
up O
regulated O
drosha O
in O
cervical O
scc O
cells O
. O

drosha O
depletion B-abstraction
by O
rna O
interference B-abstraction
rnai O
produced O
significant O
, O
specific B-abstraction
reductions O
in O
cell B-physical_entity
motility B-abstraction
invasiveness O
in O
vitro O
, O
with O
a O
silent O
rnai O
resistant O
drosha O
mutation B-abstraction
providing O
phenotype B-abstraction
rescue B-abstraction
. O

unsupervised O
hierarchical O
clustering O
following B-abstraction
global O
profiling O
of O
319 O
micrornas O
in O
18 O
cervical O
scc O
cell B-physical_entity
line B-physical_entity
specimens O
generated O
two O
groups O
according O
to O
drosha O
expression B-abstraction
levels O
. O

altering B-abstraction
drosha O
levels O
in O
individual B-physical_entity
scc O
lines O
changed O
the O
group O
into O
which O
the O
cells O
clustered O
, O
with O
gene O
depletion B-abstraction
effects O
being B-physical_entity
rescued O
by O
the O
rnai O
resistant O
mutation B-abstraction
. O

forty O
five B-physical_entity
micrornas O
showed O
significant O
differential B-physical_entity
expression B-physical_entity
between O
the O
groups O
, O
including O
four B-physical_entity
of O
14 O
that O
were O
differentially O
expressed O
in O
association B-abstraction
with O
drosha O
levels O
in O
clinical O
samples O
. O

mir O
31 O
up O
regulation B-physical_entity
in O
drosha O
overexpressing O
samples O
cell B-physical_entity
lines O
was O
the O
highest O
ranked O
change B-physical_entity
by O
adjusted O
p O
value B-abstraction
in O
both O
analyses O
, O
an O
observation B-abstraction
validated O
by O
northern O
blotting O
. O

these O
functional O
data O
support B-abstraction
the O
role B-abstraction
of O
drosha O
as O
an O
oncogene O
in O
cervical O
scc O
, O
by O
affecting O
expression B-abstraction
of O
cancer O
associated O
micrornas O
that O
have B-physical_entity
the O
potential O
to O
regulate O
numerous O
protein O
coding B-abstraction
genes O
. O

copyright B-abstraction
c O
2011 O
pathological O
society O
of O
great B-physical_entity
britain O
and O
ireland O
. O

published O
by O
john B-physical_entity
wiley O
sons O
, O
ltd O
. O


aim B-physical_entity
an O
rna O
seq O
analysis B-abstraction
recently O
identified O
a O
236 O
nucleotide O
transcript O
upstream O
from O
mals O
in O
salmonella B-physical_entity
enterica O
serovar O
typhi O
. O

here B-physical_entity
, O
we O
investigated O
its O
molecular O
characteristics O
and O
function B-abstraction
. O

materials O
methods O
race B-abstraction
and O
northern O
blotting O
were O
used O
to O
determine O
the O
molecular O
characteristics O
of O
the O
sequence B-physical_entity
, O
and O
mutagenesis B-abstraction
, O
microarray O
, O
immunoblotting O
and O
an O
invasion B-abstraction
assay B-abstraction
were O
used O
to O
investigate O
the O
functions O
of O
the O
transcript O
. O

results O
the O
transcript O
was O
identified O
as O
the O
mals O
5' O
untranslated O
region B-physical_entity
utr O
, O
which O
could O
influence B-abstraction
the O
expression B-physical_entity
of O
the O
flagellar O
and O
spi O
1 O
genes O
and O
the O
invasion B-abstraction
of O
hela O
cells O
by O
s B-abstraction
. O

typhi O
. O

deletion B-abstraction
of O
bax O
increased O
the O
expression B-abstraction
of O
the O
invasion B-abstraction
genes O
and O
the O
invasive O
capacity B-abstraction
of O
s B-abstraction
. O

typhi O
, O
whereas O
the O
expression B-abstraction
of O
the O
mals O
5' O
utr O
reduced O
the O
expression B-physical_entity
of O
bax O
. O

conclusion B-abstraction
the O
mals O
5' O
utr O
reduces O
the O
expression B-abstraction
of O
bax O
and O
increases O
the O
invasive O
capacity B-abstraction
of O
s B-abstraction
. O

typhi O
. O


this O
paper B-physical_entity
presents O
the O
design B-abstraction
of O
a O
compact B-physical_entity
60 O
ghz O
phase B-abstraction
shifter B-physical_entity
that O
provides O
a O
5 O
bit B-abstraction
digital O
phase B-abstraction
control B-abstraction
and O
360 O
degrees O
phase B-abstraction
range B-abstraction
for O
beam B-physical_entity
forming O
systems O
. O

the O
phase B-abstraction
shifter B-physical_entity
is O
designed O
using B-abstraction
the O
proposed O
cross B-physical_entity
coupled O
bridged O
t O
type B-abstraction
topology B-abstraction
and O
switched O
varactor O
reflective O
type B-abstraction
topology B-abstraction
. O

the O
topologies O
are O
analyzed O
using B-abstraction
a O
small B-abstraction
signal B-abstraction
equivalent B-abstraction
circuit B-abstraction
model B-physical_entity
. O

furthermore O
, O
the O
design B-abstraction
equations O
are O
derived O
and O
investigated O
. O

to O
validate O
the O
theoretical O
analysis B-abstraction
, O
60 O
ghz O
5 O
bit B-physical_entity
360 O
degrees O
phase B-abstraction
shifters O
are O
designed O
in O
a O
commercial O
65 O
nm O
cmos O
technology B-abstraction
. O

the O
fabricated O
360 O
degrees O
phase B-abstraction
shifter B-physical_entity
features O
good B-physical_entity
performance B-abstraction
of O
32 O
phase B-abstraction
states O
from O
57 O
to O
64 O
ghz O
with O
an O
rms O
phase B-abstraction
error B-abstraction
of O
4 O
. O

4 O
degrees O
, O
a O
total B-abstraction
insertion B-abstraction
loss B-abstraction
of O
14 O
. O

3 O
2 O
db O
, O
an O
rms O
gain B-abstraction
error B-abstraction
of O
0 O
. O

5 O
db O
, O
p O
1 O
db O
of O
better B-abstraction
than O
9 O
. O

5 O
dbm O
, O
and O
the O
power B-physical_entity
consumption B-physical_entity
of O
almost O
zero B-abstraction
. O

to O
the O
best B-physical_entity
of O
our O
knowledge B-abstraction
, O
the O
designed O
360 O
degrees O
phase B-abstraction
shifter B-physical_entity
with O
the O
size B-abstraction
of O
0 O
. O

094 O
mm O
2 O
is O
the O
smallest O
5 O
bit B-physical_entity
passive O
phase B-abstraction
shifter B-physical_entity
at O
frequencies O
around O
60 O
ghz O
. O


by O
differential B-physical_entity
high B-abstraction
throughput B-physical_entity
rna O
sequencing O
drna O
seq O
we O
have B-physical_entity
identified O
" O
product B-abstraction
rnas O
" O
prnas O
as O
short B-abstraction
as O
8 O
12 O
nucleotides O
that O
are O
synthesized O
by O
bacillus B-physical_entity
subtilis O
rna O
polymerase O
rnap O
in O
vivo O
using B-abstraction
the O
regulatory O
6s O
1 O
rna O
as O
template B-abstraction
. O

the O
drna O
seq O
data O
were O
confirmed O
by O
in O
vitro O
transcription B-abstraction
experiments O
and O
northern O
blotting O
. O

in O
our O
libraries O
, O
we O
were O
unable O
to O
detect O
statistically O
meaningful O
numbers B-abstraction
of O
reads O
potentially O
representing O
prnas O
derived O
from O
6s O
2 O
rna O
. O

however O
, O
prnas O
could O
be O
synthesized O
in O
vitro O
from O
6s O
2 O
rna O
as O
template B-abstraction
by O
the O
b O
. O

subtilis O
sigma O
a O
rnap O
. O

6s O
1 O
prna O
levels O
are O
low B-physical_entity
during O
exponential O
, O
increase B-abstraction
in O
stationary O
and O
burst B-abstraction
during O
outgrowth B-abstraction
from O
stationary O
phase B-abstraction
, O
demonstrating O
that O
prna O
synthesis B-abstraction
is O
a O
conserved O
regulatory O
mechanism B-abstraction
, O
but O
a O
more O
dynamic B-abstraction
and O
fine O
tuning B-abstraction
process B-abstraction
than O
previously O
thought B-abstraction
. O

most O
prnas O
have B-physical_entity
a O
length B-abstraction
of O
8 O
15 O
nt O
, O
very O
few O
up O
to O
24 O
nt O
. O

the O
average B-abstraction
length B-abstraction
of O
prnas O
tended O
to O
increase B-abstraction
from O
stationary O
to O
outgrowth B-abstraction
conditions O
. O

synthesis B-abstraction
of O
prna O
is O
initiated O
at O
c40 O
of O
6s O
1 O
rna O
and O
u41 O
of O
6s O
2 O
rna O
, O
yielding B-abstraction
prnas O
with O
a O
5' O
terminal B-physical_entity
g O
or O
a O
residue O
, O
respectively O
. O

a O
b O
. O

subtilis O
6s O
1 O
rna O
mutant B-physical_entity
strain B-abstraction
encoding B-abstraction
a O
prna O
with O
a O
5' O
terminal B-physical_entity
a O
residue O
showed O
the O
same O
relative B-physical_entity
distribution B-abstraction
of O
similar O
to O
14 O
nt O
prnas O
between O
the O
different O
growth B-abstraction
states O
, O
but O
generally O
displayed O
lower B-physical_entity
prna O
levels O
than O
the O
reference B-abstraction
strain B-abstraction
encoding B-abstraction
wild B-physical_entity
type B-abstraction
6s O
1 O
rna O
. O

a O
similar O
to O
two O
fold B-abstraction
lower B-physical_entity
affinity B-abstraction
of O
the O
c40u O
mutant B-physical_entity
6s O
1 O
rna O
towards O
sigma O
a O
rnap O
may B-physical_entity
have B-physical_entity
contributed O
to O
this O
reduction B-physical_entity
in O
prna O
levels O
. O

we O
infer O
that O
6s O
1 O
prna O
synthesis B-abstraction
, O
although O
evolutionarily O
optimized O
for O
initiation B-abstraction
with O
a O
1g O
residue O
, O
is O
not O
primarily O
regulated O
at O
the O
transcription B-physical_entity
initiation B-abstraction
level B-physical_entity
via O
growth B-physical_entity
phase B-abstraction
dependent B-physical_entity
variations O
in O
the O
cellular O
gtp O
pool B-abstraction
. O


the O
" O
central B-physical_entity
dogma B-abstraction
" O
of O
molecular B-O
biology I-O
describes O
how O
information B-abstraction
contained O
in O
dna O
is O
transformed O
into O
rna O
and O
finally O
into O
proteins O
. O

in O
order B-abstraction
for O
proteins O
to O
maintain O
their O
functionality B-abstraction
in O
both O
the O
parent B-physical_entity
cell B-physical_entity
and O
subsequent O
generations O
, O
it O
is O
essential O
that O
the O
information B-abstraction
encoded O
in O
dna O
and O
rna O
remains B-physical_entity
unaltered O
. O

dna O
and O
rna O
are O
constantly O
exposed O
to O
damaging O
agents O
, O
which O
can B-physical_entity
modify O
nucleic O
acids O
and O
change B-abstraction
the O
information B-abstraction
they O
encode O
. O

while B-abstraction
much O
is O
known O
about O
how O
cells O
respond O
to O
damaged O
dna O
, O
the O
importance B-abstraction
of O
protecting O
rna O
has O
only O
become O
appreciated O
over B-abstraction
the O
past B-abstraction
decade B-abstraction
. O

modification B-physical_entity
of O
the O
nucleobase O
through O
oxidation B-physical_entity
and O
alkylation O
has O
long O
been O
known O
to O
affect O
its O
base B-physical_entity
pairing B-abstraction
properties O
during O
dna O
replication B-physical_entity
. O

similarly O
, O
recent O
studies O
have B-physical_entity
begun O
to O
highlight B-abstraction
some O
of O
the O
unwanted O
consequences O
of O
chemical O
damage B-abstraction
on O
mrna O
decoding B-abstraction
during O
translation B-abstraction
. O

oxidation B-physical_entity
and O
alkylation O
of O
mrna O
appear O
to O
have B-physical_entity
drastic O
effects O
on O
the O
speed B-abstraction
and O
fidelity B-abstraction
of O
protein O
synthesis B-physical_entity
. O

as O
some O
mrnas O
can B-physical_entity
persist O
for O
days B-abstraction
in O
certain O
tissues O
, O
it O
is O
not O
surprising O
that O
it O
has O
recently O
emerged O
that O
mrna O
surveillance B-abstraction
and O
rna O
repair B-physical_entity
pathways O
have B-physical_entity
evolved O
to O
clear B-physical_entity
or O
correct O
damaged O
mrna O
. O


a O
cdna O
clone B-physical_entity
of O
eucommia O
ulmoides O
oliv O
. O

encoding B-abstraction
auxin O
binding B-abstraction
protein O
1 O
abp1 O
, O
one B-abstraction
of O
the O
putative O
receptors O
of O
auxin O
, O
was O
isolated O
, O
and O
the O
seasonal B-physical_entity
expression B-physical_entity
of O
abp1 O
in O
relation B-physical_entity
to O
iaa O
and O
aba B-physical_entity
annual B-physical_entity
variation B-abstraction
was O
investigated O
by O
different O
technical B-abstraction
approaches O
including O
rt O
pcr O
, O
real B-O
time I-O
pcr O
, O
northern O
blotting O
, O
western O
blotting O
, O
and O
immunolocalization O
. O

in O
the O
cambial O
region B-abstraction
, O
abp1 O
expression B-abstraction
at O
both O
the O
protein O
and O
the O
mrna O
level B-physical_entity
was O
found O
to O
be O
high B-abstraction
, O
low B-physical_entity
, O
and O
remarkably O
scarce O
in O
the O
active B-physical_entity
, O
quiescent O
, O
and O
resting O
stages O
, O
respectively O
, O
during O
cambium B-physical_entity
periodicity B-abstraction
. O

the O
signal B-abstraction
abundance B-abstraction
of O
abp1 O
follows O
the O
opposite B-physical_entity
pattern B-physical_entity
to O
aba B-physical_entity
accumulation B-abstraction
and O
correlates O
with O
auxin O
responsiveness B-abstraction
of O
the O
cambial O
tissues O
, O
suggesting O
a O
role B-abstraction
for O
abp1 O
in O
mediating O
auxin O
dependent B-physical_entity
regulation B-physical_entity
of O
cambial O
activation B-abstraction
in O
the O
activity B-physical_entity
dormancy B-abstraction
cycle B-abstraction
. O

this O
paper B-physical_entity
attempts O
to O
explain O
why B-abstraction
iaa O
would O
'boost' O
the O
reactivation O
of O
a O
quiescent O
cambium B-physical_entity
, O
and O
not O
that O
of O
a O
resting O
cambium B-physical_entity
. O

results O
also O
show B-abstraction
that O
abp1 O
expression B-physical_entity
is O
improved O
by O
iaa O
, O
while B-abstraction
inhibited O
by O
aba B-physical_entity
. O


the O
monkey B-physical_entity
is O
an O
important O
experimental O
model B-abstraction
in O
the O
pharmacological O
evaluation B-abstraction
of O
new O
drugs O
. O

we O
isolated O
monkey B-physical_entity
multidrug O
resistance B-physical_entity
associated O
protein O
2 O
mrp2 O
cdna O
to O
examine O
expression B-physical_entity
profiles O
among O
various O
tissues O
and O
measured O
atpase O
activity B-abstraction
to O
assess O
substrate B-physical_entity
specificity B-abstraction
. O

the O
amino O
acid O
sequence B-abstraction
encoded O
by O
monkey B-physical_entity
mrp2 O
cdna O
was O
very O
similar O
96 O
identity B-abstraction
to O
the O
reported O
human B-physical_entity
mrp2 O
cdna O
genbank O
accession B-abstraction
no B-abstraction
. O

nm_000392 O
. O

the O
tissue O
distribution B-abstraction
of O
mrp2 O
in O
monkeys O
was O
partially O
different O
from O
that O
in O
humans B-physical_entity
. O

we O
found O
relatively O
high B-physical_entity
expression B-physical_entity
of O
mrp2 O
in O
the O
monkey B-physical_entity
kidney O
and O
small B-abstraction
intestine O
using B-abstraction
northern O
blotting O
. O

substrate B-physical_entity
specificity B-abstraction
was O
compared O
between O
human B-physical_entity
and O
monkey B-physical_entity
mrp2 O
. O

the O
affinity B-abstraction
of O
17 O
beta O
estradiol O
17 O
beta O
d O
glucuronide O
, O
methotrexate O
, O
vinblastine O
, O
and O
probenecid O
to O
monkey B-physical_entity
mrp2 O
was O
higher O
than O
that O
to O
human B-physical_entity
mrp2 O
. O

functional O
and O
expression B-abstraction
differences O
between O
human B-physical_entity
and O
monkey B-physical_entity
mrp2 O
should O
be O
incorporated O
into O
the O
evaluation B-abstraction
of O
candidate B-physical_entity
drugs O
. O

c O
2008 O
elsevier O
b O
. O

v O
. O

all O
rights O
reserved O
. O


introduction B-abstraction
most O
disseminated O
cancers O
remain O
fatal O
despite B-abstraction
the O
availability B-abstraction
of O
a O
variety B-abstraction
of O
conventional O
and O
novel B-physical_entity
treatments O
including O
surgery B-physical_entity
, O
chemotherapy B-abstraction
, O
radiotherapy B-abstraction
, O
immunotherapy B-abstraction
, O
and O
biologically O
targeted O
therapy B-abstraction
. O

a O
major B-physical_entity
factor B-abstraction
responsible O
for O
the O
failure B-physical_entity
of O
chemotherapy B-abstraction
in O
the O
treatment B-abstraction
of O
cancer O
is O
the O
development B-abstraction
of O
multidrug O
resistance B-abstraction
mdr O
. O

the O
overexpression O
of O
various O
abc O
transporters O
in O
cancer O
cells O
can B-physical_entity
efficiently O
remove O
the O
anticancer O
drug O
from O
the O
cell B-physical_entity
, O
thus O
causing B-abstraction
the O
drug O
to O
lose O
its O
effect B-abstraction
. O

areas O
covered O
in O
this O
review B-abstraction
, O
we O
summarised O
the O
ongoing O
research B-abstraction
related O
to O
the O
mechanism B-physical_entity
, O
function B-abstraction
, O
and O
regulation B-physical_entity
of O
abc O
transporters O
. O

we O
integrated O
our O
current B-abstraction
knowledge B-abstraction
at O
different O
levels O
from O
molecular B-O
biology I-O
to O
clinical O
trials O
. O

we O
also O
discussed O
potential O
therapeutic O
strategies O
of O
targeting O
abc O
transporters O
to O
reverse B-abstraction
mdr O
in O
cancer O
cells O
. O

expert B-physical_entity
opinion B-abstraction
involvement B-abstraction
of O
various O
abc O
transporters O
to O
cancer O
mdr O
lays O
the O
foundation B-physical_entity
for O
developing O
tailored O
therapies O
that O
can B-physical_entity
overcome O
mdr O
. O

an O
ideal B-physical_entity
mdr O
reversal B-abstraction
agent B-physical_entity
should O
have B-physical_entity
broad B-physical_entity
spectrum B-abstraction
abc O
transporter B-physical_entity
inhibitory O
activity B-abstraction
, O
be O
potent O
, O
have B-physical_entity
good B-abstraction
pharmacokinetics B-abstraction
, O
have B-physical_entity
no B-abstraction
trans O
stimulation B-physical_entity
effects O
, O
and O
have B-physical_entity
low B-physical_entity
or O
no B-abstraction
toxicity B-abstraction
. O

alternatively O
, O
nanotechnology B-abstraction
based O
drug O
delivery B-abstraction
systems O
containing O
both O
the O
cytotoxic O
drug O
and O
reversing O
agent B-physical_entity
may B-physical_entity
represent O
a O
useful O
approach B-abstraction
to O
reversing O
mdr O
with O
minimal O
off O
target B-physical_entity
toxicity B-abstraction
. O


purposedespite O
being B-physical_entity
the O
third B-abstraction
most O
common B-physical_entity
abca4 O
variant B-abstraction
observed O
in O
patients O
with O
stargardt O
disease O
, O
the O
functional O
effect B-abstraction
of O
the O
intronic O
abca4 O
variant B-abstraction
c O
. O

5461 O
10t O
c O
is O
unknown B-physical_entity
. O

the O
purpose B-abstraction
of O
this O
study B-physical_entity
was O
to O
investigate O
the O
molecular O
effect B-abstraction
of O
this O
variant B-abstraction
. O

methodsfibroblast O
samples O
from O
patients O
carrying O
the O
abca4 O
variant B-abstraction
c O
. O

5461 O
10t O
c O
were O
analysed O
by O
isolating O
total B-abstraction
rna O
, O
followed O
by O
real B-O
time I-O
polymerase O
chain B-physical_entity
reaction I-physical_entity
rt O
pcr O
using B-abstraction
specific B-abstraction
primers O
spanning O
the O
variant B-abstraction
. O

for O
detection B-abstraction
of O
abca4 O
protein O
, O
fibroblast B-physical_entity
samples O
were O
lysed O
and O
analysed O
by O
sds O
page B-physical_entity
followed O
by O
immunoblotting O
using B-abstraction
a O
monoclonal O
abca4 O
antibody O
. O

resultsthe O
abca4 O
variant B-abstraction
c O
. O

5461 O
10t O
c O
causes O
a O
splicing B-physical_entity
defect B-abstraction
resulting O
in O
the O
reduction B-abstraction
of O
full B-abstraction
length B-abstraction
mrna O
in O
fibroblasts O
from O
patients O
and O
the O
presence B-abstraction
of O
alternatively O
spliced O
mrnas O
where O
exon O
39 O
40 O
is O
skipped O
. O

a O
reduced O
level B-physical_entity
of O
full B-abstraction
length B-abstraction
abca4 O
protein O
is O
observed O
compared O
to O
controls O
not O
carrying O
the O
variant B-abstraction
. O

conclusionsthis O
study B-abstraction
describes O
the O
functional O
effect B-abstraction
and O
the O
molecular O
mechanism B-abstraction
of O
the O
pathogenic O
abca4 O
variant B-abstraction
c O
. O

5461 O
10t O
c O
. O

the O
variant B-abstraction
is O
functionally O
important O
as O
it O
leads O
to O
splicing B-physical_entity
defects O
and O
a O
reduced O
level B-physical_entity
of O
abca4 O
protein O
. O


objective B-abstraction
background B-physical_entity
matrix B-physical_entity
metalloproteinases O
mmps O
have B-physical_entity
already O
been O
identified O
as O
key B-abstraction
players O
in O
the O
pathogenesis B-physical_entity
of O
abdominal O
aortic O
aneurysm O
aaa O
. O

however O
, O
the O
current B-abstraction
data O
remain O
inconclusive O
. O

in O
this O
study B-abstraction
, O
the O
expression B-physical_entity
of O
mmps O
at O
mrna O
and O
protein O
levels O
were O
investigated O
in O
relation B-abstraction
to O
the O
degradation B-abstraction
of O
collagen O
i O
and O
collagen O
iii O
. O

methods O
tissue O
samples O
were O
obtained O
from O
40 O
patients O
with O
aaa O
undergoing O
open B-physical_entity
aortic O
repair B-physical_entity
, O
and O
from O
five B-physical_entity
healthy O
controls O
during O
kidney O
transplantation B-abstraction
. O

expression B-physical_entity
of O
mmps O
1 O
, O
2 O
, O
3 O
, O
7 O
, O
8 O
, O
9 O
, O
and O
12 O
, O
and O
tissue O
inhibitor O
of O
metalloproteinase O
timp O
1 O
, O
and O
timp2 O
were O
measured O
at O
the O
mrna O
level B-abstraction
using B-abstraction
quantitative O
reverse B-physical_entity
transcription B-physical_entity
polymerase O
chain B-physical_entity
reaction I-physical_entity
. O

at O
the O
protein O
level B-abstraction
, O
mmps O
, O
collagen O
i O
, O
and O
collagen O
iii O
, O
and O
their O
degradation B-abstraction
products O
carboxy O
terminal B-physical_entity
collagen O
cross B-physical_entity
links B-physical_entity
ctx O
i O
and O
ctx O
iii O
, O
were O
quantified O
via O
enzyme O
linked O
immunosorbent O
assay B-abstraction
. O

in O
addition B-abstraction
, O
immunohistochemistry B-abstraction
and O
gelatine O
zymography O
were O
performed O
. O

results O
in O
aaa O
, O
significantly O
enhanced O
mrna O
expression B-physical_entity
was O
observed O
for O
mmps O
3 O
, O
9 O
, O
and O
12 O
compared O
with O
controls O
p O
. O

001 O
. O

mmps O
3 O
, O
9 O
, O
and O
12 O
correlated O
significantly O
with O
macrophages O
p O
. O

007 O
, O
p O
. O

018 O
, O
and O
p O
. O

015 O
, O
respectively O
, O
and O
synthetic O
smooth B-abstraction
muscle B-abstraction
cells O
with O
mmps O
1 O
, O
2 O
, O
and O
9 O
p O
. O

020 O
, O
p O
. O

018 O
, O
and O
p O
. O

027 O
, O
respectively O
. O

at O
the O
protein O
level B-abstraction
, O
mmps O
8 O
, O
9 O
, O
and O
12 O
were O
significantly O
elevated O
in O
aaa O
p O
. O

006 O
, O
p O
. O

0004 O
, O
and O
p O
. O

001 O
, O
respectively O
. O

no B-abstraction
significant O
correlation B-abstraction
between O
mrna O
and O
protein O
was O
observed O
for O
any O
mmp O
. O

aaa O
contained O
significantly O
reduced O
intact O
collagen O
i O
twofold O
; O
p O
. O

002 O
, O
whereas O
collagen O
iii O
was O
increased O
4 O
. O

6 O
fold B-abstraction
; O
p O
. O

001 O
. O

regarding O
degraded O
collagen O
i O
and O
iii O
relative B-physical_entity
to O
intact O
collagens O
, O
observations O
were O
inverse O
1 O
. O

4 O
fold B-abstraction
increase B-abstraction
for O
ctx O
1 O
p O
. O

001 O
; O
fivefold O
decrease B-abstraction
for O
ctx O
iii O
p O
. O

004 O
. O

mmps O
8 O
, O
9 O
, O
and O
12 O
correlated O
with O
collagen O
i O
p O
. O

019 O
, O
p O
. O

001 O
, O
and O
p O
0 O
. O

003 O
, O
respectively O
, O
collagen O
iii O
p O
. O

015 O
, O
p O
. O

001 O
, O
and O
p O
. O

001 O
, O
respectively O
, O
and O
degraded O
collagen O
i O
p O
. O

012 O
, O
p O
. O

049 O
, O
and O
p O
. O

001 O
, O
respectively O
. O

conclusion B-abstraction
no B-abstraction
significant O
relationship O
was O
found O
between O
mrna O
and O
protein O
and O
mmp O
levels O
. O

mmps O
9 O
and O
12 O
were O
overexpressed O
in O
aaa O
at O
the O
mrna O
and O
protein O
level B-physical_entity
, O
and O
mmp O
8 O
at O
the O
protein O
level B-physical_entity
. O

mmp O
2 O
was O
detected O
in O
synthetic O
smcs O
. O

collagen O
i O
and O
iii O
showed O
inverse O
behaviour B-abstraction
in O
aaa O
. O

in O
particular B-abstraction
, O
mmps O
8 O
, O
9 O
, O
and O
; O
12 O
appear O
to O
be O
associated O
with O
collagen O
i O
, O
collagen O
iii O
, O
and O
their O
degradation B-abstraction
products O
. O

c O
2017 O
european O
society O
for O
vascular O
surgery B-abstraction
. O

published O
by O
elsevier O
ltd O
. O

all O
rights O
reserved O
. O


purpose B-abstraction
of O
review B-physical_entity
one B-abstraction
of O
the O
most O
important O
challenges O
in O
the O
intestinal O
itx O
and O
multivisceral O
transplant B-abstraction
mvtx O
is O
to O
achieve O
a O
successful O
abdominal B-O
wall I-O
closure B-physical_entity
. O

recent O
findings O
a O
tension B-abstraction
free O
primary B-abstraction
closure B-abstraction
should O
be O
our O
aim B-abstraction
. O

in O
most O
of O
the O
cases O
, O
we O
need B-abstraction
to O
perform O
a O
component B-abstraction
separation B-abstraction
technique B-abstraction
, O
alone O
or O
combined O
, O
to O
the O
use B-abstraction
of O
a O
synthetic O
mesh B-physical_entity
. O

if O
those O
options O
are O
not O
feasible O
, O
the O
abdominal B-O
wall I-O
composite B-abstraction
vascularized O
allograft O
transplant B-abstraction
aw O
cva O
utilizing O
direct O
orthotopic O
vascularization B-physical_entity
can B-physical_entity
be O
considered O
. O

the O
nonvascularized O
abdominal O
rectus O
fascia B-physical_entity
has O
also O
become O
an O
alternative B-abstraction
method B-abstraction
used O
worldwide O
, O
proving O
to O
be O
simple B-physical_entity
and O
well B-physical_entity
tolerated O
procedure B-abstraction
. O

furthermore O
, O
the O
use B-physical_entity
of O
the O
aw O
has O
been O
recently O
proposed O
as O
a O
new O
tool B-abstraction
for O
a O
sentinel B-physical_entity
monitoring B-abstraction
of O
the O
intestinal O
or O
pancreas O
allograft O
. O

summary O
there B-physical_entity
are O
different O
validated O
options O
for O
abdominal B-O
wall I-O
closure B-physical_entity
following B-abstraction
intestinal O
transplantation B-abstraction
. O

the O
long O
term B-physical_entity
benefits O
of O
transplanting B-abstraction
the O
abdominal B-O
wall I-O
, O
full B-abstraction
or O
partial B-abstraction
thickness B-abstraction
and O
vascularized O
or O
nonvascularised O
, O
were O
shown O
. O

new O
developments O
might B-abstraction
help B-physical_entity
to O
expand O
their O
applications O
in O
different O
areas O
such O
as O
reconstructive B-O
surgery I-O
and O
immunology B-abstraction
. O


the O
arabidopsis O
thaliana O
late O
embryogenesis O
abundant O
gene O
atem6 O
is O
required O
for O
normal B-abstraction
seed B-physical_entity
development B-physical_entity
and O
for O
buffering O
the O
rate B-abstraction
of O
dehydration B-physical_entity
during O
the O
latter O
stages O
of O
seed B-physical_entity
maturation B-physical_entity
. O

however O
, O
its O
function B-abstraction
in O
salt B-abstraction
stress O
tolerance B-abstraction
is O
not O
fully O
understood O
. O

in O
this O
investigation B-abstraction
, O
cell B-physical_entity
suspension B-abstraction
cultures O
of O
three O
plant B-abstraction
species B-abstraction
rice B-physical_entity
oryza O
sativa O
l O
. O

, O
cotton B-physical_entity
gossypium O
hirsutum O
l O
. O

, O
and O
white B-abstraction
pine I-abstraction
pinus O
strobes O
l O
. O

were O
transformed O
using B-abstraction
agrobacterium O
tumefaciens O
strain B-abstraction
lba4404 O
harboring O
pbi O
atem6 O
. O

integration B-abstraction
of O
the O
atem6 O
gene O
into O
the O
genome O
of O
rice B-physical_entity
, O
cotton B-physical_entity
, O
and O
white B-abstraction
pine I-abstraction
has O
been O
confirmed O
by O
polymerase O
chain B-physical_entity
reaction I-physical_entity
, O
southern O
blotting O
, O
and O
northern O
blotting O
analyses O
. O

three O
transgenic O
cell B-physical_entity
lines O
from O
each O
of O
o O
. O

sativa O
, O
g O
. O

hirsutum O
, O
and O
p O
. O

strobus O
were O
used O
to O
analyze O
salt B-abstraction
stress O
tolerance B-abstraction
conferred O
by O
the O
overexpression O
of O
the O
atem6 O
gene O
. O

our O
results O
demonstrated O
that O
expression B-physical_entity
of O
the O
atem6 O
gene O
enhanced O
salt B-abstraction
tolerance B-abstraction
in O
transgenic O
cell B-physical_entity
lines O
. O

a O
decrease B-abstraction
in O
lipid O
peroxidation O
and O
an O
increment B-abstraction
in O
antioxidant O
enzymes O
ascorbate O
peroxidase O
, O
glutathione O
reductase O
and O
superoxide B-physical_entity
dismutase O
activities O
were O
observed O
in O
the O
transgenic O
cell B-physical_entity
lines O
, O
compared O
to O
the O
non O
transgenic O
control B-physical_entity
. O

in O
rice B-physical_entity
, O
atem6 O
increased O
expression B-abstraction
of O
ca2 O
dependent B-physical_entity
protein O
kinase O
genes O
oscpk6 O
, O
oscpk9 O
, O
oscpk10 O
, O
oscpk19 O
, O
oscpk25 O
, O
and O
oscpk26 O
under O
treatment B-abstraction
of O
salt B-abstraction
. O

these O
results O
suggested O
that O
overexpression O
of O
the O
atem6 O
gene O
in O
transgenic O
cell B-physical_entity
lines O
improved O
salt B-abstraction
stress O
tolerance B-abstraction
by O
regulating B-abstraction
expression B-physical_entity
of O
ca2 O
dependent B-physical_entity
protein O
kinase O
genes O
. O

overexpression O
of O
the O
atem6 O
gene O
could O
be O
an O
alternative B-abstraction
choice B-abstraction
for O
engineering B-physical_entity
plant B-abstraction
abiotic O
stress O
tolerance B-abstraction
. O


a O
novel B-physical_entity
gene O
, O
named O
ngaox1a O
, O
was O
isolated O
from O
nicotiana O
glutinosa O
by O
rt O
pcr O
reverse B-physical_entity
transcription B-abstraction
pcr O
. O

the O
full B-abstraction
length B-abstraction
cdna O
of O
ngaox1a O
was O
1448 O
bp O
, O
including O
a O
1062 O
bp O
orf O
open B-physical_entity
reading B-abstraction
frame B-abstraction
, O
a O
124 O
bp O
5' O
utr O
untranslated O
region B-abstraction
and O
a O
262 O
bp O
3' O
utr O
. O

the O
orf O
encodes O
a O
353 O
amino O
acid O
protein O
which O
contains O
two O
conserved O
cysteine O
residues O
, O
four B-physical_entity
iron B-physical_entity
binding B-abstraction
motifs O
, O
five B-physical_entity
alpha B-abstraction
helix B-physical_entity
regions O
and O
six B-physical_entity
conserved O
histidine O
residues O
. O

the O
phylogenetic O
tree B-physical_entity
showed O
that O
ngaox1a O
belongs O
to O
the O
aqx1 O
alternative B-abstraction
oxidase O
1 O
type B-physical_entity
group O
. O

alignment B-abstraction
analysis B-abstraction
showed O
that O
ngaox1a O
shares O
a O
high B-abstraction
similarity B-abstraction
with O
other O
known O
aoxs O
. O

four B-physical_entity
exons O
and O
three O
introns O
were O
detected O
in O
the O
genomic O
dna O
sequence B-abstraction
, O
and O
southern O
blotting O
analysis B-abstraction
suggested O
that O
ngaox1a O
is O
a O
single B-abstraction
copy B-physical_entity
gene O
. O

a O
series B-abstraction
of O
putative O
cis O
acting B-abstraction
elements O
were O
examined O
in O
the O
5' O
flanking O
region B-abstraction
of O
ngaox1a O
. O

northern O
blotting O
analysis B-abstraction
showed O
that O
the O
transcript O
levels O
of O
ngaox1a O
can B-physical_entity
be O
markedly O
accumulated O
when O
tobacco B-physical_entity
seedlings O
are O
treated O
with O
various O
abiotic O
stimuli O
, O
such O
as O
exogenous O
signalling O
molecules O
for O
plant B-physical_entity
defence B-abstraction
response B-physical_entity
, O
salicylic O
acid O
and O
h2o2 O
, O
and O
the O
exogenous O
tca O
tricarboxylic O
acid O
cycle B-physical_entity
metabolite O
citrate O
. O

however O
, O
it O
could O
be O
suppressed O
by O
abiotic O
stress O
, O
such O
as O
cocl2 O
, O
an O
inhibitor O
of O
ethylene O
, O
which O
indicates O
that O
the O
expression B-physical_entity
of O
ngaox1a O
may B-physical_entity
be O
regulated O
by O
ethylene O
. O

in O
addition B-physical_entity
, O
ngaox1a O
can B-physical_entity
also O
be O
strongly O
induced O
by O
three O
viral O
pathogens O
, O
tobacco B-physical_entity
mosaic B-abstraction
virus B-physical_entity
, O
potato B-physical_entity
virus B-physical_entity
x O
and O
potato B-physical_entity
virus B-physical_entity
y O
. O

these O
results O
indicate O
that O
ngaox1a O
may B-physical_entity
be O
involved O
in O
multi O
signal B-abstraction
transduction B-physical_entity
pathways O
and O
may B-physical_entity
play B-abstraction
an O
important O
role B-abstraction
in O
defence B-physical_entity
response B-physical_entity
. O


to O
identify O
genes O
expression B-abstraction
in O
chenopodium O
album B-physical_entity
exposed O
to O
nacl O
stress O
and O
screen B-physical_entity
ests O
related O
to O
salt B-abstraction
stress O
, O
a O
subtractive O
suppression B-abstraction
hybridization B-physical_entity
ssh O
library B-physical_entity
of O
c O
. O

album B-physical_entity
under O
salt B-abstraction
stress O
was O
constructed O
in O
the O
present B-abstraction
study B-physical_entity
. O

random O
est O
sequencing O
produced O
825 O
high B-abstraction
quality I-abstraction
ests O
with O
genbank O
id B-abstraction
ge746311 O
ge747007 O
, O
which O
had O
301 O
bp O
of O
average B-abstraction
size B-abstraction
and O
were O
clustered O
into O
88 O
contigs O
and O
550 O
singletons O
. O

they O
were O
classified O
into O
12 O
categories O
according O
to O
their O
function B-abstraction
annotations O
. O

635 O
ests O
76 O
. O

97 O
showed O
similarities O
to O
gene O
sequences O
in O
the O
non O
redundancy B-abstraction
database O
, O
while B-abstraction
190 O
ests O
23 O
. O

03 O
showed O
low B-physical_entity
or O
no B-abstraction
similarities O
. O

the O
transcriptional O
profiles O
of O
56 O
ests O
randomly O
selected O
from O
347 O
unknown B-physical_entity
or O
novel B-physical_entity
ests O
of O
ssh O
library B-physical_entity
under O
varying O
nacl O
concentration B-abstraction
and O
at O
different O
time B-abstraction
points O
were O
analyzed O
. O

the O
results O
indicated O
that O
a O
high B-physical_entity
proportion B-physical_entity
of O
tested O
ests O
were O
activated O
by O
salt B-abstraction
stress O
. O

four B-physical_entity
in O
56 O
ests O
responded O
to O
nacl O
were O
also O
enhanced O
in O
expression B-physical_entity
level B-abstraction
when O
exposed O
to O
aba B-physical_entity
and O
peg B-physical_entity
stresses O
. O

the O
above O
four B-physical_entity
ests O
were O
validated O
by O
northern O
blotting O
which O
was O
consistent O
with O
the O
results O
of O
rt O
pcr O
. O

the O
results O
suggested O
that O
genes O
corresponded O
to O
these O
ests O
might B-abstraction
be O
involved O
in O
stress O
response B-physical_entity
or O
regulation B-abstraction
. O

the O
complete O
sequences O
and O
detailed O
function B-abstraction
of O
these O
ests O
need B-abstraction
to O
be O
further O
studied O
. O


phosphorylation O
of O
protein O
kinases O
has O
profound O
effects O
on O
their O
activity B-abstraction
and O
interaction B-abstraction
with O
other O
proteins O
. O

tyrosine O
phosphorylation O
was O
reported O
to O
be O
involved O
in O
various O
physiological O
processes O
in O
plants O
; O
however O
, O
no B-abstraction
typical O
receptor O
tyrosine O
kinase O
has O
been O
isolated O
from O
plants O
thus O
far O
. O

dual O
specificity B-abstraction
kinases O
are O
potentially O
responsible O
for O
the O
phosphorylation O
of O
both O
tyrosine O
and O
serine O
threonine O
of O
target B-physical_entity
proteins O
. O

a O
cdna O
clone B-physical_entity
encoding B-abstraction
a O
putative O
dual O
specificity B-abstraction
protein O
kinase O
was O
isolated O
by O
screening B-physical_entity
the O
cdna O
gal4 O
activation B-abstraction
domain B-abstraction
ad O
fusion B-physical_entity
library B-physical_entity
of O
soybean B-physical_entity
glycine O
max O
l O
. O

, O
and O
its O
entire B-physical_entity
length B-abstraction
was O
obtained O
using B-abstraction
5' O
rapid O
amplification B-abstraction
of O
cdna O
ends O
. O

the O
predicted O
polypeptide O
of O
330 O
amino O
acid O
residues O
, O
designated O
as O
gmsty1 O
, O
contains O
all O
11 O
conserved O
subdomains O
, O
which O
share B-abstraction
common B-physical_entity
characteristics O
with O
both O
the O
serine O
threonine O
and O
tyrosine O
protein O
kinases O
reported O
thus O
far O
. O

in O
addition B-physical_entity
, O
three O
potential O
n O
linked O
glycosylation O
sites O
nxs O
t O
, O
as O
well B-physical_entity
as O
phosphorylation O
motifs O
sxxxs O
t O
, O
were O
observed O
, O
suggesting O
that O
gmsty1 O
may B-physical_entity
be O
post B-physical_entity
translationally O
modified O
. O

furthermore O
, O
a O
potential O
n O
myristoylation O
motif B-abstraction
mgarcsk O
was O
found O
, O
suggesting O
that O
the O
gmsty1 O
protein O
could O
associate B-abstraction
with O
membranes O
in O
vivo O
. O

southern O
blotting O
analysis B-abstraction
revealed O
a O
single B-abstraction
copy B-physical_entity
of O
gmsty1 O
in O
the O
genome O
. O

northern O
blotting O
analysis B-abstraction
showed O
that O
this O
gene O
was O
upregulated O
by O
drought B-abstraction
and O
salt B-abstraction
treatment B-abstraction
in O
a O
time B-abstraction
dependent B-physical_entity
manner B-abstraction
; O
however O
, O
exogenous O
abscisic O
acid O
aba B-physical_entity
could O
not O
significantly O
affect O
the O
mrna O
accumulation B-abstraction
of O
gmsty1 O
. O

interestingly O
, O
the O
transcript O
of O
this O
gene O
was O
remarkably O
downregulated O
by O
cold B-abstraction
treatment B-abstraction
during O
the O
early O
stages O
of O
the O
response B-abstraction
, O
but O
upregulated O
later O
. O

these O
results O
indicate O
that O
the O
protein O
kinase O
was O
possibly O
regulated O
by O
abiotic O
stresses O
in O
an O
aba B-physical_entity
independent B-physical_entity
pathway B-physical_entity
. O


mitogen O
activated O
protein O
kinase O
mapk O
cascades O
are O
signalling O
modules O
that O
transduce O
extracellular O
signalling O
to O
a O
range B-physical_entity
of O
cellular O
responses O
. O

plant B-physical_entity
mapk O
cascades O
have B-physical_entity
been O
implicated O
in O
development B-abstraction
and O
stress O
response B-physical_entity
. O

in O
this O
study B-physical_entity
, O
we O
isolated O
a O
novel B-physical_entity
group O
c O
mapkk O
gene O
, O
zmmkk4 O
, O
from O
maize B-abstraction
. O

northern O
blotting O
analysis B-abstraction
revealed O
that O
the O
zmmkk4 O
transcript O
expression B-abstraction
was O
up O
regulated O
by O
cold B-abstraction
, O
high B-physical_entity
salt B-abstraction
and O
exogenous O
h O
2 O
o O
2 O
, O
but O
down B-abstraction
regulated O
by O
exogenous O
abscisic O
acid O
aba B-physical_entity
. O

over B-abstraction
expression B-abstraction
of O
zmmkk4 O
in O
arabidopsis O
conferred O
tolerance B-abstraction
to O
cold B-abstraction
and O
salt B-abstraction
stresses O
by O
increased O
germination B-physical_entity
rate B-abstraction
, O
lateral B-abstraction
root B-physical_entity
numbers B-abstraction
, O
plant B-abstraction
survival B-abstraction
rate B-abstraction
, O
chlorophyll O
, O
proline O
and O
soluble O
sugar O
contents O
, O
and O
antioxidant O
enzyme O
peroxidase O
pod B-physical_entity
, O
catalase O
cat B-physical_entity
activities O
compared O
with O
control B-physical_entity
plants O
. O

furthermore O
, O
zmmkk4 O
enhanced O
a O
37 O
kda O
kinase O
activity B-abstraction
after O
cold B-abstraction
and O
salt B-abstraction
stresses O
. O

rt O
pcr O
analysis B-abstraction
revealed O
that O
the O
transcript O
levels O
of O
stress O
responsive O
transcription B-abstraction
factors O
and O
functional O
genes O
were O
higher O
in O
zmmkk4 O
over B-abstraction
expressing O
plants O
than O
in O
control B-physical_entity
plants O
. O

in O
addition B-physical_entity
, O
zmmkk4 O
protein O
is O
localized O
in O
the O
nucleus B-physical_entity
. O

taken O
together O
, O
these O
results O
indicate O
that O
zmmkk4 O
is O
a O
positive B-physical_entity
regulator B-physical_entity
of O
salt B-abstraction
and O
cold B-abstraction
tolerance B-abstraction
in O
plants O
. O


citrullus O
colocynthis O
l O
. O

schrad O
. O

is O
commonly O
known O
as O
colocynth O
. O

the O
fruit B-abstraction
pulp B-physical_entity
of O
colocynth O
has O
medicinal O
properties O
while B-abstraction
the O
seeds O
have B-physical_entity
nutritive O
qualities O
. O

c O
. O

colosynthis O
is O
resistant O
to O
high B-physical_entity
temperatures O
and O
grows O
in O
the O
desert B-physical_entity
regions O
of O
north B-physical_entity
africa O
, O
the O
middle B-physical_entity
east B-physical_entity
and O
western O
asia O
. O

c O
. O

colocynthis O
likely O
carries O
genes O
of O
interest B-abstraction
that O
could O
be O
explored O
for O
inducing B-abstraction
abiotic O
stress O
resistance B-abstraction
in O
transgenic O
plants O
. O

although O
the O
tissue O
culture B-physical_entity
and O
molecular B-O
biology I-O
of O
this O
species B-abstraction
have B-physical_entity
been O
explored O
, O
the O
latter O
has O
been O
primarily O
used O
to O
resolve O
taxonomic O
relationships O
with O
other O
members O
of O
the O
citrullus O
genus B-abstraction
and O
curcubits O
. O

genetic O
mining B-abstraction
of O
the O
plant B-abstraction
is O
scarce O
while B-abstraction
genetic O
transformation B-abstraction
protocols O
are O
also O
rare O
. O

the O
aim B-physical_entity
of O
the O
present B-abstraction
review B-abstraction
is O
to O
present B-abstraction
a O
brief O
overview O
of O
the O
biotechnological O
perspectives O
of O
c O
. O

colocynthis O
. O


purpose B-abstraction
of O
review B-abstraction
this O
review B-physical_entity
provides O
an O
update O
and O
summary O
of O
recent O
neuropsychological O
findings O
in O
epilepsy O
focusing B-abstraction
on O
three O
major B-physical_entity
clinical O
topics O
among O
the O
many O
developments O
in O
the O
field B-physical_entity
. O

we O
will B-abstraction
critically O
outline B-physical_entity
the O
current B-abstraction
state B-physical_entity
with O
regard B-abstraction
to O
cognition B-abstraction
in O
new O
onset B-abstraction
epilepsies O
, O
social O
cognition B-abstraction
in O
epilepsy O
, O
and O
the O
long O
term B-physical_entity
outcome B-abstraction
of O
epilepsy O
surgery B-abstraction
and O
the O
cognitive O
outcomes O
of O
superselective O
surgical O
procedures O
. O

recent O
findings O
current B-abstraction
studies O
indicate O
that O
neuropsychological O
impairments O
are O
prevalent O
already O
at O
the O
onset B-abstraction
of O
epilepsy O
and O
even B-abstraction
before O
, O
social O
cognition B-abstraction
i O
. O

e O
. O

, O
emotion O
recognition B-abstraction
and O
theory B-abstraction
of O
mind B-abstraction
is O
impaired O
in O
different O
epilepsy O
populations O
, O
the O
long O
term B-physical_entity
outcome B-abstraction
of O
epilepsy O
surgery B-physical_entity
is O
mostly O
characterized O
by O
a O
stable B-physical_entity
or O
even B-abstraction
improved O
cognitive O
status O
, O
and O
superselective O
epilepsy O
surgeries O
are O
associated O
with O
a O
promising O
neuropsychological O
outcome B-abstraction
. O

summary O
the O
high B-physical_entity
prevalence B-abstraction
of O
cognitive O
deficits O
around O
epilepsy O
onset B-abstraction
challenges O
the O
assumption B-abstraction
that O
epilepsy O
is O
the O
major B-physical_entity
cause B-abstraction
of O
cognitive O
problems O
and O
calls O
for O
early O
neuropsychological O
diagnostics B-abstraction
. O

social O
cognition B-abstraction
seems O
to O
be O
a O
relevant O
domain B-abstraction
that O
is O
not O
yet O
routinely O
considered O
in O
epilepsy O
. O

the O
cognitive O
long O
term B-abstraction
outcome B-abstraction
of O
epilepsy O
surgery B-abstraction
is O
mostly O
positive B-physical_entity
. O

stereotactic O
thermocoagulation B-physical_entity
and O
gamma O
knife B-physical_entity
surgery B-physical_entity
appear O
to O
be O
cognitively O
safe B-physical_entity
procedures O
. O


micrornas O
mirnas O
play B-abstraction
a O
crucial O
role B-abstraction
in O
tissue O
development B-physical_entity
and O
the O
pathology B-abstraction
of O
many O
diseases O
, O
however O
, O
the O
effects O
and O
roles O
of O
mirnas O
in O
the O
development B-physical_entity
of O
semen O
abnormalities O
in O
infertile O
males O
have B-physical_entity
not O
yet O
been O
investigated O
. O

in O
this O
study B-physical_entity
, O
we O
analyzed O
and O
compared O
the O
mirna O
expression B-physical_entity
profiles O
of O
abnormal O
semen O
from O
86 O
infertile O
males O
with O
normal B-abstraction
semen O
from O
86 O
healthy O
males O
using B-abstraction
an O
mirna O
microarray O
. O

in O
total B-abstraction
, O
52 O
mirnas O
were O
differentially O
expressed O
between O
the O
abnormal O
semen O
of O
infertile O
males O
and O
the O
normal B-abstraction
semen O
of O
healthy O
males O
. O

the O
differential B-abstraction
expression B-abstraction
of O
selected O
mirnas O
was O
validated O
by O
real B-O
time I-O
qrt O
pcr O
and O
northern O
blotting O
mir O
574 O
5p O
, O
mir O
297 O
, O
mir O
122 O
, O
mir O
1275 O
, O
mir O
373 O
, O
mir O
185 O
and O
mir O
193b O
were O
upregulated O
fold B-abstraction
change B-abstraction
1 O
. O

5 O
, O
p O
0 O
. O

001 O
and O
mir O
100 O
, O
mir O
512 O
3p O
, O
mir O
16 O
, O
mir O
19b O
, O
mir O
23b O
and O
mir O
26a O
were O
downregulated O
fold B-abstraction
change B-physical_entity
0 O
. O

667 O
, O
p O
0 O
. O

001 O
in O
the O
semen O
of O
infertile O
males O
with O
semen O
abnormalities O
. O

in O
conclusion B-abstraction
, O
this O
study B-physical_entity
provides O
new O
insights O
into O
specific B-abstraction
mirnas O
that O
arc O
associated O
with O
semen O
abnormalities O
in O
infertile O
males O
. O


background B-abstraction
respiratory O
morbidity B-abstraction
in O
australian O
indigenous O
children O
is O
higher O
than O
their O
non O
indigenous O
counterparts O
, O
irrespective O
of O
urban O
or O
remote B-physical_entity
residence B-physical_entity
. O

there B-physical_entity
are O
limited B-physical_entity
studies O
addressing O
acute O
respiratory O
illness O
ari O
in O
urban O
indigenous O
children O
, O
particularly O
those O
that O
address B-physical_entity
the O
upper B-physical_entity
airway B-physical_entity
microbiome O
and O
its O
relationship O
to O
disease O
. O

we O
aimed O
to O
describe O
the O
prevalence B-abstraction
of O
upper B-physical_entity
airway B-physical_entity
viruses O
and O
bacteria B-physical_entity
in O
symptomatic O
and O
asymptomatic O
urban O
based O
australian O
indigenous O
children O
aged O
less O
than O
5 O
years B-abstraction
. O

methods O
a O
cross B-physical_entity
sectional B-physical_entity
analysis B-abstraction
of O
data O
collected O
at O
baseline O
in O
an O
ongoing O
prospective O
cohort O
study B-physical_entity
of O
urban O
aboriginal B-physical_entity
and O
torres O
strait O
islander B-physical_entity
children O
registered O
with O
a O
primary B-physical_entity
health B-O
care I-O
service B-abstraction
in O
the O
northern O
suburbs O
of O
brisbane O
, O
australia O
. O

clinical O
, O
demographic B-abstraction
and O
epidemiological O
data O
and O
bilateral O
anterior O
nasal O
swabs O
were O
collected O
on O
enrolment B-abstraction
. O

polymerase O
chain B-physical_entity
reaction I-physical_entity
was O
performed O
on O
nasal O
swabs O
to O
detect O
17 O
respiratory O
viruses O
and O
7 O
bacteria B-physical_entity
. O

the O
primary B-physical_entity
outcome B-abstraction
was O
the O
prevalence B-abstraction
of O
these O
microbes O
at O
enrolment B-abstraction
. O

logistic O
regression B-physical_entity
was O
performed O
to O
investigate O
differences O
in O
microbe B-physical_entity
prevalence B-abstraction
between O
children O
with O
and O
without O
acute O
respiratory O
illness O
with O
cough B-abstraction
as O
a O
symptom B-abstraction
ariwc O
at O
time B-abstraction
of O
specimen B-physical_entity
collection B-abstraction
. O

results O
between O
february O
2013 O
and O
october O
2015 O
, O
164 O
children O
were O
enrolled O
. O

the O
median B-abstraction
age B-abstraction
at O
enrolment B-abstraction
was O
18 O
. O

0 O
months O
iqr O
7 O
. O

2 O
34 O
. O

3 O
, O
49 O
. O

4 O
were O
boys O
and O
56 O
children O
34 O
. O

2 O
had O
ariwc O
. O

overall B-physical_entity
, O
133 O
164 O
81 O
nasal O
swabs O
were O
positive B-physical_entity
for O
at O
least O
one B-abstraction
organism B-physical_entity
; O
131 O
79 O
. O

9 O
for O
any O
bacteria B-physical_entity
, O
59 O
36 O
. O

2 O
for O
any O
virus B-physical_entity
and O
57 O
34 O
. O

8 O
for O
both O
viruses O
and O
bacteria B-physical_entity
. O

co O
detection B-abstraction
of O
viruses O
and O
bacteria B-physical_entity
was O
more O
common B-physical_entity
in O
females O
than O
males O
61 O
. O

4 O
vs O
38 O
. O

6 O
, O
p O
0 O
. O

044 O
. O

no B-abstraction
microbes O
, O
alone O
or O
in O
combination B-abstraction
, O
were O
significantly O
associated O
with O
the O
presence B-abstraction
of O
ariwc O
. O

conclusions O
the O
prevalence B-abstraction
of O
upper B-physical_entity
airways O
microbes O
in O
asymptomatic O
children O
is O
similar O
to O
non O
indigenous O
children O
with O
ariwc O
from O
the O
same O
region B-abstraction
. O

determining O
the O
aetiology B-abstraction
of O
ariwc O
in O
this O
community B-physical_entity
is O
complicated O
by O
the O
high B-physical_entity
prevalence B-abstraction
of O
multiple B-abstraction
respiratory O
pathogens O
in O
the O
upper B-physical_entity
airways O
. O


we O
identified O
a O
nodulin O
related O
protein O
1 O
nrp1 O
encoded O
by O
at2g03440 O
, O
which O
was O
previously O
reported O
to O
be O
rps2 O
interacting O
protein O
in O
yeast B-physical_entity
two O
hybrid B-physical_entity
assay B-abstraction
. O

northern O
blotting O
showed O
that O
atnrp1 O
expression B-abstraction
was O
suppressed O
by O
heat B-abstraction
stress O
42a O
degrees O
c O
and O
induced O
by O
low B-abstraction
temperature I-physical_entity
4a O
degrees O
c O
treatment B-abstraction
. O

strong O
gus O
staining B-abstraction
was O
observed O
in O
the O
sites O
of O
meristematic O
tissues O
of O
patnrp1 O
gus O
transgenic O
plants O
, O
such O
as O
shoot B-physical_entity
apex B-physical_entity
and O
root B-physical_entity
tips O
, O
young B-physical_entity
leaf B-physical_entity
veins O
, O
stamens O
and O
stigmas O
of O
flowers O
, O
and O
abscission B-physical_entity
layers O
of O
young B-physical_entity
siliques O
. O

to O
study B-physical_entity
atnrp1 O
biological O
functions O
, O
we O
have B-physical_entity
characterized O
both O
loss B-abstraction
of O
function B-abstraction
t O
dna O
insertion B-abstraction
and O
transgenic O
overexpression O
plants O
for O
atnrp1 O
in O
arabidopsis O
. O

the O
t O
dna O
insertion B-abstraction
mutants O
displayed O
no B-abstraction
obvious O
difference B-abstraction
as O
compared O
to O
wild B-physical_entity
type B-abstraction
arabidopsis O
under O
heat B-abstraction
stress O
, O
but O
the O
significant O
enhanced O
susceptibility O
to O
heat B-physical_entity
stress O
was O
revealed O
in O
two O
independent B-physical_entity
atnrp1 O
overexpressing O
transgenic O
lines O
. O

further O
study B-abstraction
found O
that O
the O
decreased O
thermtolerance O
in O
atnrp1 O
overexpressing O
lines O
accompanied O
significantly O
decreased O
accumulation B-abstraction
of O
aba B-physical_entity
after O
heat B-physical_entity
treatment B-abstraction
, O
which O
was O
probably O
due B-abstraction
to O
atnrp1 O
playing B-abstraction
a O
role B-abstraction
in O
negative B-abstraction
feedback I-abstraction
regulation B-abstraction
of O
the O
aba B-physical_entity
synthesis B-abstraction
pathway B-physical_entity
. O

these O
results O
support B-abstraction
the O
viewpoint B-physical_entity
that O
the O
application B-abstraction
of O
aba B-physical_entity
inhibits O
nodulation O
and O
nodulin O
related O
gene O
expression B-abstraction
and O
threaten O
adverse O
ambient O
temperature B-abstraction
can B-physical_entity
impact B-abstraction
the O
nodulin O
related O
gene O
expression B-abstraction
. O


although O
a O
great B-physical_entity
deal B-physical_entity
of O
progress B-abstraction
has O
been O
made O
toward O
understanding B-abstraction
the O
role B-abstraction
of O
abscisic O
acid O
aba B-physical_entity
in O
fruit B-physical_entity
ripening B-physical_entity
, O
many O
components O
in O
the O
aba B-physical_entity
signalling O
pathway B-physical_entity
remain O
to O
be O
elucidated O
. O

here B-physical_entity
, O
a O
strawberry B-physical_entity
gene O
homologous O
to O
the O
arabidopsis O
gene O
abi1 O
, O
named O
faabi1 O
, O
was O
isolated O
and O
characterized O
. O

the O
1641bp O
cdna O
includes O
an O
intact O
open B-abstraction
reading B-abstraction
frame B-physical_entity
that O
encodes O
a O
deduced O
protein O
of O
546 O
amino O
acids O
, O
in O
which O
putative O
conserved O
domains O
were O
determined O
by O
homology B-abstraction
analysis B-abstraction
. O

transcriptional O
analysis B-abstraction
showed O
that O
the O
levels O
of O
faabi1 O
mrna O
expression B-abstraction
declined O
rapidly O
during O
strawberry B-abstraction
fruit B-physical_entity
development B-abstraction
as O
evidenced O
by O
real B-O
time I-O
pcr O
, O
semi B-physical_entity
quantitative O
reverse B-abstraction
transcriptionpcr O
, O
and O
northern O
blotting O
analyses O
, O
suggesting O
that O
the O
ser O
thr O
protein O
phosphatase O
pp2c1 O
encoded O
by O
faabi1 O
may B-physical_entity
be O
involved O
in O
fruit B-physical_entity
ripening B-physical_entity
as O
a O
negative B-physical_entity
regulator B-physical_entity
. O

the O
results O
of O
tobacco B-physical_entity
rattle B-abstraction
virus B-physical_entity
induced O
gene O
silencing O
and O
pbi121 O
vector B-physical_entity
mediated O
overexpression O
suggested O
that O
the O
down B-abstraction
and O
up O
regulation B-physical_entity
of O
faabi1 O
mrna O
expression B-physical_entity
levels O
in O
degreening O
strawberry B-abstraction
fruit B-physical_entity
could O
promote O
and O
inhibit O
ripening B-physical_entity
, O
respectively O
. O

furthermore O
, O
alteration B-abstraction
of O
faabi1 O
expression B-abstraction
could O
differentially O
regulate O
the O
transcripts O
of O
a O
set B-abstraction
of O
both O
aba B-physical_entity
responsive O
and O
ripening B-physical_entity
related O
genes O
, O
including O
abi3 O
, O
abi4 O
, O
abi5 O
, O
snrk2 O
, O
abre1 O
, O
chs O
, O
pg1 O
, O
pl O
, O
chi O
, O
f3h O
, O
dfr O
, O
ans O
, O
and O
ufgt O
. O

taken O
together O
, O
the O
data O
provide O
new O
evidence B-abstraction
for O
an O
important O
role B-abstraction
for O
aba B-physical_entity
in O
regulating B-abstraction
strawberry B-abstraction
fruit B-physical_entity
ripening B-physical_entity
in O
the O
processes O
of O
which O
the O
type B-physical_entity
2c O
protein O
phosphatase O
abi1 O
serves O
as O
a O
negative B-abstraction
regulator B-physical_entity
. O

finally O
, O
a O
possible B-physical_entity
core B-abstraction
mechanism B-abstraction
underlying O
aba B-physical_entity
perception B-abstraction
and O
signalling O
transduction B-physical_entity
in O
strawberry B-abstraction
fruit B-physical_entity
ripening B-physical_entity
is O
discussed O
. O


in O
this O
paper B-physical_entity
, O
the O
concept B-abstraction
of O
multi O
objective B-abstraction
optimization B-abstraction
is O
introduced O
in O
the O
automation B-physical_entity
of O
the O
placement B-abstraction
task B-abstraction
in O
analog B-abstraction
integrated O
circuits O
layout B-abstraction
design B-abstraction
. O

to O
bridge B-physical_entity
the O
difficulties O
found O
on O
state B-physical_entity
of O
the O
art B-abstraction
works B-physical_entity
on O
fulfilling O
proximity B-abstraction
constraints O
, O
here B-physical_entity
, O
cells O
are O
organized O
into O
proximity B-abstraction
groups O
which O
implement B-physical_entity
the O
desired O
set B-physical_entity
of O
symmetry B-abstraction
and O
proximity B-physical_entity
requirements O
. O

then O
, O
an O
innovative O
archived O
based O
multi O
objective B-physical_entity
simulated O
annealing B-abstraction
algorithm B-abstraction
, O
operating O
over B-abstraction
an O
absolute B-abstraction
representation B-physical_entity
, O
is O
proposed O
to O
optimize O
the O
placement B-abstraction
of O
each O
proximity B-physical_entity
group O
. O

in O
contrast B-abstraction
to O
traditional O
single B-abstraction
objective B-abstraction
placement B-abstraction
approaches O
, O
the O
resulting O
pareto O
fronts O
of O
placements O
, O
representing O
the O
tradeoffs O
between O
the O
optimization B-abstraction
objectives O
of O
each O
group O
, O
are O
combined O
, O
bottom B-abstraction
up O
, O
through O
the O
design B-physical_entity
hierarchy O
, O
until O
a O
final B-abstraction
front B-abstraction
is O
obtained O
. O

this O
way B-physical_entity
, O
the O
problem's O
complexity B-abstraction
is O
reduced O
, O
and O
split B-physical_entity
over B-abstraction
multiple B-abstraction
executions O
of O
the O
optimization B-abstraction
kernel B-abstraction
with O
less O
design B-abstraction
variables O
, O
and O
also O
, O
analog B-abstraction
designer B-physical_entity
becomes O
aware O
of O
the O
design B-physical_entity
tradeoffs O
. O

the O
proposed O
multi O
objective B-physical_entity
and O
hierarchical O
methodology B-abstraction
was O
implemented O
, O
and O
, O
experimental O
results O
prove O
that O
previous O
efforts O
on O
single B-abstraction
objective B-abstraction
absolute B-abstraction
representations O
are O
no B-abstraction
match B-abstraction
for O
the O
obtained O
floorplans O
. O

furthermore O
, O
the O
obtained O
pareto O
fronts O
contain O
the O
solutions O
found O
with O
the O
most O
recent O
published O
topological O
representations O
for O
the O
well B-physical_entity
known O
microelectronics B-abstraction
center B-abstraction
of O
north B-physical_entity
carolina O
benchmark O
sets O
, O
and O
, O
allowed O
an O
improvement B-abstraction
of O
placement B-abstraction
area B-abstraction
up O
to O
23 O
on O
a O
previously O
optimized O
folded O
cascode O
operational O
amplifier B-physical_entity
for O
the O
united O
microelectronics B-abstraction
corporation O
0 O
. O

13 O
gm O
fabrication B-abstraction
process B-physical_entity
. O

c O
2015 O
elsevier O
ltd O
. O

all O
rights O
reserved O
. O


this O
study B-physical_entity
examined O
whether O
child B-physical_entity
abuse I-physical_entity
history B-abstraction
in O
teen B-physical_entity
mothers O
impacts O
offspring B-physical_entity
externalizing O
problems O
indirectly O
, O
through O
its O
influence B-abstraction
on O
attachment B-physical_entity
and O
maternal O
hostility B-abstraction
. O

in O
a O
longitudinal O
sample B-physical_entity
of O
112 O
teen B-physical_entity
mother B-physical_entity
child B-physical_entity
dyads O
, O
mothers O
reported O
on O
their O
own O
abuse B-abstraction
experiences O
, O
attachment B-abstraction
and O
maternal O
hostility B-abstraction
were O
assessed O
via O
direct O
observations O
, O
and O
externalizing O
problems O
were O
measured O
using B-abstraction
maternal O
reports O
. O

compared O
with O
mothers O
with O
no B-abstraction
abuse B-abstraction
history B-abstraction
, O
mothers O
with O
a O
history B-abstraction
of O
sexual O
and O
physical O
abuse B-abstraction
were O
more O
likely O
to O
have B-physical_entity
an O
insecurely O
attached O
infant B-physical_entity
, O
which O
predicted O
higher O
externalizing O
problems O
in O
preschool O
, O
which O
in O
turn B-abstraction
predicted O
subsequent O
increases O
in O
externalizing O
problems O
in O
grade B-physical_entity
3 O
. O

furthermore O
, O
relative B-physical_entity
to O
the O
no B-abstraction
abuse B-abstraction
history B-abstraction
group O
, O
mothers O
with O
a O
history B-abstraction
of O
sexual O
and O
physical O
abuse B-abstraction
showed O
more O
hostility B-abstraction
toward O
their O
child B-physical_entity
at O
preschool O
, O
which O
in O
turn B-abstraction
predicted O
elevated O
externalizing O
problems O
in O
grade B-physical_entity
3 O
. O

mothers' O
history B-abstraction
of O
either O
sexual O
or O
physical O
abuse B-abstraction
alone O
did O
not O
have B-physical_entity
significant O
indirect O
effects O
on O
externalizing O
problems O
. O

fostering B-abstraction
secure O
attachment B-abstraction
and O
reducing B-physical_entity
risk B-abstraction
for O
maternal O
hostility B-abstraction
might B-abstraction
be O
important O
intervention B-abstraction
goals O
for O
prevention B-abstraction
programs O
involving O
at O
risk B-abstraction
mothers O
with O
abuse B-abstraction
histories O
. O

c O
2016 O
elsevier O
ltd O
. O

all O
rights O
reserved O
. O


background B-physical_entity
this O
study B-physical_entity
assessed O
the O
knowledge B-abstraction
of O
personal B-physical_entity
safety B-physical_entity
skills O
among O
children O
with O
developmental O
disabilities O
and O
their O
parents' O
perceptions O
of O
children's O
knowledge B-abstraction
. O

method B-abstraction
this O
exploratory O
study B-physical_entity
examined O
the O
mental O
health O
records O
of O
37 O
children O
with O
developmental O
disabilities O
referred O
for O
an O
abuse B-abstraction
risk B-abstraction
reduction B-physical_entity
group O
in O
a O
community B-physical_entity
mental O
health O
setting B-physical_entity
. O

qualitative B-O
analysis I-O
of O
children's O
responses O
to O
questions O
about O
personal B-physical_entity
safety B-physical_entity
skills O
knowledge B-abstraction
related O
to O
physical O
development B-abstraction
and O
personal B-physical_entity
safety B-physical_entity
, O
an O
appropriate O
and O
inappropriate O
touch B-abstraction
and O
safety B-physical_entity
skills O
to O
respond O
to O
an O
inappropriate O
touch B-abstraction
indicated O
participants' O
varied O
and O
inconsistent O
levels O
of O
knowledge B-abstraction
. O

results O
consistent O
with O
the O
literature B-abstraction
, O
the O
results O
indicate O
risk B-abstraction
factors O
for O
sexual B-O
abuse I-O
among O
children O
with O
developmental O
disabilities O
, O
including O
children's O
difficulty B-abstraction
distinguishing O
between O
an O
appropriate O
and O
inappropriate O
touch B-abstraction
and O
the O
lack O
of O
knowledge B-abstraction
regarding O
appropriate O
venues O
for O
disclosing O
an O
inappropriate O
touch B-abstraction
. O

among O
parents O
, O
a O
lack O
of O
certainty B-abstraction
regarding O
their O
children's O
knowledge B-abstraction
and O
the O
ability B-abstraction
to O
keep B-physical_entity
themselves O
safe B-physical_entity
was O
identified O
. O

conclusion B-abstraction
results O
support B-abstraction
the O
need B-abstraction
for O
education B-abstraction
about O
personal B-physical_entity
safety B-physical_entity
for O
children O
with O
developmental O
disabilities O
and O
their O
families O
. O


introduction B-physical_entity
posttraumatic O
stress O
symptoms O
pts O
are O
associated O
with O
increased O
risk B-abstraction
of O
obstetric O
complications O
among O
pregnant O
survivors O
of O
trauma O
, O
abuse B-abstraction
and O
interpersonal O
violence B-abstraction
, O
but O
little O
is O
known O
about O
how O
pts O
affects O
women's O
actual O
experiences O
of O
obstetric O
care B-abstraction
. O

this O
study B-abstraction
investigated O
the O
rate B-abstraction
at O
which O
abuse B-abstraction
history B-abstraction
was O
detected O
by O
obstetricians O
, O
whether O
abuse B-abstraction
survivors O
experienced O
more O
invasive O
exams O
than O
is O
typically O
indicated O
for O
routine B-abstraction
obstetric O
care B-abstraction
, O
and O
whether O
psychological O
distress B-abstraction
was O
associated O
with O
abuse B-abstraction
survivors' O
sense B-abstraction
of O
self B-physical_entity
efficacy B-abstraction
when O
communicating B-abstraction
their O
obstetric O
care B-abstraction
needs O
. O

methods O
forty O
one B-abstraction
pregnant O
abuse B-abstraction
survivors O
completed O
questionnaires O
about O
abuse B-abstraction
history B-abstraction
, O
current B-abstraction
psychological O
distress B-abstraction
and O
self B-physical_entity
efficacy B-abstraction
for O
communicating B-abstraction
obstetric O
care B-abstraction
needs O
and O
preferences O
. O

electronic O
medical B-abstraction
records O
emrs O
were O
reviewed O
to O
examine O
frequency O
of O
invasive O
prenatal O
obstetric O
procedures O
e O
. O

g O
. O

removal B-abstraction
of O
clothing B-physical_entity
for O
external B-abstraction
genital O
examination B-abstraction
, O
pelvic O
exams O
and O
procedures O
and O
to O
examine O
the O
detection B-abstraction
rate B-abstraction
of O
abuse B-abstraction
histories O
during O
the O
initial O
obstetric O
visit B-abstraction
. O

results O
the O
majority B-abstraction
of O
participants O
83 O
reported O
at O
least O
one B-abstraction
past B-abstraction
incident B-abstraction
of O
violent O
physical O
or O
sexual B-O
assault I-O
. O

obstetricians O
detected O
abuse B-abstraction
histories O
in O
less O
than O
one B-abstraction
quarter B-physical_entity
of O
cases O
. O

nearly O
half B-abstraction
of O
participants O
46 O
received O
invasive O
exams O
for O
non O
routine B-abstraction
reasons O
. O

pts O
and O
depression B-physical_entity
symptoms O
were O
associated O
with O
lower B-physical_entity
self B-physical_entity
efficacy B-abstraction
in O
communicating B-abstraction
obstetric O
care B-abstraction
preferences O
. O

discussion B-abstraction
women O
most O
at O
risk B-abstraction
for O
experiencing O
distress B-abstraction
during O
their O
obstetric O
visits O
and O
or O
undergoing O
potentially O
distressing O
procedures O
may B-physical_entity
also O
be O
the O
least O
likely O
to O
communicate O
their O
distress B-abstraction
to O
obstetricians O
. O

results O
are O
discussed O
with O
implications O
for O
improving O
screening B-physical_entity
for O
abuse B-abstraction
screening B-physical_entity
and O
distress B-abstraction
symptoms O
as O
well B-physical_entity
as O
need B-abstraction
for O
trauma O
sensitive B-physical_entity
obstetric O
practices O
. O


this O
paper B-physical_entity
tests O
the O
hypothesis B-abstraction
that O
the O
association B-physical_entity
between O
childhood B-abstraction
maltreatment B-abstraction
and O
adult B-physical_entity
personality B-physical_entity
dysfunction O
is O
at O
least O
partially O
attributable O
to O
insecure O
attachment B-abstraction
, O
that O
is O
that O
attachment B-physical_entity
style B-physical_entity
mediates O
the O
relationship O
between O
childhood B-abstraction
maltreatment B-abstraction
and O
adult B-physical_entity
personality B-physical_entity
dysfunction O
. O

associations O
between O
childhood B-abstraction
trauma O
, O
as O
measured O
by O
the O
childhood B-abstraction
trauma O
questionnaire O
ctq O
, O
anxious O
and O
avoidant O
attachment B-abstraction
in O
romantic B-physical_entity
relationships O
, O
as O
measured O
by O
the O
experiences O
in O
close B-abstraction
relationships O
revised O
ecr O
r B-abstraction
, O
and O
five B-physical_entity
personality B-physical_entity
domains O
, O
as O
measured O
by O
the O
severity B-abstraction
indices O
of O
personality B-physical_entity
problems O
sipp O
118 O
, O
were O
examined O
in O
a O
sample B-physical_entity
of O
72 O
psychiatric O
inpatients O
. O

the O
sipp O
118 O
domains O
included O
relational O
capacities O
, O
identity B-abstraction
integration B-abstraction
, O
self B-physical_entity
control B-abstraction
, O
responsibility B-abstraction
, O
and O
social O
concordance B-abstraction
. O

the O
direct O
effect B-abstraction
of O
childhood B-abstraction
trauma O
on O
all O
sipp O
118 O
domains O
was O
not O
significant O
after O
controlling O
for O
the O
indirect O
effect B-abstraction
of O
attachment B-abstraction
. O

in O
regression B-abstraction
modeling B-abstraction
, O
a O
significant O
indirect O
effect B-abstraction
of O
childhood B-abstraction
trauma O
via O
adult B-physical_entity
attachment B-physical_entity
style B-physical_entity
was O
found O
for O
sipp O
118 O
relational O
capacities O
, O
identity B-abstraction
integration B-abstraction
, O
self B-physical_entity
control B-abstraction
, O
and O
social O
concordance B-abstraction
. O

specifically O
, O
anxious O
attachment B-physical_entity
was O
a O
significant O
mediator B-physical_entity
of O
the O
effect B-abstraction
of O
childhood B-abstraction
trauma O
on O
self B-physical_entity
control B-abstraction
, O
identity B-abstraction
integration B-abstraction
, O
and O
relational O
domains O
. O

these O
results O
suggest O
that O
childhood B-abstraction
trauma O
impacts O
a O
broad B-physical_entity
range B-physical_entity
of O
personality B-physical_entity
domains O
and O
does O
so O
in O
large B-abstraction
part B-physical_entity
through O
the O
pathway B-physical_entity
of O
anxious O
romantic B-physical_entity
attachment B-abstraction
style B-physical_entity
. O


background B-abstraction
alterations O
in O
gray B-physical_entity
matter B-abstraction
development B-physical_entity
represent O
a O
potential O
pathway B-physical_entity
through O
which O
childhood B-abstraction
abuse B-abstraction
is O
associated O
with O
psychopathology B-abstraction
. O

several O
prior B-physical_entity
studies O
find B-abstraction
reduced O
volume B-abstraction
and O
thickness B-abstraction
of O
prefrontal O
pfc O
and O
temporal O
cortex B-physical_entity
regions O
in O
abused O
compared O
with O
nonabused O
adolescents O
, O
although O
most O
prior B-physical_entity
research B-abstraction
is O
based O
on O
adults O
and O
volume B-physical_entity
based O
measures O
. O

this O
study B-physical_entity
tests O
the O
hypothesis B-abstraction
that O
child B-physical_entity
abuse I-physical_entity
, O
independent B-physical_entity
of O
parental O
education B-abstraction
, O
predicts O
reduced O
cortical O
thickness B-abstraction
in O
prefrontal O
and O
temporal O
cortices O
as O
well B-physical_entity
as O
reduced O
gray B-abstraction
mater B-physical_entity
volume B-abstraction
gmv O
in O
subcortical O
regions O
during O
adolescence B-abstraction
. O

methods O
structural O
mri O
scans O
were O
obtained O
from O
21 O
adolescents O
exposed O
to O
physical O
and O
or O
sexual B-O
abuse I-O
and O
37 O
nonabused O
adolescents O
ages O
13 O
20 O
. O

abuse B-abstraction
was O
operationalized O
using B-abstraction
dichotomous O
and O
continuous O
measures O
. O

we O
examined O
associations O
between O
abuse B-abstraction
and O
brain B-physical_entity
structure B-physical_entity
in O
several O
a O
priori O
defined O
regions O
, O
controlling O
for O
parental O
education B-abstraction
, O
age B-abstraction
, O
sex B-abstraction
, O
race B-physical_entity
, O
and O
total B-abstraction
brain B-physical_entity
volume B-physical_entity
for O
subcortical O
gmv O
. O

significance B-abstraction
was O
evaluated O
at O
p O
. O

05 O
with O
a O
false O
discovery B-abstraction
rate B-abstraction
correction B-abstraction
. O

results O
child B-physical_entity
abuse I-physical_entity
exposure B-physical_entity
and O
severity B-abstraction
were O
associated O
with O
reduced O
thickness B-abstraction
in O
ventromedial O
prefrontal O
cortex B-physical_entity
pfc O
, O
right B-physical_entity
lateral B-abstraction
orbitofrontal O
cortex B-physical_entity
, O
right B-physical_entity
inferior B-physical_entity
frontal B-physical_entity
gyrus O
, O
bilateral O
parahippocampal O
gyrus O
phg O
, O
left B-physical_entity
temporal O
pole B-abstraction
, O
and O
bilateral O
inferior B-physical_entity
, O
right B-abstraction
middle B-abstraction
, O
and O
right B-abstraction
superior B-physical_entity
temporal O
gyri O
. O

neither O
abuse B-abstraction
measure B-abstraction
predicted O
cortical O
surface B-abstraction
area I-physical_entity
or O
subcortical O
gmv O
. O

bilateral O
phg O
thickness B-abstraction
was O
inversely O
related O
to O
externalizing O
symptoms O
. O

conclusions O
child B-physical_entity
abuse I-physical_entity
, O
an O
experience B-abstraction
characterized O
by O
a O
high B-abstraction
degree B-abstraction
of O
threat B-abstraction
, O
is O
associated O
with O
reduced O
cortical O
thickness B-abstraction
in O
ventromedial O
and O
ventrolateral O
pfc O
and O
medial O
and O
lateral B-abstraction
temporal O
cortex B-physical_entity
in O
adolescence B-abstraction
. O

reduced O
phg O
thickness B-abstraction
may B-physical_entity
be O
a O
mediator B-physical_entity
linking O
abuse B-abstraction
with O
externalizing O
psychopathology B-abstraction
, O
although O
prospective O
research B-abstraction
is O
needed O
to O
evaluate O
this O
possibility B-abstraction
. O


the O
significant O
co O
occurrence B-abstraction
between O
men's B-physical_entity
violence B-abstraction
against O
female B-physical_entity
partners O
and O
child B-physical_entity
abuse I-physical_entity
and O
neglect B-abstraction
is O
well B-physical_entity
documented O
. O

it O
is O
less O
clear B-physical_entity
how O
child B-physical_entity
safety B-physical_entity
should O
be O
managed O
in O
family B-physical_entity
violence B-abstraction
research B-abstraction
with O
their O
mothers O
. O

this O
issue B-physical_entity
is O
salient O
to O
isafe O
, O
a O
new O
zealand O
based O
internet B-physical_entity
intervention B-abstraction
study B-abstraction
testing B-abstraction
improvement B-abstraction
in O
safety B-abstraction
decisions O
and O
mental O
health O
outcomes O
for O
women O
experiencing O
intimate B-physical_entity
partner B-physical_entity
violence B-abstraction
. O

this O
article B-physical_entity
discusses O
the O
legislative O
, O
professional B-physical_entity
, O
and O
ethical O
considerations O
that O
contribute O
to O
the O
development B-abstraction
of O
the O
child B-physical_entity
safety B-abstraction
protocols O
and O
discusses O
the O
development B-physical_entity
of O
the O
isafe O
protocol B-abstraction
. O

hypothetical B-abstraction
scenarios O
of O
the O
application B-abstraction
of O
the O
isafe O
protocol B-abstraction
are O
used O
to O
illuminate O
the O
issues O
and O
provide O
a O
basis B-abstraction
for O
future B-abstraction
discussion B-abstraction
. O


child B-physical_entity
sexual B-O
abuse I-O
csa O
is O
a O
global O
public O
health O
problem B-abstraction
with O
major B-physical_entity
consequences O
for O
the O
individual B-physical_entity
child B-physical_entity
and O
society O
. O

an O
earlier O
swedish O
study B-abstraction
showed O
that O
the O
school B-physical_entity
nurses O
did O
not O
initially O
talk B-abstraction
about O
nor O
mention O
csa O
as O
one B-abstraction
form B-abstraction
of O
child B-physical_entity
abuse I-physical_entity
. O

for O
the O
child B-physical_entity
to O
receive O
adequate O
support B-physical_entity
, O
the O
disclosure B-abstraction
is O
a O
precondition B-abstraction
and O
is O
dependent B-physical_entity
on O
an O
available O
person B-physical_entity
prepared O
to O
listen O
. O

the O
aim B-physical_entity
of O
the O
study B-abstraction
was O
to O
explore O
the O
ability B-abstraction
of O
the O
school B-abstraction
nurses O
to O
detect O
and O
support B-physical_entity
sexually O
abused O
children O
. O

it O
is O
a O
secondary B-physical_entity
analysis B-abstraction
of O
focus B-physical_entity
group O
interviews O
with O
school B-physical_entity
nurses O
. O

thematic O
analysis B-abstraction
was O
performed O
. O

results O
showed O
that O
the O
school B-abstraction
nurses O
avoided O
addressing O
csa O
due B-abstraction
to O
arousal B-physical_entity
of O
strong O
emotions O
, O
ambivalence O
, O
and O
a O
complicated O
disclosure B-abstraction
process B-abstraction
. O

in O
order B-abstraction
to O
detect O
csa O
and O
support B-abstraction
abused O
children O
, O
attentiveness B-abstraction
of O
sexual B-O
abuse I-O
as O
a O
possible B-physical_entity
cause B-abstraction
of O
physical O
and O
mental O
illhealth O
is O
crucial O
. O


the O
current B-abstraction
study B-abstraction
examined O
the O
mediating O
effects O
of O
the O
teacher B-physical_entity
and O
peer B-physical_entity
relationships O
between O
parental O
abuse B-abstraction
neglect B-abstraction
and O
a O
child's O
emotional O
behavioral O
problems O
. O

a O
total B-abstraction
of O
2070 O
student B-physical_entity
surveys O
from O
the O
panel B-physical_entity
of O
the O
korean O
child B-physical_entity
youth B-physical_entity
panel B-physical_entity
study B-abstraction
kcyps O
were O
analyzed O
by O
path B-abstraction
analysis B-abstraction
. O

the O
key B-abstraction
findings O
of O
this O
study B-abstraction
are O
outlined O
below O
. O

firstly O
, O
parental O
physical O
and O
emotional O
abuse B-abstraction
and O
neglect B-abstraction
had O
significant O
effects O
on O
children's O
problems O
. O

the O
direct O
effect B-abstraction
of O
parental O
abuse B-abstraction
on O
emotional O
behavioral O
problems O
was O
higher O
than O
the O
direct O
effect B-abstraction
of O
parental O
neglect B-abstraction
on O
emotional O
behavioral O
problems O
. O

secondly O
, O
the O
teacher B-abstraction
relationship O
partially O
mediated O
the O
effects O
of O
the O
parental O
abuse B-abstraction
neglect B-abstraction
on O
emotional O
behavioral O
problems O
. O

thirdly O
, O
the O
peer B-physical_entity
relationship O
also O
partially O
mediated O
the O
effects O
of O
parental O
abuse B-abstraction
neglect B-abstraction
on O
children's O
emotional O
behavioral O
problems O
. O

the O
indirect O
effect B-abstraction
of O
parental O
neglect B-abstraction
via O
teacher B-abstraction
relationships O
and O
peer B-physical_entity
relationships O
was O
stronger O
than O
the O
indirect O
effect B-abstraction
of O
parental O
abuse B-abstraction
. O

this O
study B-physical_entity
is O
significant O
in O
that O
it O
identified O
that O
parental O
abuse B-abstraction
neglect B-abstraction
was O
mediated O
by O
the O
teacher B-abstraction
and O
peer B-physical_entity
relationship O
, O
thereby O
suggesting O
an O
implication B-abstraction
for O
effective O
intervention B-abstraction
with O
children O
who O
have B-physical_entity
suffered O
abuse B-abstraction
and O
neglect B-abstraction
. O

in O
terms O
of O
the O
teacher B-abstraction
and O
peer B-physical_entity
relationship O
, O
understanding B-abstraction
the O
influence B-abstraction
of O
parental O
abuse B-abstraction
and O
neglect B-abstraction
on O
children's O
problems O
was O
discussed O
, O
and O
the O
limitations O
and O
recommendations O
for O
future B-abstraction
study B-abstraction
were O
suggested O
. O

c O
2016 O
elsevier O
ltd O
. O

all O
rights O
reserved O
. O


abuse B-abstraction
related O
trauma O
remains B-physical_entity
a O
global O
health O
issue B-abstraction
. O

however O
, O
there B-physical_entity
is O
paucity B-abstraction
in O
nationwide O
reports O
. O

we O
aim B-physical_entity
to O
estimate B-abstraction
the O
incidence O
of O
abuse B-abstraction
related O
trauma O
forward B-abstraction
medical B-abstraction
care I-abstraction
and O
identify O
its O
characteristics O
and O
clinical O
course B-physical_entity
in O
taiwan O
. O

patients O
with O
trauma O
between O
2005 O
and O
2007 O
that O
occurred O
3 O
months O
before O
or O
after O
a O
diagnosis B-abstraction
of O
abuse B-abstraction
were O
identified O
from O
a O
randomly O
sampled O
nationwide O
longitudinal O
health O
insurance O
database O
of O
1 O
million O
beneficiaries O
. O

the O
patients' O
demographic B-abstraction
data O
, O
injury B-abstraction
pattern B-physical_entity
, O
and O
medical B-abstraction
resource B-abstraction
utilization B-abstraction
were O
measured O
, O
stratified O
by O
age B-abstraction
and O
sex B-physical_entity
, O
and O
compared O
using B-abstraction
chi O
square B-physical_entity
test B-physical_entity
. O

risk B-abstraction
factors O
of O
next O
trauma O
event B-abstraction
were O
identified O
using B-abstraction
cox B-physical_entity
regression B-physical_entity
analysis I-abstraction
. O

ninety O
three O
patients O
65 O
females O
were O
identified O
mean B-abstraction
age B-abstraction
, O
20 O
. O

6 O
16 O
. O

3 O
years B-abstraction
, O
including O
61 O
. O

3 O
under O
18 O
years B-abstraction
of O
age B-abstraction
. O

for O
the O
first B-abstraction
trauma O
event B-abstraction
, O
68 O
patients O
73 O
. O

1 O
visited O
the O
emergency B-physical_entity
room I-abstraction
, O
63 O
67 O
. O

7 O
received O
intervention B-abstraction
, O
and O
14 O
15 O
. O

1 O
needed O
hospital B-physical_entity
care I-physical_entity
. O

seven O
7 O
. O

5 O
, O
all O
less O
than O
11 O
years B-abstraction
old B-abstraction
, O
had O
intracranial O
hemorrhage O
and O
required O
intensive B-O
care I-O
. O

thirty O
three O
35 O
. O

5 O
left B-abstraction
with O
complications O
or O
sequelae O
, O
or O
required O
rehabilitation B-abstraction
, O
but O
all O
survived O
. O

of O
the O
34 O
victims O
of O
sexual B-O
abuse I-O
, O
32 O
were O
aged O
less O
than O
18 O
years B-abstraction
. O

men O
received O
more O
mood O
stabilizers O
or O
antipsychotics O
50 O
. O

0 O
vs O
10 O
. O

7 O
, O
p O
0 O
. O

030 O
and O
reeducative O
psychotherapy B-abstraction
25 O
. O

0 O
vs O
0 O
, O
p O
0 O
. O

044 O
. O

risk B-abstraction
factors O
for O
a O
next O
trauma O
event B-abstraction
were O
injury B-abstraction
involving O
the O
extremities O
hazard B-physical_entity
ratio O
hr B-abstraction
5 O
. O

27 O
2 O
. O

45 O
11 O
. O

33 O
and O
use B-abstraction
of O
antibiotics O
hr B-abstraction
4 O
. O

21 O
1 O
. O

45 O
12 O
. O

24 O
on O
the O
first B-physical_entity
trauma O
event B-abstraction
. O

abuse B-abstraction
related O
trauma O
has O
heterogeneous O
presentations O
among O
subgroups O
. O

clinicians O
should O
be O
alert B-abstraction
in O
providing O
timely O
diagnosis B-abstraction
and O
individualized O
intervention B-abstraction
. O


purpose B-abstraction
of O
review B-abstraction
this O
review B-physical_entity
addresses O
some O
of O
the O
more O
salient O
articles O
in O
the O
field B-abstraction
of O
child B-physical_entity
maltreatment B-abstraction
published O
in O
2015 O
, O
with O
a O
goal B-physical_entity
of O
helping O
the O
general B-physical_entity
practitioner I-abstraction
understand O
the O
evolution B-physical_entity
of O
research B-abstraction
in O
the O
field B-physical_entity
of O
child B-physical_entity
abuse I-physical_entity
pediatrics B-abstraction
a O
board B-physical_entity
certified O
specialty B-abstraction
since O
2009 O
. O

recent O
findings O
researchers O
continue O
to O
refine O
the O
database O
for O
child B-physical_entity
abuse I-physical_entity
pediatrics B-abstraction
. O

several O
articles O
focus B-physical_entity
on O
the O
inconsistencies O
in O
approach B-abstraction
to O
the O
evaluation B-abstraction
of O
possible B-physical_entity
physical O
child B-physical_entity
abuse I-physical_entity
between O
hospitals O
and O
practitioners O
. O

multiple B-abstraction
researchers O
aim B-physical_entity
to O
develop O
a O
protocol B-abstraction
that O
standardizes O
the O
response B-physical_entity
to O
findings O
of O
a O
sentinel B-physical_entity
injury B-abstraction
, O
such O
as O
a O
rib B-physical_entity
fracture B-abstraction
, O
abdominal O
trauma O
, O
or O
unexplained O
bruising O
in O
a O
nonambulatory O
infant B-physical_entity
. O

professionals O
are O
also O
working B-physical_entity
to O
improve O
our O
understanding B-abstraction
about O
the O
impact B-abstraction
of O
trauma O
on O
children O
and O
how O
best B-abstraction
to O
ameliorate O
its O
effects O
. O

summary O
with O
solid O
, O
evidence B-abstraction
based O
literature B-abstraction
published O
on O
various O
topics O
in O
the O
field B-physical_entity
of O
child B-physical_entity
abuse I-physical_entity
pediatrics B-abstraction
, O
experts O
work B-physical_entity
to O
refine O
and O
unify O
the O
clinician's O
approach B-abstraction
to O
the O
evaluation B-abstraction
of O
possible B-abstraction
physical O
abuse B-abstraction
. O


when O
abusive O
head B-physical_entity
trauma O
aht O
is O
suspected O
in O
a O
child B-physical_entity
, O
a O
dilated O
eye B-physical_entity
examination B-abstraction
by O
an O
ophthalmologist B-physical_entity
is O
an O
essential O
part B-physical_entity
of O
the O
medical B-abstraction
workup O
, O
as O
the O
presence B-abstraction
and O
pattern B-abstraction
of O
retinal O
hemorrhages O
can B-physical_entity
have B-physical_entity
a O
high B-physical_entity
positive B-physical_entity
predictive O
rate B-abstraction
for O
abusive O
head B-abstraction
injury B-abstraction
. O

this O
article B-physical_entity
proposes O
to O
review B-abstraction
the O
clinical O
presentation B-abstraction
, O
pathophysiology O
, O
natural B-physical_entity
history I-physical_entity
, O
sequelae O
, O
and O
differential B-physical_entity
diagnosis I-physical_entity
of O
retinal O
hemorrhages O
and O
other O
ocular B-physical_entity
lesions O
associated O
with O
aht O
. O


the O
frequency O
and O
severity B-abstraction
of O
physical O
abuse B-abstraction
influences O
children's O
outcomes O
, O
yet O
little O
theory B-abstraction
based O
research B-abstraction
has O
explored O
what O
predicts O
its O
course B-physical_entity
. O

this O
study B-abstraction
examined O
the O
potential O
role B-abstraction
of O
social O
information B-abstraction
processing I-abstraction
sip B-physical_entity
factors O
in O
the O
course B-abstraction
of O
abuse B-abstraction
. O

mothers O
with O
histories O
of O
perpetrating O
physical O
abuse B-abstraction
n O
62 O
completed O
measures O
of O
sip B-physical_entity
, O
and O
the O
frequency O
and O
severity B-abstraction
of O
mother B-physical_entity
perpetrated O
physical O
abuse B-abstraction
were O
collected O
from O
child B-physical_entity
protection B-abstraction
services B-abstraction
records O
. O

poorer O
problem B-abstraction
solving I-abstraction
capacities O
were O
significantly O
related O
to O
greater O
frequency O
of O
physical O
abuse B-abstraction
. O

hostile O
attributions O
toward O
children O
were O
positively O
associated O
with O
abuse B-abstraction
severity B-abstraction
. O

controlling O
for O
demographics O
and O
co O
occurrence B-abstraction
of O
neglect B-abstraction
, O
sip B-physical_entity
factors O
together O
accounted O
for O
a O
significant O
proportion B-physical_entity
of O
variance B-abstraction
in O
the O
frequency O
of O
physical O
abuse B-abstraction
, O
but O
not O
severity B-abstraction
. O

with O
the O
exception B-abstraction
of O
unrealistic O
expectations O
, O
preliminary B-abstraction
evidence B-abstraction
supported O
a O
link B-physical_entity
between O
maternal O
sip B-physical_entity
and O
the O
course B-physical_entity
of O
abuse B-abstraction
perpetration B-abstraction
. O

future B-physical_entity
research B-abstraction
directions O
and O
implications O
for O
intervention B-abstraction
are O
discussed O
. O


shaken O
baby B-abstraction
syndrome B-abstraction
is O
a O
term B-abstraction
often O
used O
by O
the O
physicians O
and O
public O
to O
describe O
abusive O
trauma O
inflicted O
on O
infants O
and O
young B-physical_entity
children O
. O

advances O
in O
the O
understanding B-abstraction
of O
the O
mechanisms O
and O
the O
associated O
clinical O
spectrum B-abstraction
of O
injury B-abstraction
has O
lead B-abstraction
us O
to O
modify O
our O
terminology O
and O
address B-abstraction
it O
as O
" O
abusive O
trauma O
" O
at O
. O

pediatric O
abusive O
head B-physical_entity
trauma O
is O
defined O
as O
an O
injury B-abstraction
to O
the O
skull O
or O
intracranial O
contents O
of O
an O
infant B-physical_entity
or O
a O
young B-physical_entity
child B-physical_entity
5 O
y O
age B-abstraction
due B-abstraction
to O
inflicted O
blunt O
impact B-abstraction
and O
or O
violent O
shaking B-abstraction
. O

this O
chapter B-abstraction
focuses O
on O
the O
imaging B-abstraction
aspects O
of O
childhood B-abstraction
abusive O
trauma O
along O
with O
a O
brief O
description B-abstraction
of O
the O
mechanismand O
pathophysiology O
of O
abusive O
injury B-abstraction
. O

the O
diagnosis B-abstraction
of O
at O
is O
not O
always O
obvious O
, O
and O
abusive O
injuries O
in O
many O
infants O
may B-physical_entity
remain O
unrecognized O
. O

pediatricians O
should O
be O
cognizant O
of O
at O
since O
pediatricians O
play B-abstraction
a O
crucial O
role B-abstraction
in O
the O
diagnosis B-abstraction
, O
management B-abstraction
and O
prevention B-abstraction
of O
at O
. O


this O
article B-physical_entity
reviews O
the O
evolution B-physical_entity
of O
the O
diagnosis B-abstraction
and O
treatment B-abstraction
of O
hodgkin O
lymphoma O
hl O
since O
its O
discovery B-abstraction
in O
1832 O
. O

the O
morphological O
, O
phenotypic O
and O
molecular O
characteristics O
of O
both O
nodular O
lymphocyte B-physical_entity
predominant O
hl O
and O
classical O
hl O
are O
revised O
in O
the O
light B-abstraction
of O
recent O
molecular O
information B-abstraction
and O
possible B-abstraction
impact B-abstraction
on O
the O
identification B-abstraction
of O
risk B-abstraction
groups O
as O
well B-physical_entity
as O
the O
use B-physical_entity
of O
targeted O
therapies O
. O

the O
seminal O
contribution B-abstraction
of O
gianni O
bonadonna O
to O
developing O
new O
treatment B-abstraction
strategies O
for O
both O
advanced O
and O
early O
stage B-physical_entity
hl O
is O
highlighted O
. O


an O
analytic O
design B-abstraction
guide B-abstraction
to O
design B-physical_entity
a O
three O
stage B-abstraction
cascade B-abstraction
cmos O
operational O
amplifier B-physical_entity
compensated O
by O
ac O
boosting O
frequency O
compensation B-physical_entity
acbc O
method B-abstraction
is O
presented O
in O
this O
paper B-physical_entity
. O

the O
procedure B-abstraction
allows O
electrical O
parameters O
such O
as O
gain B-abstraction
bandwidth O
gbw O
product B-abstraction
or O
phase B-abstraction
margin B-abstraction
to O
be O
related O
to O
the O
value B-abstraction
of O
circuit B-abstraction
elements O
such O
as O
aspect B-abstraction
ratio O
or O
biasing O
currents O
of O
transistors O
. O

the O
presented O
design B-physical_entity
guide B-physical_entity
is O
suited O
for O
pencil B-physical_entity
and O
paper B-physical_entity
design B-physical_entity
and O
yields O
accurate O
performance B-abstraction
without O
unnecessary O
circuit B-abstraction
constraint B-physical_entity
introduction B-physical_entity
. O

simulation B-physical_entity
results O
using B-abstraction
tsmc O
0 O
. O

18 O
mu O
m O
cmos O
process B-abstraction
verifies O
accuracy B-abstraction
and O
robustness B-abstraction
of O
proposed O
procedure B-abstraction
. O

various O
load B-abstraction
capacitors O
and O
circuit B-abstraction
conditions O
are O
simulated O
and O
, O
based O
on O
obtained O
results O
, O
the O
presented O
design B-physical_entity
guide B-abstraction
is O
comprehensive B-abstraction
and O
efficient O
since O
it O
leads O
us O
from O
frequency B-O
response I-O
parameters O
to O
aspect B-abstraction
ratio O
of O
mosfets O
. O


programmable O
ac O
power B-physical_entity
sources O
have B-physical_entity
been O
widely O
used O
to O
implement B-physical_entity
and O
support B-abstraction
a O
wide O
range B-abstraction
of O
test B-abstraction
procedure B-abstraction
specifications O
tps's O
. O

traditionally O
, O
these O
power B-abstraction
sources O
use B-physical_entity
analog B-abstraction
control B-abstraction
circuits O
to O
provide O
key B-abstraction
control B-abstraction
and O
protection B-abstraction
functions O
like B-abstraction
load B-physical_entity
regulation B-physical_entity
, O
current B-abstraction
limit B-abstraction
and O
frequency O
conversion B-abstraction
. O

while B-abstraction
this O
is O
a O
proven O
design B-abstraction
, O
it O
suffers O
from O
a O
number B-abstraction
of O
drawbacks O
. O

with O
the O
advent B-abstraction
of O
recent O
advances O
in O
dsp O
technologies O
, O
a O
full B-abstraction
digital O
implementation B-abstraction
of O
an O
ac O
power B-abstraction
source B-abstraction
design B-physical_entity
supporting B-abstraction
high B-physical_entity
switching B-abstraction
frequencies O
is O
now B-abstraction
feasible O
. O

this O
paper B-physical_entity
discussed O
some O
of O
the O
advantages O
derived O
from O
an O
all O
digital O
implementation B-abstraction
of O
a O
programmable O
poser B-physical_entity
source B-abstraction
and O
the O
benefits O
this O
provides O
for O
ate O
system B-physical_entity
use B-abstraction
. O


this O
paper B-physical_entity
describes O
a O
new O
calibration B-abstraction
system B-abstraction
developed O
at O
inmetro O
to O
guarantee O
traceability O
of O
low B-physical_entity
frequency I-physical_entity
alternating O
current B-abstraction
ac O
voltage O
calibrations O
1 O
khz O
to O
a O
programmable O
josephson O
ac O
waveform B-abstraction
synthesizer B-physical_entity
. O

the O
automated O
full B-abstraction
synchronous O
system B-physical_entity
allows O
the O
synchronization B-abstraction
of O
a O
commercial O
calibrator O
or O
signal B-abstraction
synthesizer B-physical_entity
with O
a O
programmable O
josephson O
voltage O
synthesizer B-physical_entity
system B-physical_entity
to O
be O
made O
by O
employing O
digital O
sampling B-abstraction
and O
signal B-abstraction
processing O
techniques O
, O
aided O
by O
adaptive O
digital O
control B-physical_entity
. O

it O
allows O
accurate O
determination B-abstraction
of O
the O
spectral O
content B-abstraction
of O
ac O
signals O
with O
minimum B-physical_entity
human B-physical_entity
intervention B-abstraction
. O

system B-abstraction
operation B-abstraction
, O
measurement B-abstraction
techniques O
, O
and O
data O
analysis B-abstraction
are O
detailed O
. O


the O
voltage O
source B-physical_entity
converters O
vsc O
are O
the O
key B-abstraction
power B-abstraction
interfaces O
between O
the O
individual B-physical_entity
ac O
grids O
and O
dc O
grids O
in O
the O
hybrid B-abstraction
power B-abstraction
system I-physical_entity
. O

when O
the O
ac O
grid B-physical_entity
is O
unbalanced O
, O
the O
grid B-physical_entity
currents O
are O
distorted O
and O
the O
harmonic B-abstraction
is O
induced O
. O

meanwhile B-abstraction
, O
the O
oscillations O
in O
the O
active B-physical_entity
and O
reactive O
power B-abstraction
are O
also O
increased O
, O
which O
may B-physical_entity
damage B-abstraction
these O
interfaces O
. O

in O
order B-abstraction
to O
ensure O
the O
safety B-physical_entity
of O
the O
converters O
and O
the O
grid B-abstraction
facility B-physical_entity
, O
a O
flexible O
control B-abstraction
strategy B-abstraction
is O
proposed O
for O
the O
ac O
dc O
hybrid B-physical_entity
grid B-abstraction
in O
this O
paper B-physical_entity
. O

at O
first B-abstraction
, O
the O
current B-abstraction
harmonic B-abstraction
for O
the O
vsc O
is O
theoretically O
analyzed O
under O
unbalanced O
conditions O
. O

furthermore O
, O
the O
methods O
to O
separate B-physical_entity
the O
positive B-physical_entity
and O
negative B-physical_entity
sequence B-abstraction
components O
of O
the O
ac O
grid B-physical_entity
voltages O
are O
summed O
up O
and O
analyzed O
. O

based O
on O
the O
theoretical O
analysis B-abstraction
, O
different O
protected O
control B-abstraction
methods O
are O
compared O
. O

a O
new O
control B-abstraction
method B-abstraction
, O
which O
can B-physical_entity
flexibly O
control B-abstraction
oscillations O
of O
the O
active B-physical_entity
and O
reactive O
power B-abstraction
by O
introducing O
a O
parameter B-abstraction
k O
, O
has O
been O
proposed O
. O

the O
estimation B-abstraction
of O
maximum B-abstraction
current B-abstraction
in O
each O
phase B-abstraction
is O
discussed O
; O
meanwhile B-abstraction
, O
the O
relationship O
between O
the O
voltage O
ripple B-abstraction
on O
dc O
link B-physical_entity
and O
the O
parameter B-abstraction
k O
is O
given B-abstraction
. O

finally O
, O
the O
validity B-abstraction
and O
advantages O
of O
the O
proposed O
method B-abstraction
are O
verified O
by O
the O
simulating O
and O
experimental O
results O
. O


based O
on O
single B-abstraction
phase B-abstraction
ac O
ac O
converter B-physical_entity
with O
controllable O
phase B-abstraction
and O
amplitude B-abstraction
accpa O
, O
a O
three O
phase B-abstraction
accpa O
without O
third B-physical_entity
harmonic B-abstraction
trap B-abstraction
was O
proposed O
for O
power B-abstraction
transmission B-abstraction
control B-physical_entity
in O
grid B-abstraction
by O
adopting O
a O
symmetrical O
relationship O
of O
three O
phase B-abstraction
. O

the O
three O
phase B-abstraction
accpa O
is O
comprised O
of O
two O
parts B-physical_entity
, O
which O
are O
used O
to O
adjust O
the O
phase B-abstraction
and O
amplitude B-abstraction
of O
three O
phase B-abstraction
output B-physical_entity
voltage O
, O
respectively O
, O
and O
continuously O
. O

its O
front B-physical_entity
part B-physical_entity
is O
made O
up O
of O
three O
buck B-physical_entity
type B-abstraction
ac O
converters O
, O
and O
the O
back B-physical_entity
part B-abstraction
is O
a O
three O
phase B-abstraction
boost B-abstraction
type B-physical_entity
ac O
converter B-physical_entity
. O

the O
operation B-abstraction
principle B-abstraction
of O
three O
phase B-abstraction
accpa O
, O
the O
adjustable O
ranges O
of O
the O
phase B-abstraction
and O
amplitude B-abstraction
of O
the O
front B-abstraction
part B-abstraction
, O
and O
the O
calculation B-abstraction
formulas O
of O
control B-abstraction
parameters O
under O
ideal B-physical_entity
conditions O
were O
studied O
and O
deduced O
in O
detail B-abstraction
. O

furthermore O
, O
the O
control B-physical_entity
accuracy B-abstraction
of O
the O
phase B-abstraction
angle B-physical_entity
was O
discussed O
for O
the O
three O
phase B-abstraction
accpa O
with O
digital O
control B-physical_entity
, O
and O
then O
, O
the O
method B-abstraction
to O
select O
close B-abstraction
loop B-abstraction
control B-abstraction
parameters O
was O
obtained O
. O

the O
control B-abstraction
strategy B-abstraction
of O
three O
phase B-abstraction
accpa O
was O
presented O
and O
a O
prototype B-abstraction
was O
fabricated O
. O

the O
experimental O
waveforms O
and O
testing B-abstraction
results O
verified O
the O
correctness B-abstraction
of O
the O
theoretical O
analysis B-abstraction
and O
the O
feasibility B-abstraction
of O
the O
control B-physical_entity
strategy B-abstraction
. O


this O
article B-physical_entity
deals O
with O
the O
simulation B-abstraction
of O
the O
power B-physical_entity
converter B-physical_entity
with O
voltage O
source B-abstraction
inverter B-physical_entity
and O
sine O
filter B-physical_entity
. O

the O
repetitive O
control B-abstraction
system I-physical_entity
was O
designed O
. O

the O
existing O
power B-abstraction
converter B-physical_entity
has O
a O
control B-physical_entity
system I-abstraction
which O
makes O
fourier O
transform O
of O
the O
output B-abstraction
voltage O
to O
inject O
these O
harmonics B-abstraction
with O
opposite B-physical_entity
phase B-abstraction
. O

the O
new O
proposed O
system B-abstraction
based O
on O
repetitive O
controller B-physical_entity
which O
is O
much O
simpler O
and O
with O
smaller O
cpu O
load B-abstraction
. O

the O
higher O
harmonics B-abstraction
elimination B-physical_entity
works B-abstraction
perfect O
and O
the O
power B-abstraction
converter B-physical_entity
produces O
output B-physical_entity
voltage O
with O
less O
than O
5 O
thd O
under O
linear O
or O
non O
linear O
load B-abstraction
. O

this O
paper B-physical_entity
describes O
the O
improved O
control B-physical_entity
system I-abstraction
structure B-abstraction
and O
its O
implementation B-abstraction
in O
matlab O
simulink O
environment B-physical_entity
. O

the O
advantages O
of O
the O
repetitive O
algorithm B-abstraction
facing B-abstraction
fourier O
transform O
harmonic B-abstraction
compensation B-abstraction
are O
shown O
. O

the O
performance B-abstraction
of O
the O
new O
control B-abstraction
method B-abstraction
is O
shown O
in O
simulation B-physical_entity
results O
. O

the O
algorithm B-abstraction
is O
carried O
out B-abstraction
in O
c O
language B-abstraction
using B-abstraction
matlab O
s B-abstraction
function B-abstraction
block B-physical_entity
so O
it O
is O
suitable O
for O
implementation B-abstraction
in O
the O
real B-O
time I-O
control B-physical_entity
systems O
. O


various O
species B-abstraction
of O
amoebas O
belonging O
to O
the O
genus B-abstraction
acanthamoeba O
are O
widely O
distributed O
in O
many O
parts B-physical_entity
of O
the O
world B-abstraction
. O

some O
strains O
of O
these O
protozoans O
may B-physical_entity
exist O
as O
parasites O
and O
pose B-abstraction
risks O
to O
human B-physical_entity
health O
as O
causative O
agents O
of O
serious O
human B-physical_entity
diseases O
. O

currently O
in O
china B-physical_entity
there B-physical_entity
is O
a O
lack O
of O
information B-abstraction
about O
the O
distribution B-abstraction
of O
acanthamoeba O
strains O
in O
the O
environment B-physical_entity
. O

accordingly O
, O
261 O
environmental O
water B-physical_entity
samples O
taken O
from O
rivers O
, O
sewage O
, O
and O
pharmaceutical O
factory B-physical_entity
drains O
were O
collected O
in O
qinghai O
province B-physical_entity
, O
china B-physical_entity
. O

the O
material B-physical_entity
was O
filtered O
and O
then O
analysed O
with O
both O
lamp B-physical_entity
and O
pcr O
assays O
. O

of O
the O
samples O
examined O
, O
acanthamoeba O
dna O
was O
found O
in O
32 O
14 O
. O

68 O
samples O
with O
the O
use B-physical_entity
of O
lamp B-physical_entity
; O
in O
13 O
of O
these O
samples O
, O
dna O
from O
this O
amoeba B-physical_entity
was O
also O
detected O
using B-abstraction
pcr O
. O

sequencing O
of O
selected O
positive B-physical_entity
samples O
confirmed O
that O
the O
pcr O
products O
were O
fragments O
of O
the O
acanthamoeba O
18s O
rrna O
gene O
and O
that O
isolates O
represent O
the O
t4 O
genotype B-abstraction
, O
known O
as O
the O
most O
common B-physical_entity
strain B-abstraction
related O
to O
ak O
cases O
. O

the O
results O
indicate O
that O
surface B-physical_entity
water B-physical_entity
, O
as O
well B-physical_entity
as O
water B-physical_entity
taken O
from O
sewage O
and O
pharmaceutical O
drains O
, O
may B-physical_entity
be O
a O
source B-abstraction
of O
acanthamoebic O
strains O
potentially O
pathogenic O
for O
humans B-physical_entity
in O
china B-physical_entity
. O

it O
has O
been O
also O
demonstrated O
that O
lamp B-physical_entity
assays O
is O
more O
sensitive B-physical_entity
than O
pcr O
and O
can B-physical_entity
be O
regarded O
as O
useful O
tool B-abstraction
for O
screening B-abstraction
the O
environment B-physical_entity
for O
acanthamoeba O
spp O
. O

c O
2017 O
elsevier O
b O
. O

v O
. O

all O
rights O
reserved O
. O


particle B-physical_entity
accelerators O
consist O
of O
an O
enormous O
number B-abstraction
of O
components O
and O
many O
of O
them O
operate O
with O
pulse B-abstraction
voltage O
or O
current B-abstraction
. O

such O
accelerator B-physical_entity
components O
require O
precise O
voltage O
or O
current B-abstraction
to O
keep B-physical_entity
the O
beams O
very O
stable B-physical_entity
. O

for O
this O
reason B-abstraction
, O
many O
pulse B-abstraction
power B-abstraction
supplies O
used O
for O
accelerators O
have B-physical_entity
own O
subsystems O
to O
improve O
their O
performances O
. O

one B-abstraction
example B-abstraction
is O
a O
power B-abstraction
supply B-physical_entity
for O
the O
scanning B-abstraction
magnets O
of O
a O
pencil B-physical_entity
beam B-physical_entity
proton B-physical_entity
therapy B-abstraction
. O

they O
use B-abstraction
not O
only O
high B-abstraction
voltage O
inverters O
for O
the O
high B-physical_entity
speed B-abstraction
ramping O
but O
also O
low B-physical_entity
voltage O
inverters O
for O
the O
precise O
current B-abstraction
control B-abstraction
. O

however O
, O
the O
use B-physical_entity
of O
intelligent O
digital O
controllers O
possibly O
simplifies O
such O
precise O
power B-physical_entity
supplies O
. O

we O
propose O
a O
method B-abstraction
for O
precise O
current B-abstraction
control B-physical_entity
using B-abstraction
a O
digital O
control B-physical_entity
system I-abstraction
. O

our O
previous O
work B-physical_entity
has O
successfully O
controlled O
the O
pulse B-abstraction
current B-abstraction
of O
power B-physical_entity
supplies O
for O
synchrotron B-physical_entity
main B-physical_entity
magnets O
. O

in O
the O
next O
step B-physical_entity
, O
we O
have B-physical_entity
modified O
our O
previous O
method B-abstraction
for O
faster O
power B-physical_entity
supplies O
such O
as O
ones O
for O
scanning B-abstraction
magnets O
. O

in O
addition B-abstraction
, O
we O
developed O
a O
control B-abstraction
board I-abstraction
using B-abstraction
a O
high B-physical_entity
performance B-abstraction
fpga O
so O
that O
our O
method B-abstraction
can B-physical_entity
be O
implemented O
in O
the O
board B-physical_entity
. O

in O
this O
paper B-physical_entity
, O
we O
describe O
the O
details O
of O
our O
proposed O
method B-abstraction
, O
and O
the O
experiments O
using B-abstraction
a O
small B-abstraction
scale B-physical_entity
power B-abstraction
supply B-physical_entity
and O
the O
developed O
control B-abstraction
board I-abstraction
. O


this O
paper B-physical_entity
presents O
the O
design B-abstraction
of O
a O
compact B-physical_entity
, O
wearable B-physical_entity
, O
rechargeable O
acceleration B-abstraction
recorder B-physical_entity
to O
support B-abstraction
long O
term B-abstraction
monitoring B-abstraction
of O
ambulatory B-physical_entity
patients O
with O
motor B-physical_entity
disorders O
, O
and O
of O
software O
to O
display B-abstraction
and O
analyze O
its O
output B-physical_entity
. O

the O
device B-abstraction
consists O
of O
a O
microcontroller O
, O
operational O
amplifier B-physical_entity
, O
accelerometer B-physical_entity
, O
sd O
card B-physical_entity
, O
indicator B-physical_entity
led O
, O
rechargeable O
battery B-abstraction
, O
and O
associated O
minor B-physical_entity
components O
. O

it O
can B-physical_entity
operate O
for O
over B-abstraction
a O
day B-abstraction
without O
charging O
and O
can B-physical_entity
continuously O
collect B-abstraction
data O
for O
three O
weeks O
without O
downloading O
to O
an O
outside B-physical_entity
system B-abstraction
, O
as O
currently O
configured O
. O

with O
slight B-abstraction
modifications O
, O
this O
period B-abstraction
could O
be O
extended O
to O
several O
months O
. O

the O
accompanying O
software O
provides O
flexible O
visualization B-abstraction
of O
the O
acceleration B-abstraction
data O
over B-abstraction
long O
periods O
, O
basic B-physical_entity
file B-physical_entity
operations B-abstraction
and O
compression B-abstraction
for O
easier O
archiving O
, O
annotation B-abstraction
of O
segments O
of O
interest B-abstraction
, O
and O
functions O
for O
calculation B-abstraction
of O
various O
parameters O
and O
detection B-abstraction
of O
immobility B-abstraction
and O
vibration B-abstraction
frequencies O
. O

applications O
in O
analysis B-abstraction
of O
gait B-abstraction
and O
other O
movements O
are O
discussed O
. O


a O
high B-abstraction
performance B-abstraction
interface B-physical_entity
circuit B-physical_entity
of O
sigma O
delta B-physical_entity
accelerometer B-physical_entity
with O
low B-abstraction
harmonic B-abstraction
distortion B-abstraction
used O
many O
kinds O
of O
circuit B-abstraction
processing O
techniques O
is O
presented O
in O
this O
work B-abstraction
. O

multi O
bit B-abstraction
, O
dynamic B-abstraction
element B-abstraction
matching O
, O
correlated O
double B-abstraction
sampling B-abstraction
and O
electrostatic O
force B-abstraction
feedback B-physical_entity
linearization O
circuit B-physical_entity
are O
used O
simultaneously O
in O
order B-abstraction
to O
achieve O
the O
design B-physical_entity
indicators O
. O

because O
of O
the O
usage B-abstraction
of O
multi O
bit B-abstraction
, O
the O
design B-abstraction
to O
operational O
amplifier B-physical_entity
opa O
becomes O
easier O
, O
and O
only O
a O
single B-abstraction
stage B-abstraction
folded O
cascode O
amplifier B-physical_entity
is O
used O
in O
the O
modulator O
, O
the O
osr O
is O
only O
64 O
. O

it O
highly O
reduced O
the O
difficulty B-abstraction
of O
circuit B-physical_entity
. O

the O
test B-physical_entity
results O
indicate O
that O
the O
chip B-physical_entity
area B-abstraction
is O
only O
about O
10mm O
2 O
and O
the O
power B-abstraction
dissipation B-abstraction
is O
10mw O
with O
a O
sampling B-abstraction
frequency O
of O
60 O
khz O
. O

the O
dynamic B-abstraction
range B-physical_entity
dr O
of O
the O
system B-abstraction
can B-physical_entity
be O
lower B-physical_entity
than O
130 O
db O
, O
the O
snr O
and O
sndr O
reach B-abstraction
to O
120 O
db O
and O
110 O
db O
respectively O
with O
a O
resolution B-abstraction
about O
17 O
bits O
when O
referred O
to O
3g O
full B-abstraction
scale B-physical_entity
dc O
acceleration B-abstraction
under O
cmos O
0 O
. O

5 O
mu O
m O
process B-abstraction
. O

the O
dc O
nonlinearity O
of O
it O
is O
0 O
. O

2 O
. O

this O
paper B-physical_entity
realizes O
an O
approach B-abstraction
which O
can B-physical_entity
both O
simplify O
the O
design B-abstraction
of O
the O
interface B-abstraction
circuit B-physical_entity
and O
improve O
the O
performance B-abstraction
of O
it O
. O


in O
this O
article B-physical_entity
we O
address B-physical_entity
the O
increasingly O
important O
yet O
understudied O
phenomenon B-abstraction
of O
nonnative O
accentedness O
on O
decision B-abstraction
making I-abstraction
. O

in O
three O
experimental O
studies O
, O
we O
investigated O
whether O
messages O
about O
a O
company B-physical_entity
delivered O
in O
nonstandard O
american O
accented O
speech B-abstraction
influenced O
choice B-abstraction
. O

in O
study B-abstraction
1 O
, O
we O
found O
that O
individuals O
were O
more O
likely O
to O
choose O
a O
company B-physical_entity
or O
a O
product B-abstraction
when O
a O
message O
was O
read B-physical_entity
in O
a O
standard B-physical_entity
american O
english O
accent O
than O
when O
the O
message O
was O
delivered O
with O
a O
mandarin B-physical_entity
chinese O
or O
a O
french O
accent O
. O

in O
study B-physical_entity
2 O
, O
we O
found O
that O
expectations O
regarding O
company B-physical_entity
messages O
are O
violated O
when O
speakers O
have B-physical_entity
accents O
and O
that O
, O
in O
turn B-abstraction
, O
expectation B-abstraction
violations O
mediated O
the O
relationship O
between O
accent O
and O
choice B-abstraction
. O

in O
study B-abstraction
3 O
, O
we O
replicated O
the O
findings O
of O
the O
effect B-abstraction
of O
accent O
on O
choice B-abstraction
using B-abstraction
indian O
and O
british O
accents O
. O

we O
also O
hypothesized O
and O
found O
support B-abstraction
for O
a O
conditional O
indirect O
effects O
model B-abstraction
such O
that O
implicit O
pro B-physical_entity
american O
bias B-abstraction
moderated O
the O
indirect O
relationship O
between O
accent O
and O
choice B-abstraction
as O
mediated O
by O
expectation B-abstraction
violations O
. O

theoretical O
and O
practical O
implications O
of O
this O
topic B-abstraction
of O
study B-physical_entity
are O
discussed O
. O


acceptance B-abstraction
is O
a O
key B-abstraction
construct B-abstraction
in O
both O
rational O
emotive O
behavior B-abstraction
therapy I-abstraction
rebt O
and O
acceptance B-abstraction
and O
commitment B-abstraction
therapy B-abstraction
act B-abstraction
. O

the O
objectives O
of O
this O
study B-physical_entity
were O
to O
assess O
and O
compare B-abstraction
the O
properties O
of O
act B-abstraction
acceptance B-abstraction
with O
those O
of O
rebt O
acceptance B-abstraction
in O
predicting O
emotions O
. O

a O
sample B-physical_entity
of O
112 O
subjects O
, O
comprising O
different O
educational O
and O
occupational O
status O
, O
completed O
three O
measures O
of O
acceptance B-abstraction
rebt O
and O
act B-abstraction
, O
two O
of O
mindfulness O
, O
as O
well B-physical_entity
as O
completing O
depression B-abstraction
and O
anxiety O
scales O
. O

both O
act B-abstraction
acceptance B-abstraction
as O
process B-abstraction
and O
rebt O
acceptance B-abstraction
could O
predict O
significant O
act B-abstraction
acceptance B-abstraction
as O
outcome B-abstraction
. O

mindfulness O
as O
a O
trait O
also O
predicted O
the O
level B-physical_entity
of O
act B-abstraction
outcome B-abstraction
acceptance B-abstraction
as O
well B-physical_entity
as O
the O
level B-abstraction
of O
rebt O
acceptance B-abstraction
, O
but O
mindfulness O
as O
process B-abstraction
predicted O
only O
act B-abstraction
outcome B-abstraction
acceptance B-abstraction
. O

the O
results O
show B-abstraction
that O
rebt O
acceptance B-abstraction
, O
act B-abstraction
acceptance B-abstraction
and O
mindfulness O
can B-physical_entity
explain O
anxiety O
and O
depression B-physical_entity
in O
different O
ways B-physical_entity
. O

the O
results O
show B-abstraction
that O
the O
difference B-abstraction
between O
act B-abstraction
acceptance B-abstraction
and O
rebt O
acceptance B-abstraction
primary B-physical_entity
concern B-abstraction
the O
process B-physical_entity
of O
acceptance B-abstraction
, O
most O
likely O
due B-abstraction
to O
the O
underlying O
cognitive O
processing O
. O

the O
outcome B-abstraction
acceptance B-abstraction
and O
emotional O
level B-physical_entity
are O
similar O
in O
the O
two O
conditions O
. O

future B-abstraction
research B-abstraction
should O
employ O
multiple B-abstraction
cognitive O
measurements O
. O


immigrant B-physical_entity
and O
refugee B-physical_entity
women O
from O
diverse O
ethnic B-physical_entity
backgrounds O
encounter B-abstraction
multiple B-abstraction
barriers O
in O
accessing O
mental O
healthcare B-abstraction
in O
various O
settings O
. O

a O
systematic O
review B-physical_entity
on O
the O
prevalence B-abstraction
of O
mental O
health O
disorders O
among O
culturally O
and O
linguistically O
diverse O
cald O
women O
in O
australia O
documented O
the O
following B-abstraction
barriers O
logistical O
, O
language B-abstraction
and O
communication B-abstraction
, O
dissonance B-abstraction
between O
participants O
and O
care B-abstraction
providers O
and O
preference B-abstraction
for O
alternative B-abstraction
interventions O
. O

this O
article B-physical_entity
proposes O
recommendations O
for O
policies O
to O
better B-physical_entity
address B-abstraction
the O
mental O
health O
needs O
of O
immigrant B-physical_entity
and O
refugee B-physical_entity
women O
. O

key B-abstraction
policy B-abstraction
recommendations O
include O
support B-physical_entity
for O
gender B-abstraction
specific B-abstraction
research B-abstraction
, O
implementation B-abstraction
and O
evaluation B-abstraction
of O
transcultural O
policies O
, O
cultural O
responsiveness B-abstraction
in O
service B-abstraction
delivery B-abstraction
, O
review B-abstraction
of O
immigration B-abstraction
and O
refugee B-physical_entity
claims O
policies O
and O
social O
integration B-abstraction
of O
immigrants O
. O


objective B-physical_entity
cervical O
imaging B-abstraction
practices O
are O
poorly O
understood O
in O
young B-physical_entity
children O
with O
traumatic O
brain B-abstraction
injury B-abstraction
tbi O
. O

we O
therefore O
sought O
to O
identify O
child B-physical_entity
level B-abstraction
and O
hospital B-physical_entity
level B-abstraction
factors O
associated O
with O
performance B-abstraction
of O
cervical O
imaging B-abstraction
of O
children O
with O
tbi O
from O
falls B-physical_entity
and O
abusive O
head B-physical_entity
trauma O
aht O
and O
to O
describe O
across O
hospital B-physical_entity
variation B-physical_entity
in O
cervical O
imaging B-abstraction
performance B-abstraction
. O

we O
hypothesized O
that O
imaging B-abstraction
decisions O
would O
be O
influenced O
by O
hospital B-physical_entity
volume B-physical_entity
of O
young B-physical_entity
injured O
children O
. O

methods O
we O
performed O
a O
retrospective O
study B-physical_entity
of O
children O
younger O
than O
2 O
years B-abstraction
of O
age B-abstraction
with O
tbi O
from O
2009 O
to O
2013 O
in O
the O
premier B-physical_entity
perspective B-abstraction
database O
. O

after O
adjustment B-physical_entity
for O
observed O
patient B-physical_entity
characteristics O
, O
we O
evaluated O
variation B-abstraction
in O
advanced O
cervical O
imaging B-abstraction
computed B-O
tomography I-O
or O
magnetic O
resonance B-abstraction
imaging B-abstraction
in O
children O
with O
aht O
and O
tbi O
from O
falls B-physical_entity
. O

results O
of O
2347 O
children O
with O
tbi O
, O
18 O
. O

7 O
were O
from O
abuse B-abstraction
and O
57 O
. O

1 O
were O
from O
falls B-physical_entity
. O

fifteen O
percent O
of O
children O
with O
tbi O
underwent O
advanced O
cervical O
imaging B-abstraction
. O

moderate B-physical_entity
or O
severe O
head B-abstraction
injuries O
were O
associated O
with O
increased O
odds B-abstraction
of O
cervical O
imaging B-abstraction
in O
aht O
odds B-abstraction
ratio O
7 O
. O

10 O
; O
95 O
confidence O
interval B-abstraction
2 O
. O

75 O
, O
18 O
. O

35 O
and O
falls B-physical_entity
odds B-abstraction
ratio O
2 O
. O

25 O
; O
95 O
confidence O
interval B-abstraction
1 O
. O

19 O
, O
4 O
. O

27 O
. O

there B-physical_entity
was O
no B-abstraction
association B-abstraction
between O
annual B-physical_entity
hospital B-physical_entity
volume B-physical_entity
of O
injured O
children O
and O
cervical O
imaging B-abstraction
performance B-abstraction
. O

the O
adjusted O
probability B-abstraction
of O
imaging B-abstraction
across O
hospitals O
ranged O
from O
4 O
. O

3 O
to O
84 O
. O

3 O
in O
aht O
and O
3 O
. O

1 O
to O
39 O
. O

0 O
in O
tbi O
from O
falls B-physical_entity
p O
. O

001 O
. O

conclusions O
these O
results O
highlight B-abstraction
variation B-abstraction
across O
hospitals O
in O
adjusted O
probability B-abstraction
of O
cervical O
imaging B-abstraction
in O
aht O
nearly O
20 O
fold B-abstraction
and O
tbi O
from O
falls B-physical_entity
over B-abstraction
10 O
fold B-abstraction
not O
explained O
by O
observed O
patient B-physical_entity
characteristics O
. O

this O
variation B-abstraction
suggests O
opportunities O
for O
further O
research B-abstraction
to O
inform O
imaging B-abstraction
practices O
. O


objectivethe O
aim B-abstraction
of O
this O
study B-physical_entity
was O
to O
explore O
the O
preferred O
acculturation B-abstraction
strategies O
adopted O
by O
indian O
subcontinental O
adolescents O
living B-abstraction
in O
australia O
. O

the O
study B-abstraction
also O
examined O
the O
demographic B-abstraction
, O
ethnocultural O
, O
and O
psychological O
factors O
that O
could O
influence B-abstraction
subcontinental O
migrant B-physical_entity
groups' O
attitudes O
towards O
acculturation B-abstraction
and O
their O
acculturation B-abstraction
strategies O
. O

methoda O
cross B-physical_entity
sectional B-physical_entity
design B-abstraction
was O
used O
in O
which O
the O
dependent B-physical_entity
variables O
were O
the O
four B-physical_entity
acculturation B-abstraction
strategies O
. O

multivariate O
data O
analysis B-abstraction
was O
conducted O
. O

pearson's O
correlation B-abstraction
, O
analysis B-abstraction
of O
variance B-abstraction
, O
and O
step B-physical_entity
wise B-abstraction
multiple B-abstraction
regression I-abstraction
analyses O
were O
performed O
to O
establish O
the O
relationships O
among O
the O
study B-abstraction
variables O
. O

resultsintegration O
was O
the O
most O
preferred O
strategy B-abstraction
and O
marginalisation B-physical_entity
was O
the O
least O
preferred O
strategy B-abstraction
for O
all O
ethnic B-physical_entity
groups O
. O

acculturation B-abstraction
preferences O
are O
predicted O
partly O
by O
the O
adolescents' O
ethnicity B-abstraction
, O
their O
ethnic B-physical_entity
identity B-abstraction
, O
friendship O
choices O
, O
acculturative O
stress O
, O
sense B-abstraction
of O
mastery B-abstraction
self B-physical_entity
concept B-abstraction
and O
gender B-abstraction
. O

the O
findings O
provide O
significant O
information B-abstraction
on O
the O
acculturation B-abstraction
practices O
of O
indian O
subcontinental O
adolescents O
, O
including O
their O
ethnic B-physical_entity
identity B-abstraction
search B-abstraction
and O
commitment B-abstraction
, O
their O
psychological O
well B-physical_entity
being B-physical_entity
and O
their O
integration B-abstraction
strategies O
. O

conclusionseducational O
institutions O
could O
benefit B-abstraction
from O
increased O
awareness B-abstraction
of O
the O
needs O
of O
these O
culturally O
diverse O
groups O
, O
especially O
if O
this O
information B-abstraction
is O
incorporated O
into O
teacher B-abstraction
training B-abstraction
materials O
. O

the O
inclusion B-abstraction
of O
intercultural O
relations O
courses O
in O
the O
academic B-physical_entity
curriculum O
would O
promote O
harmonious O
relations O
between O
culturally O
diverse O
ethnic B-physical_entity
groups O
. O


in O
order B-abstraction
to O
improve O
the O
dynamic B-abstraction
responses O
of O
multimode O
controlled O
primary B-abstraction
side B-physical_entity
regulation B-physical_entity
flyback O
converter B-physical_entity
, O
a O
novel B-physical_entity
digital O
control B-physical_entity
method B-abstraction
is O
proposed O
in O
this O
paper B-physical_entity
. O

a O
new O
dac O
sampling B-abstraction
method B-abstraction
, O
which O
can B-physical_entity
capture B-abstraction
the O
output B-physical_entity
voltage O
during O
dynamic B-abstraction
transition B-abstraction
, O
is O
introduced O
. O

based O
on O
it O
, O
a O
dynamic B-abstraction
module B-abstraction
which O
can B-physical_entity
monitor B-physical_entity
the O
variation B-abstraction
of O
the O
output B-physical_entity
voltage O
to O
improve O
the O
dynamic B-abstraction
performance B-abstraction
is O
proposed O
. O

in O
a O
5 O
v O
1 O
a O
primary B-abstraction
side B-physical_entity
regulation B-physical_entity
flyback O
converter B-physical_entity
, O
the O
maximum B-physical_entity
undershoot O
voltage O
and O
overshoot B-abstraction
voltage O
of O
the O
proposed O
control B-abstraction
scheme B-abstraction
in O
this O
study B-abstraction
are O
0 O
. O

472 O
and O
0 O
. O

192 O
v O
, O
respectively O
. O

they O
are O
much O
lower B-physical_entity
compared O
to O
1 O
. O

296 O
and O
0 O
. O

584 O
v O
in O
the O
traditional O
control B-abstraction
scheme B-abstraction
. O

the O
maximum B-physical_entity
undershoot O
and O
overshoot B-abstraction
recovery B-physical_entity
times B-abstraction
are O
reduced O
from O
10 O
. O

86 O
to O
1 O
. O

29 O
ms O
and O
126 O
. O

3 O
to O
53 O
. O

68 O
ms O
, O
respectively O
. O

the O
proposed O
control B-abstraction
scheme B-abstraction
was O
then O
verified O
by O
a O
fpga O
controlled O
prototype B-abstraction
. O


this O
study B-abstraction
proposes O
high B-physical_entity
performance B-abstraction
voltage O
controller B-physical_entity
design B-physical_entity
that O
employs O
a O
capacitor B-physical_entity
current B-abstraction
control B-abstraction
model B-abstraction
for O
single B-abstraction
phase B-abstraction
stand B-physical_entity
alone O
inverters O
. O

the O
single B-abstraction
phase B-abstraction
stand B-physical_entity
alone O
inverter B-physical_entity
is O
analyzed O
via O
modeling B-physical_entity
, O
which O
is O
then O
used O
to O
design B-abstraction
the O
controller B-physical_entity
. O

a O
design B-physical_entity
methodology B-abstraction
is O
proposed O
to O
maximize O
the O
bandwidth O
of O
the O
feedback B-physical_entity
controller B-physical_entity
. O

subsequently O
, O
to O
compensate O
for O
the O
problems O
caused O
by O
the O
bandwidth O
limitations O
of O
the O
controller B-physical_entity
, O
an O
error B-abstraction
transfer B-abstraction
function B-abstraction
that O
includes O
the O
feedback B-physical_entity
controller B-physical_entity
is O
derived O
, O
and O
the O
stability B-abstraction
of O
the O
repetitive O
control B-physical_entity
scheme B-abstraction
is O
evaluated O
using B-abstraction
the O
error B-abstraction
transfer B-abstraction
function B-abstraction
. O

the O
digital O
repetitive O
controller B-physical_entity
is O
then O
implemented O
. O

the O
simulation B-abstraction
and O
experimental O
results O
show B-abstraction
that O
the O
performance B-abstraction
of O
the O
proposed O
controller B-physical_entity
is O
high B-physical_entity
in O
a O
1 O
. O

5 O
kw O
single B-abstraction
phase B-abstraction
stand B-abstraction
alone O
inverter B-physical_entity
prototype B-abstraction
. O


this O
work B-physical_entity
presents O
a O
novel B-physical_entity
mixed O
signal B-abstraction
control B-abstraction
scheme B-abstraction
for O
a O
boost B-abstraction
power B-physical_entity
factor B-physical_entity
correction B-abstraction
pfc O
rectifier B-physical_entity
. O

the O
digital O
controller B-physical_entity
modulates O
the O
inductor B-physical_entity
peak B-physical_entity
current B-abstraction
to O
produce O
a O
low B-abstraction
distortion B-abstraction
ac O
line B-physical_entity
current B-abstraction
in O
discontinuous O
conduction O
mode B-abstraction
dcm O
and O
continuous O
conduction O
mode B-abstraction
ccm O
, O
without O
the O
need B-abstraction
for O
average B-abstraction
current B-abstraction
sensing B-abstraction
. O

a O
lookup O
table B-physical_entity
lut O
optimizes O
efficiency O
at O
low B-abstraction
input B-abstraction
currents O
, O
by O
allowing O
operation B-abstraction
at O
125 O
500 O
khz O
dcm O
based O
on O
calculated O
thresholds O
. O

at O
high B-abstraction
input B-abstraction
currents O
, O
the O
converter B-physical_entity
operates O
at O
1 O
mhz O
ccm O
for O
reduced O
inductor B-physical_entity
footprint B-abstraction
. O

an O
analog B-abstraction
off O
time B-abstraction
generator B-physical_entity
with O
a O
digital O
frequency O
locked O
loop B-physical_entity
facilitates O
ccm O
operation B-abstraction
, O
eliminating O
the O
need B-abstraction
for O
slope B-physical_entity
compensation B-physical_entity
in O
the O
current B-abstraction
loop B-abstraction
and O
reduces O
frequency O
variations O
. O

the O
lut O
is O
programmed O
with O
an O
adaptive O
output B-abstraction
voltage O
of O
250 O
450 O
v O
for O
low B-abstraction
highmains O
line B-physical_entity
voltage O
85 O
265vrms O
to O
optimize O
efficiency O
over B-abstraction
a O
broad B-physical_entity
range B-physical_entity
of O
conditions O
. O

the O
150 O
w O
pfc O
prototype B-abstraction
operates O
up O
to O
1 O
mhz O
with O
a O
peak B-abstraction
efficiency O
of O
95 O
and O
a O
total B-abstraction
harmonic B-abstraction
distortion B-abstraction
of O
5 O
. O


the O
theoretical O
and O
experimental O
analysis B-abstraction
of O
a O
modified O
version B-abstraction
of O
the O
sepic O
dc O
dc O
converter B-physical_entity
used O
as O
preregulator O
operating O
in O
discontinuous O
conduction O
mode B-abstraction
dcm O
is O
presented O
in O
this O
paper B-physical_entity
. O

the O
proposed O
converter B-physical_entity
presents O
a O
low B-abstraction
input B-abstraction
current B-abstraction
ripple B-abstraction
operating O
in O
dcm O
, O
and O
the O
switch B-abstraction
voltage O
is O
lower B-physical_entity
than O
the O
output B-abstraction
voltage O
. O

the O
switch B-physical_entity
voltage O
reduction B-abstraction
increases O
the O
converter B-physical_entity
reliability O
and O
a O
low B-physical_entity
drain B-abstraction
to O
source B-abstraction
on O
resistance B-physical_entity
rdson O
mosfet O
can B-physical_entity
be O
used O
depending O
on O
the O
converter B-physical_entity
specification B-abstraction
. O

moreover O
, O
a O
digital O
control B-abstraction
technique B-abstraction
is O
applied O
to O
the O
proposed O
converter B-physical_entity
in O
order B-abstraction
to O
reduce O
the O
third B-physical_entity
harmonic B-abstraction
input B-abstraction
current B-abstraction
distortion B-abstraction
resultant B-abstraction
of O
the O
operation B-abstraction
in O
dcm O
. O

finally O
, O
a O
100 O
w O
prototype B-abstraction
was O
developed O
operating O
with O
efficiency O
equal B-physical_entity
to O
95 O
. O

6 O
. O


in O
high B-physical_entity
performance B-abstraction
magnetic O
resonance B-abstraction
imaging B-abstraction
systems O
, O
the O
gradient O
driver B-physical_entity
is O
required O
to O
supply B-abstraction
the O
gradient O
coil B-physical_entity
with O
a O
large B-abstraction
current B-abstraction
600 O
a O
and O
a O
high B-abstraction
voltage O
2000 O
v O
to O
achieve O
a O
strong O
gradient O
field B-abstraction
and O
a O
fast B-abstraction
slew O
rate B-abstraction
. O

in O
addition B-abstraction
, O
extremely O
high B-abstraction
fidelity I-abstraction
for O
reproducing O
the O
current B-abstraction
command B-abstraction
from O
the O
central B-physical_entity
system B-physical_entity
is O
very O
critical O
to O
imaging B-abstraction
quality B-abstraction
. O

this O
paper B-physical_entity
presents O
the O
solutions O
for O
the O
different O
elements O
of O
the O
driver B-physical_entity
1 O
high B-physical_entity
bandwidth O
bw O
power B-physical_entity
inverter B-physical_entity
; O
2 O
ripple B-abstraction
cancelation O
filter B-physical_entity
; O
3 O
multioutput O
power B-abstraction
supply B-physical_entity
ps O
; O
and O
4 O
digital O
control B-abstraction
. O

a O
high B-abstraction
bw O
power B-physical_entity
inverter B-physical_entity
requires O
a O
stacked O
bridges O
structure B-abstraction
to O
achieve O
a O
high B-physical_entity
output B-physical_entity
ripple B-abstraction
frequency O
with O
the O
existing O
commercial O
power B-physical_entity
semiconductor B-physical_entity
modules O
. O

the O
high B-abstraction
voltage O
and O
the O
high B-physical_entity
frequency I-abstraction
for O
large B-abstraction
power B-physical_entity
modules O
can B-physical_entity
be O
obtained O
easier O
and O
with O
lower B-physical_entity
loss B-abstraction
using B-abstraction
the O
new O
silicon O
carbide O
devices B-abstraction
. O

the O
control B-abstraction
needs O
a O
digital O
implementation B-abstraction
and O
a O
very O
fast B-abstraction
processor B-physical_entity
. O

digital O
control B-abstraction
provides O
compensation B-abstraction
and O
feedforward O
to O
improve O
the O
response B-abstraction
. O

a O
capability B-abstraction
improvement B-abstraction
is O
obtained O
by O
reducing B-physical_entity
the O
switching B-abstraction
frequency O
when O
large B-abstraction
currents O
with O
a O
very O
low B-abstraction
frequency I-physical_entity
variation B-physical_entity
are O
needed O
. O

the O
control B-abstraction
can B-physical_entity
handle O
it O
very O
well B-physical_entity
, O
but O
the O
filter B-physical_entity
has O
to O
be O
designed O
to O
eliminate O
more O
than O
one B-abstraction
ripple B-abstraction
frequency O
. O

finally O
, O
many O
ps O
solutions O
have B-physical_entity
been O
used O
for O
multiple B-abstraction
isolated O
outputs O
, O
but O
digital O
control B-abstraction
compensation B-abstraction
permits O
the O
use B-abstraction
of O
much O
simpler O
unregulated O
ps O
and O
keeps O
the O
performance B-abstraction
. O

a O
2 O
mva O
, O
900 O
a O
1200 O
v O
, O
platform B-physical_entity
has O
been O
built O
and O
fully O
tested O
. O

the O
experimental O
results O
proved O
the O
validity B-abstraction
of O
the O
proposed O
structure B-abstraction
and O
the O
modulation B-abstraction
technique B-abstraction
. O


drug O
release B-abstraction
belongs O
to O
the O
most O
challenging O
aspects O
of O
nanoparticles O
addressing O
molecular B-O
biology I-O
and O
medicine B-abstraction
. O

besides O
targeted O
delivery B-abstraction
, O
obvious O
challenges O
are O
related O
to O
high B-physical_entity
drug O
load B-abstraction
and O
continuous O
slow O
drug O
release B-abstraction
. O

based O
on O
our O
recently O
developed O
concept B-abstraction
of O
inorganic O
organic O
hybrid B-abstraction
nanoparticles O
ioh O
np O
, O
we O
here B-physical_entity
present B-abstraction
zro O
2 O
aap O
2 O
ioh O
nps O
containing O
the O
analgetic O
phosphate O
prodrug O
acetaminophen O
phosphate O
for O
drug O
release B-abstraction
. O

zro O
2 O
aap O
2 O
combines O
an O
uncomplex O
synthesis B-abstraction
in O
water B-physical_entity
with O
a O
high B-physical_entity
prodrug O
load B-abstraction
of O
68 O
wt O
. O

. O

zro O
2 O
aap O
2 O
nanoparticles O
exhibit B-abstraction
a O
diameter B-abstraction
of O
37 O
11 O
nm O
and O
can B-physical_entity
be O
readily O
obtained O
as O
colloidally O
highly O
stable B-physical_entity
suspension B-abstraction
in O
water B-physical_entity
. O

the O
chemical O
composition B-physical_entity
is O
studied O
in O
detail B-abstraction
based O
on O
infrared O
spectroscopy B-abstraction
, O
energy B-abstraction
dispersive O
x O
ray B-physical_entity
analysis B-abstraction
, O
thermogravimetry B-abstraction
and O
elemental O
analysis B-abstraction
. O

moreover O
, O
the O
release B-physical_entity
of O
acetaminophen O
from O
zro O
2 O
aap O
2 O
is O
studied O
by O
means B-abstraction
of O
model B-physical_entity
experiments O
indicating O
the O
carbon B-physical_entity
content B-abstraction
of O
the O
nanoparticles O
and O
, O
in O
alternative B-abstraction
, O
the O
fluorescence O
of O
labeled O
nanoparticles O
. O

both O
data O
show B-abstraction
a O
continuous O
release B-abstraction
of O
80 O
wt O
. O

of O
the O
analgetic O
acetaminophen O
on O
a O
time B-abstraction
scale I-abstraction
up O
to O
48 O
h O
. O

c O
2016 O
elsevier O
inc O
. O

all O
rights O
reserved O
. O


we O
have B-physical_entity
reported O
that O
orally O
administrated O
acetate B-physical_entity
contributed O
to O
suppression B-physical_entity
of O
lipogenesis O
in O
the O
liver B-physical_entity
and O
to O
reduction B-abstraction
of O
lipid O
accumulation B-abstraction
in O
the O
adipose O
tissue O
of O
otsuka O
long O
evans O
tokushima O
fatty B-physical_entity
oletf O
rats O
. O

the O
aim B-physical_entity
of O
this O
study B-physical_entity
was O
to O
investigate O
the O
effect B-abstraction
of O
acetate B-physical_entity
on O
skeletal O
muscle B-abstraction
and O
adipose O
tissues O
. O

treatment B-abstraction
with O
acetate B-physical_entity
showed O
a O
higher O
rate B-abstraction
of O
oxygen O
consumption B-physical_entity
and O
a O
smaller O
size B-abstraction
of O
lipid O
droplets O
in O
white B-abstraction
adipose O
and O
brown B-abstraction
adipose O
tissues O
. O

an O
analysis B-abstraction
by O
northern O
blotting O
revealed O
that O
the O
transcripts O
of O
myoglobin O
and O
glut4 O
genes O
in O
the O
abdominal O
muscle B-abstraction
of O
the O
oletf O
rats O
were O
increased O
by O
acetate B-physical_entity
treatment B-abstraction
, O
while B-abstraction
the O
transcripts O
of O
lipolytic O
genes O
increased O
in O
the O
white B-abstraction
adipose O
and O
brown B-abstraction
adipose O
tissues O
. O

it O
is O
possible B-physical_entity
that O
acetate B-physical_entity
has O
effects O
on O
lipid O
metabolism B-physical_entity
in O
the O
skeletal O
muscles O
and O
the O
adipose O
tissues O
, O
and O
has O
functions O
that O
work B-physical_entity
against O
obesity B-abstraction
and O
obesity B-abstraction
linked O
type B-physical_entity
2 O
diabetes O
. O


acetate B-physical_entity
has O
been O
found O
to O
have B-physical_entity
an O
inhibitory O
effect B-abstraction
on O
the O
activity B-abstraction
of O
carbohydrate O
responsive O
element B-abstraction
binding B-physical_entity
protein O
chrebp O
in O
cultured O
hepatocytes O
, O
this O
being B-physical_entity
a O
transcription B-physical_entity
factor B-abstraction
that O
regulates O
several O
genes O
required O
for O
the O
conversion B-physical_entity
of O
glucose O
to O
fatty B-physical_entity
acids O
in O
the O
liver B-physical_entity
. O

the O
aim B-physical_entity
of O
this O
study B-physical_entity
was O
to O
investigate O
whether O
an O
oral B-abstraction
administration B-abstraction
of O
acetate B-physical_entity
would O
contribute O
to O
reducing B-physical_entity
lypogenic O
genes O
and O
protecting O
against O
obesity B-abstraction
. O

we O
orally O
injected O
5 O
. O

2mg O
kg O
bw O
of O
acetate B-physical_entity
to O
obesity B-abstraction
linked O
type B-physical_entity
2 O
diabetic B-physical_entity
otsuka O
long O
evans O
tokushima O
fatty B-physical_entity
oletf O
rats O
. O

the O
treatment B-abstraction
with O
acetate B-physical_entity
showed O
a O
marked O
reduction B-physical_entity
in O
lipid O
accumulation B-abstraction
in O
the O
adipose O
tissue O
, O
protection B-physical_entity
against O
accumulation B-abstraction
of O
fat B-abstraction
in O
the O
liver B-physical_entity
, O
and O
improved O
glucose O
tolerance B-abstraction
. O

an O
analysis B-abstraction
by O
northern O
blotting O
revealed O
that O
the O
transcripts O
of O
several O
lipogenic O
genes O
in O
the O
liver B-physical_entity
of O
oletf O
rats O
were O
decreased O
by O
the O
acetate B-physical_entity
treatment B-abstraction
. O

on O
the O
basis B-abstraction
of O
those O
results O
, O
it O
was O
indicated O
that O
acetate B-physical_entity
was O
a O
potential O
compound B-abstraction
to O
improve O
obesity B-abstraction
and O
obesity B-abstraction
linked O
type B-physical_entity
2 O
diabetes O
. O


research B-abstraction
was O
carried O
out B-abstraction
for O
the O
appraisal B-abstraction
of O
toxic O
and O
anti B-physical_entity
enzymetic O
action B-physical_entity
of O
acetone O
extracts O
of O
datura O
inoxia O
and O
azadirachta O
indica O
against O
tribolium O
castaneum O
, O
trogoderma O
granarium O
and O
sitophilus O
granarius O
in O
the O
grain B-abstraction
research B-abstraction
training B-abstraction
and O
storage B-physical_entity
management B-abstraction
cell B-physical_entity
of O
department B-physical_entity
of O
entomology B-abstraction
and O
in O
protein O
molecular B-O
biology I-O
laboratory B-physical_entity
pmbl O
department B-physical_entity
of O
biochemistry B-abstraction
uaf O
during O
the O
year B-abstraction
2014 O
. O

various O
dilution B-abstraction
levels O
viz O
. O

, O
5 O
. O

0 O
, O
10 O
. O

0 O
, O
15 O
. O

0 O
and O
20 O
. O

0 O
of O
both O
plants O
extracts O
were O
assessed O
against O
test B-physical_entity
insects O
. O

toxic O
effect B-abstraction
of O
plant B-physical_entity
extracts O
in O
t O
. O

castaneum O
, O
t O
. O

granarium O
and O
s B-abstraction
. O

granarius O
was O
observed O
after O
an O
exposure B-abstraction
period B-physical_entity
of O
2 O
, O
4 O
, O
6 O
, O
8 O
and O
10 O
days B-abstraction
while B-abstraction
inhibition B-physical_entity
of O
different O
enzymes O
acetylcholinesterase O
ache B-abstraction
, O
a O
carboxylesterase O
alpha B-abstraction
ce O
, O
beta O
carboxylesterase O
beta O
ce O
, O
acid O
phosphatases O
acp O
and O
alkaline O
phosphatases O
alp B-physical_entity
were O
calculated O
spectrophotometrically O
in O
the O
survivors O
of O
toxicity B-abstraction
assay B-abstraction
. O

the O
results O
evidenced O
that O
both O
plant B-abstraction
extracts O
had O
lethal O
effects O
against O
three O
stored O
grain B-abstraction
insect B-physical_entity
species B-abstraction
. O

comparison B-abstraction
of O
means B-physical_entity
of O
mortality B-abstraction
in O
t O
. O

castaneum O
, O
t O
. O

granarium O
and O
s B-abstraction
. O

granarius O
proved O
that O
a O
. O

indica O
extract O
was O
more O
effective O
, O
causing B-abstraction
maximum B-abstraction
38 O
. O

41 O
, O
24 O
. O

35 O
and O
28 O
. O

56 O
mortality B-abstraction
, O
respectively O
. O

d O
. O

inoxia O
resulted O
in O
15 O
. O

12 O
, O
13 O
. O

52 O
and O
14 O
. O

07 O
maximum B-abstraction
mortality B-abstraction
in O
t O
. O

castaneum O
, O
t O
. O

granarium O
and O
s B-abstraction
. O

granarius O
, O
respectively O
. O

the O
results O
also O
revealed O
significant O
inhibition B-physical_entity
of O
ache B-abstraction
, O
alpha B-abstraction
ce O
, O
beta O
ce O
, O
acp O
and O
alp B-physical_entity
upon O
exposure B-abstraction
to O
various O
concentrations O
of O
tested O
plants O
. O

plant B-abstraction
extract O
of O
a O
. O

indica O
proved O
more O
efficient O
for O
the O
inhibition B-physical_entity
of O
all O
test B-abstraction
enzymes O
in O
three O
stored O
grain B-abstraction
insect B-physical_entity
pests O
. O

the O
results O
suggest O
the O
ability B-abstraction
of O
using B-abstraction
these O
plants O
extracts O
for O
wheat B-abstraction
flour O
and O
grains O
protection B-abstraction
as O
a O
safe B-physical_entity
alternative B-abstraction
to O
insecticides O
. O


bacterial O
community B-physical_entity
analyses O
of O
samples O
from O
a O
pilot B-abstraction
plant B-abstraction
for O
the O
treatment B-abstraction
of O
acid O
mine B-physical_entity
drainage B-abstraction
amd O
from O
the O
lignite O
mining B-abstraction
district B-physical_entity
in O
lusatia O
east B-physical_entity
germany O
had O
previously O
demonstrated O
the O
dominance B-abstraction
of O
two O
groups O
of O
acidophilic O
iron B-physical_entity
oxidizers O
the O
novel B-physical_entity
candidate B-physical_entity
genus B-abstraction
" O
ferrovum O
" O
and O
a O
group O
comprising O
gallionella O
like B-abstraction
strains O
. O

since O
pure O
culture B-abstraction
had O
proven O
difficult O
, O
previous O
studies O
have B-physical_entity
used O
genome O
analyses O
of O
co O
cultures O
consisting O
of O
" O
ferrovum O
" O
and O
a O
strain B-abstraction
of O
the O
heterotrophic O
acidophile B-physical_entity
acidiphilium O
in O
order B-abstraction
to O
obtain O
insight B-abstraction
into O
the O
life B-abstraction
style I-abstraction
of O
these O
novel B-physical_entity
bacteria B-physical_entity
. O

here B-physical_entity
we O
report B-abstraction
on O
attempts O
to O
undertake O
a O
similar O
study B-physical_entity
on O
gallionella O
like B-abstraction
acidophiles O
from O
amd O
. O

isolates O
belonging O
to O
the O
family B-physical_entity
gallionellaceae O
are O
still B-physical_entity
restricted O
to O
the O
microaerophilic O
and O
neutrophilic O
iron B-physical_entity
oxidizers O
sideroxydans O
and O
gallionella O
. O

availability B-abstraction
of O
genomic O
or O
metagenomic O
sequence B-abstraction
data O
of O
acidophilic O
strains O
of O
these O
genera O
should O
, O
therefore O
, O
be O
relevant O
for O
defining O
adaptive O
strategies O
in O
ph O
homeostasis O
. O

this O
is O
particularly O
the O
case B-abstraction
since O
complete O
genome O
sequences O
of O
the O
neutrophilic O
strains O
g O
. O

capsiferriformans O
es O
2 O
and O
s B-abstraction
. O

lithotrophicus O
es O
1 O
permit B-abstraction
the O
direct O
comparison B-abstraction
of O
the O
metabolic O
capacity B-abstraction
of O
neutrophilic O
and O
acidophilic O
members O
of O
the O
same O
genus B-abstraction
and O
, O
thus O
, O
the O
detection B-physical_entity
of O
biochemical O
features O
that O
are O
specific B-abstraction
to O
acidophilic O
strains O
to O
support B-abstraction
life B-physical_entity
under O
acidic O
conditions O
. O

isolation B-physical_entity
attempts O
undertaken O
in O
this O
study B-physical_entity
resulted O
in O
the O
microaerophilic O
enrichment B-abstraction
culture B-abstraction
ade O
12 O
1 O
which O
, O
based O
on O
16s O
rrna O
gene O
sequence B-abstraction
analysis B-abstraction
, O
consisted O
of O
at O
least O
three O
to O
four B-physical_entity
distinct O
gallionellaceae O
strains O
that O
appear O
to O
be O
closely O
related O
to O
the O
neutrophilic O
iron B-physical_entity
oxidizer O
s B-abstraction
. O

lithotrophicus O
es O
1 O
. O

key B-abstraction
hypotheses O
inferred O
from O
the O
metabolic O
reconstruction B-abstraction
of O
the O
metagenomic O
sequence B-physical_entity
data O
of O
these O
acidophilic O
sideroxydans O
strains O
include O
the O
putative O
role B-abstraction
of O
urea O
hydrolysis B-physical_entity
, O
formate O
oxidation B-physical_entity
and O
cyanophycin O
decarboxylation B-physical_entity
in O
ph O
homeostasis O
. O


in O
this O
study B-abstraction
, O
laccase O
from O
trametes O
versicolor O
was O
immobilized O
in O
poly O
acrylamide O
crotonic O
acid O
sodium O
alginate O
p O
aam O
cra O
alginate O
, O
poly O
acrylamide O
crotonic O
acid O
k O
carrageenan O
p O
aam O
cra O
k O
car B-physical_entity
, O
poly O
acrylamide O
citraconic O
acid O
sodium O
alginate O
p O
aam O
ca O
alginate O
, O
and O
poly O
acrylamide O
citraconic O
acid O
k O
carrageenan O
p O
aam O
ca O
k O
car B-physical_entity
semi B-abstraction
interpenetrating O
network B-physical_entity
by O
entrapment B-abstraction
method B-abstraction
. O

optimum B-abstraction
ph O
and O
temperatures O
values B-abstraction
were O
determined O
between O
5 O
. O

0 O
6 O
. O

0 O
and O
40 O
50 O
degrees O
c O
for O
free O
laccase O
fl O
and O
immobilized O
laccases O
, O
respectively O
. O

after O
42 O
days B-abstraction
of O
storage B-abstraction
at O
4 O
degrees O
c O
, O
fl O
and O
immobilized O
laccases O
retained O
their O
original B-physical_entity
activities O
in O
the O
range B-abstraction
of O
55 O
73 O
. O

percent O
decolorization O
of O
acid O
orange B-abstraction
52 O
by O
free O
enyzme O
and O
enyzmes O
immobilized O
in O
hydrogels O
was O
found O
between O
63 O
and O
39 O
. O

percent O
decolorization O
of O
acid O
orange B-abstraction
52 O
in O
the O
presence B-abstraction
of O
mediator B-physical_entity
by O
free O
enyzme O
was O
found O
73 O
and O
enyzmes O
immobilized O
in O
hydrogels O
were O
found O
as O
73 O
. O

c O
2015 O
international O
union B-abstraction
of O
biochemistry B-abstraction
and O
molecular B-O
biology I-O
, O
inc O
. O


c O
myc O
overexpression O
has O
been O
implicated O
in O
several O
malignancies O
including O
gastric O
cancer O
. O

here B-physical_entity
, O
we O
report B-abstraction
that O
acidified O
bile O
acids O
enhance O
tumor O
progression B-abstraction
and O
telomerase O
activity B-physical_entity
in O
gastric O
cancer O
via O
c O
myc O
activation B-abstraction
both O
in O
vivo O
and O
in O
vitro O
. O

c O
myc O
mrna O
and O
protein O
levels O
were O
assessed O
in O
ten O
primary B-physical_entity
and O
five B-physical_entity
local B-physical_entity
recurrent O
gastric O
cancer O
samples O
by O
quantitative O
real B-O
time I-O
polymerase O
chain B-physical_entity
reaction I-physical_entity
and O
western O
blotting O
analysis B-abstraction
. O

the O
gastric O
cancer B-O
cell I-O
line B-physical_entity
mgc803 O
was O
exposed O
to O
bile O
salts O
100mol O
l O
glycochenodeoxycholic O
acid O
and O
deoxycholic O
acid O
in O
anacidmedium O
ph O
5 O
. O

5 O
for O
10min O
daily B-physical_entity
for O
60weeks O
to O
develop O
an O
mgc803 O
resistant O
cell B-physical_entity
line B-physical_entity
. O

control B-physical_entity
mgc803 O
cells O
were O
grown O
without O
acids O
or O
bile O
salts O
for O
60weeks O
as O
a O
control B-physical_entity
. O

cell B-physical_entity
morphology B-abstraction
, O
proliferation B-physical_entity
, O
colony B-physical_entity
formation B-physical_entity
and O
apoptosis O
of O
mgc803 O
resistant O
cells O
were O
analyzed O
after O
60weeks O
. O

to O
determine O
the O
involvement B-abstraction
of O
c O
myc O
in O
tumor O
progression B-abstraction
and O
telomere B-physical_entity
aging B-physical_entity
in O
mgc803 O
resistant O
cells O
, O
we O
generated O
xenografts O
in O
nude B-physical_entity
mice O
and O
measured O
xenograft O
volume B-abstraction
and O
in O
vivo O
telomerase O
activity B-abstraction
. O

the O
c O
myc O
and O
htert O
protein O
and O
mrna O
levels O
were O
significantly O
higher O
in O
local B-physical_entity
recurrent O
gastric O
cancer O
samples O
than O
in O
primary B-physical_entity
gastric O
cancer O
samples O
. O

mgc803 O
resistant O
cells O
showed O
a O
marked O
phenotypic O
change B-physical_entity
under O
normal B-abstraction
growth B-physical_entity
conditions O
with O
more O
clusters O
and O
acini O
, O
and O
exhibited O
increased O
cell B-physical_entity
viability B-abstraction
and O
colony B-physical_entity
formation B-physical_entity
and O
decreased O
apoptosis O
in O
vitro O
. O

these O
phenotypic O
changes O
were O
found O
to O
be O
dependent B-physical_entity
on O
c O
myc O
activation B-physical_entity
using B-abstraction
the O
c O
myc O
inhibitor O
10058 O
f4 O
. O

mgc803 O
resistant O
cells O
also O
showed O
a O
c O
myc O
dependent B-physical_entity
increase B-abstraction
in O
xenograft O
growth B-physical_entity
and O
telomerase O
activity B-abstraction
in O
vivo O
. O

in O
conclusion B-abstraction
, O
these O
observations O
support B-abstraction
the O
hypothesis B-abstraction
that O
acidified O
bile O
acids O
enhance O
tumor O
progression B-abstraction
and O
telomerase O
activity B-abstraction
in O
gastric O
cancer O
and O
that O
these O
effects O
are O
dependent B-physical_entity
on O
c O
myc O
activity B-physical_entity
. O

these O
findings O
suggest O
that O
acidified O
bile O
acids O
play B-abstraction
an O
important O
role B-abstraction
in O
the O
malignant O
progression B-abstraction
of O
local B-physical_entity
recurrent O
gastric O
cancer O
. O


thermoelectric O
te O
materials O
are O
important O
for O
the O
sustainable O
development B-physical_entity
because O
they O
enable O
the O
direct O
harvesting B-abstraction
of O
low B-abstraction
quality I-abstraction
heat B-abstraction
into O
electricity O
. O

among O
them O
, O
conducting B-abstraction
polymers O
have B-physical_entity
attracted O
great B-physical_entity
attention B-abstraction
arising O
from O
their O
advantages O
, O
such O
as O
flexibility B-abstraction
, O
nontoxicity O
, O
easy O
availability B-abstraction
, O
and O
intrinsically O
low B-abstraction
thermal O
conductivity O
. O

in O
this O
work B-abstraction
, O
a O
novel B-physical_entity
and O
facile O
method B-abstraction
is O
reported O
to O
significantly O
enhance O
the O
te O
property B-abstraction
of O
poly O
3 O
, O
4 O
ethylenedioxythiophene O
poly O
styrenesulfonate O
pedot O
pss O
films O
through O
sequential O
post B-abstraction
treatments O
with O
common B-physical_entity
acids O
and O
bases O
. O

compared O
with O
the O
as O
prepared O
pedot O
pss O
, O
both O
the O
seebeck O
coefficients O
and O
electrical O
conductivities O
can B-physical_entity
be O
remarkably O
enhanced O
after O
the O
treatments O
. O

the O
oxidation B-physical_entity
level B-physical_entity
, O
which O
significantly O
impacts O
the O
te O
property B-physical_entity
of O
the O
pedot O
pss O
films O
, O
can B-physical_entity
also O
be O
well B-physical_entity
tuned O
by O
controlling O
the O
experimental O
conditions O
during O
the O
base B-abstraction
treatment B-abstraction
. O

the O
optimal O
pedot O
pss O
films O
can B-physical_entity
have B-physical_entity
a O
seebeck O
coefficient O
of O
39 O
. O

2 O
mu O
v O
k O
1 O
and O
a O
conductivity O
of O
2170 O
s B-abstraction
cm O
1 O
at O
room B-physical_entity
temperature I-physical_entity
, O
and O
the O
corresponding O
power B-abstraction
factor B-physical_entity
is O
334 O
mu O
w O
m O
1 O
k O
2 O
. O

the O
enhancement B-abstraction
in O
the O
te O
properties O
is O
attributed O
to O
the O
synergetic O
effect B-abstraction
of O
high B-abstraction
charge B-abstraction
mobility B-abstraction
by O
the O
acid O
treatment B-abstraction
and O
the O
optimal O
oxidation B-physical_entity
level B-abstraction
tuned O
by O
the O
base B-physical_entity
treatment B-abstraction
. O


background B-abstraction
carbapenem O
resistant O
acinetobacter O
baumannii O
has O
emerged O
as O
an O
important O
cause B-abstraction
of O
infection B-physical_entity
in O
burn B-abstraction
patients O
. O

this O
study B-physical_entity
aimed O
to O
characterize O
the O
antimicrobial O
susceptibility O
pattern B-physical_entity
, O
determine O
the O
prevalence B-abstraction
of O
oxacillinase O
and O
metallo O
beta O
lactamase O
mbl O
genes O
, O
and O
type B-abstraction
the O
a O
. O

baumannii O
isolates O
obtained O
from O
burn B-abstraction
patients O
. O

methods O
during O
a O
1 O
year B-abstraction
period B-abstraction
, O
a O
total B-abstraction
of O
40 O
nonduplicated O
isolates O
of O
a O
. O

baumannii O
were O
obtained O
from O
burn B-abstraction
patients O
who O
were O
hospitalized O
in O
the O
taleghani O
burn B-abstraction
hospital B-physical_entity
in O
ahvaz O
, O
in O
the O
southwest B-physical_entity
of O
iran O
. O

testing B-abstraction
for O
antimicrobial O
susceptibility O
was O
carried O
out B-abstraction
by O
disk B-physical_entity
diffusion B-physical_entity
and O
e O
test B-physical_entity
. O

to O
screen B-physical_entity
mbl O
production B-abstraction
, O
a O
double B-abstraction
disk B-physical_entity
synergy B-physical_entity
and O
mbl O
e O
test B-physical_entity
were O
performed O
. O

the O
presence B-abstraction
of O
bla O
oxa O
23 O
like B-abstraction
, O
bla O
oxa O
24 O
like B-abstraction
, O
bla O
oxa O
51 O
like B-abstraction
and O
bla O
oxa O
58 O
like B-abstraction
, O
bla O
vim O
, O
bla O
imp B-physical_entity
and O
bla O
spm O
, O
and O
bla O
ndm O
was O
sought O
by O
polymerase O
chain B-physical_entity
reaction I-physical_entity
pcr O
. O

repetitive O
extragenic O
palindromic O
sequence B-abstraction
based O
pcr O
was O
carried O
out B-abstraction
for O
determination B-abstraction
of O
isolates O
clonality O
. O

results O
overall B-physical_entity
, O
92 O
. O

5 O
of O
isolates O
were O
carbapenem O
resistant O
. O

polymyxin O
b O
, O
colistin O
, O
and O
ampicillin O
sulbactam O
were O
the O
most O
effective O
agents O
in O
vitro O
, O
with O
a O
susceptibility O
rate B-abstraction
of O
100 O
, O
97 O
. O

5 O
, O
and O
72 O
. O

5 O
, O
respectively O
. O

according O
to O
the O
double B-physical_entity
disk B-physical_entity
synergy B-physical_entity
and O
e O
test B-physical_entity
, O
55 O
. O

6 O
and O
97 O
. O

3 O
of O
isolates O
were O
mbl O
producers O
, O
respectively O
. O

furthermore O
, O
70 O
of O
isolates O
harbored O
bla O
oxa O
23 O
like B-abstraction
and O
20 O
were O
positive B-physical_entity
for O
bla O
oxa O
24 O
like B-abstraction
. O

however O
, O
no B-abstraction
encoding B-abstraction
genes O
were O
detected O
for O
bla O
vim O
, O
bla O
imp B-physical_entity
and O
bla O
spm O
, O
bla O
ndm O
, O
and O
bla O
oxa O
58 O
like B-abstraction
. O

repetitive O
extragenic O
palindromic O
sequence B-abstraction
based O
pcr O
revealed O
that O
carbapenem O
resistant O
isolates O
belonged O
to O
four B-physical_entity
clones O
, O
including O
a O
, O
b O
, O
c O
, O
and O
d O
; O
the O
predominant O
clones O
were O
b O
and O
c O
. O

conclusion B-abstraction
the O
rate B-abstraction
of O
carbapenem O
resistance B-abstraction
was O
high B-physical_entity
, O
and O
it O
appeared O
that O
bla O
oxa O
23 O
like B-abstraction
and O
bla O
oxa O
24 O
like B-abstraction
contributed O
to O
the O
carbapenem O
resistance B-abstraction
of O
a O
. O

baumannii O
isolates O
. O

this O
result B-abstraction
suggests O
that O
the O
two O
predominant O
clones O
of O
a O
. O

baumannii O
were O
spread B-physical_entity
among O
burn B-abstraction
patients O
. O

in O
order B-abstraction
to O
prevent O
future B-abstraction
dissemination B-abstraction
of O
resistant O
isolates O
among O
burn B-abstraction
patients O
, O
an O
effective O
infection B-abstraction
control B-abstraction
plan B-physical_entity
is O
necessary O
. O

copyright B-abstraction
c O
2017 O
. O

published O
by O
elsevier O
taiwan O
llc O
. O


the O
aim B-abstraction
of O
the O
present B-abstraction
study B-abstraction
was O
to O
investigate O
the O
resistance B-abstraction
of O
acinetobacter O
baumannii O
, O
which O
was O
induced O
by O
cefepime O
fep O
, O
cefoperazone O
sulbactam O
scf O
, O
tazobactam O
tzp O
, O
levofloxacin O
lev O
, O
amikacin O
ak O
, O
imipenem O
ipm O
, O
and O
ciprofloxacin O
cip O
, O
in O
vitro O
. O

multi O
step B-physical_entity
drug O
resistance B-physical_entity
selection B-abstraction
of O
16 O
a O
. O

baumannii O
strains O
was O
performed O
using B-abstraction
seven O
antibacterial O
agents O
fep O
, O
tzp O
, O
cip O
, O
ak O
, O
ipm O
, O
scf O
, O
and O
lev O
. O

the O
minimum B-physical_entity
inhibitory O
concentration B-abstraction
mic O
was O
determined O
using B-abstraction
the O
agar O
dilution B-abstraction
method B-abstraction
. O

random O
amplified O
polymorphic O
dna O
polymerase O
chain B-physical_entity
reaction I-physical_entity
was O
performed O
to O
analyze O
the O
genotypes O
and O
the O
carrying O
rates O
of O
aac O
3 O
i O
, O
aac O
6 O
i O
, O
ant B-physical_entity
3 O
i O
, O
aph O
3 O
via O
, O
oxa O
23 O
, O
oxa O
24 O
, O
ampc O
, O
tem O
1 O
, O
metallo O
lactamase O
gene O
imp B-abstraction
, O
arma O
, O
rmta O
, O
rmtb O
, O
parc O
, O
gyra O
and O
adeb O
. O

expression B-physical_entity
of O
adeb O
was O
determined O
using B-abstraction
semi B-physical_entity
quantitative O
reverse B-abstraction
transcription B-abstraction
polymerase O
chain B-physical_entity
reaction I-physical_entity
semi B-physical_entity
qrt O
pcr O
. O

among O
the O
16 O
strains O
, O
15 O
strains O
with O
drug O
resistance B-abstraction
93 O
. O

8 O
were O
obtained O
following B-abstraction
in O
vitro O
induction B-abstraction
. O

notable B-physical_entity
increases O
8 O
to O
128 O
fold B-abstraction
were O
noted O
in O
the O
mic O
and O
different O
genotypes O
were O
showed O
in O
rapd O
of O
the O
strains O
before O
and O
after O
performing B-abstraction
the O
drug O
resistant O
test B-abstraction
. O

pcr O
data O
revealed O
significant O
differences O
p O
0 O
. O

05 O
between O
the O
carrying O
rates O
of O
resistant O
genes O
before O
and O
after O
drug O
induction B-abstraction
, O
with O
the O
exception B-abstraction
of O
rmta O
, O
oxa O
24 O
, O
tem O
1 O
, O
and O
imp B-physical_entity
. O

significant O
increases O
were O
demonstrated O
in O
the O
comparative O
adeb O
grayscale O
in O
strains O
that O
underwent O
drug O
induction B-abstraction
when O
compared O
with O
the O
sensitive B-physical_entity
strains O
55 O
. O

69 O
43 O
. O

11 O
vs O
. O

10 O
. O

08 O
26 O
. O

35 O
; O
p O
0 O
. O

001 O
. O

findings O
of O
the O
present B-abstraction
study B-physical_entity
suggest O
that O
the O
active B-physical_entity
efflux B-physical_entity
pump B-physical_entity
, O
adeb O
, O
has O
an O
important O
role B-abstraction
in O
multidrug O
resistance B-abstraction
of O
the O
a O
. O

baumannii O
induced O
by O
antibacterial O
agents O
in O
vitro O
. O


we O
characterized O
72 O
isolates O
with O
reduced O
susceptibility O
to O
carbapenems O
50 O
acinetobacter O
spp O
. O

, O
13 O
proteus O
mirabilis O
, O
five B-physical_entity
escherichia B-physical_entity
coli O
, O
one B-abstraction
morganella O
morganii O
, O
one B-abstraction
enterobacter O
cloacae O
, O
one B-abstraction
providencia O
rettgeri O
, O
and O
one B-abstraction
pseudomonas O
aeruginosa O
from O
a O
hospital B-physical_entity
in O
sofia O
, O
bulgaria O
. O

different O
lactamase O
genes O
were O
identified O
by O
polymerase O
chain B-physical_entity
reaction I-physical_entity
and O
sequencing O
. O

bacterial O
strain B-abstraction
typing O
was O
performed O
by O
enzymatic O
macrorestriction O
and O
pulsed O
field B-abstraction
gel B-physical_entity
electrophoresis B-physical_entity
pfge O
typing O
as O
well B-physical_entity
as O
multilocus O
sequence B-abstraction
typing O
for O
selected O
isolates O
. O

the O
majority B-abstraction
of O
acinetobacter O
baumannii O
46 O
50 O
and O
one B-abstraction
acinetobacter O
pittii O
isolate O
harbored O
carbapenemase O
genes O
bla O
oxa O
23 O
or O
bla O
oxa O
72 O
; O
two O
a O
. O

baumannii O
contained O
both O
genes O
. O

pfge O
typing O
of O
all O
a O
. O

baumannii O
showed O
the O
presence B-abstraction
of O
nine O
different O
clones O
belonging O
to O
eight O
sequence B-abstraction
types O
st350 O
, O
st208 O
, O
st436 O
, O
st437 O
, O
st449 O
, O
st231 O
, O
st502 O
, O
and O
st579 O
. O

molecular O
characterization B-abstraction
of O
the O
remaining O
isolates O
confirmed O
the O
presence B-physical_entity
of O
one B-abstraction
ndm O
1 O
producing O
e O
. O

coli O
st101 O
clone B-physical_entity
five B-physical_entity
isolates O
and O
one B-abstraction
p O
. O

mirabilis O
clone B-physical_entity
13 O
isolates O
with O
vim O
1 O
and O
cmy O
99 O
. O

furthermore O
, O
ndm O
1 O
was O
identified O
in O
p O
. O

rettgeri O
and O
m O
. O

morganii O
and O
vim O
2 O
in O
the O
p O
. O

aeruginosa O
isolate O
. O

the O
permanent B-physical_entity
introduction B-physical_entity
of O
oxa O
23 O
72 O
carbapenemase O
producing O
a O
. O

baumannii O
clones O
into O
the O
hospital B-physical_entity
and O
the O
repeated O
occurrence B-abstraction
of O
one B-abstraction
vim O
1 O
producing O
p O
. O

mirabilis O
and O
one B-abstraction
ndm O
1 O
producing O
e O
. O

coli O
st101 O
clone B-physical_entity
over B-abstraction
a O
period B-abstraction
of O
more O
than O
1 O
year B-abstraction
is O
of O
concern B-abstraction
and O
requires O
intensified O
investigations O
. O


background B-physical_entity
acotiamide O
is O
widely O
used O
to O
improve O
symptoms O
in O
patients O
with O
functional O
dyspepsia B-abstraction
fd O
in O
multiple B-abstraction
large B-abstraction
scale B-physical_entity
clinical O
studies O
, O
but O
there B-physical_entity
are O
few O
reports O
about O
the O
drug's O
mechanism B-abstraction
of O
action B-physical_entity
. O

the O
aim B-physical_entity
of O
this O
study B-abstraction
was O
to O
assess O
the O
effects O
of O
acotiamide O
on O
gastric O
accommodation B-physical_entity
and O
gastric O
emptying B-abstraction
, O
gastrointestinal O
symptoms O
, O
and O
health O
related O
quality B-abstraction
of O
life B-physical_entity
hr B-abstraction
qol O
in O
a O
placebo B-abstraction
controlled O
study B-abstraction
. O

methods O
we O
conducted O
a O
randomized O
, O
double B-physical_entity
blind I-physical_entity
placebo B-abstraction
controlled O
study B-abstraction
. O

fifty O
japanese O
fd O
patients O
were O
randomly O
assigned O
to O
either O
placebo B-abstraction
n O
25 O
or O
acotiamide O
100 O
mg O
x O
3 O
day B-abstraction
for O
2 O
weeks O
n O
25 O
. O

at O
baseline O
and O
at O
2 O
weeks O
of O
treatment B-abstraction
, O
we O
evaluated O
the O
patients' O
gastric O
motility B-abstraction
using B-abstraction
scintigraphy O
to O
determine O
the O
accommodation B-physical_entity
and O
emptying B-abstraction
values B-abstraction
, O
gastrointestinal O
symptom B-abstraction
rating B-abstraction
scale B-physical_entity
gsrs O
, O
hr B-abstraction
qol O
sf O
8 O
, O
and O
anxiety O
and O
depression B-physical_entity
scale B-physical_entity
hads O
. O

results O
four B-physical_entity
patients O
failed O
to O
complete O
the O
medication B-abstraction
regimen B-abstraction
and O
were O
omitted O
from O
analysis B-abstraction
; O
data O
from O
24 O
placebo B-abstraction
patients O
and O
22 O
acotiamide O
patients O
were O
analyzed O
. O

acotiamide O
significantly O
increased O
gastric O
accommodation B-physical_entity
compared O
to O
the O
placebo B-abstraction
p O
0 O
. O

04 O
vs O
. O

p O
0 O
. O

08 O
; O
respectively O
. O

acotiamide O
significantly O
accelerated O
gastric O
emptying B-abstraction
50 O
half B-abstraction
emptying B-abstraction
time B-abstraction
p O
0 O
. O

02 O
vs O
. O

p O
0 O
. O

59 O
. O

acotiamide O
significantly O
improved O
the O
total B-abstraction
gsrs O
scores O
compared O
to O
placebo B-abstraction
p O
0 O
. O

0007 O
vs O
. O

p O
0 O
. O

14 O
. O

hr B-abstraction
qol O
did O
not O
differ O
significantly O
between O
the O
two O
groups O
, O
but O
acotiamide O
significantly O
improved O
the O
hads O
anxiety O
score B-abstraction
compared O
to O
placebo B-abstraction
p O
0 O
. O

04 O
vs O
. O

p O
0 O
. O

20 O
. O

conclusions O
our O
placebo B-abstraction
controlled O
study B-abstraction
demonstrated O
that O
acotiamide O
significantly O
increased O
both O
gastric O
accommodation B-abstraction
and O
gastric O
emptying B-abstraction
in O
japanese O
fd O
patients O
. O

acotiamide O
also O
improved O
the O
patients' O
dyspeptic B-physical_entity
symptoms O
and O
anxiety O
score B-abstraction
. O


the O
objective B-physical_entity
of O
this O
study B-physical_entity
was O
to O
determine O
global O
gene O
expression B-abstraction
in O
relation B-abstraction
to O
vestibular O
schwannomas O
vs O
growth B-physical_entity
rate B-abstraction
and O
to O
identify O
signal B-abstraction
transduction B-physical_entity
pathways O
and O
functional O
molecular O
networks O
associated O
with O
growth B-abstraction
. O

repeated O
magnetic O
resonance B-abstraction
imaging B-abstraction
mri O
prior B-physical_entity
to O
surgery B-abstraction
determined O
tumor O
growth B-abstraction
rate B-abstraction
. O

following B-abstraction
tissue O
sampling B-abstraction
during O
surgery B-physical_entity
, O
mrna O
was O
extracted O
from O
16 O
sporadic O
vs O
. O

double B-abstraction
stranded O
cdna O
was O
synthesized O
from O
the O
mrna O
and O
used O
as O
template B-abstraction
for O
in O
vitro O
transcription B-abstraction
reaction B-abstraction
to O
synthesize O
biotin O
labeled O
antisense O
crna O
, O
which O
was O
hybridized O
to O
affymetrix O
hg O
u133a O
arrays O
and O
analyzed O
by O
dchip O
software O
. O

differential B-abstraction
gene O
expression B-abstraction
was O
defined O
as O
a O
1 O
. O

5 O
fold B-abstraction
difference B-abstraction
between O
fast B-abstraction
and O
slow O
growing B-physical_entity
tumors O
0 O
. O

5 O
ccm O
year B-abstraction
, O
employing O
a O
p O
value B-abstraction
0 O
. O

01 O
. O

deregulated O
transcripts O
were O
matched O
against O
established O
gene O
ontology B-abstraction
. O

ingenuity B-abstraction
pathway B-physical_entity
analysis B-abstraction
was O
used O
for O
identification B-abstraction
of O
signal B-abstraction
transduction B-physical_entity
pathways O
and O
functional O
molecular O
networks O
associated O
with O
tumor O
growth B-abstraction
. O

in O
total B-abstraction
109 O
genes O
were O
deregulated O
in O
relation B-physical_entity
to O
tumor O
growth B-abstraction
rate B-abstraction
. O

genes O
associated O
with O
apoptosis O
, O
growth B-abstraction
and O
cell B-physical_entity
proliferation B-physical_entity
were O
deregulated O
. O

gene O
ontology B-abstraction
included O
regulation B-physical_entity
of O
the O
cell B-physical_entity
cycle B-physical_entity
, O
cell B-physical_entity
differentiation B-physical_entity
and O
proliferation B-physical_entity
, O
among O
other O
functions O
. O

fourteen O
pathways O
were O
associated O
with O
tumor O
growth B-abstraction
. O

five B-physical_entity
functional O
molecular O
networks O
were O
generated O
. O

this O
first B-physical_entity
study B-abstraction
on O
global O
gene O
expression B-abstraction
in O
relation B-abstraction
to O
vestibular O
schwannoma O
growth B-physical_entity
rate B-abstraction
identified O
several O
genes O
, O
signal B-abstraction
transduction B-physical_entity
pathways O
and O
functional O
networks O
associated O
with O
tumor O
progression B-abstraction
. O

specific B-abstraction
genes O
involved O
in O
apoptosis O
, O
cell B-physical_entity
growth B-physical_entity
and O
proliferation B-physical_entity
were O
deregulated O
in O
fast B-abstraction
growing B-physical_entity
tumors O
. O

fourteen O
pathways O
were O
associated O
with O
tumor O
growth B-physical_entity
. O

generated O
functional O
networks O
underlined O
the O
importance B-abstraction
of O
the O
pi3k O
family B-physical_entity
, O
among O
others O
. O


this O
work B-physical_entity
presents O
a O
method B-abstraction
to O
determine O
mechanical O
transfer B-physical_entity
functions O
from O
forces O
, O
acting B-abstraction
on O
the O
stator B-physical_entity
teeth O
of O
an O
electrical O
machine B-physical_entity
, O
to O
surface B-physical_entity
velocities O
at O
sound B-abstraction
radiating O
surfaces O
. O

the O
method B-abstraction
allows O
an O
efficient O
analysis B-abstraction
of O
drive B-physical_entity
trains O
in O
their O
target B-physical_entity
application B-abstraction
and O
real O
environment B-physical_entity
. O

the O
determined O
transfer B-physical_entity
functions O
are O
used O
in O
a O
transient B-abstraction
acoustic O
model B-abstraction
for O
the O
simulation B-abstraction
of O
electrical O
drive B-physical_entity
trains O
. O

the O
proposed O
model B-physical_entity
takes O
care B-abstraction
of O
the O
nonlinear O
power B-abstraction
electronics B-abstraction
, O
the O
digital O
control B-physical_entity
and O
sensors O
, O
as O
well B-physical_entity
as O
of O
tolerance B-abstraction
afflicted O
geometries O
of O
electrical O
machines O
and O
real O
and O
in O
tolerance B-abstraction
deviating O
material B-physical_entity
properties O
. O

the O
model B-physical_entity
is O
validated O
by O
means B-abstraction
of O
vibration B-abstraction
measurements O
. O

the O
benefits O
of O
a O
closed O
simulation B-physical_entity
in B-O
time I-O
domain B-physical_entity
are O
declared O
. O

exemplary O
applications O
of O
the O
proposed O
model B-physical_entity
are O
discussed O
and O
the O
potential O
of O
the O
acoustic O
evaluation B-abstraction
during O
the O
design B-physical_entity
process B-physical_entity
of O
an O
electrical O
machine B-physical_entity
is O
illustrated O
. O


conversion B-physical_entity
of O
mechanical O
forces O
, O
vibrations O
and O
sound B-abstraction
which O
have B-physical_entity
energy B-abstraction
in O
the O
range B-abstraction
of O
milli O
to O
tens O
of O
watts O
also O
referred O
to O
as O
" O
small B-abstraction
kinetic O
energies O
" O
in O
this O
paper B-physical_entity
into O
electricity O
has O
received O
global O
attention B-abstraction
owing O
to O
the O
potential O
in O
powering O
electronic O
devices B-abstraction
. O

however O
, O
most O
of O
the O
small B-abstraction
kinetic O
energy B-abstraction
generators O
can B-physical_entity
only O
generate O
electric B-physical_entity
power B-physical_entity
below O
1 O
mu O
w O
cm O
3 O
. O

as O
a O
result B-abstraction
, O
an O
energy B-abstraction
storage B-abstraction
device I-physical_entity
is O
required O
to O
accumulate O
the O
energy B-abstraction
generated O
until O
it O
reaches O
a O
sufficient O
level B-physical_entity
. O

herein O
, O
we O
report B-abstraction
the O
exceptionally O
high B-abstraction
acoustoelectric O
conversion B-abstraction
ability B-abstraction
of O
randomly O
orientated O
electrospun O
poly O
vinylidenefluoride O
co O
trifluoroethylene O
nanofiber O
nonwoven O
webs O
. O

the O
optimized O
device B-physical_entity
under O
sound B-abstraction
is O
able O
to O
generate O
peak B-physical_entity
voltage O
and O
current B-abstraction
of O
14 O
. O

5 O
v O
and O
28 O
. O

5 O
mu O
a O
with O
a O
volume B-abstraction
power B-physical_entity
density B-abstraction
output B-abstraction
of O
306 O
. O

5 O
mu O
w O
cm O
3 O
5 O
. O

9 O
mw O
cm O
3 O
based O
on O
nanofiber O
web B-physical_entity
thickness B-abstraction
. O

without O
accumulation B-abstraction
in O
any O
energy B-abstraction
storage B-physical_entity
unit B-abstraction
, O
the O
electricity O
generated O
by O
the O
nanofiber O
device B-physical_entity
is O
sufficient O
to O
light B-abstraction
up O
tens O
of O
commercial O
leds O
, O
run B-abstraction
electrochemical O
reactions O
and O
protect O
metals O
from O
corrosion B-physical_entity
. O

such O
a O
novel B-physical_entity
acoustoelectric O
generator B-physical_entity
may B-physical_entity
offer B-abstraction
an O
effective O
solution B-abstraction
to O
recycling B-abstraction
noise B-abstraction
pollution B-abstraction
into O
usable O
electricity O
. O


intergeneric O
hybridization B-physical_entity
is O
an O
important O
strategy B-abstraction
to O
introgress O
alien B-abstraction
genes O
into O
common B-physical_entity
wheat I-physical_entity
for O
its O
improvement B-abstraction
. O

but O
presence B-abstraction
of O
cross B-physical_entity
ability B-abstraction
barrier B-abstraction
mechanism B-physical_entity
regulated O
by O
kr1 O
gene O
played O
a O
major B-abstraction
destructive O
role B-abstraction
for O
hybridization B-physical_entity
than O
other O
reported O
genes O
. O

in O
order B-abstraction
to O
know B-abstraction
the O
underlying O
molecular O
mechanism B-physical_entity
and O
to O
dissect O
out B-abstraction
this O
barrier B-physical_entity
, O
a O
new O
annealing B-abstraction
system B-physical_entity
, O
acp O
anneling O
control B-abstraction
primer B-physical_entity
system B-physical_entity
was O
used O
in O
chromosome B-physical_entity
5b O
containing O
kr1 O
gene O
specific B-abstraction
recombinant B-physical_entity
inbred O
line B-abstraction
ril O
population B-abstraction
. O

two O
differentially O
expressed O
fragments O
for O
kr1 O
gene O
was O
identified O
, O
cloned O
and O
sequenced O
. O

further O
the O
expression B-physical_entity
was O
confirmed O
by O
northern O
blotting O
analysis B-abstraction
. O

sequence B-physical_entity
analysis B-abstraction
of O
the O
resulted O
clones O
revealed O
classes O
of O
putative O
genes O
, O
including O
stress O
responsive O
and O
signal B-abstraction
transduction B-physical_entity
. O


objective B-abstraction
to O
unravel O
the O
interplay B-abstraction
between O
hiv O
1 O
and O
its O
host B-physical_entity
cell B-physical_entity
, O
the O
effect B-abstraction
of O
hiv O
1 O
infection B-abstraction
on O
cellular O
gene O
expression B-abstraction
was O
investigated O
. O

methods O
hiv O
1 O
sf33 O
infected O
and O
uninfected O
h9 O
t O
cells O
were O
screened O
by O
differential B-physical_entity
display B-physical_entity
and O
rnase O
protection B-abstraction
assay B-abstraction
. O

the O
finding B-abstraction
pds5a O
was O
confirmed O
in O
hiv O
1 O
lai O
infected O
p4 O
ccr5 O
hela O
cells O
, O
which O
were O
also O
examined O
after O
pds5a O
sirna O
knockdown B-abstraction
in O
regard B-abstraction
to O
hiv O
1 O
replication B-physical_entity
by O
quantitative O
rt O
pcr O
, O
p24 O
elisa O
and O
ltr O
driven O
beta O
galactosidase O
expression B-abstraction
. O

the O
pds5a O
knockdown B-abstraction
effect B-abstraction
on O
cellular O
gene O
expressions O
was O
studied O
by O
microarray O
analysis B-abstraction
. O

pds5a O
tissue O
expression B-physical_entity
was O
determined O
by O
northern O
blotting O
. O

results O
regulator B-physical_entity
of O
cohesion B-physical_entity
maintenance B-abstraction
, O
homolog O
a O
pds5a O
was O
found O
to O
be O
down B-abstraction
regulated O
by O
hiv O
1 O
. O

when O
pds5a O
was O
suppressed O
by O
sirna O
, O
hiv O
1 O
replication B-abstraction
was O
unaffected O
. O

pds5a O
was O
found O
to O
be O
highly O
expressed O
in O
skeletal O
muscle B-physical_entity
tissue O
, O
and O
to O
lesser O
degrees O
in O
pancreas O
, O
heart B-abstraction
, O
placenta B-physical_entity
, O
lung O
, O
kidney O
, O
liver B-physical_entity
and O
brain B-physical_entity
. O

microarray O
analysis B-abstraction
of O
pds5a O
knockdown B-abstraction
revealed O
91 O
differential B-physical_entity
gene O
products O
over B-abstraction
representing O
cell B-physical_entity
cycle B-physical_entity
, O
transport B-physical_entity
and O
protein O
stability B-abstraction
regulation B-physical_entity
, O
including O
4 O
genes O
pp2a O
, O
rantes O
, O
pcaf O
, O
tcf7l2 O
previously O
reported O
to O
interact O
with O
hiv O
1 O
. O

conclusion B-abstraction
the O
data O
show B-abstraction
a O
downregulation O
of O
proliferation B-physical_entity
associated O
host B-physical_entity
gene O
pds5a O
and O
suggest O
a O
role B-abstraction
of O
pds5a O
in O
hiv O
1 O
induced O
cellular O
pathogenesis B-physical_entity
but O
not O
viral O
replication B-physical_entity
. O

copyright B-abstraction
c O
2011 O
s B-abstraction
. O

karger O
ag O
, O
. O


powder B-physical_entity
coatings O
have B-physical_entity
been O
receiving O
attention B-abstraction
because O
they O
are O
environmentally O
friendly O
. O

they O
do B-abstraction
not O
contain O
solvents O
in O
their O
composition B-abstraction
, O
and O
their O
components O
have B-physical_entity
decorative O
and O
corrosion B-physical_entity
protection B-physical_entity
functions O
, O
among O
many O
others O
. O

however O
, O
the O
presence B-abstraction
of O
polymers O
in O
their O
composition B-abstraction
increases O
the O
risk B-abstraction
of O
combustion B-abstraction
in O
adverse O
situations O
. O

in O
this O
context O
, O
this O
study B-abstraction
aims O
to O
develop O
and O
characterize O
acrylic B-physical_entity
based O
powder B-physical_entity
paints O
with O
the O
addition B-abstraction
of O
2 O
wt O
and O
4 O
wt O
montmorillonite O
clays O
mmt O
as O
cloisite O
30b O
mmt O
30b O
and O
cloisite O
15a O
mtt O
15a O
, O
employed O
as O
flame B-physical_entity
retardants O
. O

the O
characterization B-abstraction
of O
the O
coatings O
was O
carried O
out B-abstraction
by O
thermogravimetric O
analysis B-abstraction
tga O
, O
x O
ray B-physical_entity
diffraction O
, O
and O
scanning B-abstraction
electron B-physical_entity
microscopy I-physical_entity
. O

after O
application B-abstraction
of O
the O
coatings O
on O
carbon B-physical_entity
steel B-physical_entity
substrates O
, O
flammability B-abstraction
tests O
were O
performed O
. O

the O
coatings O
with O
2 O
wt O
mmt O
30b O
showed O
overall B-physical_entity
better B-physical_entity
results O
, O
especially O
in O
the O
flammability B-abstraction
tests O
. O

flames O
spread B-physical_entity
less O
on O
these O
coatings O
than O
on O
the O
other O
systems O
. O

however O
, O
when O
the O
surface B-physical_entity
and O
bottom B-physical_entity
temperatures O
were O
analyzed O
by O
the O
cone B-physical_entity
calorimeter B-physical_entity
test B-abstraction
, O
the O
samples O
prepared O
with O
4 O
wt O
mmt O
15a O
were O
considered O
safer O
to O
be O
applied O
in O
fire B-abstraction
scenarios O
. O

c O
2017 O
wiley O
periodicals O
, O
inc O
. O

j O
. O

appl O
. O

polym O
. O

sci O
. O

2017 O
, O
134 O
, O
45031 O
. O


purpose B-abstraction
background B-physical_entity
the O
aim B-abstraction
of O
this O
study B-physical_entity
was O
to O
evaluate O
the O
effects O
of O
quetiapine O
xr O
and O
lithium O
on O
actigraphy O
measured O
circadian O
parameters O
in O
patients O
with O
bipolar O
ii O
depression B-abstraction
. O

methods O
procedures O
this O
was O
an O
8 O
week B-abstraction
, O
open B-abstraction
label B-abstraction
, O
prospective O
, O
randomized O
comparative O
study B-physical_entity
. O

the O
assessments O
included O
the O
17 O
item B-abstraction
hamilton O
depression B-abstraction
rating B-abstraction
scale B-physical_entity
score B-abstraction
and O
actigraphic O
measures O
concerning O
the O
previous O
7 O
days B-abstraction
, O
collected O
at O
each O
visit B-abstraction
weeks O
0 O
baseline O
, O
1 O
, O
2 O
, O
4 O
, O
6 O
, O
and O
8 O
; O
the O
actigraphic O
data O
were O
analyzed O
with O
a O
cosinor O
analysis B-abstraction
. O

findings O
results O
medication B-abstraction
, O
time B-abstraction
, O
and O
the O
interaction B-abstraction
between O
medication B-abstraction
and O
time B-abstraction
were O
significantly O
associated O
with O
acrophase O
for O
the O
entire B-physical_entity
group O
ps O
0 O
. O

003 O
, O
0 O
. O

020 O
, O
and O
0 O
. O

042 O
, O
respectively O
. O

more O
specifically O
, O
acrophase O
was O
significantly O
delayed O
at O
weeks O
1 O
and O
6 O
ps O
0 O
. O

004 O
and O
0 O
. O

039 O
, O
respectively O
in O
the O
quetiapine O
xr O
group O
. O

the O
f O
statistics B-abstraction
significantly O
increased O
over B-abstraction
time B-abstraction
for O
the O
entire B-physical_entity
group O
p O
0 O
. O

001 O
, O
and O
there B-physical_entity
was O
a O
significant O
increase B-abstraction
in O
f O
statistics B-abstraction
on O
weeks O
4 O
and O
6 O
in O
the O
quetiapine O
xr O
group O
ps O
0 O
. O

016 O
and O
0 O
. O

020 O
, O
respectively O
and O
on O
weeks O
4 O
and O
8 O
in O
the O
lithium O
group O
ps O
0 O
. O

001 O
and O
0 O
. O

016 O
, O
respectively O
. O

in O
addition B-physical_entity
, O
scores O
on O
the O
17 O
item B-abstraction
hamilton O
depression B-abstraction
rating B-abstraction
scale B-physical_entity
were O
significantly O
associated O
with O
the O
f O
statistics B-abstraction
during O
8 O
weeks O
for O
the O
entire B-physical_entity
group O
p O
0 O
. O

008 O
. O

implications O
conclusions O
both O
quetiapine O
xr O
and O
lithium O
affected O
several O
circadian O
parameters O
, O
including O
peak B-physical_entity
activity B-physical_entity
time B-abstraction
and O
robustness B-abstraction
of O
circadian B-O
rhythm I-O
, O
but O
exerted O
different O
effects O
on O
acrophase O
in O
patients O
with O
bipolar O
ii O
depression B-physical_entity
. O

in O
particular B-abstraction
, O
clinical O
depressive B-physical_entity
symptoms O
were O
associated O
with O
robustness B-abstraction
of O
circadian B-O
rhythm I-O
during O
the O
course B-abstraction
of O
the O
8 O
week B-abstraction
treatment B-abstraction
. O


actinobacteria O
are O
gram O
positive B-physical_entity
bacteria B-physical_entity
commonly O
found O
in O
soil B-physical_entity
, O
freshwater O
and O
marine B-physical_entity
ecosystems O
. O

in O
this O
investigation B-abstraction
, O
bias B-abstraction
in O
codon O
usages O
of O
ninety O
actinobacterial O
genomes O
was O
analyzed O
by O
estimating O
different O
indices O
of O
codon O
bias B-abstraction
such O
as O
nc O
effective O
number B-physical_entity
of O
codons O
, O
scuo O
synonymous O
codon O
usage B-abstraction
order B-abstraction
, O
rscu O
relative B-physical_entity
synonymous O
codon O
usage B-abstraction
, O
as O
well B-physical_entity
as O
sequence B-abstraction
patterns O
of O
codon O
contexts O
. O

the O
results O
revealed O
several O
characteristic B-abstraction
features O
of O
codon O
usage B-abstraction
in O
actinobacteria O
, O
as O
follows O
1 O
c O
or O
g O
ending B-abstraction
codons O
are O
used O
frequently O
in O
comparison B-abstraction
with O
a O
and O
u O
ending B-abstraction
codons O
; O
2 O
there B-physical_entity
is O
a O
direct O
relationship O
of O
gc O
content B-abstraction
with O
use B-physical_entity
of O
specific B-abstraction
amino O
acids O
such O
as O
alanine O
, O
proline O
and O
glycine O
; O
3 O
there B-physical_entity
is O
an O
inverse O
relationship O
between O
gc O
content B-abstraction
and O
nc O
estimates O
, O
4 O
there B-physical_entity
is O
low B-abstraction
scuo O
value B-abstraction
0 O
. O

5 O
for O
most O
genes O
; O
and O
5 O
gcc O
gcc O
, O
gcc O
ggc O
, O
gcc O
gag B-physical_entity
and O
cuc O
gac O
are O
the O
frequent O
context O
sequences O
among O
codons O
. O

this O
study B-abstraction
highlights O
the O
fact B-abstraction
that O
1 O
in O
actinobacteria O
, O
extreme B-abstraction
gc O
content B-abstraction
and O
codon O
bias B-abstraction
are O
driven O
by O
mutation B-abstraction
rather O
than O
natural B-physical_entity
selection I-abstraction
; O
2 O
traits O
like B-abstraction
aerobicity O
are O
associated O
with O
effective O
natural B-abstraction
selection I-abstraction
and O
therefore O
low B-abstraction
gc O
content B-abstraction
and O
low B-abstraction
codon O
bias B-abstraction
, O
demonstrating O
the O
role B-abstraction
of O
both O
mutational O
bias B-abstraction
and O
translational O
selection B-physical_entity
in O
shaping B-abstraction
the O
habitat B-physical_entity
and O
phenotype B-abstraction
of O
actinobacterial O
species B-abstraction
. O

c O
2016 O
institut O
pasteur O
. O

published O
by O
elsevier O
masson O
sas O
. O

all O
rights O
reserved O
. O


mirror B-abstraction
neurons O
mns O
are O
a O
fascinating O
class B-abstraction
of O
cells O
originally O
discovered O
in O
the O
ventral O
premotor O
cortex B-physical_entity
pmv O
and O
, O
subsequently O
, O
in O
the O
inferior B-physical_entity
parietal O
lobule O
ipl O
of O
the O
macaque B-physical_entity
, O
which O
become O
active B-physical_entity
during O
both O
the O
execution B-abstraction
and O
observation B-abstraction
of O
actions O
. O

in O
this O
review B-abstraction
, O
i O
will B-abstraction
first B-abstraction
highlight B-abstraction
the O
mounting B-physical_entity
evidence B-abstraction
indicating O
that O
mirroring O
others' O
actions O
engages O
a O
broad B-physical_entity
system B-physical_entity
of O
reciprocally O
connected O
cortical O
areas O
, O
which O
extends O
well B-physical_entity
beyond O
the O
classical O
ipl O
pmv O
circuit B-physical_entity
and O
might B-abstraction
even B-abstraction
include O
subcortical O
regions O
such O
as O
the O
basal O
ganglia O
. O

then O
, O
i O
will B-abstraction
present B-abstraction
the O
most O
recent O
findings O
supporting B-abstraction
the O
idea B-abstraction
that O
the O
observation B-abstraction
of O
one's O
own O
actions O
, O
which O
might B-abstraction
play B-abstraction
a O
role B-abstraction
in O
the O
ontogenetic O
origin B-physical_entity
and O
tuning B-abstraction
of O
mns O
, O
retains O
a O
particular B-abstraction
relevance O
within O
the O
adult B-physical_entity
mn O
system B-abstraction
. O

finally O
, O
i O
will B-abstraction
propose O
that O
both O
cortical O
and O
subcortical O
mechanisms O
do B-abstraction
exist O
to O
decouple O
mn O
activity B-abstraction
from O
the O
motor B-physical_entity
output B-physical_entity
, O
in O
order B-abstraction
to O
render B-physical_entity
it O
exploitable O
for O
high B-physical_entity
order B-abstraction
perceptual O
, O
cognitive O
, O
and O
even B-abstraction
social O
functions O
. O

the O
findings O
reviewed O
here B-physical_entity
provide O
an O
original B-abstraction
framework B-abstraction
for O
envisaging O
the O
main B-physical_entity
challenges O
and O
experimental O
directions O
of O
future B-physical_entity
neurophysiological O
and O
neuroanatomical O
studies O
of O
the O
monkey B-physical_entity
mn O
system B-physical_entity
. O


in O
this O
paper B-physical_entity
a O
new O
framework B-abstraction
is O
introduced O
to O
develop O
a O
coupled O
active B-physical_entity
and O
reactive O
market B-abstraction
in O
distribution B-abstraction
networks O
. O

distributed O
energy B-abstraction
resources O
ders O
such O
as O
synchronous O
machine B-physical_entity
based O
distributed O
generations O
and O
wind B-abstraction
turbines O
offer B-abstraction
their O
active B-physical_entity
and O
reactive O
powers O
to O
the O
proposed O
market B-abstraction
. O

for O
the O
considered O
ders O
, O
multicomponent O
reactive O
power B-physical_entity
bidding B-abstraction
structures O
are O
introduced O
based O
on O
their O
capability B-abstraction
curves O
. O

also O
, O
the O
hourly O
speed B-abstraction
variations O
of O
wind B-physical_entity
turbines O
are O
considered O
in O
the O
proposed O
model B-abstraction
. O

a O
distribution B-abstraction
company B-physical_entity
buys O
active B-physical_entity
and O
reactive O
powers O
from O
a O
wholesale B-abstraction
market B-abstraction
and O
sells O
them O
via O
this O
market B-abstraction
. O

the O
demand B-abstraction
side B-abstraction
is O
active B-physical_entity
, O
and O
responsive O
loads O
or O
aggregators O
can B-physical_entity
participate O
in O
the O
market B-physical_entity
using B-abstraction
a O
demand B-physical_entity
bidding B-physical_entity
buyback B-abstraction
program B-abstraction
. O

the O
objective B-physical_entity
function B-abstraction
of O
the O
proposed O
market B-abstraction
is O
to O
minimize O
the O
active B-physical_entity
and O
reactive O
power B-abstraction
costs O
of O
ders O
and O
distribution B-abstraction
companies O
, O
the O
penalty B-abstraction
cost B-abstraction
of O
co2 O
emission B-physical_entity
, O
and O
the O
cost B-abstraction
of O
running B-abstraction
a O
demand B-physical_entity
bidding B-abstraction
buyback B-abstraction
program B-abstraction
. O

the O
effectiveness B-abstraction
of O
the O
proposed O
method B-abstraction
is O
examined O
on O
a O
22 O
bus B-physical_entity
20 O
kv O
radial B-physical_entity
distribution B-abstraction
test B-abstraction
system B-physical_entity
. O


a O
highly O
reconfigurable O
merged O
analog B-abstraction
baseband O
mabb O
with O
not O
only O
tunable O
bandwidth O
bw O
, O
gain B-abstraction
, O
and O
order B-abstraction
but O
also O
reconfigurable O
power B-physical_entity
, O
noise B-abstraction
, O
and O
linearity B-abstraction
is O
proposed O
for O
multistandard O
integrated O
wireless B-physical_entity
receivers O
in O
this O
brief O
. O

the O
mabb O
could O
arrange O
the O
total B-abstraction
gain B-abstraction
to O
different O
stages O
for O
noise B-abstraction
and O
linearity B-abstraction
tradeoffs O
by O
introducing O
the O
merged O
biquad O
topology B-abstraction
. O

to O
save B-abstraction
power B-physical_entity
, O
the O
operational O
amplifier B-physical_entity
opamp O
for O
the O
proposed O
mabb O
can B-physical_entity
reduce O
the O
gbw O
, O
as O
long O
as O
it O
meets O
the O
gbw O
requirement B-abstraction
for O
different O
bw O
, O
gain B-abstraction
, O
and O
order B-abstraction
. O

a O
flexible O
power B-abstraction
efficient O
high B-abstraction
gbw O
opamp O
with O
an O
adaptive O
common B-physical_entity
mode B-abstraction
bias B-abstraction
circuit B-abstraction
is O
also O
proposed O
for O
the O
eighth O
order B-abstraction
active B-physical_entity
rc O
mabb O
. O

the O
proposed O
mabb O
covers O
a O
cutoff B-physical_entity
frequency O
range B-physical_entity
from O
200 O
khz O
to O
20 O
mhz O
, O
whereas O
the O
gain B-abstraction
could O
be O
tuned O
between O
0 O
and O
72 O
db O
. O

the O
proposed O
highly O
reconfigurable O
mabb O
is O
suitable O
for O
multistandard O
integrated O
wireless B-physical_entity
receivers O
. O


with O
the O
development B-abstraction
of O
integrated O
circuits O
, O
the O
fully O
integrated O
continuous O
time B-abstraction
filter B-physical_entity
has O
been O
focused O
widely O
. O

a O
nth O
order B-abstraction
universal B-physical_entity
filter B-physical_entity
based O
on O
current B-abstraction
feedback B-physical_entity
operational O
amplifier B-physical_entity
cfoa O
is O
proposed O
. O

compared O
with O
available O
circuits O
, O
the O
proposed O
circuit B-physical_entity
using B-abstraction
less O
components O
2n O
cfoas O
, O
n O
capacitors O
, O
and O
3n O
resistors O
can B-physical_entity
realize O
the O
universal B-abstraction
filter B-physical_entity
functions O
without O
changing O
circuit B-abstraction
configuration B-abstraction
, O
and O
the O
operating O
frequency O
of O
proposed O
filter B-physical_entity
circuit B-physical_entity
is O
at O
least O
10 O
mhz O
. O

all O
of O
capacitors O
in O
proposed O
circuit B-abstraction
are O
grounded O
, O
this O
is O
another O
benefit B-abstraction
from O
integration B-abstraction
point B-physical_entity
of O
view B-physical_entity
. O

pspice O
simulations O
have B-physical_entity
been O
carried O
out B-abstraction
using B-abstraction
0 O
. O

18 O
mu O
m O
cmos O
technology B-abstraction
, O
and O
sensitivity B-abstraction
analysis B-abstraction
of O
proposed O
nth O
order B-abstraction
low B-physical_entity
pass B-abstraction
filter B-physical_entity
circuit B-physical_entity
is O
completed O
. O

c O
2015 O
elsevier O
gmbh O
. O

all O
rights O
reserved O
. O


this O
paper B-physical_entity
presents O
different O
state B-physical_entity
feedback B-physical_entity
approaches O
of O
finite O
control B-abstraction
set B-abstraction
model B-abstraction
predictive O
control B-abstraction
fcs O
mpc O
applied O
to O
a O
grid B-abstraction
connected O
voltage O
source B-physical_entity
converter B-physical_entity
vsc O
with O
an O
lcl O
filter B-physical_entity
. O

besides O
converter B-physical_entity
side B-abstraction
current B-abstraction
feedback B-physical_entity
, O
two O
multivariable O
control B-abstraction
approaches O
and O
line B-physical_entity
side B-physical_entity
current B-abstraction
control B-abstraction
are O
introduced O
and O
compared O
based O
on O
theoretical O
and O
experimental O
evaluation B-abstraction
. O

as O
the O
lcl O
filter B-physical_entity
introduces O
an O
additional O
resonance B-abstraction
frequency O
to O
the O
system B-abstraction
, O
the O
use B-physical_entity
of O
different O
active B-physical_entity
damping O
ad O
methods O
in O
combination B-abstraction
with O
fcs O
mpc O
is O
discussed O
. O

furthermore O
, O
practical O
control B-physical_entity
implementation B-abstraction
issues O
are O
discussed O
. O

the O
presented O
methods O
reveal O
the O
great B-physical_entity
potential O
, O
high B-abstraction
dynamic B-abstraction
performance B-abstraction
, O
and O
flexibility B-abstraction
of O
fcs O
mpc O
, O
enabling O
multivariable O
control B-physical_entity
as O
well B-physical_entity
as O
both O
reduced O
switching B-abstraction
losses O
and O
low B-physical_entity
harmonic B-abstraction
current B-abstraction
distortion B-abstraction
at O
the O
same O
time B-abstraction
. O

eventually O
, O
the O
feasibility B-abstraction
of O
the O
theoretical O
control B-physical_entity
concepts O
is O
shown O
in O
a O
laboratory B-physical_entity
environment B-physical_entity
. O


capacitor B-physical_entity
current B-abstraction
feedback B-physical_entity
active B-physical_entity
damping O
is O
extensively O
used O
in O
grid B-abstraction
connected O
converters O
with O
an O
lcl O
filter B-physical_entity
. O

however O
, O
systems O
tends O
to O
become O
unstable O
when O
the O
digital O
control B-physical_entity
delay B-abstraction
is O
taken O
into O
account B-abstraction
, O
especially O
in O
low B-physical_entity
switching B-abstraction
frequencies O
. O

this O
paper B-physical_entity
discusses O
this O
issue B-abstraction
by O
deriving O
a O
discrete O
model B-physical_entity
with O
a O
digital O
control B-abstraction
delay B-abstraction
and O
by O
presenting O
the O
stable B-physical_entity
region B-abstraction
of O
an O
active B-physical_entity
damping O
loop B-abstraction
from O
high B-physical_entity
to O
low B-physical_entity
switching B-abstraction
frequencies O
. O

in O
order B-abstraction
to O
overcome O
the O
disadvantage B-abstraction
of O
capacitor B-physical_entity
current B-abstraction
feedback B-physical_entity
active B-physical_entity
damping O
, O
this O
paper B-physical_entity
proposes O
a O
modified O
approach B-abstraction
using B-abstraction
grid B-physical_entity
current B-abstraction
and O
converter B-physical_entity
current B-abstraction
for O
feedback B-physical_entity
. O

this O
can B-physical_entity
expand O
the O
stable B-physical_entity
region B-physical_entity
and O
provide O
sufficient O
active B-physical_entity
damping O
whether O
in O
high B-physical_entity
or O
low B-physical_entity
switching B-abstraction
frequencies O
. O

by O
applying O
the O
modified O
approach B-physical_entity
, O
the O
active B-physical_entity
damping O
loop B-physical_entity
can B-physical_entity
be O
simplified O
from O
fourth O
order B-abstraction
into O
second B-abstraction
order B-abstraction
, O
and O
the O
design B-abstraction
of O
the O
grid B-abstraction
current B-abstraction
loop B-abstraction
can B-physical_entity
be O
simplified O
. O

the O
modified O
approach B-abstraction
can B-physical_entity
work B-physical_entity
well B-physical_entity
when O
the O
grid B-physical_entity
impedance O
varies O
. O

both O
the O
active B-physical_entity
damping O
performance B-abstraction
and O
the O
dynamic B-abstraction
performance B-abstraction
of O
the O
current B-abstraction
loop B-abstraction
are O
verified O
by O
simulations O
and O
experimental O
results O
. O


the O
high B-physical_entity
power B-abstraction
grid I-physical_entity
connected O
inverters O
with O
lcl O
filters O
have B-physical_entity
been O
widely O
used O
. O

current B-abstraction
control B-physical_entity
plays O
a O
key B-physical_entity
role B-abstraction
in O
the O
grid B-abstraction
connected O
inverter B-physical_entity
control B-physical_entity
system I-physical_entity
. O

to O
cope B-physical_entity
with O
the O
inherent O
resonance B-abstraction
of O
the O
lcl O
filter B-physical_entity
, O
active B-physical_entity
damping O
ad O
methods O
are O
usually O
employed O
. O

however O
, O
the O
ad O
performance B-abstraction
is O
impaired O
by O
control B-abstraction
delays O
which O
are O
introduced O
in O
the O
digital O
control B-physical_entity
implementation B-abstraction
process B-abstraction
. O

besides O
, O
the O
lag B-physical_entity
phase B-abstraction
due B-abstraction
to O
control B-abstraction
delays O
limits O
the O
system B-abstraction
bandwidth O
and O
stability B-abstraction
margin B-abstraction
. O

the O
effects O
of O
control B-physical_entity
delays O
are O
more O
noteworthy O
in O
the O
high B-physical_entity
power B-abstraction
grid I-physical_entity
connected O
inverter B-physical_entity
due B-abstraction
to O
its O
low B-physical_entity
switching B-abstraction
frequency O
. O

this O
paper B-physical_entity
investigates O
the O
current B-abstraction
control B-physical_entity
strategy B-abstraction
based O
on O
multisampling O
for O
the O
high B-abstraction
power B-physical_entity
grid I-physical_entity
connected O
inverter B-physical_entity
with O
the O
lcl O
filter B-physical_entity
. O

first B-abstraction
, O
the O
multisampled O
ad O
scheme B-abstraction
is O
studied O
, O
which O
can B-physical_entity
reduce O
control B-abstraction
delays O
effectively O
and O
improve O
ad O
performance B-abstraction
. O

besides O
, O
the O
multisampled O
control B-abstraction
without O
additional O
damping O
whether O
passive O
or O
active B-physical_entity
is O
researched O
. O

through O
the O
inverter B-physical_entity
side B-physical_entity
current B-abstraction
feedback B-physical_entity
, O
the O
system B-physical_entity
can B-physical_entity
realize O
single B-abstraction
current B-abstraction
loop B-abstraction
control B-physical_entity
based O
on O
multisampling O
. O

thus O
, O
the O
control B-physical_entity
system I-abstraction
is O
simplified O
and O
it O
can B-physical_entity
be O
stable B-physical_entity
, O
and O
achieve O
better B-physical_entity
dynamic B-abstraction
performance B-abstraction
. O

finally O
, O
experimental O
results O
show B-abstraction
that O
the O
proposed O
control B-abstraction
schemes O
are O
effective O
. O


resonant O
poles O
of O
lcl O
filters O
may B-physical_entity
challenge B-abstraction
the O
entire B-physical_entity
system B-physical_entity
stability B-abstraction
especially O
in O
digital O
controlled O
pulse B-abstraction
width B-abstraction
modulation B-abstraction
pwm O
inverters O
. O

in O
order B-abstraction
to O
tackle B-abstraction
the O
resonance B-abstraction
issues O
, O
many O
active B-physical_entity
damping O
solutions O
have B-physical_entity
been O
reported O
. O

for O
instance B-abstraction
, O
a O
notch B-abstraction
filter B-physical_entity
can B-physical_entity
be O
employed O
to O
damp O
the O
resonance B-abstraction
, O
where O
the O
notch B-physical_entity
frequency O
should O
be O
aligned O
exactly O
to O
the O
resonant O
frequency O
of O
the O
lcl O
filter B-physical_entity
. O

however O
, O
parameter B-abstraction
variations O
of O
the O
lcl O
filter B-physical_entity
as O
well B-physical_entity
as O
the O
time B-abstraction
delay B-abstraction
appearing B-abstraction
in O
digital O
control B-physical_entity
systems O
will B-abstraction
induce O
resonance B-abstraction
drifting B-abstraction
, O
and O
thus O
break B-abstraction
this O
alignment B-abstraction
, O
possibly O
deteriorating O
the O
original B-physical_entity
damping O
. O

in O
this O
paper B-physical_entity
, O
the O
effectiveness B-abstraction
of O
the O
notch B-abstraction
filter B-physical_entity
based O
active B-physical_entity
damping O
is O
first B-abstraction
explored O
, O
considering O
the O
drifts O
of O
the O
resonant O
frequency O
. O

it O
is O
revealed O
that O
when O
the O
resonant O
frequency O
drifts O
away O
from O
its O
nominal B-O
value I-O
, O
the O
phase B-abstraction
lead B-physical_entity
or O
lag B-abstraction
introduced O
by O
the O
notch B-abstraction
filter B-physical_entity
may B-physical_entity
make B-abstraction
itself O
fail O
to O
damp O
the O
resonance B-abstraction
. O

specifically O
, O
the O
phase B-abstraction
lag B-physical_entity
can B-physical_entity
make B-abstraction
the O
current B-abstraction
control B-physical_entity
stable B-physical_entity
despite B-abstraction
of O
the O
resonant O
frequency O
drifting B-abstraction
, O
when O
the O
grid B-physical_entity
current B-abstraction
is O
fed O
back B-abstraction
. O

in O
contrast B-abstraction
, O
in O
the O
case B-abstraction
of O
an O
inverter B-physical_entity
current B-abstraction
feedback B-physical_entity
control B-physical_entity
, O
the O
influence B-abstraction
of O
the O
phase B-abstraction
lead B-abstraction
or O
lag B-abstraction
on O
the O
active B-physical_entity
damping O
is O
dependent B-physical_entity
on O
the O
actual O
resonant O
frequency O
. O

accordingly O
, O
in O
this O
paper B-physical_entity
, O
the O
notch B-physical_entity
frequency O
is O
designed O
away O
from O
the O
nominal O
resonant O
frequency O
to O
tolerate O
the O
resonance B-abstraction
drifting B-abstraction
, O
being B-physical_entity
the O
proposed O
robust O
active B-physical_entity
damping O
. O

simulations O
and O
experiments O
performed O
on O
a O
2 O
. O

2 O
kw O
three O
phase B-abstraction
grid B-physical_entity
connected O
pwm O
inverter B-physical_entity
verify O
the O
effectiveness B-abstraction
of O
the O
proposed O
design B-physical_entity
for O
robust O
active B-physical_entity
damping O
using B-abstraction
digital O
notch B-physical_entity
filters O
. O


control B-abstraction
of O
the O
lcl O
type B-abstraction
three O
phase B-abstraction
grid B-physical_entity
connected O
converter B-physical_entity
is O
difficult O
due B-abstraction
to O
high B-physical_entity
resonance B-abstraction
peak B-abstraction
of O
the O
lcl O
filter B-physical_entity
. O

active B-physical_entity
damping O
is O
the O
state B-physical_entity
of O
the O
art B-physical_entity
solution B-abstraction
to O
this O
problem B-abstraction
, O
but O
the O
damping O
performance B-abstraction
will B-abstraction
be O
affected O
by O
the O
inherent O
time B-abstraction
delay B-abstraction
of O
digital O
control B-physical_entity
, O
especially O
for O
high B-physical_entity
power B-physical_entity
low B-physical_entity
switching B-abstraction
frequency O
applications O
. O

based O
on O
a O
discrete O
time B-abstraction
stability B-abstraction
analysis B-abstraction
of O
an O
lcl O
type B-abstraction
converter B-physical_entity
with O
capacitor B-physical_entity
current B-abstraction
feedback B-physical_entity
active B-physical_entity
damping O
, O
a O
simple B-physical_entity
and O
effective O
time B-abstraction
delay B-abstraction
compensation B-physical_entity
method B-abstraction
, O
which O
is O
based O
on O
area B-abstraction
equalization B-abstraction
concept B-abstraction
, O
is O
proposed O
. O

the O
method B-abstraction
can B-physical_entity
reduce O
the O
negative B-physical_entity
impact B-abstraction
of O
the O
computation B-abstraction
delay B-abstraction
significantly O
. O

it O
has O
the O
potential O
to O
serve B-abstraction
as O
a O
general B-abstraction
solution B-abstraction
to O
time B-abstraction
delay B-abstraction
compensation B-physical_entity
of O
a O
digitally O
controlled O
pwm O
converter B-physical_entity
. O

the O
validity B-abstraction
of O
the O
proposed O
method B-abstraction
is O
proved O
by O
experimental O
results O
. O


the O
wind B-abstraction
power B-abstraction
generation B-physical_entity
techniques O
are O
continuing O
to O
develop O
and O
increasing O
numbers B-abstraction
of O
doubly O
fed O
induction B-abstraction
generator B-physical_entity
dfig O
based O
wind B-abstraction
power B-abstraction
systems O
are O
connecting O
to O
the O
on O
shore B-physical_entity
and O
off O
shore B-physical_entity
grids O
, O
local B-physical_entity
standalone O
weak O
networks O
, O
and O
microgrid O
applications O
. O

the O
impedances O
of O
the O
weak O
networks O
are O
too O
large B-abstraction
to O
be O
neglected O
and O
require O
careful O
attention B-abstraction
. O

due B-abstraction
to O
the O
impedance O
interaction B-abstraction
between O
the O
weak O
network B-physical_entity
and O
the O
dfig O
system B-physical_entity
, O
both O
subsynchronous O
resonance B-abstraction
ssr O
and O
high B-abstraction
frequency I-abstraction
resonance B-abstraction
hfr O
may B-physical_entity
occur O
when O
the O
dfig O
system B-physical_entity
is O
connected O
to O
the O
series B-abstraction
or O
parallel B-abstraction
compensated O
weak O
network B-physical_entity
. O

this O
paper B-physical_entity
will B-abstraction
discuss O
the O
ssr O
and O
the O
hfr O
phenomena O
based O
on O
the O
impedance O
modeling B-physical_entity
of O
the O
dfig O
system B-abstraction
and O
the O
weak O
networks O
, O
and O
the O
cause B-abstraction
of O
these O
two O
resonances O
will B-abstraction
be O
explained O
in O
details O
. O

the O
following B-abstraction
factors O
will B-abstraction
be O
discussed O
in O
this O
paper B-physical_entity
1 O
transformer B-physical_entity
configuration B-abstraction
; O
2 O
different O
power B-physical_entity
scale B-physical_entity
of O
dfig O
system B-abstraction
with O
different O
parameters O
; O
3 O
l O
or O
lcl O
filter B-physical_entity
adopted O
in O
the O
grid B-physical_entity
side B-physical_entity
converter B-physical_entity
gsc O
; O
4 O
rotor B-physical_entity
speed B-abstraction
; O
5 O
current B-abstraction
closed B-O
loop I-O
controller B-physical_entity
parameters O
; O
and O
6 O
digital O
control B-physical_entity
delay B-abstraction
. O

on O
the O
basis B-abstraction
of O
the O
analysis B-abstraction
, O
active B-physical_entity
damping O
strategies O
for O
hfr O
using B-abstraction
virtual O
impedance O
concept B-abstraction
will B-abstraction
be O
proposed O
. O


energy B-abstraction
storage B-abstraction
systems O
esss O
are O
generally O
planned O
based O
on O
the O
active B-physical_entity
power B-physical_entity
. O

while B-abstraction
, O
reactive O
power B-physical_entity
is O
another O
important O
aspect B-abstraction
of O
the O
esss O
that O
has O
not O
been O
adequately O
addressed O
and O
discussed O
. O

moreover O
, O
esss O
are O
often O
managed O
individually O
, O
but O
coordinated O
planning B-abstraction
on O
the O
esss O
and O
distributed O
generators O
dgs O
may B-physical_entity
result B-abstraction
in O
more O
suitable O
outcomes O
. O

in O
order B-abstraction
to O
address B-abstraction
these O
issues O
, O
a O
coordinated O
ess O
and O
dg O
planning B-abstraction
is O
presented O
in O
this O
paper B-physical_entity
. O

in O
the O
proposed O
planning B-abstraction
, O
the O
place B-physical_entity
and O
capacity B-abstraction
of O
the O
esss O
and O
dgs O
are O
determined O
at O
the O
same O
time B-abstraction
. O

the O
active B-physical_entity
and O
reactive O
powers O
are O
included O
in O
the O
planning B-abstraction
for O
both O
the O
esss O
and O
dgs O
. O

in O
other O
words B-abstraction
, O
the O
optimal O
active B-physical_entity
and O
reactive O
capacities O
are O
denoted O
for O
both O
the O
esss O
and O
dgs O
on O
the O
network B-physical_entity
. O

the O
proposed O
coordinated O
ess O
and O
dg O
planning B-abstraction
is O
carried O
out B-abstraction
on O
a O
radial B-physical_entity
distribution B-abstraction
network B-physical_entity
under O
deregulated O
electricity O
market B-abstraction
. O

objective B-abstraction
function B-abstraction
of O
the O
proposed O
planning B-abstraction
is O
to O
maximize O
the O
profit B-abstraction
of O
distribution B-abstraction
company B-physical_entity
disco B-physical_entity
subject B-physical_entity
to O
the O
secure O
operation B-abstraction
of O
the O
network B-physical_entity
. O

the O
planning B-abstraction
is O
expressed O
as O
a O
nonlinear O
, O
mixed O
integer O
optimization B-abstraction
problem B-abstraction
and O
solved O
by O
advanced O
pso O
as O
a O
strong O
meta O
heuristic B-abstraction
optimization B-abstraction
technique B-abstraction
. O

simulation B-abstraction
results O
demonstrate O
the O
great B-physical_entity
impacts O
of O
the O
proposed O
planning B-abstraction
on O
the O
network B-physical_entity
. O

the O
results O
demonstrate O
the O
priority B-abstraction
of O
the O
proposed O
coordinated O
dg O
and O
ess O
planning B-abstraction
compared O
to O
the O
individual B-physical_entity
ess O
planning B-abstraction
. O

additionally O
, O
it O
is O
verified O
that O
considering O
reactive O
power B-physical_entity
of O
the O
dgs O
and O
esss O
changes O
the O
results O
of O
the O
planning B-abstraction
and O
provides O
more O
realistic O
and O
reasonable O
outputs O
. O

the O
proposed O
planning B-abstraction
significantly O
increases O
disco B-physical_entity
profit B-abstraction
while B-abstraction
guarantees O
the O
safe B-physical_entity
operation B-abstraction
of O
the O
network B-physical_entity
through O
satisfying O
several O
security B-physical_entity
constraints O
. O


in O
this O
paper B-physical_entity
we O
present B-abstraction
an O
analysis B-abstraction
of O
the O
voltage O
amplifier B-physical_entity
needed O
for O
double B-physical_entity
differential B-physical_entity
dd O
semg O
measurements O
and O
a O
novel B-physical_entity
, O
very O
simple B-physical_entity
circuit B-abstraction
for O
implementing O
dd O
active B-physical_entity
electrodes O
. O

the O
three O
input B-abstraction
amplifier B-physical_entity
that O
standalone O
dd O
active B-physical_entity
electrodes O
require O
is O
inherently O
different O
from O
a O
differential B-physical_entity
amplifier B-physical_entity
, O
and O
general B-physical_entity
knowledge I-physical_entity
about O
its O
design B-abstraction
is O
scarce O
in O
the O
literature B-abstraction
. O

first B-abstraction
, O
the O
figures O
of O
merit B-abstraction
of O
the O
amplifier B-physical_entity
are O
defined O
through O
a O
decomposition B-abstraction
of O
its O
input B-abstraction
signal B-abstraction
into O
three O
orthogonal O
modes O
. O

this O
analysis B-abstraction
reveals O
a O
mode B-abstraction
containing O
emg O
crosstalk B-abstraction
components O
that O
the O
dd O
electrode B-physical_entity
should O
reject B-abstraction
. O

then O
, O
the O
effect B-abstraction
of O
finite O
input B-abstraction
impedance O
is O
analyzed O
. O

because O
there B-physical_entity
are O
three O
terminals O
, O
minimum B-physical_entity
bounds B-physical_entity
for O
interference B-physical_entity
rejection B-abstraction
ratios O
due B-abstraction
to O
electrode B-physical_entity
and O
input B-abstraction
impedance O
unbalances O
with O
two O
degrees O
of O
freedom O
are O
obtained O
. O

finally O
, O
a O
novel B-physical_entity
circuit B-physical_entity
design B-physical_entity
is O
presented O
, O
including O
only O
a O
quadruple B-abstraction
operational O
amplifier B-physical_entity
and O
a O
few O
passive O
components O
. O

this O
design B-abstraction
is O
nearly O
as O
simple B-physical_entity
as O
the O
branched O
electrode B-physical_entity
and O
much O
simpler O
than O
the O
three O
instrumentation B-physical_entity
amplifier B-physical_entity
design B-physical_entity
, O
while B-abstraction
providing O
robust O
emg O
crosstalk B-abstraction
rejection B-abstraction
and O
better B-abstraction
input B-abstraction
impedance O
using B-abstraction
unity B-abstraction
gain B-abstraction
buffers O
for O
each O
electrode B-physical_entity
input B-abstraction
. O

the O
interference B-physical_entity
rejection B-abstraction
limits O
of O
this O
input B-abstraction
stage B-abstraction
are O
analyzed O
. O

an O
easily O
replicable O
implementation B-abstraction
of O
the O
proposed O
circuit B-abstraction
is O
described O
, O
together O
with O
a O
parameter B-abstraction
design B-physical_entity
guideline B-abstraction
to O
adjust O
it O
to O
specific B-abstraction
needs O
. O

the O
electrode B-physical_entity
is O
compared O
with O
the O
established O
alternatives O
, O
and O
sample B-physical_entity
semg O
signals O
are O
obtained O
, O
acquired O
on O
different O
body B-abstraction
locations O
with O
dry B-physical_entity
contacts O
, O
successfully O
rejecting O
interference B-physical_entity
sources O
. O


the O
performance B-abstraction
of O
some O
fourier O
transform O
based O
fundamental B-abstraction
current B-abstraction
detection B-abstraction
algorithms O
is O
evaluated O
and O
compared O
in O
this O
paper B-physical_entity
. O

some O
difficult O
conditions O
are O
imposed O
by O
a O
load B-physical_entity
which O
draws O
a O
highly O
distorted O
current B-abstraction
with O
a O
slight B-abstraction
fluctuation B-abstraction
, O
i O
. O

e O
. O

with O
non O
equal B-physical_entity
semi B-physical_entity
periods O
. O

the O
implemented O
algorithms O
are O
recursive O
discrete O
fourier O
transform O
rdft O
, O
discrete O
fourier O
transform O
dft O
implemented O
through O
a O
finite O
impulse B-abstraction
response B-abstraction
fir B-physical_entity
filter B-physical_entity
and O
respectively O
the O
fast B-abstraction
fourier O
transform O
fft O
with O
butterfly B-abstraction
operation B-abstraction
and O
radix O
2 O
decimation B-abstraction
in B-O
time I-O
dit O
. O

a O
digital O
signal B-abstraction
processor B-physical_entity
dsp O
based O
solution B-abstraction
is O
used O
for O
real B-O
time I-O
implementation B-abstraction
, O
namely O
a O
dspace O
1103 O
controller B-physical_entity
development B-physical_entity
board B-physical_entity
. O

matlab O
simulink O
software O
is O
used O
for O
the O
design B-abstraction
of O
the O
algorithms O
because O
it O
provides O
specialized O
tools O
and O
blocks O
. O

for O
the O
performance B-abstraction
comparison B-abstraction
one B-abstraction
used O
criteria O
like B-abstraction
total B-abstraction
harmonic B-abstraction
distortion B-abstraction
thd O
and O
settling B-abstraction
time B-abstraction
of O
detected O
fundamental B-abstraction
current B-abstraction
and O
also O
the O
run B-abstraction
time B-abstraction
for O
the O
dsp O
. O

this O
study B-physical_entity
may B-physical_entity
be O
useful O
as O
a O
guide B-physical_entity
for O
engineers O
in O
selecting O
the O
suitable O
fourier O
transform O
based O
control B-abstraction
algorithm B-abstraction
for O
active B-physical_entity
power B-physical_entity
filters O
or O
other O
grid B-physical_entity
synchronized O
equipments O
which O
are O
operating O
in O
difficult O
load B-abstraction
conditions O
. O


a O
high B-abstraction
efficiency O
, O
high B-abstraction
power B-abstraction
density B-abstraction
buffer B-physical_entity
architecture B-physical_entity
is O
proposed O
for O
power B-abstraction
pulsation B-abstraction
decoupling O
in O
power B-abstraction
conversion B-physical_entity
between O
dc O
and O
single B-abstraction
phase B-abstraction
ac O
. O

we O
present B-abstraction
an O
active B-physical_entity
decoupling O
solution B-abstraction
that O
yields O
improved O
efficiency O
and O
reduced O
circuit B-abstraction
complexity B-abstraction
compared O
to O
existing O
solutions O
. O

in O
the O
proposed O
architecture B-abstraction
, O
the O
main B-physical_entity
energy B-abstraction
storage B-abstraction
capacitor B-physical_entity
is O
connected O
in O
series B-abstraction
with O
an O
active B-physical_entity
buffer B-physical_entity
converter B-physical_entity
across O
the O
dc O
bus B-physical_entity
. O

the O
series B-physical_entity
stacked O
capacitor B-physical_entity
blocks O
the O
majority B-abstraction
of O
the O
dc O
bus B-physical_entity
voltage O
to O
reduce O
the O
voltage O
stress O
on O
the O
buffer B-physical_entity
converter B-physical_entity
, O
such O
that O
fast B-abstraction
, O
low B-abstraction
voltage O
transistors O
can B-physical_entity
be O
employed O
for O
the O
buffer B-physical_entity
converter B-physical_entity
. O

moreover O
, O
the O
series B-physical_entity
capacitor B-physical_entity
provides O
the O
majority B-abstraction
of O
the O
power B-physical_entity
pulsation B-abstraction
decoupling O
through O
a O
wide O
voltage O
swing B-physical_entity
, O
and O
the O
buffer B-physical_entity
converter B-physical_entity
only O
needs O
to O
process B-abstraction
a O
small B-abstraction
fraction O
of O
the O
total B-abstraction
power B-abstraction
of O
the O
entire B-physical_entity
architecture B-physical_entity
, O
allowing O
a O
very O
small B-abstraction
active B-physical_entity
circuit B-physical_entity
volume B-abstraction
and O
very O
high B-abstraction
system B-physical_entity
efficiency O
. O

the O
circuit B-abstraction
operation B-abstraction
and O
design B-physical_entity
constraints O
are O
analyzed O
in O
detail B-abstraction
. O

in O
the O
proposed O
buffer B-physical_entity
architecture B-physical_entity
, O
the O
series B-physical_entity
stacking O
of O
a O
nearly O
lossless O
capacitor B-physical_entity
and O
a O
lossy O
converter B-physical_entity
presents O
a O
challenge B-abstraction
of O
capacitor B-physical_entity
voltage O
balancing B-abstraction
and O
power B-abstraction
loss B-abstraction
compensation B-physical_entity
. O

we O
propose O
a O
control B-physical_entity
scheme B-abstraction
exploiting O
the O
small B-abstraction
ripple B-abstraction
in O
the O
bus B-physical_entity
voltage O
and O
dc O
input B-abstraction
current B-abstraction
to O
compensate O
for O
the O
power B-abstraction
loss B-abstraction
in O
the O
buffer B-physical_entity
converter B-physical_entity
while B-abstraction
maintaining O
the O
voltage O
balance B-physical_entity
. O

light B-physical_entity
load B-physical_entity
techniques O
are O
also O
introduced O
to O
ensure O
that O
the O
buffer B-physical_entity
architecture B-abstraction
meets O
strict O
ripple B-abstraction
requirements O
while B-abstraction
providing O
sufficient O
loss B-abstraction
compensation B-physical_entity
. O

a O
2 O
kw O
hardware B-physical_entity
prototype B-abstraction
based O
on O
low B-abstraction
voltage O
gan O
switches O
has O
been O
built O
to O
demonstrate O
the O
performance B-abstraction
of O
the O
proposed O
solution B-abstraction
. O

a O
power B-physical_entity
density B-abstraction
of O
25w O
cm O
3 O
410 O
w O
in O
3 O
by O
rectangular O
box B-abstraction
volume B-abstraction
and O
an O
efficiency O
above O
98 O
. O

9 O
across O
a O
wide O
load B-physical_entity
range B-abstraction
has O
been O
experimentally O
verified O
. O


a O
power B-physical_entity
divider B-physical_entity
combiner O
circuit B-abstraction
, O
which O
simultaneously O
achieves O
wide O
bandwidth O
, O
flat B-physical_entity
gain B-abstraction
characteristics O
, O
and O
bidirectional O
operation B-abstraction
, O
is O
proposed O
for O
multichannel O
broadband O
system B-abstraction
applications O
. O

the O
proposed O
circuit B-physical_entity
utilizes O
cascode O
based O
bidirectional O
amplifier B-physical_entity
cores O
, O
which O
steer B-physical_entity
the O
operation B-abstraction
modes O
between O
a O
divider B-physical_entity
and O
a O
combiner O
depending O
on O
the O
control B-physical_entity
input B-abstraction
, O
and O
a O
two O
stage B-physical_entity
distributed O
amplifier B-physical_entity
topology B-abstraction
with O
artificial O
transmission B-physical_entity
lines O
. O

implemented O
in O
a O
130 O
nm O
silicon O
germanium O
bicmos O
technology B-abstraction
platform B-physical_entity
, O
the O
proposed O
divider B-physical_entity
combiner O
provides O
the O
advantage B-abstraction
of O
seamless O
integration B-abstraction
with O
digital O
control B-physical_entity
blocks O
. O

the O
power B-physical_entity
divider B-physical_entity
combiner O
exhibits O
the O
flat B-physical_entity
in O
band B-physical_entity
gain B-abstraction
of O
9 O
db O
and O
the O
operational O
bandwidth O
of O
2 O
22 O
ghz O
, O
which O
covers O
s B-abstraction
, O
c O
, O
x O
, O
and O
ku O
bands O
. O

in O
addition B-abstraction
, O
it O
shows O
the O
amplitude B-abstraction
imbalance B-abstraction
of O
0 O
. O

8 O
db O
, O
the O
phase B-abstraction
imbalance B-abstraction
of O
3 O
. O

5 O
degrees O
, O
the O
port B-physical_entity
to O
port B-physical_entity
isolation B-abstraction
of O
22 O
db O
, O
the O
output B-physical_entity
1 O
db O
compression B-abstraction
point B-abstraction
of O
3 O
dbm O
, O
and O
good B-physical_entity
impedance O
matching O
under O
100 O
mw O
dc O
power B-physical_entity
consumption B-abstraction
. O


equivalently O
implementing O
a O
generalized O
memristor O
by O
using B-abstraction
common B-physical_entity
components O
and O
then O
making B-abstraction
a O
nonlinear O
circuit B-abstraction
with O
a O
reliable O
property B-physical_entity
, O
are O
conducive O
to O
experimentally O
exhibit B-abstraction
the O
nonlinear O
phenomena O
of O
the O
memristive O
chaotic O
circuit B-abstraction
and O
show B-abstraction
practical O
applications O
in O
generating O
chaotic O
signals O
. O

firstly O
, O
based O
on O
a O
memristive O
diode B-physical_entity
bridge B-abstraction
circuit I-abstraction
, O
a O
new O
first B-physical_entity
order B-abstraction
actively O
generalized O
memristor O
emulator B-physical_entity
is O
constructed O
with O
no B-abstraction
grounded O
restriction B-abstraction
and O
ease B-abstraction
to O
realize O
. O

the O
mathematical O
model B-physical_entity
of O
the O
emulator B-physical_entity
is O
established O
and O
its O
fingerprints O
are O
analyzed O
by O
the O
pinched O
hysteresis O
loops O
with O
different O
sinusoidal O
voltage O
stimuli O
. O

the O
results O
verified O
by O
experimental O
measurements O
indicate O
that O
the O
emulator B-physical_entity
uses O
only O
one B-abstraction
operational O
amplifier B-physical_entity
and O
nine O
elementary O
electronic O
circuit B-abstraction
elements O
and O
is O
an O
active B-physical_entity
voltage O
controlled O
generalized O
memristor O
. O

secondly O
, O
by O
parallelly O
connecting O
the O
proposed O
emulator B-physical_entity
to O
a O
capacitor B-physical_entity
and O
then O
linearly O
coupling B-physical_entity
with O
an O
rc O
bridge B-abstraction
oscillator B-physical_entity
, O
a O
memristor O
based O
chaotic O
circuit B-physical_entity
without O
any O
inductance B-physical_entity
element B-physical_entity
is O
constructed O
. O

the O
dynamical O
model B-physical_entity
of O
the O
inductorless O
memristive O
chaotic O
circuit B-physical_entity
is O
established O
and O
the O
phase B-abstraction
portraits O
of O
the O
chaotic B-O
attractor I-O
with O
typical O
circuit B-physical_entity
parameters O
are O
obtained O
numerically O
. O

the O
dissipativity O
, O
equilibrium B-physical_entity
points O
, O
and O
stabilities O
are O
derived O
, O
which O
indicate O
that O
in O
the O
phase B-abstraction
space B-abstraction
of O
the O
inductorless O
memristive O
chaotic O
circuit B-physical_entity
there B-physical_entity
exists O
a O
dissipative O
area B-physical_entity
where O
are O
distributed O
two O
unstable O
nonzero O
saddle B-physical_entity
foci O
and O
a O
non O
dissipative O
area B-abstraction
containing O
an O
unstable O
origin B-physical_entity
saddle B-physical_entity
point B-abstraction
. O

furthermore O
, O
by O
utilizing O
the O
bifurcation B-abstraction
diagram B-physical_entity
, O
lyapunov O
exponent B-physical_entity
spectra O
, O
and O
phase B-abstraction
portraits O
, O
the O
dynamical O
behaviors O
of O
the O
inductorless O
memristive O
chaotic O
circuit B-abstraction
are O
investigated O
. O

results O
show B-abstraction
that O
with O
the O
evolution B-physical_entity
of O
the O
parameter B-abstraction
value B-abstraction
of O
the O
coupling B-physical_entity
resistor B-physical_entity
, O
the O
complex B-physical_entity
nonlinear O
phenomena O
of O
the O
coexisting O
bifurcation B-abstraction
modes O
and O
coexisting O
attractors O
under O
two O
different O
initial O
conditions O
of O
the O
state B-physical_entity
variables O
can B-physical_entity
be O
found O
in O
the O
inductorless O
memristive O
chaotic O
circuit B-physical_entity
. O

finally O
, O
a O
prototype B-abstraction
circuit B-abstraction
with O
the O
same O
circuit B-abstraction
parameters O
for O
numerical O
simulations O
is O
developed O
, O
from O
which O
it O
can B-physical_entity
be O
seen O
that O
the O
prototype B-abstraction
circuit B-abstraction
has O
a O
simple B-physical_entity
circuit B-abstraction
structure B-physical_entity
and O
is O
inexpensive O
and O
easy O
to O
practically O
fabricate O
with O
common B-physical_entity
components O
. O

results O
of O
both O
the O
experimental O
measurements O
and O
the O
numerical O
simulations O
are O
consistent O
, O
verifying O
the O
validity B-abstraction
of O
the O
theoretical O
analyses O
. O


transformation B-abstraction
of O
research B-abstraction
in O
all O
biological O
fields O
necessitates O
the O
design B-abstraction
, O
analysis B-abstraction
and O
, O
interpretation B-abstraction
of O
large B-abstraction
data O
sets O
. O

preparing O
students O
with O
the O
requisite O
skills O
in O
experimental O
design B-abstraction
, O
statistical O
analysis B-abstraction
, O
and O
interpretation B-abstraction
, O
and O
mathematical O
reasoning B-abstraction
will B-abstraction
require O
both O
curricular O
reform B-abstraction
and O
faculty B-abstraction
who O
are O
willing B-abstraction
and O
able O
to O
integrate O
mathematical O
and O
statistical O
concepts O
into O
their O
life B-abstraction
science I-abstraction
courses O
. O

a O
new O
faculty B-abstraction
learning B-abstraction
community B-physical_entity
flc O
was O
constituted O
each O
year B-abstraction
for O
four B-physical_entity
years B-abstraction
to O
assist B-abstraction
in O
the O
transformation B-abstraction
of O
the O
life B-abstraction
sciences O
curriculum O
and O
faculty B-abstraction
at O
a O
large B-abstraction
, O
midwestern O
research B-abstraction
university B-physical_entity
. O

participants O
were O
interviewed O
after O
participation B-abstraction
and O
surveyed O
before O
and O
after O
participation B-abstraction
to O
assess O
the O
impact B-abstraction
of O
the O
flc O
on O
their O
attitudes O
toward O
teaching B-abstraction
, O
perceived O
pedagogical O
skills O
, O
and O
planned O
teaching B-abstraction
practice B-abstraction
. O

overall B-physical_entity
, O
the O
flc O
had O
a O
meaningful O
positive B-physical_entity
impact B-abstraction
on O
participants' O
attitudes O
toward O
teaching B-abstraction
, O
knowledge B-abstraction
about O
teaching B-abstraction
, O
and O
perceived O
pedagogical O
skills O
. O

interestingly O
, O
confidence O
for O
viewing B-abstraction
the O
classroom B-physical_entity
as O
a O
site B-physical_entity
for O
research B-abstraction
about O
teaching B-abstraction
declined O
. O

implications O
for O
the O
creation B-abstraction
and O
development B-abstraction
of O
flcs O
for O
science B-abstraction
faculty B-abstraction
are O
discussed O
. O

c O
2016 O
by O
the O
international O
union B-abstraction
of O
biochemistry B-abstraction
and O
molecular B-O
biology I-O
. O


an O
active B-physical_entity
matrix B-physical_entity
organic O
light B-abstraction
emitting O
diode B-physical_entity
amoled O
display B-abstraction
driver B-physical_entity
ic O
, O
enabling O
real B-O
time I-O
thin O
film B-abstraction
transistor B-physical_entity
tft O
nonuniformity B-abstraction
compensation B-abstraction
, O
is O
presented O
with O
a O
hybrid B-abstraction
driving B-abstraction
method B-abstraction
to O
satisfy O
fast B-abstraction
driving B-abstraction
speed B-abstraction
, O
high B-abstraction
tft O
current B-abstraction
accuracy B-abstraction
, O
and O
a O
high B-physical_entity
aperture B-physical_entity
ratio O
. O

the O
proposed O
hybrid B-abstraction
column B-physical_entity
driver B-physical_entity
ic O
drives O
a O
mobile B-physical_entity
uhd O
3840 O
x O
2160 O
amoled O
panel B-physical_entity
, O
with O
one B-abstraction
horizontal O
time B-abstraction
of O
7 O
. O

7 O
mu O
s B-abstraction
at O
a O
scan B-abstraction
frequency O
of O
60 O
hz O
, O
simultaneously O
senses O
the O
tft O
current B-abstraction
for O
back B-abstraction
end I-physical_entity
tft O
variation B-abstraction
compensation B-physical_entity
. O

due B-abstraction
to O
external B-abstraction
compensation B-physical_entity
, O
a O
simple B-physical_entity
3t1c O
pixel O
circuit B-abstraction
is O
employed O
in O
each O
pixel O
. O

accurate O
current B-abstraction
sensing B-abstraction
and O
high B-abstraction
panel B-physical_entity
noise B-abstraction
immunity B-abstraction
is O
guaranteed O
by O
a O
proposed O
current B-abstraction
sensing B-abstraction
circuit B-physical_entity
. O

by O
reusing O
the O
hybrid B-physical_entity
column B-physical_entity
driver B-physical_entity
circuitries O
, O
the O
driver B-physical_entity
embodies O
an O
8 O
bit B-physical_entity
current B-abstraction
mode B-abstraction
adc O
to O
measure B-abstraction
oled O
v O
i O
transfer B-physical_entity
characteristic B-abstraction
for O
oled O
luminance B-abstraction
degradation B-abstraction
compensation B-physical_entity
. O

measurement B-abstraction
results O
show B-abstraction
that O
the O
hybrid B-abstraction
driving B-abstraction
method B-abstraction
reduces O
the O
maximum B-physical_entity
current B-abstraction
error B-abstraction
between O
two O
emulated O
tfts O
with O
a O
60 O
mv O
threshold B-abstraction
voltage O
difference B-abstraction
under O
1 O
gray B-abstraction
level B-physical_entity
error B-abstraction
of O
0 O
. O

94 O
gray B-abstraction
level B-abstraction
37 O
na O
in O
8 O
bit B-physical_entity
gray B-physical_entity
scales O
from O
12 O
. O

82 O
gray B-physical_entity
level B-physical_entity
501 O
na O
. O

the O
circuit B-physical_entity
reused O
current B-abstraction
mode B-abstraction
adc O
achieves O
0 O
. O

56 O
lsb O
dnl O
and O
0 O
. O

75 O
lsb O
inl O
. O


there B-physical_entity
are O
many O
factors O
that O
affect O
the O
performance B-abstraction
of O
active B-physical_entity
power B-physical_entity
filter B-physical_entity
, O
which O
is O
a O
key B-physical_entity
factor B-physical_entity
for O
command B-abstraction
current B-abstraction
tracking B-abstraction
control B-physical_entity
. O

aiming O
at O
the O
deficiency B-abstraction
of O
traditional O
pr O
controller B-physical_entity
, O
this O
paper B-physical_entity
puts O
forward B-physical_entity
an O
improved O
pr O
controller B-physical_entity
vector B-abstraction
resonant O
controller B-physical_entity
. O

the O
controller B-physical_entity
has O
the O
advantages O
of O
stronger O
anti B-physical_entity
interference B-physical_entity
ability B-abstraction
and O
greater O
gain B-abstraction
at O
the O
resonance B-abstraction
point B-abstraction
, O
and O
it O
can B-physical_entity
improve O
the O
accuracy B-abstraction
of O
harmonic B-abstraction
compensation B-physical_entity
in O
the O
current B-abstraction
compensation B-physical_entity
control B-abstraction
. O

in O
this O
paper B-physical_entity
, O
the O
digital O
controller B-physical_entity
in O
the O
digital O
control B-abstraction
system I-physical_entity
has O
been O
given B-abstraction
a O
detailed O
design B-abstraction
. O

finally O
, O
the O
experimental O
results O
show B-abstraction
that O
the O
control B-abstraction
strategy B-abstraction
can B-physical_entity
further O
reduce O
the O
harmonic B-abstraction
content B-abstraction
and O
improve O
the O
compensation B-abstraction
accuracy B-abstraction
. O


this O
paper B-physical_entity
presents O
a O
power B-physical_entity
electronic B-O
converter I-O
used O
to O
redistribute O
the O
power B-abstraction
among O
the O
phases O
in O
unbalanced O
power B-abstraction
systems O
, O
which O
is O
supposed O
to O
be O
designed O
based O
on O
the O
involved O
degree B-abstraction
of O
unbalance O
. O

a O
bidirectional O
converter B-physical_entity
is O
chosen B-physical_entity
for O
this O
purpose B-abstraction
, O
whose O
modeling B-abstraction
is O
presented O
in O
the O
dq0 O
system B-abstraction
. O

this O
solution B-abstraction
can B-physical_entity
be O
considered O
as O
part B-physical_entity
of O
a O
unified O
control B-physical_entity
system I-physical_entity
, O
where O
conventional O
active B-physical_entity
power B-abstraction
filters O
may B-physical_entity
be O
solely O
responsible O
for O
compensating O
harmonics B-abstraction
and O
or O
the O
tuning B-abstraction
of O
passive O
filters O
becomes O
easier O
, O
with O
consequent O
reduction B-physical_entity
in O
involved O
costs O
in O
a O
decentralized O
approach B-physical_entity
. O

the O
adopted O
control B-abstraction
strategy B-abstraction
is O
implemented O
in O
digital O
signal B-abstraction
processor B-physical_entity
tms320f2812 O
, O
while B-abstraction
experimental O
results O
obtained O
from O
an O
experimental O
prototype B-abstraction
rated O
at O
17 O
. O

86 O
kva O
are O
properly O
discussed O
considering O
that O
the O
converter B-physical_entity
is O
placed O
at O
the O
secondary B-physical_entity
side B-abstraction
of O
a O
transformer B-physical_entity
supplying B-abstraction
three O
distinct O
single B-abstraction
phase B-abstraction
loads O
. O

it O
is O
effectively O
shown O
that O
the O
converter B-physical_entity
is O
able O
to O
balance B-abstraction
the O
currents O
in O
the O
transformer B-physical_entity
phases O
, O
thus O
leading B-abstraction
to O
the O
suppression B-abstraction
of O
the O
neutral B-physical_entity
current B-abstraction
. O


this O
paper B-physical_entity
reports O
a O
source B-abstraction
follower B-physical_entity
based O
active B-physical_entity
rc O
filter B-physical_entity
topology B-abstraction
for O
rf O
front B-physical_entity
ends O
in O
wideband O
systems O
. O

in O
the O
proposed O
active B-physical_entity
rc O
filter B-physical_entity
, O
the O
noise B-abstraction
figure B-abstraction
and O
bandwidth O
are O
improved O
through O
adopting O
the O
proposed O
sub B-physical_entity
1 O
omega B-abstraction
z O
out B-abstraction
source B-abstraction
follower B-physical_entity
, O
which O
replaces O
the O
conventional O
operational O
amplifier B-physical_entity
based O
unity B-abstraction
gain B-abstraction
buffer B-physical_entity
and O
through O
simply O
changing O
its O
location B-physical_entity
in O
the O
filter B-physical_entity
. O

applying O
the O
proposed O
scheme B-abstraction
to O
the O
conventional O
sallen O
key B-abstraction
filter B-physical_entity
also O
improves O
the O
stopband O
rejection B-abstraction
performance B-abstraction
. O

furthermore O
, O
the O
proposed O
filter B-physical_entity
topology B-abstraction
ultimately O
suppresses O
the O
dc O
offset B-physical_entity
voltage O
and O
flicker B-abstraction
noise B-abstraction
of O
the O
unity B-abstraction
gain B-abstraction
buffer B-physical_entity
, O
which O
is O
the O
only O
active B-physical_entity
circuit B-physical_entity
in O
the O
filter B-physical_entity
. O

the O
proposed O
biquad O
filter B-physical_entity
is O
implemented O
in O
0 O
. O

18 O
mu O
m O
cmos O
and O
the O
measurements O
exhibit B-abstraction
26 O
dbm O
iip3 O
, O
12 O
dbm O
input B-abstraction
p O
1db O
, O
and O
15 O
db O
noise B-abstraction
figure B-physical_entity
over B-abstraction
50 O
450 O
mhz O
of O
a O
6 O
bit B-physical_entity
tunable O
frequency O
range B-physical_entity
. O

the O
proposed O
biquad O
filter B-physical_entity
consumes O
14 O
ma B-physical_entity
from O
a O
1 O
. O

8 O
v O
supply B-physical_entity
and O
the O
chip B-physical_entity
occupies O
1000x500 O
mu O
m O
2 O
. O


recently O
, O
we O
have B-physical_entity
reported O
on O
a O
compact B-physical_entity
microcontroller O
based O
unit B-abstraction
developed O
to O
accurately O
synchronize O
excimer O
laser B-physical_entity
pulses O
mingesz O
et O
al O
. O

2012 O
fluct O
. O

noise B-abstraction
lett O
. O

11 O
, O
1240007 O
doi O
10 O
. O

1142 O
s021947751240007x O
. O

we O
have B-physical_entity
shown O
that O
dithering O
based O
on O
random O
jitter B-abstraction
noise B-abstraction
plus B-abstraction
pseudorandom O
numbers B-abstraction
can B-physical_entity
be O
used O
in O
the O
digital O
control B-abstraction
system I-physical_entity
to O
radically O
reduce O
the O
long O
term B-physical_entity
drift B-abstraction
of O
the O
laser B-physical_entity
pulse B-abstraction
from O
the O
trigger B-abstraction
and O
to O
improve O
the O
accuracy B-abstraction
of O
the O
synchronization B-abstraction
. O

in O
this O
update O
paper B-physical_entity
, O
we O
present B-abstraction
our O
new O
experimental O
results O
obtained O
by O
the O
use B-physical_entity
of O
the O
delay B-abstraction
controller B-physical_entity
unit B-abstraction
to O
tune B-abstraction
the O
timing B-abstraction
of O
a O
krf O
excimer O
laser B-physical_entity
as O
an O
addition B-physical_entity
to O
our O
previous O
numerical O
simulation B-abstraction
results O
. O

the O
hardware B-physical_entity
was O
interfaced O
to O
the O
laser B-physical_entity
using B-abstraction
optical O
signal B-abstraction
paths O
in O
order B-abstraction
to O
reduce O
sensitivity B-abstraction
to O
electromagnetic O
interference B-abstraction
and O
the O
control B-abstraction
algorithm B-abstraction
tested O
by O
simulations O
was O
applied O
in O
the O
experiments O
. O

we O
have B-physical_entity
found O
that O
the O
system B-abstraction
is O
able O
to O
reduce O
the O
delay B-abstraction
uncertainty B-abstraction
very O
close B-abstraction
to O
the O
theoretical O
limit B-abstraction
and O
performs O
well B-physical_entity
in O
real O
applications O
. O

the O
simple B-physical_entity
, O
compact B-physical_entity
and O
flexible O
system B-physical_entity
is O
universal B-physical_entity
enough O
to O
also O
be O
used O
in O
various O
multidisciplinary O
applications O
. O


the O
current B-abstraction
mode B-abstraction
first B-physical_entity
order B-abstraction
allpass O
filter B-physical_entity
app O
using B-abstraction
only O
the O
active B-physical_entity
elements O
has O
been O
studied O
in O
the O
present B-abstraction
paper B-physical_entity
. O

the O
proposed O
circuit B-physical_entity
comprises O
two O
operational O
transconductance O
amplifiers O
otas O
and O
one B-abstraction
operational O
amplifier B-physical_entity
oa O
which O
is O
suitable O
to O
future B-physical_entity
development B-physical_entity
into O
an O
integrated B-O
circuit I-O
. O

the O
pole B-abstraction
frequency O
and O
phase B-abstraction
response B-physical_entity
can B-physical_entity
be O
electronically O
adjusted O
with O
changing O
the O
dc O
bias B-abstraction
currents O
of O
otas O
. O

the O
apf O
has O
high B-abstraction
output B-abstraction
impedance O
, O
which O
is O
easy O
to O
cascade B-abstraction
in O
high B-abstraction
order B-abstraction
filter B-physical_entity
or O
drive B-abstraction
load B-abstraction
without O
using B-abstraction
a O
buffering O
device B-physical_entity
. O

the O
current B-abstraction
mode B-abstraction
quadrature B-abstraction
oscillator B-physical_entity
is O
included O
to O
show B-abstraction
the O
usability B-abstraction
of O
the O
proposed O
filter B-physical_entity
. O

the O
results O
of O
pspice O
simulation B-physical_entity
are O
accordant O
with O
the O
theoretical O
analysis B-abstraction
. O


an O
8th O
order B-abstraction
cheybshev O
ii O
ladder B-abstraction
active B-physical_entity
rc O
bpf O
was O
fabricated O
in O
a O
40 O
nm O
cmos O
low B-physical_entity
leakage B-abstraction
digital O
process B-abstraction
. O

a O
new O
technique B-abstraction
to O
design B-abstraction
for O
zero B-abstraction
capacitance B-physical_entity
spread B-abstraction
zcs O
is O
reported O
to O
enable O
the O
application B-abstraction
of O
integrator B-physical_entity
frequency O
compensation B-physical_entity
ifc O
. O

combined O
with O
wideband O
op O
amps O
employing O
a O
current B-abstraction
reusing O
, O
split B-physical_entity
path B-abstraction
feed O
forward B-abstraction
compensation B-abstraction
ffc O
technique B-abstraction
, O
significant O
power B-physical_entity
savings O
is O
achieved O
in O
a O
standard B-abstraction
40 O
nm O
cmos O
process B-abstraction
. O

the O
bpf O
measures O
a O
center B-abstraction
frequency O
cf O
of O
85 O
225 O
mhz O
and O
four B-physical_entity
programmable O
bandwidth O
to O
center B-abstraction
frequency O
bw O
cf O
ratios O
of O
5 O
40 O
. O

both O
the O
cf O
and O
bw O
cf O
ratio O
are O
digitally O
programmable O
. O

it O
also O
measures O
a O
maximum B-physical_entity
in O
band B-physical_entity
iip3 O
of O
31 O
dbm O
at O
0 O
db O
gain B-abstraction
and O
a O
maximum B-physical_entity
in O
band B-physical_entity
frequency B-O
response I-O
deviation B-abstraction
of O
0 O
. O

2 O
db O
while B-abstraction
consuming O
33 O
ma B-physical_entity
from O
a O
1 O
. O

5 O
v O
supply B-physical_entity
. O


aims O
activin O
e O
is O
a O
newly O
identified O
member B-physical_entity
of O
the O
transforming O
growth B-abstraction
factor B-abstraction
beta O
superfamily O
. O

to O
assess O
the O
role B-abstraction
of O
activin O
e O
in O
glucose O
energy B-abstraction
metabolism B-physical_entity
, O
we O
investigated O
the O
transcriptional O
regulation B-abstraction
of O
activin O
e O
in O
the O
liver B-physical_entity
. O

main B-physical_entity
methods O
northern O
blotting O
, O
western O
blotting O
, O
quantitative O
real B-O
time I-O
polymerase O
chain B-physical_entity
reaction I-physical_entity
pcr O
, O
reporter B-physical_entity
assays O
and O
chromatin O
immunoprecipitation O
assays O
were O
used O
in O
this O
study B-physical_entity
. O

key B-physical_entity
findings O
insulin O
up O
regulated O
activin O
e O
expression B-abstraction
at O
the O
mrna O
and O
protein O
level B-abstraction
in O
hepg2 O
cells O
. O

reporter B-physical_entity
assays O
revealed O
that O
the O
putative O
, O
functional O
, O
promoter B-physical_entity
sequence B-abstraction
of O
human B-physical_entity
activin O
e O
gene O
was O
responsible O
for O
the O
effect B-abstraction
of O
insulin O
. O

mutational O
analysis B-abstraction
of O
the O
promoter B-physical_entity
revealed O
that O
ccaat O
enhancer B-abstraction
binding B-abstraction
proteins O
c O
ebps O
play B-abstraction
a O
key B-physical_entity
role B-abstraction
in O
regulating B-abstraction
activin O
e O
expression B-abstraction
and O
in O
the O
stimulatory O
effect B-abstraction
of O
insulin O
on O
activin O
e O
transcription B-physical_entity
. O

chromatin O
immunoprecipitation O
assays O
revealed O
that O
the O
c O
ebps O
can B-physical_entity
bind B-abstraction
to O
the O
activin O
e O
promoter B-physical_entity
in O
hepg2 O
cells O
. O

the O
expression B-physical_entity
of O
activin O
e O
mrna O
was O
up O
regulated O
in O
the O
liver B-physical_entity
of O
diet B-abstraction
induced O
obese O
mice O
. O

significance B-abstraction
these O
observations O
suggest O
that O
activin O
e O
plays O
a O
pathophysiological O
role B-abstraction
in O
glucose O
metabolism B-physical_entity
. O

c O
2009 O
elsevier O
inc O
. O

all O
rights O
reserved O
. O


background B-physical_entity
and O
purpose B-abstraction
few O
studies O
have B-physical_entity
examined O
why B-abstraction
some O
patients O
with O
dementia O
stop B-physical_entity
attending B-abstraction
medical B-abstraction
consultations O
. O

we O
conducted O
a O
retrospective O
study B-physical_entity
to O
investigate O
factors O
associated O
with O
discontinuous O
clinic B-physical_entity
attendance B-abstraction
. O

methods O
participants O
were O
988 O
patients O
with O
dementia O
from O
university B-physical_entity
hospital B-physical_entity
uh O
clinics O
and O
affiliated O
local B-physical_entity
hospital B-physical_entity
lh O
clinics O
. O

we O
compared O
continuous O
and O
discontinuous O
attenders O
on O
cognitive O
and O
affective O
functions O
and O
activities O
of O
daily B-physical_entity
living B-abstraction
adl O
, O
and O
also O
compared O
uh O
and O
lh O
patients O
uh O
continuous O
, O
n O
176 O
; O
discontinuous O
, O
n O
207 O
; O
lh O
continuous O
, O
n O
418 O
; O
discontinuous O
, O
n O
187 O
. O

results O
the O
total B-abstraction
annual B-physical_entity
rate B-abstraction
of O
discontinuation B-abstraction
was O
8 O
. O

0 O
, O
and O
the O
mean B-abstraction
period B-abstraction
of O
attendance B-abstraction
before O
discontinuation B-abstraction
was O
2 O
. O

2 O
2 O
. O

4 O
years B-abstraction
uh O
, O
2 O
. O

8 O
3 O
. O

0 O
; O
lh O
, O
1 O
. O

5 O
1 O
. O

3 O
, O
p O
0 O
. O

01 O
. O

scores O
for O
the O
mini B-physical_entity
mental O
state B-physical_entity
examination B-abstraction
, O
hasegawa O
dementia O
scale B-physical_entity
revised O
, O
geriatric O
depression B-abstraction
scale B-physical_entity
, O
apathy O
scale B-physical_entity
, O
abe's O
behavioral O
and O
psychological O
symptoms O
of O
dementia O
bpsd O
score B-abstraction
, O
and O
adl O
were O
significantly O
worse B-abstraction
in O
the O
discontinuous O
group O
than O
the O
continuous O
group O
for O
both O
uh O
and O
lh O
patients O
p O
0 O
. O

01 O
. O

the O
best B-abstraction
predictor B-abstraction
of O
discontinuation B-abstraction
was O
adl O
decline B-physical_entity
uh O
and O
lh O
and O
abe's O
bpsd O
score B-abstraction
uh O
. O

the O
most O
common B-physical_entity
reason B-abstraction
for O
discontinuation B-abstraction
was O
returning O
to O
the O
family B-physical_entity
doctor I-physical_entity
39 O
. O

1 O
for O
uh O
, O
and O
cessation B-abstraction
of O
hospital B-physical_entity
attendance B-abstraction
at O
their O
own O
discretion B-abstraction
35 O
. O

3 O
for O
lh O
. O

conclusions O
we O
identified O
the O
main B-physical_entity
reasons O
for O
discontinuation B-abstraction
of O
attendance B-abstraction
as O
returning O
to O
the O
family B-physical_entity
doctor I-physical_entity
and O
cessation B-abstraction
of O
hospital B-physical_entity
attendance B-abstraction
at O
their O
own O
discretion B-abstraction
. O

the O
best B-abstraction
predictors O
of O
discontinuation B-abstraction
were O
adl O
decline B-physical_entity
and O
worsening B-abstraction
bpsd O
. O

there B-physical_entity
were O
significant O
differences O
in O
discontinuation B-abstraction
between O
uh O
and O
lh O
patients O
with O
dementia O
. O


this O
paper B-physical_entity
presents O
the O
a O
diakoptics O
methodology B-abstraction
diakoptics O
based O
on O
actors O
for O
the O
high B-physical_entity
performance B-abstraction
simulation B-abstraction
of O
microgrids O
. O

microgrids O
are O
clusters O
of O
loads O
and O
microsources O
that O
operate O
within O
a O
single B-abstraction
controllable O
system B-abstraction
, O
which O
provides O
electricity O
and O
heat B-physical_entity
to O
its O
local B-physical_entity
area B-physical_entity
even B-abstraction
if O
they O
get B-abstraction
separated O
from O
the O
distribution B-abstraction
system B-abstraction
. O

several O
commercial O
solutions O
are O
addressing O
this O
topic B-abstraction
using B-abstraction
numerous O
methods O
; O
however O
, O
to O
keep B-physical_entity
the O
computing B-abstraction
time B-abstraction
required O
to O
solve O
the O
system B-abstraction
when O
the O
size B-abstraction
of O
the O
system B-abstraction
grows O
represents O
a O
major B-abstraction
challenge B-abstraction
. O

in O
this O
paper B-physical_entity
, O
this O
challenge B-abstraction
is O
addressed O
by O
separating O
the O
distribution B-abstraction
grid B-physical_entity
in O
independent B-physical_entity
subnetworks O
. O

then O
, O
for O
the O
computational O
implementation B-abstraction
, O
each O
subnetwork O
is O
assigned O
to O
an O
independent B-physical_entity
solver B-physical_entity
using B-abstraction
the O
actor B-physical_entity
model B-physical_entity
. O

as O
a O
result B-abstraction
, O
the O
solution B-abstraction
algorithm B-abstraction
is O
composed O
of O
multiple B-abstraction
parallel B-physical_entity
and O
concurrent O
solvers O
. O

these O
exchange B-physical_entity
information B-abstraction
using B-abstraction
high B-physical_entity
speed B-abstraction
communication B-abstraction
interfaces O
for O
reducing B-physical_entity
the O
computational O
burden B-abstraction
without O
losing O
accuracy B-abstraction
. O

a O
diakoptics O
is O
an O
advanced O
algorithm B-abstraction
that O
combines O
existing O
methods O
for O
simulating O
large B-abstraction
distribution B-abstraction
systems O
; O
these O
methods O
are O
upgraded O
to O
make B-abstraction
them O
suitable O
for O
parallel B-physical_entity
processing O
and O
to O
cover B-physical_entity
the O
basic B-physical_entity
needs O
for O
the O
simulation B-abstraction
of O
smart B-abstraction
grid B-physical_entity
applications O
. O


this O
paper B-physical_entity
presents O
a O
digital O
control B-physical_entity
technique B-abstraction
to O
achieve O
valley B-physical_entity
switching B-abstraction
in O
a O
bidirectional O
flyback O
converter B-physical_entity
used O
to O
drive B-abstraction
a O
dielectric O
electroactive O
polymer O
based O
capacitive O
incremental O
actuator B-physical_entity
. O

this O
paper B-physical_entity
also O
provides O
the O
design B-abstraction
of O
a O
low B-physical_entity
input B-abstraction
voltage O
24 O
v O
and O
variable B-abstraction
high B-physical_entity
output B-physical_entity
voltage O
0 O
2 O
. O

5 O
kv O
bidirectional O
dc O
dc O
flyback O
converter B-physical_entity
for O
driving B-abstraction
a O
capacitive O
incremental O
actuator B-physical_entity
. O

the O
incremental O
actuator B-physical_entity
consists O
of O
three O
electrically O
isolated O
mechanically O
connected O
capacitive O
actuators O
. O

it O
requires O
three O
high B-abstraction
voltage O
hv O
2 O
2 O
. O

5 O
kv O
bidirectional O
dc O
dc O
converters O
to O
accomplish O
the O
incremental O
motion B-abstraction
by O
charging O
and O
discharging O
the O
capacitive O
actuators O
. O

the O
bidirectional O
flyback O
converter B-physical_entity
employs O
a O
digital O
controller B-physical_entity
to O
improve O
the O
efficiency O
and O
charge B-abstraction
discharge B-abstraction
speed B-abstraction
using B-abstraction
the O
valley B-physical_entity
switching B-abstraction
technique B-abstraction
during O
both O
charge B-physical_entity
and O
discharge B-physical_entity
processes O
, O
without O
the O
need B-abstraction
to O
sense B-abstraction
signals O
on O
the O
output B-abstraction
hv O
side B-physical_entity
. O

experimental O
results O
verifying O
the O
bidirectional O
operation B-abstraction
of O
a O
hv O
flyback O
converter B-physical_entity
are O
presented O
using B-abstraction
a O
3 O
kv O
polypropylene O
film B-abstraction
capacitor B-physical_entity
as O
the O
load B-physical_entity
. O

the O
energy B-abstraction
loss B-abstraction
distributions O
of O
the O
converter B-physical_entity
are O
presented O
when O
4 O
and O
4 O
. O

5 O
kv O
hv O
mosfets O
are O
used O
on O
hv O
side B-physical_entity
. O

the O
flyback O
prototype B-abstraction
with O
a O
4 O
kv O
mosfet O
demonstrated O
89 O
charge B-abstraction
energy B-abstraction
efficiency O
to O
charge B-abstraction
the O
capacitive O
load B-physical_entity
from O
0 O
v O
to O
2 O
. O

5 O
kv O
, O
and O
84 O
discharge B-physical_entity
energy B-abstraction
efficiency O
to O
discharge B-abstraction
it O
from O
2 O
. O

5 O
kv O
to O
0 O
v O
. O


the O
mother's O
immune B-physical_entity
system B-physical_entity
has O
to O
adapt O
to O
pregnancy O
accepting O
the O
semi B-abstraction
allograft O
fetus B-physical_entity
and O
preventing O
harmful O
effects O
to O
the O
developing O
child B-physical_entity
. O

aberrations O
in O
feto O
maternal O
immune B-physical_entity
adaptation B-abstraction
may B-physical_entity
result B-abstraction
in O
disease O
of O
the O
mother B-physical_entity
, O
such O
as O
liver B-physical_entity
injury B-abstraction
. O

five B-physical_entity
pregnancy O
associated O
liver B-physical_entity
disorders O
have B-physical_entity
been O
described O
so O
far O
, O
however O
, O
little O
is O
known O
concerning O
immune B-physical_entity
alterations O
promoting O
the O
respective O
disease O
. O

these O
liver B-physical_entity
disorders O
are O
pre O
eclampsia O
, O
hemolysis B-physical_entity
, O
elevated O
liver B-physical_entity
enzymes O
, O
low B-physical_entity
platelet O
count B-abstraction
hellp O
, O
acute O
fatty B-physical_entity
liver B-physical_entity
, O
hyperemesis B-abstraction
gravidarum I-physical_entity
, O
and O
intrahepatic O
cholestasis O
of O
pregnancy O
. O

on O
the O
other O
hand B-abstraction
, O
pre O
existing O
autoimmune O
liver B-physical_entity
injury B-abstraction
of O
the O
mother B-abstraction
can B-physical_entity
be O
affected O
by O
pregnancy O
. O

this O
review B-physical_entity
intends O
to O
summarize O
current B-abstraction
knowledge B-abstraction
linking O
feto O
maternal O
immunology B-abstraction
and O
liver B-physical_entity
inflammation B-abstraction
with O
a O
special B-abstraction
emphasis B-abstraction
on O
novel B-physical_entity
potential O
biomarkers O
. O


background B-physical_entity
reporting O
new O
cases O
of O
enterovirus B-physical_entity
ev O
d68 O
associated O
acute O
flaccid O
myelitis B-abstraction
afm O
is O
essential O
to O
understand O
how O
the O
virus B-physical_entity
causes O
neurological O
damage B-abstraction
and O
to O
characterize O
ev O
d68 O
strains O
associated O
with O
afm O
. O

case B-abstraction
presentation B-physical_entity
a O
previously O
healthy O
4 O
year B-abstraction
old B-abstraction
boy I-abstraction
presented O
with O
sudden O
weakness B-abstraction
and O
limited B-physical_entity
mobility B-abstraction
in O
his O
left B-physical_entity
arm B-physical_entity
. O

two O
days B-abstraction
earlier O
, O
he O
had O
an O
upper B-physical_entity
respiratory O
illness O
with O
mild O
fever B-abstraction
. O

at O
admission B-abstraction
, O
his O
physical O
examination B-abstraction
showed O
that O
the O
child B-physical_entity
was O
febrile O
38 O
. O

5 O
degrees O
c O
and O
alert B-abstraction
but O
had O
a O
stiff B-physical_entity
neck B-physical_entity
and O
weakness B-abstraction
in O
his O
left B-physical_entity
arm B-physical_entity
, O
which O
was O
hypotonic O
and O
areflexic O
. O

cerebrospinal O
fluid O
csf O
examination B-abstraction
showed O
a O
mild O
increase B-abstraction
in O
white B-abstraction
blood B-physical_entity
cell I-physical_entity
count B-physical_entity
80 O
mm O
3 O
, O
41 O
neutrophils O
and O
a O
slightly O
elevated O
protein O
concentration B-abstraction
76 O
gm O
dl O
. O

bacterial O
culture B-abstraction
and O
molecular B-O
biology I-O
tests O
for O
detecting B-abstraction
viral O
infection B-abstraction
in O
csf O
were O
negative B-physical_entity
. O

the O
patient B-physical_entity
was O
then O
treated O
with O
intravenous O
ceftriaxone O
and O
acyclovir O
. O

despite B-abstraction
therapy B-abstraction
, O
within O
24 O
h O
, O
the O
muscle B-physical_entity
weakness B-abstraction
extended O
to O
all O
four B-physical_entity
limbs O
, O
which O
exhibited O
greatly O
reduced O
mobility B-abstraction
. O

due B-abstraction
to O
his O
worsening B-abstraction
clinical O
prognosis B-abstraction
, O
the O
child B-physical_entity
was O
transferred O
to O
our O
pediatric O
intensive B-O
care I-O
unit B-abstraction
; O
at O
admission B-abstraction
he O
was O
diagnosed O
with O
acute O
flaccid O
paralysis O
of O
all O
four B-physical_entity
limbs O
. O

brain B-abstraction
magnetic O
resonance B-abstraction
imaging B-abstraction
mri O
was O
negative B-abstraction
, O
except O
for O
a O
focal O
signal B-abstraction
alteration B-abstraction
in O
the O
dorsal O
portion B-abstraction
of O
the O
medulla B-physical_entity
oblongata O
, O
also O
involving O
the O
pontine O
tegmentum O
, O
whereas O
spine O
mri O
showed O
an O
extensive O
signal B-abstraction
alteration B-abstraction
of O
the O
cervical O
and O
dorsal O
spinal O
cord B-physical_entity
reported O
as O
myelitis B-abstraction
. O

signal B-abstraction
alteration B-abstraction
was O
mainly O
localized O
in O
the O
central B-physical_entity
grey B-physical_entity
matter B-abstraction
, O
most O
likely O
in O
the O
anterior O
horns O
. O

molecular B-O
biology I-O
tests O
performed O
on O
nasopharyngeal O
aspirate O
and O
on O
bronchoalveolar O
lavage B-abstraction
fluid O
were O
negative B-physical_entity
for O
bacteria B-physical_entity
but O
positive B-physical_entity
for O
ev O
d68 O
clade O
b3 O
. O

plasmapheresis B-abstraction
was O
performed O
and O
corticosteroids O
and O
intravenous O
immunoglobulins O
were O
administered O
. O

after O
4 O
weeks O
of O
treatment B-abstraction
, O
the O
signs O
and O
symptoms O
of O
afm O
were O
significantly O
reduced O
, O
although O
some O
weakness B-abstraction
and O
tingling B-abstraction
remained O
in O
the O
patient's O
four B-physical_entity
limbs O
. O

mri O
acquired O
after O
3 O
weeks O
showed O
that O
the O
previously O
reported O
alterations O
were O
no B-abstraction
longer B-physical_entity
present B-abstraction
. O

conclusion B-abstraction
this O
case B-physical_entity
suggests O
that O
ev O
d68 O
is O
a O
neurotropic O
agent B-physical_entity
that O
can B-physical_entity
cause B-abstraction
afm O
and O
strains O
are O
circulating O
in O
europe O
. O

ev O
d68 O
disease O
surveillance B-abstraction
is O
required O
to O
better B-abstraction
understand O
ev O
d68 O
pathology B-abstraction
and O
to O
compare B-abstraction
various O
strains O
that O
cause B-abstraction
afm O
. O


acute O
graft B-abstraction
versus O
host B-physical_entity
disease O
gvhd O
remains B-physical_entity
a O
major B-abstraction
complication B-abstraction
of O
allogeneic O
haematopoietic O
stem B-abstraction
cell I-abstraction
transplantation B-abstraction
, O
with O
a O
significant O
proportion B-physical_entity
of O
patients O
failing B-abstraction
to O
respond O
to O
first B-abstraction
line B-abstraction
systemic O
corticosteroids O
. O

reliable O
biomarkers O
predicting O
disease O
severity B-abstraction
and O
response B-physical_entity
to O
treatment B-abstraction
are O
warranted O
to O
improve O
its O
management B-abstraction
. O

thus O
, O
we O
sought O
to O
determine O
whether O
pentraxin O
3 O
ptx3 O
, O
an O
acutephase O
protein O
produced O
locally O
at O
the O
site B-physical_entity
of O
inflammation B-abstraction
, O
could O
represent O
a O
novel B-physical_entity
acute O
gvhd O
biomarker O
. O

using B-abstraction
a O
murine B-physical_entity
model B-physical_entity
of O
the O
disease O
, O
we O
found O
increased O
ptx3 O
plasma O
levels O
after O
irradiation B-abstraction
and O
at O
gvhd O
onset B-abstraction
. O

similarly O
, O
plasma O
ptx3 O
was O
enhanced O
in O
115 O
pediatric O
patients O
on O
day B-abstraction
of O
transplantation B-abstraction
, O
likely O
due B-abstraction
to O
conditioning B-abstraction
, O
and O
at O
gvhd O
onset B-abstraction
in O
patients O
experiencing O
clinical O
symptoms O
of O
the O
disease O
. O

ptx3 O
was O
also O
found O
increased O
in O
skin B-physical_entity
and O
colon O
biopsies O
from O
patients O
with O
active B-physical_entity
disease O
. O

furthermore O
, O
ptx3 O
plasma O
levels O
at O
gvhd O
onset B-abstraction
were O
predictive O
of O
disease O
outcome B-abstraction
since O
they O
resulted O
significantly O
higher O
in O
both O
severe O
and O
therapyunresponsive O
patients O
. O

multiple B-abstraction
injections O
of O
rhptx3 O
in O
the O
murine B-physical_entity
model B-abstraction
of O
gvhd O
did O
not O
influence B-abstraction
the O
disease O
course B-physical_entity
. O

taken O
together O
, O
our O
results O
indicate O
that O
ptx3 O
constitutes O
a O
biomarker O
of O
gvhd O
severity B-abstraction
and O
therapy B-abstraction
response B-abstraction
useful O
to O
tailor B-physical_entity
treatment B-abstraction
intensity B-abstraction
according O
to O
early O
risk B-abstraction
stratification B-physical_entity
of O
gvhd O
patients O
. O


objective B-physical_entity
and O
design B-physical_entity
cisplatin O
based O
chemotherapy B-abstraction
has O
been O
widely O
used O
in O
the O
perioperative O
period B-abstraction
of O
cancer O
surgery B-abstraction
, O
which O
exacerbates O
the O
risk B-abstraction
of O
renal O
injury B-abstraction
. O

in O
this O
study B-physical_entity
, O
we O
examined O
whether O
dexmedetomidine O
dex O
, O
a O
commonly O
used O
anesthetic O
adjuvant O
, O
shows O
a O
protective O
effect B-abstraction
against O
cisplatin O
induced O
acute O
kidney O
injury B-abstraction
. O

materials O
acute O
kidney O
injury B-abstraction
in O
mice O
was O
induced O
by O
cisplatin O
. O

treatments O
mice O
were O
administered O
with O
dex O
25 O
mu O
g O
kg O
or O
atipamezole O
250 O
mu O
g O
kg O
once O
a O
day B-abstraction
, O
for O
3 O
days B-abstraction
after O
cisplatin O
treatment B-abstraction
. O

methods O
the O
renal O
function B-abstraction
and O
tubular O
damage B-abstraction
score B-abstraction
were O
evaluated O
at O
72 O
h O
following B-abstraction
cisplatin O
administration B-abstraction
. O

apoptotic O
tubular O
cells O
were O
detected O
by O
tunel O
assay B-abstraction
. O

caspase O
3 O
, O
p53 O
, O
bax O
, O
f4 O
80 O
macrophages O
, O
cd3 O
t O
cells O
, O
and O
nf O
kappa O
b O
were O
examined O
by O
immunohistochemistry B-abstraction
staining B-abstraction
or O
western O
blot B-abstraction
. O

tumor O
necrosis O
factor B-abstraction
tnf O
alpha B-abstraction
, O
interleukin O
il O
1 O
beta O
, O
il O
6 O
, O
and O
monocyte B-physical_entity
chemoattractant O
protein O
mcp O
1 O
in O
kidney O
were O
measured O
using B-abstraction
real B-O
time I-O
polymerase O
chain B-physical_entity
reaction I-physical_entity
. O

results O
dex O
treatment B-abstraction
preserved O
renal O
function B-abstraction
and O
reduced O
tubular O
damage B-abstraction
score B-abstraction
of O
mice O
after O
cisplatin O
administration B-abstraction
. O

mice O
treated O
with O
dex O
exhibited O
less O
apoptotic O
tubular O
cells O
in O
response B-abstraction
to O
cisplatin O
insult B-abstraction
, O
which O
was O
associated O
with O
decreased O
bax O
and O
reduced O
activation B-physical_entity
of O
p53 O
and O
caspase O
3 O
. O

dex O
suppressed O
the O
infiltration B-physical_entity
of O
macrophages O
and O
t O
cells O
into O
the O
kidneys O
following B-abstraction
cisplatin O
treatment B-abstraction
, O
which O
was O
involved O
in O
the O
inhibition B-physical_entity
of O
nf O
kappa O
b O
activation B-abstraction
and O
decreased O
expression B-physical_entity
of O
tnf O
alpha B-abstraction
, O
il O
1 O
beta O
, O
il O
6 O
, O
and O
mcp O
1 O
. O

furthermore O
, O
we O
showed O
that O
the O
renoprotective O
effect B-abstraction
conferred O
by O
dex O
may B-physical_entity
be O
related O
to O
alpha B-abstraction
2 O
adrenoceptor O
dependent B-physical_entity
pathway B-physical_entity
. O

conclusion B-abstraction
we O
demonstrate O
that O
dex O
protects O
the O
kidney O
against O
cisplatin O
induced O
aki O
by O
the O
regulation B-abstraction
of O
apoptosis O
and O
inflammatory O
response B-abstraction
. O


background B-abstraction
cell B-physical_entity
necrosis O
, O
oxidative O
damage B-abstraction
, O
and O
fibrogenesis O
are O
involved O
in O
cirrhosis O
development B-physical_entity
, O
a O
condition B-abstraction
in O
which O
insulin O
like B-abstraction
growth B-abstraction
factor B-abstraction
1 O
igf O
1 O
levels O
are O
diminished O
. O

this O
study B-physical_entity
evaluates O
whether O
the O
exogenous O
administration B-abstraction
of O
low B-physical_entity
doses O
of O
igf O
1 O
can B-physical_entity
induce O
hepatoprotection O
in O
acute O
carbon B-physical_entity
tetrachloride O
ccl4 O
induced O
liver B-physical_entity
damage B-abstraction
compared O
to O
healthy O
controls O
wt O
igf O
. O

additionally O
, O
the O
impact B-abstraction
of O
igf O
1 O
deficiency B-abstraction
on O
a O
damaged O
liver B-physical_entity
was O
investigated O
in O
mice O
with O
a O
partial B-abstraction
deficit B-abstraction
of O
this O
hormone O
hz O
igf1 O
. O

methods O
three O
groups O
of O
25 O
5 O
week B-abstraction
old B-abstraction
healthy O
male B-physical_entity
mice O
wt O
igf O
were O
included O
in O
the O
protocol B-abstraction
untreated O
controls O
wt O
. O

controls O
that O
received O
ccl4 O
wt O
ccl4 O
and O
wt O
ccl4 O
were O
treated O
subcutaneously O
with O
igf O
1 O
2 O
mu O
g O
100 O
g O
body B-abstraction
weight I-abstraction
day B-abstraction
for O
10 O
days B-abstraction
wt O
ccl4 O
igf1 O
. O

in O
parallel B-physical_entity
, O
three O
igf O
1 O
deficient O
mice O
hz O
igf1 O
groups O
were O
studied O
untreated O
hz O
, O
hz O
ccl4 O
, O
and O
hz O
ccl4 O
igf O
1 O
. O

microarray O
and O
real B-O
time I-O
quantitative O
polymerase O
chain B-physical_entity
reaction I-physical_entity
rt O
qpcr O
analyses O
, O
serum O
aminotransferases O
levels O
, O
liver B-physical_entity
histology B-abstraction
, O
and O
malondialdehyde O
mda O
levels O
were O
assessed O
at O
the O
end B-physical_entity
of O
the O
treatment B-abstraction
in O
all O
groups O
. O

all O
data O
represent O
mean B-abstraction
sem O
. O

results O
an O
altered O
gene O
coding B-abstraction
expression B-abstraction
pattern B-abstraction
for O
proteins O
of O
the O
extracellular O
matrix B-physical_entity
, O
fibrosis O
, O
and O
cellular O
protection B-abstraction
were O
found O
, O
as O
compared O
to O
healthy O
controls O
, O
in O
which O
igf O
1 O
therapy B-abstraction
normalized O
in O
the O
series B-physical_entity
including O
healthy O
mice O
. O

liver B-physical_entity
histology B-abstraction
showed O
that O
wt O
ccl4 O
igf1 O
mice O
had O
less O
oxidative O
damage B-abstraction
, O
fibrosis O
, O
lymphocytic O
infiltrate O
, O
and O
cellular O
changes O
when O
compared O
to O
the O
wt O
ccl4 O
. O

moreover O
, O
there B-physical_entity
was O
a O
correlation B-abstraction
between O
mda O
levels O
and O
the O
histological O
damage B-abstraction
score B-abstraction
pearson's O
r B-abstraction
0 O
. O

858 O
. O

in O
the O
igf O
1 O
deficient O
mice O
series B-abstraction
, O
similar O
findings O
were O
identified O
, O
denoting O
a O
much O
more O
vulnerable O
hepatic B-physical_entity
parenchyma B-physical_entity
. O

conclusions O
igf1 O
treatment B-abstraction
improved O
the O
biochemistry B-abstraction
, O
histology B-abstraction
, O
and O
genetic O
expression B-abstraction
of O
pro B-physical_entity
regenerative O
and O
cytoprotective O
factors O
in O
both O
series B-physical_entity
healthy O
and O
igf O
1 O
deficient O
mice O
with O
acute O
liver B-physical_entity
damage B-abstraction
, O
suggesting O
that O
low B-physical_entity
doses O
of O
igf O
1 O
, O
in O
acute O
liver B-physical_entity
damage B-abstraction
, O
could O
be O
a O
feasible O
therapeutic O
option B-abstraction
. O


adenoviruses O
cause B-abstraction
a O
variety B-abstraction
of O
diseases O
that O
range B-abstraction
from O
mild O
to O
fatal O
in O
vulnerable O
patients O
. O

its O
evolution B-physical_entity
occurs O
as O
a O
process B-abstraction
of O
selection B-physical_entity
pressure B-abstraction
; O
for O
example B-abstraction
, O
genetic O
recombination B-abstraction
generates O
intermediate O
strains O
that O
can B-physical_entity
be O
more O
infectious O
or O
pathogenic O
than O
parental O
strains O
. O

this O
study B-physical_entity
sought O
to O
determine O
the O
diversity B-abstraction
of O
circulating O
adenoviruses O
in O
paraguayan O
children O
less O
than O
5 O
years B-abstraction
of O
age B-abstraction
hospitalized O
with O
acute O
lower B-physical_entity
respiratory O
infection B-physical_entity
, O
by O
using B-abstraction
molecular B-O
biology I-O
and O
bioinformatics O
tools O
, O
though O
amplification B-abstraction
of O
penton O
, O
hexon O
and O
fiber B-physical_entity
genes O
in O
26 O
samples O
of O
nasopharyngeal O
aspirates O
. O

it O
was O
demonstrated O
the O
circulation B-abstraction
of O
three O
species B-abstraction
b O
4 O
26 O
, O
c O
21 O
26 O
, O
and O
d O
1 O
26 O
, O
as O
well B-physical_entity
as O
recombination B-abstraction
events O
corresponding O
to O
the O
hadv O
d O
isolate O
, O
with O
at O
least O
three O
different O
genotypes O
d49 O
, O
d9 O
y O
d15 O
. O

the O
hadv O
d O
are O
associated O
with O
gastrointestinal O
or O
ocular B-physical_entity
diseases O
, O
and O
less O
commonly O
with O
respiratory O
infections O
. O

recently O
, O
however O
, O
it O
has O
been O
reported O
changes O
in O
behavior B-abstraction
of O
these O
viruses O
due B-abstraction
to O
recombination B-abstraction
, O
allowing O
them O
to O
expand O
their O
host B-physical_entity
cell B-physical_entity
repertoire O
. O

these O
data O
extend O
the O
knowledge B-abstraction
about O
the O
genetic O
diversity B-abstraction
of O
hadv O
in O
paraguay O
and O
strongly O
support B-physical_entity
the O
importance B-abstraction
of O
genomic O
analysis B-abstraction
using B-abstraction
bioinformatics O
tools O
in O
epidemiological O
surveillance B-abstraction
of O
emerging O
recombinant B-physical_entity
strains O
of O
hadv O
. O


acute O
lymphoblastic O
leukemia O
all O
is O
the O
most O
common B-physical_entity
cancer O
in O
children O
. O

while B-abstraction
survival B-physical_entity
rates O
for O
all O
have B-physical_entity
improved O
, O
central B-physical_entity
nervous O
system B-physical_entity
cns O
relapse B-abstraction
remains B-physical_entity
a O
significant O
cause B-abstraction
of O
treatment B-abstraction
failure B-physical_entity
and O
treatment B-abstraction
related O
morbidity B-abstraction
. O

accordingly O
, O
there B-physical_entity
is O
a O
need B-abstraction
to O
identify O
more O
efficacious O
and O
less O
toxic O
cns O
directed O
leukemia O
therapies O
. O

extensive O
research B-abstraction
has O
demonstrated O
a O
critical O
role B-abstraction
of O
the O
bone B-abstraction
marrow B-abstraction
bm B-physical_entity
microenvironment O
in O
leukemia O
development B-physical_entity
, O
maintenance B-abstraction
, O
and O
chemoresistance O
. O

moreover O
, O
therapies O
to O
disrupt O
mechanisms O
of O
bm B-physical_entity
microenvironment O
mediated O
leukemia O
survival B-physical_entity
and O
chemoresistance O
represent O
new O
, O
promising O
approaches O
to O
cancer O
therapy B-abstraction
. O

however O
, O
in O
direct O
contrast B-abstraction
to O
the O
extensive O
knowledge B-abstraction
of O
the O
bm B-physical_entity
microenvironment O
, O
the O
unique O
attributes O
of O
the O
cns O
microenvironment O
that O
serve B-abstraction
to O
make B-abstraction
it O
a O
leukemia O
reservoir B-physical_entity
are O
not O
yet O
elucidated O
. O

recent O
work B-physical_entity
has O
begun O
to O
define O
both O
the O
mechanisms O
by O
which O
leukemia O
cells O
migrate O
into O
the O
cns O
and O
how O
components O
of O
the O
cns O
influence B-abstraction
leukemia O
biology B-abstraction
to O
enhance O
survival B-physical_entity
, O
chemoresistance O
, O
and O
ultimately O
relapse B-abstraction
. O

in O
addition B-abstraction
to O
providing O
new O
insight B-abstraction
into O
cns O
relapse B-abstraction
and O
leukemia O
biology B-abstraction
, O
this O
area B-physical_entity
of O
investigation B-abstraction
will B-abstraction
potentially O
identify O
targetable O
mechanisms O
of O
leukemia O
chemoresistance O
and O
self B-physical_entity
renewal B-abstraction
unique O
to O
the O
cns O
environment B-physical_entity
that O
will B-abstraction
enhance O
both O
the O
durability B-abstraction
and O
quality B-abstraction
of O
the O
cure O
for O
all O
patients O
. O


rna O
sequencing O
of O
the O
patient's O
bone B-abstraction
marrow B-abstraction
detected O
fusion B-abstraction
transcripts O
in O
which O
the O
coding B-abstraction
sequence B-abstraction
of O
the O
fam53b O
gene O
from O
10q26 O
was O
fused O
to O
a O
genomic O
sequence B-physical_entity
from O
19q13 O
that O
mapped O
upstream O
of O
the O
slc7a10 O
locus B-physical_entity
. O

reverse B-abstraction
transcription B-physical_entity
polymerase O
chain B-physical_entity
reaction I-physical_entity
together O
with O
sanger O
sequencing O
verified O
the O
presence B-physical_entity
of O
this O
fusion B-physical_entity
transcript O
. O

the O
fam53b O
fusion B-abstraction
transcript O
is O
not O
expected O
to O
produce O
any O
chimeric O
protein O
. O

however O
, O
it O
may B-physical_entity
code O
for O
a O
truncated O
fam53b O
protein O
consisting O
of O
the O
first B-abstraction
302 O
amino O
acids O
of O
fam53b O
together O
with O
amino O
acids O
from O
the O
19q13 O
sequence B-physical_entity
. O

functionally O
, O
the O
truncated O
fam53b O
would O
be O
similar O
to O
the O
protein O
encoded O
by O
the O
fam53b O
sequence B-physical_entity
with O
accession B-abstraction
no B-abstraction
. O

bc031654 O
. O

1 O
fam53b O
protein O
accession B-abstraction
no B-abstraction
. O

aah31654 O
. O

1 O
. O

furthermore O
, O
the O
truncated O
protein O
contains O
the O
entire B-physical_entity
conserved O
domain B-abstraction
of O
the O
fam53 O
protein O
family B-physical_entity
. O

the O
chromosome B-physical_entity
aberration O
t O
10 O
; O
19 O
q26 O
; O
q13 O
detected O
in O
this O
study B-abstraction
was O
previously O
reported O
in O
a O
single B-abstraction
case B-abstraction
of O
all O
, O
in O
which O
it O
was O
also O
the O
sole B-physical_entity
karyotypic O
change B-abstraction
. O

both O
patients O
entered O
complete O
hematological O
and O
cytogenetic O
remission B-abstraction
following B-abstraction
treatment B-abstraction
. O


purpose B-abstraction
etv6 O
runx1 O
acute O
lymphoblastic O
leukemia O
all O
, O
which O
is O
the O
most O
common B-physical_entity
genetic O
subtype O
of O
pediatric O
all O
, O
has O
a O
favorable O
prognosis B-abstraction
. O

in O
this O
study B-abstraction
, O
we O
analyzed O
the O
outcome B-abstraction
of O
etv6 O
runx1 O
all O
patients O
treated O
at O
our O
institution B-physical_entity
with O
the O
aim B-physical_entity
of O
identifying O
significant O
prognostic B-abstraction
variables O
. O

materials O
and O
methods O
sixty O
three O
patients O
were O
diagnosed O
with O
etv6 O
runx1 O
all O
from O
2005 O
to O
2011 O
. O

prognostic B-abstraction
variables O
studied O
included O
minimal O
residual O
disease O
mrd O
as O
detected O
by O
eti O
6 O
runx1 O
fusion B-physical_entity
, O
and O
the O
presence B-physical_entity
of O
additional O
cytogenetic O
abnormalities O
. O

results O
the O
5 O
year B-abstraction
event B-abstraction
free O
survival B-physical_entity
was O
84 O
. O

1 O
4 O
. O

6 O
, O
with O
10 O
patients O
relapsing B-abstraction
at O
a O
median B-abstraction
of O
28 O
. O

3 O
months O
from O
diagnosis B-abstraction
for O
a O
5 O
year B-abstraction
cumulative O
incidence O
of O
relapse B-abstraction
of O
15 O
. O

9 O
4 O
. O

6 O
. O

multivariate B-O
analysis I-O
revealed O
that O
the O
presence B-physical_entity
mrd O
, O
as O
detected O
by O
real B-O
time I-O
quantitative O
polymerase O
chain B-physical_entity
reaction I-physical_entity
or O
fluorescence O
in O
situ O
hybridization B-physical_entity
for O
etv6 O
runx1 O
fusion B-abstraction
at O
end B-abstraction
of O
remission B-abstraction
induction B-abstraction
, O
and O
the O
presence B-abstraction
of O
additional O
structural O
abnormalities O
of O
12p O
translocations O
or O
inversions O
negatively O
affected O
outcome B-abstraction
. O

despite B-abstraction
treatment B-abstraction
such O
as O
allogeneic O
hematopoietic O
cell B-physical_entity
transplantation B-abstraction
, O
eight O
of O
the O
10 O
relapsed O
patients O
died O
from O
disease O
progression B-abstraction
for O
overall B-physical_entity
survival B-abstraction
of O
82 O
. O

5 O
6 O
. O

9 O
. O

conclusion B-abstraction
etv6 O
runx1 O
all O
may B-physical_entity
be O
heterogeneous O
in O
terms O
of O
prognosis B-abstraction
, O
and O
variables O
such O
as O
mrd O
at O
end B-abstraction
of O
remission B-abstraction
induction B-abstraction
or O
additional O
structural O
abnormalities O
of O
12p O
could O
define O
a O
subset O
of O
patients O
who O
are O
likely O
to O
have B-physical_entity
poor O
outcome B-abstraction
. O


introductionthe O
translocation B-physical_entity
t O
12 O
; O
21 O
p13 O
; O
q22 O
resulting O
in O
the O
fusion B-physical_entity
gene O
etv6 O
runx1 O
, O
is O
the O
most O
frequent O
gene O
fusion B-abstraction
in O
childhood B-abstraction
b O
lymphoblastic O
leukemia O
. O

in O
the O
nordic O
society O
of O
paediatric O
haematology B-abstraction
and O
oncology B-abstraction
all O
2008 O
treatment B-abstraction
protocol B-abstraction
, O
treatment B-abstraction
stratification B-abstraction
in O
b O
lineage B-abstraction
all O
is O
based O
on O
results O
of O
minimal O
residual O
disease O
mrd O
analysis B-abstraction
with O
fluorescence O
activated O
cell B-physical_entity
sorting B-abstraction
facs O
. O

in O
this O
study B-physical_entity
, O
we O
determined O
whether O
rt O
qpcr O
of O
the O
etv6 O
runx1 O
fusion B-abstraction
transcript O
can B-physical_entity
be O
a O
reliable O
alternative B-abstraction
for O
mrd O
analysis B-abstraction
. O

methodsseventy O
eight O
bone B-abstraction
marrow B-abstraction
samples O
from O
29 O
children O
at O
diagnosis B-abstraction
and O
day B-abstraction
15 O
, O
29 O
, O
and O
78 B-physical_entity
during O
treatment B-abstraction
were O
analyzed O
for O
mrd O
with O
facs O
and O
with O
quantitative O
reverse B-abstraction
transcription B-physical_entity
polymerase O
chain B-physical_entity
reaction I-physical_entity
rt O
qpcr O
. O

fusion B-physical_entity
transcript O
mrd O
was O
defined O
as O
the O
etv6 O
runx1 O
gusb O
ratio O
at O
the O
follow O
up O
time B-abstraction
point B-abstraction
day B-abstraction
15 O
29 O
78 B-physical_entity
divided O
with O
the O
etv6 O
runx1 O
gusb O
ratio O
at O
diagnosis B-abstraction
. O

resultsmrd O
analysis B-abstraction
with O
facs O
and O
with O
rt O
qpcr O
of O
etv6 O
runx1 O
fusion B-physical_entity
transcript O
showed O
strong O
correlation B-abstraction
. O

all O
cases O
showed O
concordant O
results O
at O
the O
treatment B-abstraction
stratifying O
time B-abstraction
points O
day B-abstraction
29 O
and O
day B-abstraction
78 B-physical_entity
, O
when O
comparing B-abstraction
the O
two O
methods O
with O
a O
cutoff B-physical_entity
set B-abstraction
to O
0 O
. O

1 O
. O

conclusionrt O
qpcr O
is O
a O
valuable O
addition B-abstraction
and O
could O
also O
be O
an O
alternative B-abstraction
to O
facs O
in O
cases O
where O
facs O
is O
not O
achievable O
for O
mrd O
analysis B-abstraction
. O


glucocorticoids O
gcs O
induce O
apoptosis O
in O
lymphoid O
lineage B-abstraction
cells O
and O
are O
therefore O
used O
in O
the O
therapy B-abstraction
of O
acute O
lymphoblastic O
leukemia O
all O
and O
related O
malignancies O
. O

micrornas O
mirnas O
and O
the O
related O
mirtrons O
are O
similar O
to O
22 O
nucleotide O
rnas O
derived O
from O
polymerase O
ii O
transcripts O
and O
implicated O
in O
the O
control B-physical_entity
of O
essential O
biological O
functions O
, O
including O
apoptosis O
. O

whether O
gcs O
regulate O
mirna O
encoding B-abstraction
transcription B-physical_entity
units O
is O
unknown B-physical_entity
. O

we O
investigated O
mirna O
mirtron O
expression B-abstraction
and O
gc O
regulation B-abstraction
in O
8 O
leukemia O
lymphoma O
in O
vitro O
models O
and O
13 O
all O
children O
undergoing O
systemic O
gc O
monotherapy O
using B-abstraction
a O
combination B-abstraction
of O
expression B-physical_entity
profiling O
techniques O
, O
real B-O
time I-O
reverse B-abstraction
transcription B-abstraction
rt O
pcr O
and O
northern O
blotting O
to O
detect O
mature O
mirnas O
and O
or O
their O
precursors O
. O

we O
found O
that O
mature O
mirna O
regulations O
can B-physical_entity
be O
inferred O
from O
expression B-physical_entity
data O
of O
their O
host B-physical_entity
genes O
. O

although O
a O
simple B-physical_entity
mirna O
initiated O
canonical O
pathway B-physical_entity
to O
gc O
induced O
apoptosis O
or O
cell B-physical_entity
cycle B-abstraction
arrest B-abstraction
did O
not O
emerge O
, O
we O
identified O
several O
mirnas O
mirtrons O
that O
were O
regulated O
by O
gc O
in O
patients O
and O
cell B-physical_entity
lines O
, O
including O
the O
myeloid O
specific B-abstraction
mir O
223 O
and O
the O
apoptosis O
and O
cell B-physical_entity
cycle B-abstraction
arrest B-abstraction
inducing B-abstraction
mir15 O
similar O
to O
16 O
clusters O
. O

in O
an O
in O
vitro O
model B-abstraction
, O
overexpression O
of O
mir15b O
similar O
to O
16 O
mimics O
increased O
and O
silencing O
by O
mir15b O
similar O
to O
16 O
inhibitors O
decreased O
gc O
sensitivity B-abstraction
. O

thus O
, O
the O
observed O
complex B-abstraction
changes O
in O
mirna O
mirtron O
expression B-physical_entity
during O
gc O
treatment B-abstraction
might B-abstraction
contribute O
to O
the O
anti B-physical_entity
leukemic O
gc O
effects O
in O
a O
cell B-physical_entity
context O
dependent B-physical_entity
manner B-abstraction
. O


treatment B-abstraction
of O
acute O
myelogenous O
leukemia O
aml O
over B-abstraction
the O
past B-abstraction
four B-physical_entity
decades O
remains B-physical_entity
mostly O
unchanged O
and O
the O
prognosis B-abstraction
for O
the O
majority B-abstraction
of O
patients O
remains B-physical_entity
poor O
. O

most O
of O
the O
significant O
advances O
that O
have B-physical_entity
been O
observed O
are O
in O
defining O
cytogenetic O
abnormalities O
, O
as O
well B-physical_entity
as O
the O
genetic O
and O
epigenetic O
profiles O
of O
aml O
patients O
. O

while B-abstraction
new O
cytogenetic O
and O
genetic O
aberrations O
such O
as O
the O
flt3 O
itd O
and O
npm1 O
mutations O
are O
able O
to O
guide B-physical_entity
prognosis B-abstraction
for O
the O
majority B-abstraction
of O
patients O
with O
aml O
, O
outcomes O
are O
still B-abstraction
dismal O
and O
relapse B-abstraction
rates O
remain O
high B-abstraction
. O

it O
is O
thought B-abstraction
that O
relapse B-abstraction
in O
aml O
is O
in O
part B-physical_entity
driven O
by O
minimal O
residual O
disease O
mrd O
that O
remains B-physical_entity
in O
the O
patient B-physical_entity
following B-abstraction
treatment B-abstraction
. O

thus O
, O
there B-physical_entity
is O
a O
need B-abstraction
for O
sensitive B-physical_entity
and O
objective B-abstraction
methodology B-abstraction
for O
mrd O
detection B-abstraction
. O

methodologies O
such O
as O
multiparameter O
flow B-abstraction
cytometry O
mfc O
, O
quantitative O
real B-O
time I-O
polymerase O
chain B-physical_entity
reaction I-physical_entity
rq O
pcr O
, O
digital O
pcr O
dpcr O
, O
or O
next O
generation B-physical_entity
sequencing O
ngs O
are O
being B-physical_entity
employed O
to O
evaluate O
their O
utility B-abstraction
in O
mrd O
assessment B-abstraction
. O

in O
this O
review B-abstraction
, O
we O
will B-abstraction
provide O
an O
overview O
of O
aml O
and O
the O
clinical O
utility B-physical_entity
of O
mrd O
measurement B-abstraction
. O

we O
will B-abstraction
discuss O
optimal O
timing B-abstraction
to O
mrd O
measurement B-abstraction
, O
the O
different O
approaches O
that O
are O
available O
, O
and O
efforts O
in O
the O
standardization B-abstraction
across O
laboratories O
. O


the O
mammalian B-physical_entity
target B-physical_entity
of O
rapamycin O
mtor O
has O
recently O
been O
implicated O
in O
leukaemic O
cell B-physical_entity
growth B-abstraction
, O
tumour O
associated O
angiogenesis B-physical_entity
and O
expression B-abstraction
of O
vascular O
endothelial O
growth B-physical_entity
factor B-abstraction
vegf O
. O

we O
examined O
whether O
mtor O
plays O
a O
role B-abstraction
as O
regulator B-physical_entity
of O
growth B-physical_entity
and O
vegf O
expression B-abstraction
in O
acute O
myeloid O
leukaemia O
aml O
. O

three O
mtor O
targeting O
drugs O
, O
rapamycin O
, O
everolimus O
rad001 O
and O
cci O
779 O
, O
were O
applied O
. O

the O
effects O
of O
these O
drugs O
on O
growth B-physical_entity
, O
survival B-physical_entity
, O
apoptosis O
and O
vegf O
expression B-physical_entity
in O
primary B-abstraction
aml O
cells O
and O
various O
aml O
cell B-physical_entity
lines O
were O
examined O
. O

growth B-physical_entity
of O
aml O
cells O
and O
aml O
derived O
cell B-physical_entity
lines O
was O
assessed O
by O
3 O
h O
thymidine O
incorporation B-abstraction
, O
survival B-abstraction
was O
examined O
by O
light B-abstraction
and O
electron B-physical_entity
microscopy I-physical_entity
, O
by O
tunel O
assay B-abstraction
and O
by O
annexinv O
staining B-abstraction
, O
and O
the O
expression B-abstraction
of O
vegf O
by O
northern O
blotting O
, O
rt O
pcr O
and O
elisa O
. O

rapamycin O
was O
found O
to O
counteract O
growth B-physical_entity
in O
the O
aml O
cell B-physical_entity
lines O
u937 O
and O
kg1a O
as O
well B-physical_entity
as O
in O
primary B-abstraction
aml O
cells O
in O
14 O
18 O
patients O
examined O
. O

the O
effects O
of O
rapamycin O
and O
its O
derivatives O
were O
dose O
dependent B-physical_entity
ic O
50 O
10 O
pm O
100 O
nm O
. O

it O
was O
also O
found O
that O
exposure B-physical_entity
to O
mtor O
targeting O
drugs O
resulted O
in O
apoptosis O
and O
in O
decreased O
expression B-physical_entity
of O
vegf O
in O
leukaemic O
cells O
. O

mtor O
targeting O
drugs O
exert O
antileukaemic O
effects O
on O
aml O
cells O
in O
vitro O
through O
multiple B-abstraction
actions O
, O
including O
direct O
inhibition B-abstraction
of O
proliferation B-physical_entity
, O
induction B-abstraction
of O
apoptosis O
and O
suppression B-physical_entity
of O
vegf O
. O

based O
on O
this O
study B-abstraction
and O
other O
studies O
, O
mtor O
can B-physical_entity
be O
regarded O
as O
a O
potential O
drug O
target B-abstraction
in O
aml O
. O


background B-physical_entity
purpose B-abstraction
mutations O
in O
the O
tet O
oncogene O
family B-physical_entity
member B-physical_entity
2 O
gene O
tet2 O
are O
frequently O
found O
in O
adult B-physical_entity
patients O
with O
acute O
myeloid O
leukemia O
aml O
. O

reports O
of O
tet2 O
mutations O
in O
children O
are O
limited B-physical_entity
. O

we O
assessed O
the O
prevalence B-abstraction
of O
tet2 O
mutations O
in O
taiwanese O
children O
with O
aml O
and O
analyzed O
their O
prognosis B-abstraction
. O

methods O
between O
1997 O
and O
2010 O
, O
a O
total B-abstraction
of O
69 O
consecutive O
children O
with O
aml O
were O
enrolled O
at O
the O
national B-physical_entity
taiwan O
university B-physical_entity
hospital B-physical_entity
. O

the O
analysis B-abstraction
for O
tet2 O
mutations O
was O
performed O
using B-abstraction
direct O
sequencing O
. O

clinical O
characteristics O
and O
overall B-physical_entity
survival B-physical_entity
os O
were O
compared O
between O
patients O
with O
and O
without O
tet2 O
alterations O
. O

results O
intronic O
and O
missense O
mutations O
were O
identified O
. O

no B-abstraction
nonsense B-physical_entity
or O
frameshift O
mutations O
were O
observed O
. O

two O
putative O
disease O
causing B-abstraction
missense O
mutations O
s609c O
and O
a1865g O
were O
identified O
in O
one B-abstraction
patient B-physical_entity
. O

we O
estimated O
the O
prevalence B-abstraction
of O
tet2 O
mutations O
in O
the O
current B-abstraction
patient B-physical_entity
population B-abstraction
to O
be O
1 O
. O

4 O
. O

the O
most O
common B-physical_entity
polymorphism O
was O
i1762v O
45 O
, O
followed O
by O
v218m O
12 O
, O
p29r O
6 O
, O
and O
f868l O
6 O
. O

patients O
with O
polymorphism O
i1762v O
had O
an O
increased O
10 O
year B-abstraction
survival B-physical_entity
rate B-abstraction
compared O
with O
patients O
without O
i1762v O
48 O
. O

4 O
vs O
. O

25 O
. O

7 O
, O
p O
0 O
. O

049 O
by O
chi O
square B-physical_entity
test B-physical_entity
; O
os O
was O
not O
different O
when O
examined O
using B-abstraction
the O
kaplan O
meier O
method B-abstraction
p O
0 O
. O

104 O
. O

conclusion B-abstraction
the O
prevalence B-abstraction
of O
tet2 O
mutations O
in O
children O
with O
aml O
compared O
with O
adults O
with O
aml O
was O
lower B-physical_entity
and O
less O
complex B-physical_entity
. O

patient B-physical_entity
prognosis B-abstraction
associated O
with O
tet2 O
mutations O
in O
children O
requires O
further O
investigation B-abstraction
. O

copyright B-abstraction
c O
2015 O
, O
formosan O
medical B-abstraction
association B-abstraction
. O

published O
by O
elsevier O
taiwan O
llc O
. O


several O
studies O
have B-physical_entity
reported O
previously O
that O
acute O
myeloid O
leukemia O
aml O
may B-physical_entity
express B-physical_entity
wt1 O
detected O
by O
rt O
pcr O
and O
or O
northern O
blotting O
. O

the O
diagnostic O
utility B-physical_entity
of O
wt1 O
expression B-abstraction
in O
aml O
using B-abstraction
immunohistochemistry B-abstraction
has O
not O
been O
reported O
previously O
. O

paraffin O
embedded O
tissue O
sections O
from O
55 O
aml O
, O
12 O
acute O
lymphoblastic O
leukemia O
all O
, O
and O
10 O
normal B-abstraction
bone B-abstraction
marrow B-physical_entity
specimens O
were O
immunostained O
for O
wt1 O
anti B-physical_entity
n O
terminus B-physical_entity
antibody O
. O

22 O
55 O
aml O
cases O
40 O
demonstrated O
nuclear O
immunopositivity O
for O
wt1 O
, O
including O
20 O
47 O
bone B-abstraction
marrow B-abstraction
trephines O
and O
2 O
4 O
granulocytic O
sarcomas O
. O

all O
the O
all O
and O
normal B-abstraction
bone B-abstraction
marrow B-physical_entity
specimens O
were O
negative B-physical_entity
. O

a O
significant O
proportion B-physical_entity
of O
aml O
expresses O
nuclear O
immunostaining O
for O
wt1 O
, O
a O
finding B-abstraction
that O
has O
only O
been O
described O
previously O
in O
wilms' O
tumor O
and O
desmoplastic O
small B-abstraction
round B-physical_entity
cell B-physical_entity
tumor O
. O

this O
finding B-abstraction
is O
important O
for O
the O
correct O
interpretation B-abstraction
of O
immunohistochemical O
findings O
in O
the O
diagnosis B-abstraction
of O
" O
small B-abstraction
round B-physical_entity
cell'' O
tumors O
of O
childhood B-abstraction
, O
especially O
in O
cases O
of O
extramedullary O
deposits O
of O
aml O
, O
in O
which O
traditional O
myeloid O
markers O
may B-physical_entity
be O
negative B-abstraction
. O


the O
karyotype B-abstraction
is O
critical O
for O
the O
evaluation B-abstraction
of O
acute O
myeloid O
leukemia O
aml O
at O
diagnosis B-abstraction
. O

cytogenetic O
abnormalities O
detected O
in O
aml O
are O
one B-abstraction
of O
the O
most O
powerful O
independent B-physical_entity
prognostic B-abstraction
factors O
. O

it O
impacts O
on O
the O
choice B-abstraction
of O
treatment B-abstraction
in O
clinical O
trials O
. O

all O
chromosomes O
can B-physical_entity
be O
targeted O
, O
common B-physical_entity
chromosomal O
abnormalities O
are O
recurrent O
and O
may B-physical_entity
be O
associated O
with O
a O
cytological O
well B-physical_entity
defined O
type B-physical_entity
. O

in O
40 O
of O
the O
cases O
, O
the O
karyotype B-abstraction
is O
normal B-abstraction
and O
must B-abstraction
be O
associated O
with O
molecular B-O
biology I-O
studies O
that O
can B-physical_entity
refine O
the O
prognosis B-abstraction
. O

the O
usefulness B-abstraction
of O
the O
karyotype B-abstraction
is O
more O
limited B-physical_entity
during O
the O
follow O
up O
of O
the O
patient B-physical_entity
due B-abstraction
to O
its O
limited B-physical_entity
sensitivity B-abstraction
, O
but O
it O
is O
still B-abstraction
useful O
in O
the O
clinical O
management B-abstraction
of O
relapse B-abstraction
. O

since O
2001 O
, O
the O
who O
world B-physical_entity
health O
organization B-abstraction
classification B-abstraction
of O
hematological O
malignancies O
integrates O
cytogenetic O
data O
in O
the O
classification B-abstraction
of O
aml O
. O

karyotype B-abstraction
is O
therefore O
mandatory B-physical_entity
in O
the O
diagnosis B-abstraction
of O
aml O
. O


purpose B-abstraction
to O
correlate B-abstraction
visual B-O
acuity I-O
outcomes O
and O
clinical O
features O
with O
quantitative O
pcr O
dna O
copy B-physical_entity
number B-physical_entity
in O
patients O
with O
acute O
retinal O
necrosis O
arn O
. O

methods O
retrospective O
, O
consecutive O
case B-physical_entity
series B-physical_entity
. O

results O
in O
total B-abstraction
, O
14 O
eyes B-abstraction
of O
13 O
patients O
were O
diagnosed O
with O
arn O
, O
based O
on O
the O
american O
uveitis B-abstraction
society O
criteria O
, O
and O
were O
followed O
for O
a O
mean B-abstraction
of O
324 O
. O

5 O
days B-abstraction
median B-abstraction
250 O
. O

5 O
days B-abstraction
, O
sd O
214 O
days B-abstraction
. O

anterior O
chamber B-physical_entity
fluid O
analyzed O
by O
quantitative O
pcr O
identified O
viral O
dna O
in O
11 O
of O
14 O
eyes B-abstraction
78 B-physical_entity
. O

5 O
. O

varicella O
zoster O
virus B-physical_entity
vzv O
was O
identified O
in O
seven O
eyes B-abstraction
50 O
and O
herpes B-physical_entity
simplex I-physical_entity
virus B-physical_entity
hsv O
in O
four B-physical_entity
eyes B-abstraction
28 O
. O

5 O
. O

mean B-abstraction
dna O
copy B-physical_entity
number B-physical_entity
was O
7 O
. O

9 O
x O
10 O
6 O
ml O
median B-abstraction
2 O
. O

10 O
x O
10 O
6 O
ml O
, O
range B-physical_entity
0 O
5 O
. O

60 O
x O
10 O
7 O
ml O
. O

eyes B-abstraction
with O
quantitative O
pcr O
dna O
copy B-physical_entity
number B-physical_entity
of O
5 O
. O

0 O
x O
10 O
6 O
ml O
n O
6 O
eyes B-abstraction
had O
worse B-abstraction
baseline O
visual B-O
acuity I-O
logmar O
1 O
. O

48 O
0 O
. O

71 O
vs O
0 O
. O

94 O
0 O
. O

76 O
, O
p O
0 O
. O

196 O
and O
final B-abstraction
visual B-O
acuity I-O
logmar O
2 O
. O

10 O
0 O
. O

60 O
vs O
0 O
. O

82 O
0 O
. O

81 O
, O
p O
0 O
. O

007 O
compared O
with O
patients O
with O
a O
dna O
copy B-physical_entity
number B-abstraction
5 O
. O

0 O
x O
10 O
6 O
ml O
n O
8 O
eyes B-abstraction
. O

patients O
with O
a O
dna O
copy B-physical_entity
number B-physical_entity
of O
5 O
. O

0 O
x O
10 O
6 O
ml O
were O
more O
likely O
to O
have B-physical_entity
at O
least O
5 O
clock B-physical_entity
hours B-abstraction
of O
retinitis B-abstraction
on O
funduscopic O
exam B-abstraction
p O
0 O
. O

03 O
and O
developed O
retinal O
detachment B-abstraction
more O
frequently O
p O
0 O
. O

08 O
. O

conclusions O
quantitative O
dna O
copy B-physical_entity
number B-physical_entity
of O
5 O
. O

0 O
x O
10 O
6 O
ml O
is O
associated O
with O
more O
extensive O
retinitis B-abstraction
, O
worse B-abstraction
visual B-O
acuity I-O
, O
and O
development B-physical_entity
of O
retinal O
detachment B-abstraction
in O
patients O
with O
acute O
retinal O
necrosis O
. O


this O
review B-physical_entity
summarizes O
present B-abstraction
evidence B-abstraction
for O
the O
role B-abstraction
of O
ykl O
40 O
in O
the O
diagnosis B-abstraction
, O
prognosis B-abstraction
and O
cause B-abstraction
of O
cardiovascular O
and O
alcoholic B-physical_entity
liver B-physical_entity
disease O
. O

the O
question B-abstraction
of O
whether O
ykl O
40 O
is O
merely O
a O
marker B-physical_entity
or O
a O
causal B-O
factor I-O
in O
the O
development B-physical_entity
of O
cardiovascular O
and O
liver B-physical_entity
disease O
is O
addressed O
, O
with O
emphasis B-abstraction
on O
the O
mendelian O
randomization B-abstraction
design B-abstraction
. O

the O
mendelian O
randomization B-abstraction
approach B-physical_entity
uses O
genetic O
variants O
associated O
with O
lifelong O
high B-abstraction
plasma O
ykl O
40 O
levels O
that O
are O
largely O
unconfounded O
and O
not O
prone O
to O
reverse B-abstraction
causation B-abstraction
. O

thus O
, O
the O
approach B-abstraction
mimics O
a O
controlled O
double B-abstraction
blind I-physical_entity
randomized O
trial B-abstraction
, O
but O
it O
uses O
genetic O
variants O
rather O
than O
a O
drug O
and O
placebo B-abstraction
, O
and O
like B-abstraction
a O
blinded O
trial B-abstraction
, O
it O
allows O
inference B-abstraction
about O
causality O
. O

moreover O
, O
the O
review B-abstraction
also O
covers O
background B-abstraction
on O
the O
molecular B-O
biology I-O
and O
functions O
of O
ykl O
40 O
, O
ykl O
40 O
levels O
in O
healthy O
individuals O
and O
reference B-abstraction
range B-physical_entity
, O
and O
the O
role B-abstraction
of O
ykl O
40 O
as O
a O
biomarker O
of O
cardiovascular O
and O
alcoholic B-physical_entity
liver B-physical_entity
disease O
. O

ykl O
40 O
is O
a O
plasma O
protein O
named O
after O
its O
three O
n O
terminal B-physical_entity
amino O
acids O
, O
y O
tyrosine O
, O
k O
lysine O
and O
l O
leucine O
, O
and O
its O
molecular B-O
weight I-O
of O
40kda O
. O

it O
is O
produced O
by O
local B-physical_entity
inflammatory O
cells O
in O
inflamed O
tissues O
, O
such O
as O
lipid O
laden O
macrophages O
inside B-physical_entity
the O
vessel B-physical_entity
wall B-physical_entity
and O
perhaps O
also O
hepatic B-physical_entity
stellate O
cells O
. O

observational O
studies O
show B-abstraction
that O
plasma O
ykl O
40 O
levels O
are O
elevated O
in O
patients O
with O
cardiovascular O
and O
liver B-physical_entity
disease O
and O
are O
associated O
with O
disease O
severity B-abstraction
and O
prognosis B-abstraction
. O

furthermore O
, O
elevated O
plasma O
ykl O
40 O
levels O
in O
apparently O
healthy O
individuals O
are O
associated O
with O
a O
2 O
fold B-abstraction
increased O
risk B-abstraction
of O
future B-abstraction
ischemic B-O
stroke I-O
and O
venous O
thromboembolism B-abstraction
, O
but O
not O
with O
myocardial O
infarction O
, O
suggesting O
that O
ykl O
40 O
could O
play B-abstraction
a O
role B-abstraction
in O
the O
formation B-abstraction
of O
embolisms O
rather O
than O
atherosclerosis O
per O
se O
. O

further O
, O
elevated O
ykl O
40 O
levels O
combined O
with O
excessive O
alcohol O
consumption B-physical_entity
are O
associated O
with O
10 O
years B-abstraction
risk B-abstraction
of O
alcoholic B-physical_entity
liver B-physical_entity
cirrhosis O
of O
up O
to O
7 O
, O
suggesting O
that O
ykl O
40 O
can B-physical_entity
be O
used O
as O
a O
strong O
noninvasive O
marker B-physical_entity
of O
predicting O
alcoholic B-physical_entity
liver B-physical_entity
cirrhosis O
. O

importantly O
, O
in O
mendelian O
randomization B-abstraction
studies O
, O
genetically O
elevated O
plasma O
ykl O
40 O
levels O
were O
not O
associated O
with O
risk B-abstraction
of O
cardiovascular O
and O
alcoholic B-physical_entity
liver B-physical_entity
disease O
, O
thus O
suggesting O
that O
plasma O
ykl O
40 O
does O
not O
play B-abstraction
a O
causal O
role B-abstraction
in O
the O
development B-abstraction
of O
these O
diseases O
. O

despite B-abstraction
this O
, O
plasma O
ykl O
40 O
levels O
may B-physical_entity
play B-abstraction
a O
role B-abstraction
in O
disease O
progression B-abstraction
after O
diagnosis B-abstraction
, O
and O
inhibition B-abstraction
of O
ykl O
40 O
activity B-physical_entity
might B-abstraction
be O
a O
novel B-physical_entity
therapy B-abstraction
in O
some O
cardiovascular O
and O
liver B-physical_entity
diseases O
. O


acyclovir O
resistance B-abstraction
is O
rarely O
seen O
in O
herpes B-physical_entity
simplex I-physical_entity
virus B-physical_entity
hsv O
type B-physical_entity
i O
encephalitis B-abstraction
. O

prevalence B-abstraction
rates O
vary O
between O
0 O
. O

5 O
in O
immunocompetent O
patients O
christophers O
et O
al O
. O

1998 O
; O
fife B-physical_entity
et O
al O
. O

1994 O
and O
3 O
. O

5 O
10 O
in O
immunocompromised O
patients O
stranska O
et O
al O
. O

2005 O
. O

we O
report B-abstraction
a O
45 O
year B-abstraction
old B-abstraction
, O
immunocompetent O
negative B-abstraction
hiv O
antigen O
antibody O
testing B-abstraction
, O
female B-physical_entity
patient B-physical_entity
, O
without O
previous O
illness O
who O
developed O
after O
a O
febrile O
prodromal O
stage B-physical_entity
aphasia O
and O
psychomotor O
slowing B-abstraction
. O

cerebral O
magnetic O
resonance B-abstraction
imaging B-abstraction
cmri O
showed O
right B-physical_entity
temporal O
and O
insular O
t2 O
hyperintense O
lesions O
with O
spreading B-abstraction
to O
the O
contralateral O
temporal O
lobe B-physical_entity
. O

cerebrospinal O
fluid O
csf O
analysis B-abstraction
yielded O
lymphocytic O
pleocytosis O
and O
elevated O
protein O
level B-abstraction
. O

polymerase O
chain B-physical_entity
reaction I-physical_entity
testing B-abstraction
for O
hsv O
type B-physical_entity
i O
showed O
a O
positive B-physical_entity
result B-abstraction
in O
repeat B-abstraction
lumbar B-O
puncture I-O
. O

hsv O
type B-abstraction
i O
encephalitis B-abstraction
was O
diagnosed O
and O
intravenous O
acyclovir O
treatment B-abstraction
was O
initiated O
750 O
mg O
t O
. O

i O
. O

d O
. O

. O

acyclovir O
treatment B-abstraction
was O
intensified O
to O
1000 O
mg O
t O
. O

i O
. O

d O
. O

, O
due B-abstraction
to O
clinical O
deterioration O
, O
ongoing O
pleocytosis O
and O
progression B-abstraction
on O
cmri O
5 O
days B-abstraction
after O
initiation B-abstraction
of O
antiviral O
therapy B-abstraction
. O

in O
parallel B-abstraction
, O
acyclovir O
resistance B-physical_entity
testing B-abstraction
showed O
mutation B-abstraction
of O
thymidine O
kinase O
gene O
at O
position B-abstraction
a156v O
prompting B-abstraction
foscarnet O
therapy B-abstraction
60 O
mg O
t O
. O

i O
. O

d O
. O

. O

patient's O
condition B-abstraction
improved O
dramatically O
over B-abstraction
2 O
weeks O
. O

acyclovir O
resistance B-physical_entity
is O
rare O
but O
should O
be O
considered O
in O
case B-physical_entity
of O
clinical O
worsening B-abstraction
of O
patient's O
condition B-abstraction
. O

to O
our O
knowledge B-abstraction
, O
this O
is O
the O
first B-abstraction
report B-abstraction
of O
acyclovir O
resistance B-physical_entity
in O
hsv O
type B-physical_entity
i O
encephalitis B-abstraction
of O
an O
immunocompetent O
and O
previously O
healthy O
patient B-physical_entity
in O
austria O
. O


introduction B-abstraction
the O
recent O
approval B-abstraction
of O
adalimumab O
trade B-abstraction
name B-abstraction
humira O
, O
abbvie O
inc O
. O

by O
the O
fda O
for O
the O
treatment B-abstraction
of O
noninfectious O
intermediate O
, O
posterior O
and O
panuveitis O
marks O
the O
first B-abstraction
on O
label' O
non O
corticosteroid O
drug O
available O
to O
ophthalmologists O
. O

immunomodulatory O
imt O
and O
biologic O
agents O
have B-physical_entity
long O
been O
shown O
to O
be O
effective O
in O
inducing B-abstraction
remission B-abstraction
of O
chronic O
uveitis B-abstraction
but O
have B-physical_entity
remained O
as O
orphan B-physical_entity
drugs O
due B-abstraction
to O
lack O
of O
financial O
incentive B-abstraction
and O
perceived O
need B-abstraction
. O

areas O
covered O
here B-physical_entity
we O
provide O
detail B-abstraction
into O
the O
background B-physical_entity
and O
use B-physical_entity
of O
adalimumab O
for O
uveitic O
patients O
. O

topics O
include O
pharmacology B-abstraction
, O
therapeutic O
indications O
and O
usage B-abstraction
, O
dosage O
, O
drug O
safety B-physical_entity
, O
physician B-physical_entity
monitoring B-abstraction
, O
side B-physical_entity
effects O
and O
adverse O
events O
. O

expert B-physical_entity
opinion B-abstraction
we O
see B-physical_entity
the O
approval B-abstraction
of O
adalimumab O
for O
uveitis B-abstraction
as O
an O
important O
milestone B-abstraction
improving O
upon O
the O
accepted O
standards O
of O
care B-abstraction
for O
patients O
with O
this O
severe O
, O
sight B-abstraction
threatening O
disease O
. O

we O
implore O
medical B-abstraction
professionals O
to O
consider O
the O
use B-abstraction
of O
imt O
and O
biologic O
treatments O
for O
patients O
with O
recurrent O
non O
infectious O
uveitis B-abstraction
, O
referring O
to O
ocular B-physical_entity
immunology B-abstraction
and O
uveitis B-abstraction
specialists O
when O
necessary O
. O


aims O
trophoblast O
fusion B-physical_entity
in O
the O
placenta B-physical_entity
is O
prerequisite B-abstraction
to O
successful O
pregnancy O
and O
the O
pathological O
conditions O
related O
to O
it O
. O

the O
presence B-abstraction
of O
syncytin O
1 O
, O
is O
not O
sufficient O
to O
explain O
the O
complete O
event B-abstraction
and O
adam12 O
is O
a O
major B-physical_entity
co O
player B-physical_entity
candidate B-physical_entity
. O

via O
differential B-abstraction
splicing B-physical_entity
, O
the O
adam12 O
gene O
produces O
a O
short B-abstraction
and O
a O
long O
form B-abstraction
, O
being B-physical_entity
the O
adam12 O
s B-abstraction
and O
the O
adam12 O
l O
respectively O
. O

methods O
and O
results O
we O
investigated O
the O
localisation B-abstraction
of O
both O
variants O
in O
the O
human B-physical_entity
placenta B-physical_entity
using B-abstraction
whole B-abstraction
mount B-abstraction
in O
situ O
hybridisation B-physical_entity
, O
immunohistochemistry B-abstraction
and O
northern O
blotting O
in O
1st O
n O
8 O
and O
3rd O
n O
8 O
trimester B-abstraction
placentae O
and O
in O
the O
case B-abstraction
of O
nb O
in O
several O
cell B-physical_entity
lines O
. O

in O
northern O
blotting O
, O
1st O
and O
3rd O
trimester B-abstraction
placentae O
were O
positive B-physical_entity
for O
the O
adam12 O
s B-abstraction
and O
bewo O
, O
293hek O
, O
jar B-abstraction
, O
leucocytes O
, O
macrophages O
, O
1st O
and O
3rd O
trimester B-abstraction
placentae O
were O
positive B-physical_entity
for O
adam12 O
l O
. O

in O
whole B-abstraction
mount B-physical_entity
in O
situ O
hybridisation B-physical_entity
, O
the O
1st O
and O
3rd O
trimester B-abstraction
placental B-physical_entity
syncytium O
was O
positive B-physical_entity
for O
both O
variants O
. O

in O
immunohistochemistry B-abstraction
, O
adam12 O
l O
localised O
in O
the O
cytotrophoblast O
of O
both O
1st O
and O
3rd O
trimester B-abstraction
placentae O
, O
while B-abstraction
adam12 O
s B-abstraction
localised O
in O
the O
complete O
syncytium O
, O
often O
including O
the O
cytotrophoblast O
. O

conclusion B-abstraction
the O
different O
localisation B-abstraction
of O
adam12 O
s B-abstraction
and O
adam12 O
l O
indicates O
a O
possible B-abstraction
different O
role B-abstraction
making B-abstraction
adam12 O
l O
a O
candidate B-physical_entity
for O
the O
fusion B-physical_entity
event B-abstraction
, O
while B-abstraction
the O
syncytial O
localisation B-abstraction
of O
the O
adam12 O
s B-abstraction
makes O
it O
a O
candidate B-physical_entity
for O
cell B-physical_entity
cell B-physical_entity
and O
cell B-physical_entity
matrix B-physical_entity
interactions O
between O
the O
placental B-physical_entity
syncytium O
and O
the O
maternal O
interface B-abstraction
. O

c O
2011 O
elsevier O
gmbh O
. O

all O
rights O
reserved O
. O


this O
paper B-physical_entity
proposes O
an O
adaptive O
controller B-physical_entity
with O
an O
improved O
high B-physical_entity
frequency I-abstraction
injection B-abstraction
method B-abstraction
for O
sensorless O
synchronous O
reluctance O
drive B-physical_entity
systems O
. O

a O
mathematical O
model B-abstraction
is O
presented O
to O
show B-abstraction
that O
the O
use B-physical_entity
of O
a O
high B-physical_entity
frequency I-physical_entity
injection B-abstraction
method B-abstraction
that O
takes O
into O
account B-abstraction
the O
effects O
of O
unequal O
mutual O
inductances O
and O
the O
influence B-abstraction
of O
speed B-abstraction
reduces O
the O
rotor B-physical_entity
position B-abstraction
estimation B-abstraction
error B-abstraction
. O

the O
adaptive O
speed B-abstraction
control B-abstraction
algorithm B-abstraction
offers O
improved O
transient B-physical_entity
performance B-abstraction
in O
comparison B-abstraction
to O
typical O
proportional B-abstraction
integral B-abstraction
pi O
controllers O
that O
are O
employed O
in O
sensorless O
drive B-physical_entity
systems O
. O

to O
demonstrate O
the O
viability B-abstraction
, O
the O
proposed O
adaptive O
controller B-physical_entity
and O
the O
modified O
high B-physical_entity
frequency I-abstraction
injection B-abstraction
method B-abstraction
are O
implemented O
using B-abstraction
a O
tms O
320f O
28335a O
digital O
signal B-abstraction
processor B-physical_entity
to O
control B-physical_entity
a O
500 O
w O
prototype B-abstraction
synchronous O
reluctance O
motor B-physical_entity
drive B-physical_entity
. O

experimental O
results O
are O
presented O
to O
show B-abstraction
that O
the O
transient B-abstraction
, O
load B-physical_entity
disturbance B-abstraction
, O
and O
tracking B-abstraction
responses O
of O
the O
proposed O
drive B-abstraction
system B-abstraction
are O
superior B-physical_entity
in O
comparison B-abstraction
to O
a O
drive B-physical_entity
that O
uses O
a O
pi O
controller B-physical_entity
. O

both O
experimental O
and O
theoretical O
analyses O
clearly O
indicate O
that O
the O
proposed O
high B-physical_entity
frequency I-physical_entity
injection B-abstraction
method B-abstraction
with O
an O
adaptive O
speed B-abstraction
loop B-abstraction
controller B-physical_entity
offers O
improved O
performance B-abstraction
in O
adjustable O
speed B-abstraction
synchronous O
reluctance O
drive B-physical_entity
systems O
. O


in O
this O
paper B-physical_entity
, O
a O
current B-abstraction
sensorless O
adaptive O
secondary B-physical_entity
side B-physical_entity
control B-physical_entity
is O
proposed O
for O
the O
series B-physical_entity
resonant O
converter B-physical_entity
src O
, O
making B-abstraction
it O
a O
good B-abstraction
candidate B-physical_entity
for O
mhz O
48 O
voltage O
regulators O
. O

by O
means B-abstraction
of O
varying O
ac O
equivalent B-abstraction
resistance B-abstraction
, O
the O
output B-abstraction
voltage O
regulation B-abstraction
is O
achieved O
by O
controlling O
the O
duty B-abstraction
cycle B-physical_entity
of O
the O
synchronous O
mosfet O
. O

by O
taking B-abstraction
advantage B-abstraction
of O
the O
secondary B-physical_entity
side B-abstraction
control B-physical_entity
, O
srcs O
can B-physical_entity
operate O
under O
zero B-abstraction
voltage O
switching B-abstraction
at O
any O
input B-abstraction
voltage O
and O
load B-abstraction
conditions O
. O

a O
current B-abstraction
sensorless O
adaptive O
digital O
control B-physical_entity
is O
proposed O
to O
control B-physical_entity
the O
current B-abstraction
type B-physical_entity
synchronous O
mosfets O
, O
which O
automatically O
compensates O
the O
delay B-abstraction
caused O
by O
the O
current B-abstraction
sensor B-physical_entity
circuit B-physical_entity
and O
the O
gate B-physical_entity
driver B-physical_entity
, O
and O
also O
eliminates O
the O
current B-abstraction
sensor B-physical_entity
in O
the O
power B-physical_entity
path B-physical_entity
. O

a O
hybrid B-physical_entity
control B-abstraction
strategy B-abstraction
is O
introduced O
to O
overcome O
the O
efficiency O
degradation B-abstraction
caused O
by O
the O
secondary B-physical_entity
side B-physical_entity
control B-abstraction
. O


a O
recursive O
smoothing O
filter B-physical_entity
employing O
a O
bank B-physical_entity
of O
fading B-abstraction
memory B-abstraction
polynomial O
sub B-physical_entity
filters O
is O
presented O
. O

variance B-abstraction
estimates O
are O
used O
to O
mix B-abstraction
the O
outputs O
of O
the O
sub B-physical_entity
filters O
, O
imparting B-abstraction
variable B-physical_entity
gain B-abstraction
and O
phase B-abstraction
characteristics O
that O
permit B-abstraction
it O
to O
automatically O
adapt O
to O
signal B-abstraction
parameter B-abstraction
changes O
. O

the O
proposed O
adaptive O
technique B-abstraction
does O
not O
involve O
the O
estimation B-abstraction
of O
plant B-abstraction
parameters O
; O
therefore O
, O
it O
may B-physical_entity
be O
used O
in O
both O
open B-physical_entity
loop B-physical_entity
and O
closed B-O
loop I-O
configurations O
. O

in O
open B-physical_entity
loop B-physical_entity
estimation B-abstraction
problems O
, O
variable B-abstraction
gain B-abstraction
bandwidth O
allows O
it O
to O
reduce O
the O
impact B-abstraction
of O
random O
errors O
caused O
by O
sensor B-physical_entity
noise B-abstraction
and O
the O
impact B-abstraction
of O
bias B-abstraction
errors O
caused O
by O
model B-abstraction
mismatch B-abstraction
during O
maneuvers' O
. O

in O
feedback B-physical_entity
control B-abstraction
problems O
, O
variable B-physical_entity
phase B-abstraction
delay B-abstraction
allows O
it O
to O
act B-abstraction
as O
a O
lag B-physical_entity
filter B-physical_entity
for O
an O
improved O
steady B-physical_entity
state B-physical_entity
response B-physical_entity
i O
. O

e O
. O

greater O
noise B-abstraction
attenuation B-abstraction
and O
act B-abstraction
as O
a O
lead B-abstraction
filter B-physical_entity
, O
or O
a O
proportionalderivative O
controller B-physical_entity
, O
for O
an O
improved O
transient B-physical_entity
response B-abstraction
i O
. O

e O
. O

increased O
closed B-O
loop I-O
damping O
for O
input B-abstraction
discontinuities O
. O

copyright B-abstraction
c O
2015 O
john B-physical_entity
wiley O
sons O
, O
ltd O
. O


in O
this O
paper B-physical_entity
, O
a O
novel B-physical_entity
mixed O
iterative O
adaptive O
dynamic B-abstraction
programming B-abstraction
adp O
algorithm B-abstraction
is O
developed O
to O
solve O
the O
optimal O
battery B-physical_entity
energy B-abstraction
management B-abstraction
and O
control B-physical_entity
problem B-abstraction
in O
smart B-abstraction
residential O
microgrid O
systems O
. O

based O
on O
the O
data O
of O
the O
load B-abstraction
and O
electricity O
rate B-abstraction
, O
two O
iterations O
are O
constructed O
, O
which O
are O
p O
iteration B-abstraction
and O
v O
iteration B-abstraction
, O
respectively O
. O

the O
v O
iteration B-abstraction
is O
implemented O
based O
on O
value B-abstraction
iteration B-abstraction
, O
which O
aims O
to O
obtain O
the O
iterative O
control B-abstraction
law B-abstraction
sequence B-physical_entity
in O
each O
period B-physical_entity
. O

the O
p O
iteration B-abstraction
is O
implemented O
based O
on O
policy B-abstraction
iteration B-abstraction
, O
which O
updates O
the O
iterative O
value B-abstraction
function B-abstraction
according O
to O
the O
iterative O
control B-abstraction
law B-abstraction
sequence B-abstraction
. O

properties O
of O
the O
developed O
mixed O
iterative O
adp O
algorithm B-abstraction
are O
analyzed O
. O

it O
is O
shown O
that O
the O
iterative O
value B-abstraction
function B-abstraction
is O
monotonically O
nonincreasing O
and O
converges O
to O
the O
solution B-abstraction
of O
the O
bellman B-physical_entity
equation B-abstraction
. O

in O
each O
iteration B-abstraction
, O
it O
is O
proven O
that O
the O
performance B-abstraction
index O
function B-abstraction
is O
finite O
under O
the O
iterative O
control B-physical_entity
law B-abstraction
sequence B-abstraction
. O

finally O
, O
numerical O
results O
and O
comparisons O
are O
given B-abstraction
to O
illustrate O
the O
performance B-abstraction
of O
the O
developed O
algorithm B-abstraction
. O


this O
paper B-physical_entity
proposes O
a O
dimmable O
energy B-abstraction
efficient O
light B-abstraction
emitting O
diode B-physical_entity
led O
driver B-physical_entity
for O
applications O
in O
interior B-physical_entity
lighting B-physical_entity
. O

high B-physical_entity
efficiency O
is O
achieved O
by O
an O
adaptive O
voltage O
regulation B-physical_entity
, O
which O
minimizes O
power B-abstraction
losses O
in O
the O
linear O
current B-abstraction
regulator B-physical_entity
. O

a O
digital O
control B-physical_entity
mechanism B-abstraction
employing O
a O
resistive O
digital O
to O
analog B-abstraction
converter B-physical_entity
for O
feeding B-abstraction
the O
analog B-abstraction
feedback B-physical_entity
input B-abstraction
of O
a O
dc O
dc O
converter B-physical_entity
is O
introduced O
. O

it O
is O
shown O
that O
the O
digital O
control B-physical_entity
methodology B-abstraction
gives O
maximum B-abstraction
design B-abstraction
flexibility B-abstraction
and O
enhances O
control B-abstraction
over B-abstraction
regulation B-physical_entity
speed B-abstraction
and O
stability B-abstraction
. O

in O
an O
experimental O
setup B-physical_entity
, O
the O
proposed O
concept B-abstraction
is O
verified O
and O
evaluated O
. O

operating O
at O
an O
input B-abstraction
voltage O
of O
24 O
v O
, O
the O
led O
driver B-physical_entity
provides O
a O
relatively O
wide O
output B-abstraction
voltage O
range B-abstraction
of O
3 O
. O

5 O
38 O
v O
. O

output B-physical_entity
current B-abstraction
is O
regulated O
to O
700 O
ma B-physical_entity
with O
a O
steady B-physical_entity
state B-physical_entity
precision B-abstraction
of O
more O
than O
98 O
. O

8 O
, O
whereas O
pulsewidth O
modulation B-abstraction
dimming O
with O
a O
frequency O
of O
1 O
khz O
and O
shortest O
on O
time B-abstraction
of O
4 O
mu O
s B-abstraction
is O
employed O
. O

a O
peak B-physical_entity
efficiency O
of O
the O
complete O
system B-physical_entity
of O
93 O
. O

9 O
is O
achieved O
. O


